China Coronavirus Updates: Latest Developments and Business Advisory

Posted by Written by Dezan Shira & Associates Staff in China Reading Time: 227 minutes

(This article will be updated regularly. It was last updated on November 28, 2022. The COVID-19 data is as of 24:00 on the previous day.)

 Latest COVID-19 updates

  • Jump to the Table of the Latest COVID-19 and Vaccination Statistics in China by clicking here.
  • November 28, 2022 – China recorded 3,822 new confirmed cases, of which 74 were imported and 3,748 were locally transmitted (1347 in Guangdong, 840 in Beijing, 238 in Chongqing, 162 in Shanxi, 157 in Henan, 157 in Sichuan, 133 in Yunnan,  121 in Inner Mongolia, 90 in Shandong, 65 in Zhejiang, 56 in Fujian, 54in Heilongjiang, 54 in Shaanxi, 50 in Liaoning, 40 in Hebei, 30 in Jiangsu, 24 in Xinjiang, 23 in Hunan, 22 in Guizhou, 18 in Hubei, 16 in Shanghai, 10 in Hainan, 8 in Jilin, 8 in Anhui, 8 in Gansu, 6 in Tianjin, 5 in Tibet, 4 in Qinghai, and 2 in Guangxi). No new deaths were recorded. There were 36,525 new asymptomatic cases, of which 221 were imported and 36,304 were locally transmitted (9,447 in Chongqing, 7761 in Guangdong, 3,048 in Beijing, 1,710 in Sichuan, 1,578 in Jilin, 1,158 in Shanxi, 998 in Shaanxi, 982 in Xinjiang, 949 in Hebei, 882 in Shandong, 754 in Qinghai, 689 in Tianjin, 665 in Henan, 665 in Hubei, 637 in Gansu, 550 in Yunnan, 469 in Ningxia, 444 in Inner Mongolia, 425 in Liaoning, 412 in Heilongjiang, 398 in Jiangsu, 396 in Guangxi, 373 n Hunan, 323 in Anhui, 190 in Zhejiang, 128 in Shanghai, 91 in Fujian, 75 in Guizhou, 66 in Jiangxi, 37 in Hainan, 13 in Tibet, and 1 in the Corps). There were 342,488 asymptomatic cases still under medical observation, of which 1,397 were imported.
  • As of 4:00, November 28, China recorded 31,719 high-risk areas.
  • Shanghai requires negative PCR test within 48 hours for entering most public venues amid new round of outbreaks: According to an announcement released by the Shanghai Culture and Tourism Administration, starting from November 25, citizens and tourists who enter such cultural and tourist places as performance venues, entertainment venues, chess and card rooms, Internet service business venues, script entertainment venues, A-class tourist attractions, museums, art galleries, public libraries, cultural centers (community cultural activity centers), and tourism consulting service centers of this City shall hold a negative nucleic acid test certificate within 48 hours. Visitors just holding a nucleic acid sample certificate within 24 hours shall not be allowed to be admitted, and a field antigen test is not allowed to replace a valid negative nucleic acid certificate. And according to another announcement released by the Shanghai Municipal Commission of Commerce, starting from November 29, consumers entering commercial places such as catering services (including bars), shopping centers (including department stores), supermarkets, wet markets, beauty salons, and bath (foot wash) places must hold a negative nucleic acid test certificate within 48 hours. As of November 28, Shanghai reported 26 high-risk areas.
  • Chengdu to conduct mass testing of all residents. According to an official notice from the Chengdu COVID-19 prevention and control authorities, the city will carry out mass testing of all residents in 18 districts and counties from November 23 to 27. All residents of these areas will be required to take a nucleic acid test each day for five consecutive days. The tests will be carried out in each housing community from 07:30 to 13:00 each day. In addition, residents will be required to show a negative nucleic acid test from the last 24 hours to enter bars, chess and card rooms (such as mahjong parlors), gyms and other indoor leisure and entertainment venues, as well as construction sites, and logistics parks, and a negative test from the last 48 hours to enter public spaces and housing communities and take public transport. Residents are urged not to leave Chengdu during this time and will need a negative test from the last 48 hours if they still need to leave.
  • Shanghai tightens restrictions for arrivals to the city. According to a notice on Shanghai’s official WeChat account, people traveling to the city from November 24 onwards will be subject to certain restrictions on movement for five days after arrival. During these five days, people are not permitted to go to restaurants or bars, shopping centers, supermarkets and vegetable markets, beauty salons, indoor gyms, and other public entertainment venues such as Internet cafes, escape rooms, game rooms, and so on. Travelers will also be required to take a test upon arrival, another two tests over the next two days (a total of three tests in the first three days of arrival), and a final test on the fifth day after arrival. During this period, their health codes will also show that they have been in Shanghai for less than five days.
  • Beijing applies new testing requirements for incoming travelers and residents. From November 22, 2022, people traveling to Beijing are required to take three nucleic acid tests over the first three days after arrival, one each day. People will only be allowed to leave their home or place of residence after the negative result of the test has been released. The first test must be taken within 24 hours of arrival. Travelers who fail to take the three tests will have a notice appear on their Beijing health code urging them to get tested, which will only be removed after all the tests are completed. In addition, from November 24 onward, Beijing will require all residents to have a negative nucleic acid test result from the last 48 hours to enter public spaces, including office buildings, shopping malls, bars and restaurants, parks and scenic spots, and public transport. The measures come as Beijing’s case numbers have increased in the past few weeks, with 316 new confirmed cases recorded as of November 21.
  • Guangzhou imposes five-day lockdown in Baiyun district. The district of Baiyun in central Guangzhou has decided to impose a five-day lockdown from November 21 to 25 to curb a recent outbreak of COVID-19. During this period, residents have been asked to stay at home and only leave for necessary errands, such as emergency medical treatment, COVID-19 testing, and purchasing daily necessities. The district has placed temporary restrictions on road traffic, and public transport has been suspended. However, the main roads within the district, as well as those going in and out, have not been closed, and vehicles are still allowed to pass through from other districts provided they do not stop within the districts. Areas that have not reported any COVID-19 cases in three consecutive days will be permitted to adjust the restrictions accordingly to decrease the impact on residents.
    China’s National Health Commission warns against excessive testing in low-risk areas. On November 19, China’s National Health Commission (NHC) released four new documents on the implementation of COVID-19 prevention and control measures. The documents are measures for the implementation of COVID-19 testing, delineation guidelines for COVID-19 risk areas, guidelines for home isolation and medical observation, and guidelines for home health monitoring. Among other requirements, the COVID-19 testing measures explicitly state that localities that have not recorded any COVID-19 cases must not expand testing requirements or carry out mass testing of all residents. Instead, testing resources should be used for key or at-risk personnel
  • China records first COVID-19 death in six months. China reported that one person had died of COVID-19 on November 19, 2022, the first death recorded since May 26. The person was reportedly an 87 year old man in Beijing, who first contracted the virus on November 11. It was not reported whether the man was vaccinated, but the case has raised concern over the vaccination rate of elderly people as China has made recent moves to loosen COVID-19 restrictions.
  • China relaxes COVID-19 curbs on domestic group trips. According to a statement from the Ministry of Culture and Tourism, China has loosened COVID-19 restrictions on domestic group trips planned by travel agencies. After presenting their negative COVID-19 test results, travelers can now take cross-province journeys planned by travel agencies. Before, travel agencies were prohibited from planning group tourist excursions between counties that reported regions with high or medium COVID-19 risk and areas outside the province in which the county is based.
  • A number of Chinese cities cancel or suspend mass PCR testing. Several Chinese cities, including Shanghai, Sanya, Dalian, Fuzhou, Shijiazhuang, and Hefei, announced they would suspend mass regional polymerase chain reaction testing for COVID-19. In the case of a protracted transmission period, exceptions will be considered if the source, the chain of contacts, and the number of cases are unclear. Community screening and routine PCR testing will continue. The objective is to better optimize the COVID-19 response, which includes the 20 updated prevention and control measures, providing new guidance for both domestic and international travelers.
  • Online searches for flights to China soar after the relaxation testing and quarantine requirements. Following China’s reduction of its quarantine standards for foreign arrivals, interest in travel to China has nearly doubled, driven primarily by rising demand in the United States, according to online travel giant Trip.com Group. According to data provided by the company, searches for flights to China from the US increased by 136 percent over the weekend of November 11–13 compared to the same period the week before. Inquiries for flights from Australia increased by 116 percent over the same period, followed by queries from Japan, which grew by 102 percent.
  • China changes quarantine requirements, cancels the circuit breaker mechanism for inbound flights, and requires only 1 negative PRC test within 48 hours before boarding: According to a circular released by the National Health Commission (NHC) on Friday, November 11, 2022, China will ease some of its COVID-19 rules to better balance COVID-19 prevention and control with economic and social development. Among others, the below adjustments have been introduced:
  1. For close contact and inbound travelers, the quarantine requirement will change from “7 days centralized quarantine + 3 days home health monitoring” to “5 days centralized quarantine + 3 days home quarantine”. Upon the completion of the quarantine at the first point of entry, the quarantine at the destination shall not be repeated for inbound travelers.
  2. The secondary close contacts will no longer be traced.
  3. For people passing through high-risk areas, the quarantine requirement will change from “7 days centralized quarantine” to “7 days home quarantine”.
  4. The three categories of “high-risk areas, medium-risk areas, low-risk areas” will be simplified to two categories—”high-risk areas and low-risk areas”.
  5. Areas that are not experiencing outbreaks are discouraged from mass testing.
  6. The circuit breaker mechanism for inbound flights will be abolished, and the requirement of “two negative nucleic acid tests within 48 hours before boarding” will be adjusted to “one negative nucleic acid test within 48 hours before boarding”.
  7. For important inbound business personnel and sports groups, etc., they shall be exempted from quarantine under a ” closed-loop bubble”, which means “point-to-point” transfer to the isolation free closed-loop management area.
  8. China shall intensify efforts to address the problem of “one-size-fits-all”. It is strictly prohibited to arbitrarily close schools and classes, suspend production, block traffic without approval, arbitrarily adopt “static management”, arbitrarily lock down, etc.
  9. During the COVID-19 outbreak, China shall make every effort to ensure smooth logistics. It is prohibited to arbitrarily ask key enterprises related to the overall industrial chain and affecting people’s livelihoods to suspend production.
  • Guangzhou becomes a new epicenter in China and launches mass testing in 9 districts: On Tuesday, November 7, 2022, Guangzhou reported 114 confirmed cases and 2,263 asymptomatic cases, the third day in a row for the city to have more than 1,000 daily cases. Nine districts of Guangzhou shall launch mass testing to curb the spread of the virus, including Haizhu District, where more than 90 percent of the new cases were found. Haizhu will extend its lockdown to Friday, November 11.
  • China weighs gradual relaxation of the zero-COVID policy but no immediate end is in sight: In a press conference held on July 23, 2022, Hu Xiang, an inspector from the Center for Disease Control and Prevention (CDC) stated that the National Health Commission (NHC) and the CDC will continue to guide all localities so they adhere to the general policy of ‘dynamic clearing’ and scientifically, accurately, and strictly implement various measures for epidemic prevention and control. Meanwhile, several cities were named and shamed at the conference for imposing a one-size-fits-all COVID-19 control policy, including the iPhone city Zhengzhou in Henan province. The city has recorded over 1,500 cases (200 confirmed and 1,300 asymptomatic ones) in the past two weeks, and a Foxconn plant in the city suffered production disruption and a chaotic exodus of panicked workers. Analysts believe this is a sign that China will gradually relax its zero-COVID policy, but expect no sudden shift. Investors are suggested to closely follow how top officials talk about COVID-19 management in the coming months.
  • Hong Kong will soon allow inbound group travelers to enter designated tourist attractions during their three-day medical surveillance period: According to a government statement released on Monday, November 7, 2022, inbound tour group travelers who are received by licensed travel agents and have pre-registered their itineraries will soon be able to enter designated tourist attractions including theme parks, museums, and temples, and enter and dine in the partitioned areas in designated catering premises that meet special anti-epidemic requirements, during their three-day medical surveillance period. Currently, travelers are prohibited from entering premises such as restaurants, pubs, theme parks, and museums during the surveillance period. This is to “support the gradual resumption of the inbound travel market in an orderly manner and provide a more favorable business environment for the travel trade”, as mentioned in the government statement. The government didn’t provide a specific launch date but said the special arrangement will be launched this month.
  • BioNTech COVID-19 vaccine to become available for foreign residents in China. Various media have reported that China will allow foreign residents in China to be inoculated with the German company BioNTech’s COVID-19 vaccine, following a meeting between German Chancellor Olaf Scholz and Chinese President Xi Jinping. In the meeting, which was the first in-person meeting between Xi Jinping and a German leader since the COVID-19 pandemic and Olaf Scholz’s first visit to China as chancellor, the German chancellor also urged China to also extend the vaccine to Chinese citizens. The program will mark the first foreign vaccine and the first mRNA vaccine to be made available in China. BioNTech has previously reached an agreement with Shanghai Fosun Pharma to set up a 50-50 joint venture to produce and sell mRNA vaccines in China, but the vaccine has not yet been approved by Chinese regulators for use in China. A spokesperson for BioNTech told Reuters that the vaccine would initially be imported.
  • Inner Mongolia and Henan provinces said No to undifferentiated lockdown to restore vitality in cities: In a COVID-19-related meeting held on October 30, the Party Secretary of Inner Mongolia Sun Shaocheng emphasized that the COVID-19 prevention measures should be adopted as precise as possible, Inner Mongolia Daily reported. “The risk area should be defined accurately to the building, and the whole community should not be sealed up because of one or two cases. The control and restriction should not be indiscriminate and endless so that the city can gradually recover vitality”, Sun said. Henan Province major Wang Kai expressed similar opinions during a COVID-19 prevention and control meeting held on October 31, 2022, accordingly to Henan Daily.
  • City of Nanjing imposes “temporary control areas” following outbreak in freight yard. Nanjing, the provincial capital of Jiangsu province, has designated certain areas of the city as “temporary control areas” after a COVID-19 outbreak was discovered at the Yaohuamen Station freight yard in a northeastern suburb. Several areas surrounding the station, including the core area of the Nanjing Economic and Technological Development Zone, a major manufacturing base, have been subjected to control measures from October 28 to November 2. As of October 27, 23 of Nanjing’s 24 new positive cases had been traced to the freight yard. Residents in the impacted areas are required to stay at home, while only authorized vehicles will be permitted to drive on the roads. Eligible or “whitelisted” companies and factories are permitted to operate under “closed loop” management, where employees are required to stay on-site.
  • Shanghai Disneyland closes indefinitely from October 31. According to a notice, Shanghai Disney Resort will close Shanghai Disneyland, Disneytown, and Wishing Star Park from October 31 onward, with no date given for possible reopening. The theme parks are being closed in order to comply with local COVID-19 restrictions after a COVID-positive person had visited the park.
  • Cities in China tighten controls to combat rising COVID-19 outbreaks. In an effort to stop spreading outbreaks, Chinese cities from Wuhan (in the center of the country) to Xining (in the northwest) are stepping up COVID-19 restrictions, closing off buildings, and shutting down entire districts. As of October 27, 2022, the country reported more than 1,000 new cases nationwide for the third day in a row. Wuhan, where the very first COVID-19 outbreak occurred in late 2019, reported 20 to 25 new cases daily this week. Local officials mandated that over 800,000 residents of one region remain at home until October 30. The authorities said that one of the COVID-19 cases was linked to the regional pork supply chain. Xining, the capital city of Qinghai, is also facing a resurgence of cases. As health officials in the 2.5 million-person city rushed to contain a COVID-19 comeback after the week-long National Day holiday in early October, social media posts warned of food shortages and price inflation for necessities.
  • Guangzhou district suspends in-person schooling and dine-in. On October 24, 2022, 69 new cases were reported in Haizhu, a district in the heart of Guangzhou. To curb the new COVID-19 outbreak, the local government has implemented the following measures: kindergartens, primary and secondary school students will attend classes online; catering service units (including beverage shops, snack bars, breakfast shops, etc.) must suspend dine-in activities, and only provide take-outs and in-store pick ups.
  • Ningbo Port gradually recovers after ship traffic hit by latest COVID-19 outbreak: After a COVID-19 outbreak was detected on October 13, 2022, and spread to the Beilun area of the Ningbo Port, the world’s largest port was not put under lockdown, but a decrease in productivity was observed, according to global maritime analytics provider Marine Traffic. To maintain stability in the supply chain, the Ningbo government implemented a series of measures to ensure smooth movement of goods to/from the port, including working of two-way green channels, port passes, and white list management of container truck drivers. On October 18, the drivers’ attendance rate increased by 20 percent as compared to the previous day. This rate increased again on October 19, 2022, by 30 percent.
  • China Airlines to resume more international flights: In order to implement the State Council’s requirements for an orderly increase of international passenger flights as soon as possible, several airline companies in China have announced the resumption or increase in the number of international routes this month. Among them, China Eastern Airlines plans to increase its weekly international routes to 42 and flights to 108 flights from October 30, 2022, up from 25 routes and 54 flights in mid-October. In November, China Eastern Airlines will continue to resume and increase its international routes with Manila and Ho Chi Minh. China Southern Airlines announced that it would increase its weekly international flights from 71 to 86. Hainan Airlines plans to increase international flights between Chongqing and Rome to two a week from November 6, 2022. The official WeChat account of Air China also announced that it would resume several international routes. Spring Airlines, for its part, said on its official WeChat account on October 13 that it would start operating multiple routes with Hong Kong and Macao and other international routes from October 14, 2022. Juneyao Airlines also resumed or added some international routes in October with Seoul and Osaka. These moves are mostly to answer the demand for business travel and don’t mean that China will resume large-scale international travel soon, according to the Caixin report. China has gradually eased COVID-19 prevention measures for international travelers over the past few months. Nevertheless, the number of daily cross-border flights is only five percent of that in 2019. 
  • Yinchuan, Ningxia province implements classified COVID-19 management after three-day static management: Starting from October 17, 2022, Yinchuan shall implement different COVID-19 control measures based on the risk level of specific areas. Residents in the low-risk areas can go to work by holding a workplace paper certificate with the required info and promising they will only travel between home and workplace without visiting other places. They are required not to gather, not to eat together, and not to take public transportation. People who need to travel across the city have to hold a negative nucleic acid test certificate from the last 48 hours.
  • Beijing imposes stricter testing requirements for new arrivals. Beijing now requires people arriving in Beijing to undergo self-isolation at home for three days upon arrival and take two rounds of tests during this period. The first test must be taken within 24 hours of arrival, and the second test must be taken after 48 hours and within 72 hours of arrival. People entering Beijing are also required to show a negative nucleic acid test from the last 48 hours. In addition, a number of the city’s museums, including the Temple of Confucius and Guozijian Museum, have issued a notice that they will refuse entry to any visitor who has been outside of Beijing in the last seven days, per inspection of their travel code. The city has begun to ramp up COVID-19 prevention measures after a recent uptick in case numbers, having recorded seven high-risk areas and seven medium-risk areas on October 13.
  • China doubles down on zero-COVID policy after speculation restrictions will ease in 2023. In an interview with CCTV, Head of the National Health Commission’s expert group on epidemic control Liang Wannian reiterated the need to maintain zero-COVID, or “dynamic clearing”, in China because at present, China “cannot achieve a complete balance between the resistance of our health system and viral diseases” and that lifting of restrictions “will lead to a large number of infections, severe illness and death” which would “lead to a run on the medical system, which in turn will further aggravate people’s fears and have a greater impact on society and the economy”. When asked about a possible timeline for return to normal life, he said that “from a scientific point of view, it is difficult to clearly delineate a specific time period”.
  • Shanghai imposes new testing requirements for people arriving in the city. As of October 10, all arrivals to the city of Shanghai will be required to undergo three days of nucleic acid tests, including one test within 24 hours of arrival. Those who do not comply with these requirements will have their travel code (随申吗) turned yellow. The announcement was made by the Director of the Municipal Big Data Center Shao Jun at a press conference on Shanghai’s COVID-19 pandemic control and comes after the city recorded 3 new confirmed cases and 31 asymptomatic infections on Sunday, October 9. As of October 10, Shanghai has also recorded 1 high-risk area in Jiading District and 34 medium-risk areas across 11 districts.
  • Travel out of Xinjiang has been halted as officials concede to failings in managing the spread of new cases.  Xinjiang has suspended all passenger train services leaving the province to stop the spread of COVID-19, as officials admit their inadequate actions have hampered attempts to contain the outbreak over the past two months. The province vice-chairman has admitted failures including low testing capacity and lack of professionalism among staff who became infected after mishandling samples. As of October 5, 2022, the province reported 91 new asymptomatic cases and recorded 54 high-risk and 25 medium-risk areas.
  • Director of infectious disease department of CDC gives update on COVID-19 cases before the National Day holiday. At a press conference on September 29, Lei Zhenglong, director of the Department of Infectious Disease Prevention and Control of the National Centers for Disease Control and Prevention, stated that the number of daily COVID-19 cases had dropped substantially in September compared to August. Currently, the main outbreaks are concentrated in Tibet, Ningxia, Guizhou, and Heilongjiang, among a few other provinces, with the Omicron variants BA.5 and BA.2.76 being the main strains present in the outbreak. Moreover, areas that had experienced relatively severe outbreaks, such as Hainan and Xinjiang, have succeeded in bringing down case numbers significantly, while Tibet and Guizhou have brought the outbreaks under control. The outbreaks in Ningxia and Heilongjiang, meanwhile, are still developing and the provinces are receiving help from the central government to deal with the situation.Ahead of the week-long National Holiday, starting on Saturday October 1, Lei Zhonglong also warned that the risk of further spread of the virus will increase as people travel and visit friends and relatives. This is despite the National Health Commission (NHC) previously urging people to stay home during the holiday period in order to prevent the spread of the virus.To this end, Lei Zhonglong called on all localities to “strengthen normalized prevention and control measures, guide the orderly flow of personnel, implement closed-loop management measures for employees in high-risk positions, and do a good job in the vaccination service of new coronavirus vaccines”.
  • Hong Kong removes mandatory hotel quarantine for international arrivals, implements “0+3” policy. From Monday, September 26 onwards, international arrivals to Hong Kong will no longer be required to undergo three days of centralized hotel quarantine and will instead be permitted to undergo three days of self-monitoring at home. Passengers are still required to take a rapid antigen COVID-19 test prior to their departure and a PCR test after arriving in Hong Kong. They will also not be permitted to go to any restaurants or other indoor public areas and are required to undergo testing during this period. In addition, Hong Kong residents who have not been vaccinated will be permitted to return to Hong Kong, and passengers transiting through Hong Kong will no longer be required to have their temperature taken at the airport.
  • China mulls reopening its border to some foreign tourists: China’s Ministry of Culture and Tourism has released an exposure draft of the Measures for Border Tourism Administration, for public comment until September 29, 2022. According to the exposure draft, China will encourage its border areas to create distinctive border tourism destinations, specify that border tourism groups can flexibly choose entry and exit ports, and remove preconditions, such as border travel approval and some entry and exit document requirements. Some analysts believe it’s a positive sign that China will make it easier for foreigners to enter the country, though only foreign tourists as part of tour groups would be allowed to visit specific border tourism sites. More details are yet to be released regarding issues such as whether such tourists need to follow China’s quarantine requirements for inbound travelers.
  • Trip.com says hotel bookings are surpassing pre-pandemic levels: According to Cindy Xiaofan Wang, chief financial officer at Trip.com, domestic China hotel reservations made through Trip.com have rebounded quickly, surpassing pre-COVID levels since late June. Also, same-city hotel bookings grew by 30 percent in the latest quarter as compared to 2019 levels, Trip.com added. However, the firm’s overall revenue in Q2 2022 still recorded a 32 percent decline YoY, likely due to the multiple COVID outbreaks and extended shutdowns.
  • EU Chamber of Commerce in China does not anticipate a full reopening of the Chinese border until H2 2023: According to the European Business in China Position Paper 2022/2023 (Position Paper) released by the EU Chamber of Commerce in China on Wednesday, September 21, 2022, the Chamber does not anticipate a full reopening of the Chinese border until the second half of 2023. Given the COVID-19 control measures and the various geopolitical tensions, more and more European firms are taking the expensive and inefficient route of creating separate systems – one for China, and one for the rest of the world, the paper said. That said, the European business community still believes that China, as the world’s largest consumer goods market, has significant growth potential and that its manufacturing base and world-class industrial clusters would be difficult – if not impossible – to replicate elsewhere. The Chamber advocates that China continue the comprehensive market reforms, as it would be the most effective way for the country to realize its economic potential and quickly rebuild investor confidence.
  • NHC encourages people to stay put during the National Day holiday: The National Health Commission (NHC), China’s health authority, has encouraged people not to leave their cities during the week-long National Day holiday that starts on October 1. Passengers who travel need to hold a negative nucleic acid test certificate from the recent 48 hours to take planes, high-speed trains, trains, inter-provincial long-distance passenger buses, inter-provincial passenger ships, and so on. The health code and a negative nucleic acid test from the recent 72 hours will be required when checking into hotels and entering crowded places such as tourist attractions. Construction workers returning from other provinces are required to have a negative nucleic acid test from the recent 48 hours. For necessary large-scale gathering activities such as training, exhibition, and artistic performance, participants shall scan the code for registration and provide a negative nucleic acid test certificate from the recent 48 hours. These COVID-19 prevention and control measures will be implemented until October 31, 2022.

Latest COVID-19 Statistics in China

Cumulative confirmed cases: 311,624; Cumulative recovered: 273,262; Cumulative deaths: 5,233; Vaccination rate: 90.26% (1.27 billion people fully vaccinated as of November 11, 2022)

Daily new cases Active cases Daily new deaths Doses of vaccination administered Risky areas
Confirmed cases Asymptomatic cases Mild Serious High-risk areas Low-risk areas*
November 28, 2022 3,822 36,525 33,015 104 0 31,719
November 27, 2022 3,709 36,082 31,299 111 1 3,443,240,000
November 26, 2022 3,474 29,745 29,633 112 0 3,443,114,000
November 25, 2022 3,103 29,840 28,043 121 0 3,442,976,000 24,353 3,467
November 24, 2022 4,010 27,646 26,697 116 1 3,442,840,000 21,695 3,110
November 23, 2022 2,719 26,438 24,517 113 0 3,442,683,000 20,160 2,874
November 22, 2022 2,225 25,902 23,186 110 2 3,442,539,000  
November 21, 2022 2,365 24,730 22,103 107 0 3,442,376,000 16,322 2,300
November 20, 2022 2,267 22,168 20,829 95 1 3,442,253,000
November 19, 2022 2,137 22,336 19,709 87 0 3,442,080,000
November 18, 2022 2,362 22,991 18,477 61 0 3,441,859,000 12,004
November 17, 2022 2,388 20,888 17,172 43 0 3,441,680,000 12,013
November 16, 2022 1,623 18,576 15,345 29 0 3,441,497,000 11,390
November 15, 2022 1,661 16,248 14,473 21 0 3,441,334,000 7,660 1,431
November 14, 2022 1,794 14,409 13,389 22 0 3,441,205,000  6,837 1,225
November 13, 2022 1,711 13,167 12,175 23 0 3,441,126,000
November 12, 2022 1,504 10,446 10,919 24 0 3,441,000,700
November 11, 2022 1,209 9,520 9,890 25 0 3,440,879,000 3,924 3,525
November 10, 2022 1,185 7,802 9,124 31 0 3,440,760,000
November 9, 2022 1,346 6,989 8,286 27 0 3,440,638,000 3,501 2,723
November 8, 2022 890 6,801 7,214 30 0 3,440,524,000 3,365 2,568
November 7, 2022 569 5,074 6,587 30 0 3,440,421,000 3,317 2,430
November 6, 2022 588 4,022 6,295 29 0 3,440,346,000
November 5, 2022 657 3,180 5,973 30 0 3,440,231,000
November 4, 2022 757 3,288 5,567 30 0 3,440,119,000 3,234 2,374
November 3, 2022 581 2,791 5,137 27 0 3,440,016,000
November 2, 2022 465 2,463 4,826 28 0 3,439,907,000 2,865 2,185
November 1, 2022 547 2,331 4,614 24 0 3,439,802,000
October 31, 2022 521 2,377 4,258 20 0 3,439,698,000 2,683 2,042
October 30, 2022 401 1,704 3,968 19 0 3,439,620,000
October 29, 2022 377 1,281 3,781 20 0 3,439,525,000
October 28, 2022 262 1,244 3,658 17 0 3,439,408,000 2,534 1,711
October 27, 2022 231 1,033 3,666 18 0 3,439,299,000 2,392 1,700
October 26, 2022 338 1,069 3,705 19 0 3,439,201,000 2,347 1,614
October 25, 2022 246  1,021 3,654 18 0 3,439,087,000 2,306 1,580
October 24, 2022 221 855 3,784 15 0 3,438,993,000 2,303 1,466
October 23, 2022 207 949 3,874 13 0 3,438,992,000
October 22, 2022 215 791 3,986 13 0 3,438,817,000
October 21, 2022 214 783 4,140 13 0 3,438,697,000 2,272 1,567
October 20, 2022 211 751 4,205 13 0 3,438,588,000 2,285 1,534
October 19, 2022 247 749 4,298 14 0 3,438,482,000 2,361 1,552
October 18, 2022 250 701 4,398 15 0 3,438,378,000
October 17, 2022 245 676 4,447 16 0 3,438,277,000 2,294 1,522
October 16, 2022 244 782 4,487 17 0 3,438,202,000
October 15, 2022 361 1,003 4,546 17 0 3,438,086,000
October 14, 2022 313 1,143 4,440 14 0 3,437,961,000 2,067 1,412
October 13, 2022 372 1,252 4,384 13 0 3,437,851,000 1,970 1,332
October 12, 2022 417 1,473 4,250 10 0 3,437,728,000 1,770 1,192
October 11, 2022 491 1,758 4,093 11 0 3,437,619,000 1,494 1,001
October 10, 2022  434 1,672 3,874 12 0 3,437,516,000 1,296 939
October 9, 2022 503 1,422 3,618 13 0 3,437,442,000  –
October 8, 2022 501 1,424 3,299 16 0 3,437,347,000  –
October 7, 2022 288 1,361 2,957 29 0 3,437,286,000  754 606
October 6, 2022 229 1,108 2,883 16 0 3,437,218,000  720 622
October 5, 2022 273 861 2,876 18 0 3,437,161,000 696 657
October 4, 2022 307 731 2,970 20 0 3,437,085,000  702 680
October 3, 2022 240 579 2,929 23 0 3,437,081,000 743 712
October 2, 2022 179 540 2,945 25 0 3,436,911,000
October 1, 2022 172 648 2,909 31 0 3,436,966,000
September 30, 2022 156 711 2,933 36 0 3,436,773,000 876 687
September 29, 2022 170 629 2,956 41 0 3,436,630,000 896 638
September 28, 2022 194 711 2,991 40 0 3,436,494,000 849 704
September 27, 2022 245 723 2,928 38 0 3,436,355,000 826 720
September 26, 2022 295 704 2,921 41 0 3,436,227,000 702 919
September 25, 2022 217 719 2,911 36 0 3,436,132,000
September 24, 2022 188 730 3,012 28 0 3,436,001,000
September 23, 2022 175 726 3,027 31 0 3,435,855,000 575 779
September 22, 2022 165 610 3,148 35 0 3,435,719,000 631 834
September 21, 2022 166 581 3,255 42 0 3,435,577,000 729 805
September 20, 2022 152 637 3,418 40 0 3,435,442,000 769 836
September 19, 2022 147 843 3,611 35 0 3,435,302,000 839 898
September 18, 2022 154 1,035 3,825 40 0 3,435,207,000
September 17, 2022 140 578 4,050 38 0 3,435,066,000
September 16, 2022 162 825 4,246 35 0 3,434,906,000 1,224 1,048
September 15, 2022 167 916 4,884 34 0 3,434,774,000 1,284 1,224
September 14, 2022 237 825 5,227 32 0 3,434,621,000 1,212 1,251
September 13, 2022 242 806 5,417 29 0 3,434,487,000 1,118 1,294
September 12, 2022 226 868 5,651 25 0 3,434,390,000 1,533 1,328
September 11, 2022 234 1,069 5,970 24 0 3,434,317,000
September 10, 2022 290 1,090 6,136 26 0 3,434,270,000
September 9, 2022 301 1,103 6,598 28 0 3,434,119,000 1,378 1,626
September 8, 2022 280 1,159 6,223 38 0 3,433,960,000 1,503 1,663
September 7, 2022 380 1,315 6,241 39 0 3,433,788,000 1,689 1,795
September 6, 2022 310 1,300 6,593 34 0 3,433,615,000 1,849 1,796
September 5, 2022 349 1,317 6,195 32 0 3,433,450,000 2,006 1,711
September 4, 2022 384 1,464 5,899 29 0 3,433,328,000
September 3, 2022 502 1,486 6,279 28 0 3,433,182,000
September 2, 2022 373 1,665 6,188 31 0 3,432,984,000 1,998 1,418
September 1, 2022 368 1,689 6,298 34 0 3,432,778,000 1,961 1,427
August 31, 2022 391 1,426 6,335 31 0 3,432,506,000 1,707 1,412
August 30, 2022 382 1,447 6,483 29 0 3,432,235,000 1,506 1,310
August 29, 2022 352 1,298 6,648 33 0 3,431,965,000 1,436 1,315
August 28, 2022 307 1,137 6,932 31 0 3,431,791,000
August 27, 2022 300 1,194 7,257 34 0 3,431,560,000
August 26, 2022 312 1,316 7,613 35 0 1,351 1,365
August 25, 2022 390 1,369 7,724 40 0 3,430,094,000 1,386 1.297
August 24, 2022 413 1,331 8,043 43 0 3,430,624,000 1,357 1,227
August 23, 2022 382 1,513 8,356 35 0 3,429,804,000
August 22, 2022 427 1,558 8,544 39 0 3,429,804,000 1,346 1,027
August 21, 2022 602 1,708 8,417 32 0 3,429,804,000
August 20, 2022 639 1,715 8,215 28 0 3,429,579,000
August 19, 2022 603 2,201 7,760 24 0 3,429,254,000 1028 681
August 18, 2022 682 2,888 7,412 22 0 3,428,933,000 893 694
August 17, 2022 637 2,399 6,844 18 0 3,428,587,000 842 642
August 16, 2022 591 1,935 6,331 16 0 3,428,258,000 823 628
August 15, 2022 770 1,708 5,861 12 0 693 615
August022 14, 2022 684 1,920 5,224 8 0 3,427,788,000
August 13, 2022 704 1,440 4,660 8 0 3,427,564,000
August 12, 2022 704 1,305 4,055 7 0 3,427,246,000 556 648
August 11, 2022 700 1,466 3,464 7 0 3,426,938,000 462 701
August 10, 2022 444 650 2,891 5 0 3,426,619,000 458 698
August 9, 2022 399 540 2,558 3 0 3,426,316,000 461 730
August 8, 2022 380 560 2,268 2 0 3,426,023,000 467 865
August 7, 2022 390 478 2,007 2 0 3,425,843,000
August 6, 2022 361  343 1,770 2 0 3,425,593,000
August 5, 2022 222 317 1,623 1 0 3,425,218,000 468 747
August 4, 2022 111 335 1,546 2 0 3,424,838,000 468 731
August 3, 2022 101 335 1,566 1 0 3,424,465,000 472 715
August 2, 2022 107 391 1,592 2 0 3,424,070,000 499 658
August 1, 2022 84 309  1,674 4 0 3,423,669,000 620 427
July 31, 2022 116 425 1,726 5 0 3,422,910,000
July 30, 2022 100 389 1,744 11 0 3,422,060,000
July 29, 2022 109 455 1,729 25 0 3,421,121,000 770 464
July 28, 2022 119 507 1,771 25 0 3,420,260,000
July 27, 2022 120 583 1,773 23 0 3,419,441,000 778 601
July 26, 2022 148 828 1,784 22 0 3,418,638,000 803 609
July 25, 2022 150 650 1,752 24 0 3,417,900,000 568 592
July 24, 2022 129 853 1,737 20 0 3,417,357,000
July 23, 2022 164 653 1,737 14 0 3,416,727,000
July 22, 2022 175 836 1,676 8 0 3,415,934,000 531 619
July 21, 2022 200 233 1,611 4 0 3,415,146,000 448 660
July 20, 2022 150 862 1,483 1 0 3,414,388,000 421 663
July 19, 2022 237 539 1,424 1 0 3,414,362,800 408 660
July 18, 2022 167 431 1,308 2 0 3,412,950,000 398 664
July 17, 2022 154 537 1,226 3 0 3,412,457,000
July 16, 2022 129 418 1,169 1 0 3,411,903,000
July 15, 2022 113 420 1,138 1 0 3,411,136,000 339 642
July 14, 2022 121 245 1,119 0 0 3,410,413,000 264 590
July 13, 2022 98 240 1,082 0 0 3,409,697,000 289 563
July 12, 2022 107 317 1,060 0 0 3,409,032,000 306 514
July 11, 2022 94 335 1,047 0 0 3,408,404,000 294 446
July 10, 2022 101 319 1,004 0 0 3,407,945,000
July 9, 2022 112 343 937 1 0 3,407,361,000
July 8, 2022 97 381 868 2 0 3,406,557,000 280 212
July 7, 2022 124 285 808 1 0 3,405,812,000 234 123
July 6, 2022 141 286 724 1 0 3,405,158,000 201 103
July 5, 2022 112 306 609 1 0 3,404,537,000 185 79
July 4, 2022 72 388 532 0 0 3,403,989,000 126 49
July 3, 2022 104 369 510 0 0 3,403,643,000
July 2, 2022 72 196 446 0 0 3,403,643,000
July 1, 2022 37 208 303 0 0 3,402,622,000 41 11
June 30, 2022 33 77 298 0 0 3,401,857,000 1 9
June 29, 2022 24 105 463 1 0 3,401,112,000 1 13
June 28, 2022 16 84 486 1 0 3,400,401,000 1 13
June 27, 2022 39 67 546 2 0 3,399,803,000 1 14
June 26, 2022 39 77 584 2 0 3,399,317,000
June 25, 2022 53 98 620 3 0 3,398,762,000
June 24, 2022 37 106 654 6 0 3,397,993,000 12 29
June 23, 2022 48 87 713 4 0 3,397,224,000 12 34
June 22, 2022 31 95 756 6 0 3,396,446,000 12 37
June 21, 2022 37 105 802 7 0 3,395,704,000 11 38
June 20, 2022 38 71 832 8 0 3,395,026,000 11 42
June 19, 2022 36 123 889 8 0 3,394,504,000
June 18, 2022 35 169 905 9 0 3,393,907,000
June 17, 2022 54 103 941 10 0 3,393,119,000 9 44
June 16, 2022 64 111 933 15 0 3,391,955,000 9 45
June 15, 2022 77 158 933 16 0 3,390,194,000
June 14, 2022 95 135 905 14 0 3,390,194,000 9 47
June 13, 2022 89 286 867 19 0 3,389,454,000 9 41
June 12, 2022 134 329 842 21 0 3,388,904,000
June 11, 2022 79 389 762 24 0 3,388,256,000
June 10, 2022 45 106 768 27 0 3,387,446,000 9 32
June 9, 2022 70 170 873 33 0 3,386,647,000 7 25
June 7, 2022 57 152 1,026 50 0 3,385,080,000 4 30
June 6, 2022 31 140 1,122 57 0 3,384,372,000 1 32
June 5, 2022 56 106 1,340 65 0 3,383,918,000
June 4, 2022 46 125 1,541 73 0 3,383,416,000
June 3, 2022 37 120 1,790 82 0 3,382,998,000
June 2, 2022 37 92 1,931 116 0 3,382,178,000 3 19
June 1, 2022 35 96 2,176 120 0 3,381,314,000 3 20
May 31, 2022 50 124 2,380 128 0 3,380,191,000 4 22
May 30, 2022 34 150 2,615 133 0 3,379,075,000 7 22
May 29, 2022 82 211 2,789 140 0 3,378,211,000
May 28, 2022 96 266 2,937 162 0 3,377,153,000
May 27, 2022 102 342 3,272 169 1 3,375,898,000 9 34
May 26, 2022 130 415 3,217 170 1 3,374,726,000 9 40
May 25, 2022 117 473 3,512 187 0 3,373,460,000 9 42
May 24, 2022 156 532 3,956 192 1 3,372,243,000 10 45
May 23, 2022 187 682 4,257 193 1 3,371,096,000 11 45
May 22, 2022 169 729 4,205 200 3 3,370,162,000
May 21, 2022 201 1,010 4,423 292 1 3,369,057,000
May 20, 2022 193 990 4,626 280 0 3,367,720,000 14 61
May 19, 2022 212 870 4,736 286 1 3,366,402,000 15 64
May 18, 2022 240 1,065 4,904 301 4 3,364,987,000 17 62
May 17, 2022 175 925 5,016 343 1 3,363,651,000 19 59
May 16, 2022 151 1,076 5,661 348 4 3,362,389,000 18 59
May 15, 2022 239 1,492 5,785 383 3 3,361,333,000
May 14, 2022 276 1,796 5,969 384 1 3,360,050,000
May 13, 2022 331 2,201 6,547 397 2 3,358,576,000 17 79
May 12, 2022 237 1,680 6,785 444 5 3,357,120,000 20 77
May 11, 2022 324 1,603 7,084 484 7 3,355,535,000 21 77
May 10, 2022 357 3,118 7,557 511 6 3,354,196,000 21 77
May 9, 2022 415 3,918 8,207 529 11 3,353,022,000 21 77
May 8, 2022 329 4,133 8,648 533 8 3,352,053,000
May 7, 2022 351 4,324 9,388 587 13 3,350,934,000 19 92
May 6, 2022 374 4,340 10,856 659 12 3,349,702,000 19 95
May 5, 2022 373 4,740 12,105 650 13 3,348,588,000 15 102
May 4, 2022 362 5,136 13,900 620 16 3,347,640,000 14 104
May 3, 2022 384 5,690 15,651 615 20 3,346,607,000 12 88
May 2, 2022 865 6,957 19,597 576 32 3,345,524,000 9 95
May 1, 2022 920 7,409 23,555 447 38 3,343,008,000 8 98
April 30, 2022 1,424 9,369 26,109 458 47 3,343,008,000
April 29, 2022 5,659 10,029 27,900 417 52 3,340,711,000 8 108
April 28, 2022 1,503 9,864 25,107 399 47 3,338,555,000 10 113
April 27, 2022 1,824 12,474 26,456 318 48 3,336,285,000 7 107
April 26, 2022 1,923 15,889 28,385 341 52 3,334,018,000 6 103
April 25, 2022 2,680 17,581 29,178 274 51 3,331,771,000 6 100
April 24, 2022 1,580 20,285 29,531 236 39 3,329,766,000
April 23, 2022 2,988 21,423 30,425 237 12 3,327,616,000 7 114
April 22, 2022 2,133 16465 30,562 251 11 3,325,049,000
April 21, 2022 2,841 16,617 31,198 223 8 3,322,488,000 7 133
April 20, 2022 2,761 17,166 30,657 116 7 3,319,950,000 9 148
April 19, 2022 3,316 18,284 30,309 75 7 3,317,463,000 7 171
April 18, 2022 2,742 20,718 28,916 71 3 3,315,186,000 9 167
April 17, 2022 3,529 22,626 27,807 78 0 3,313,338,000 11 172
April 16, 2022 3,896 20,895 25,882 74 0 3,311,245,000
April 15, 2022 3,486 20,782 24,878 76 0 3,308,616,000 15 188
April 14, 2022 3,020 26,391 22,744 78 0 3,305,884,000 16 221
April 13, 2022 1,513 26,525 21,739 87 0 3,303,126,000 16 221
April 12, 2022 1,272 23,387 21,914 77 0 3,300,328,000 17 222
April 11, 2022 1,184 26,411 22,319 76 0 3,297,551,000 18 243
April 10, 2022 1,351 25,111 22,509 80 0 3,295,208,000 28 257
April 9, 2022 1,350 23,815 23,107 79 0 3,292,643,000 27 268
April 8, 2022 1,576 22,648 23,755 77 0 3,289,463,000 28 294
April 7, 2022 1,323 21,784 24,038 85 0 3,286,373,000 41 325
April 6, 2022 1,415 19,199 24,490 75 0 3,283,586,000 45 332
April 5, 2022 1,235 15,355 24,907 63 0 3,281,604,000 47 344
April 4, 2022 1,405 11,862 25,670 54 0 3,279,249,000 50 350
April 3, 2022 1,506 11,781 26,110 57 0 3,276,886,000 58 359
April 2, 2022 2,129 7,869 27,070 58 0 3,274,120,000 63 412
April 1, 2022 1,827 5,559 29,240 66 0 3,270,874,000 60 436
March 31, 2022 1,839 6,720 28,533 66 0 3,267,140,000 61 448
March 30, 2022 1,629 7,090 28,101 62 0 3,263,129,000 62 486
March 29, 2022 1,293 5,758 27,800 59 0 3,259,042,000 55 485
March 28, 2022 1,275 5,134 27,687 58 0 3,254,984,000 56 521
March 27, 2022 1,254 4,448 27,514 53 0 3,251,412,000 55 537
March 26, 2022 1,335 4,430 27,262 50 0 3,247,624,000 58 614
March 25, 2022 1,366 3,622 26,842 50 0 3,243,599,000 56 614
March 24, 2022 2,054 2,829 26,203 50 0 3,239,170,000 54 621
March 23, 2022 2,667 2,469 25,053 50 0 3,234,601,000 49 611
March 22, 2022 2,338 2,432 23,096 42 0 3,230,367,000 40 601
March 21, 2022 2,027 2,492 21,349 39 0 3,226,334,000 33 538
March 20, 2022 1,737 2,316 19,951 35 0 3,222,868,000 32 527
March 19, 2022 2,228 1,823 18,555 31 2 3,218,716,000 30 406
March 18, 2022 2,461 1,904 16,956 18 0 3,213,773,000 23 391
March 17, 2022 1,317 1,310 14,834 16 0 3,209,041,000 23 360
March 16, 2022 1,952 1,338 13,769 11 0 3,203,688,000 20 344
March 15, 2022  3,602  1,768 11,976  8  0 3,198,272,000  17  304
March 14, 2022  1,437  906 8,523  8  0 3,193,236,000  –  –
March 13, 2022  1,938  1,455 7,224  6  0  –  –  –
March 12, 2022  588  1,173 5,455  6  0  –  –  –
March 11, 2022 555 814 5,018 6 0 3,180,060,000 11 163
March 10, 2022 528 586 4,603 7 0 3,174,984,000 9 150
March 9, 2022 337 399 4,200 8 0 3,169,916,000 9 138
March 8, 2022 325 443 4,043 9 0 3,165,486,000 11 139
March 7, 2022 327 442 3,826 11 0 3,160,685,000
March 6, 2022 329 209 3,677 14 0 3,156,899,000
March 5, 2022 281 166 3,451 14 0 3,152,419,000
March 4, 2022 294 150 3,286 18 0 3,147,007,000
March 3, 2022 214 143 3,074 20 0 3,141,473,000 10 179
March 2, 2022 224 169 2,980 19 0 3,135,598,000 10 191
March 1, 2022 200 144 2,854 19 0 3,129,845,000
Source: National Health Commission of the People’s Republic of China (NHC) Note: The COIVD-19 data of each day is as of 24:00 the previous day. The risky area data is as of the time of update. The number of people fully vaccinated data is released by the NHC on an irregular basis.

*On November 11, 2022, China simplified the risk management system for areas with positive COVID-19 cases from three categories – high-, medium, and low-risk – to just two – high- and low-risk. All figures in this column prior to November 11 are “medium-risk”, while all figures after November 11 are “low-risk”.

  • Chengdu exits full citywide lockdown. As of September 15, 2022, Chengdu has lifted its city-wide lockdown, with all districts remaining subject to stringent mobility restrictions after the most recent outbreak is now under control. Chengdu, the capital of southwestern China’s Sichuan province, was shut down on September 1 after the city discovered several COVID-19 cases, making it the largest Chinese city to be placed under lockdown since Shanghai in April and May.
  • Chengdu extends lockdown indefinitely. According to a notice from the Chengdu Pandemic Prevention and Control Headquarters, the city will continue to implement COVID-19 prevention measures across 16 of its districts and counties from September 8 onward in order to stop the spread of the current outbreak. No date was given for the lifting of restrictions. Residents in the affected districts will be required to remain at home, Residents in high- and medium-risk areas (areas that have reported new positive cases in the last seven and 14 days respectively) will be able to receive goods through delivery only, whereas one resident per household in low-risk areas (areas with no new reported cases in the last 14 days) will be able to leave once every two days to purchase groceries. All residents will also be required to undergo regular nucleic acid testing. The announcement comes as the city recorded a total of 1,175 confirmed symptomatic cases and 508 asymptomatic cases in the period from August 12 to September 6, and a further 57 symptomatic cases and 59 asymptomatic cases on September 7.
  • Shenzhen begins to ease COVID-19 restrictions. On Monday, September 5, Shenzhen’s city government announced it would begin a phased easing of COVID-19 restrictions. Streets and communities that found no community-level cases (cases found outside of the already quarantined population) between September 2 and 4 are permitted to ease the temporary restrictions, while streets and communities that recorded community-level cases will be required to maintain restrictions for three days from the date the last positive case was found. The areas that can ease restrictions will still be required to implement normal COVID-19 prevention measures, including regular nucleic acid testing, temperature checks, and face mask requirements.
  • Chengdu under lockdown. As some of the most populated and economically significant cities in the nation fight breakouts, the 21.2 million-person metropolis of Chengdu, in the Southwest Chinese province of Sichuan, declared a lockdown and began four days of COVID-19 testing for the whole city on September 1. With 157 reported cases, Chengdu is the largest city to be locked down since Shanghai in April.
  • Guangzhou and several big cities in China announce additional restrictions. As of August 31, Guangzhou imposed extra restrictions on a number of districts that are experiencing a rise in COVID-19 cases, joining Shenzhen and other major cities in tightening preventive measures. Authorities stated that these new restrictions will last only a few days.
  • Huaqiangbei, the largest wholesale electronics market in the world, closes for 4 days. An order has been issued to shut down Huaqiangbei area in Shenzhen, China’s southern tech powerhouse, from Monday, August 29, through Thursday, September 1.
  • China no longer requires COVID test information for international arrivals from August 31, 2022: On Thursday, August 25, 2022, the General Administration of Customs released a new health declaration form for international arrivals, which removes the requirement for visitors to report their nucleic acid test results, their infection status, and vaccination dates. This ninth version of the health declaration form will be implemented starting from August 31, 2022, and international visitors can report their health status online by filling out a form on the related WeChat account or webpage. Some media interpret that with this update, the current entry requirement, that is, the requirement to have international passengers need to take two PCR tests for COVID-19 within 48 hours of their departure, the second of which must be within 24 hours of their departure–will be lifted. However, considering that China is still sticking to its dynamic zero-COVID strategy, we recommend that international travelers double-check with their flight companies for further information.
  • Pfizer to make Paxlovid with the local partnership: Pfizer entered into a partnership agreement with Chinese drugmaker Zhejiang Huahai Pharmaceutical Co.Ltd to manufacture the COVID-19 pill Paxlovid in China. The partnership agreement is non-exclusive. Under the agreement, Huahai Pharmaceutical will produce Paxovid in China for five years.
  • Foreign APEC holders and foreign students with valid residence permits can enter China without applying for new visas.  Effective from August 24, 2022, foreigners who hold a valid APEC card to conduct business in China and foreign students with a valid residence permit for study purposes can enter China without applying for a new visa, as per the announcement of the Chinese embassies in various countries. In addition, China will also resume accepting Study X1-Visa applications from foreigners applying to study in China for more than 180 days. Please consult the respective embassy website of  Myanmar, Thailand, Singapore, Malaysia, Indonesia, Nepal, Kazakhstan, Palestine, Bahrain, Kyrgyzstan, Pakistan, Tajikistan, Qatar, Italy, Ireland, the United Kingdom, Sweden, Montenegro, Malta, Algeria, South Africa, Rwanda, Liberia, Zambia, Tanzania, Mexico, Canada, Cuba, Brazil for further clarification. The Chinese embassy in India has also updated the “Application Procedures and Material Requirements of China Visa”, to be implemented starting August 24, 2022.
  • Yiwu lifted static management: Starting from 0:00, August 21, 2022, the whole Yiwu city has been lifted from ‘static management’ — except for a few regions that have recorded  COVID-19 cases. However, operations at some offline venues will continue to be suspended, including theater, KTV, Internet cafe, game hall, gym, cinema, bar, chess room, billiard room, bathroom, foot bathroom, beauty salon (except barber shop), teahouse, cafe, board game hall, SPA shop, confinement service center, off-campus training institutions, and so on. Dine-in facility in restaurants is still prohibited.
  • Multiple cities are subject to static management: Amid the recent COVID-19 flare-ups, multiple cities have been put under temporary static management starting from August 14, 2022, including Wuchuan county in Inner Mongolia (3 days),  cha you hou qi under Ulanqab city of Inner Mongolia (3 days), Shigatse in Tibet (an extension of 7 days to August 21),  central districts of Yingtan city in Jiangxi (3 days), Guixi city in Jiangxi (3 days), Hainan (an extension of 2 days to August 16). Moreover, Yi wu, Zhejiang province lifted the static management measures for Chian town and Chengxi street, while the rest streets and towns are still subject to static management.
  • Dunhuang City to implement static management for 24 hours: Starting from 15:00, August 13, 2022, Dunhuang City in China’s northwestern Gansu Province, known for the Mogao Caves, will be put under static management for 24 hours.
  • In China, camping and outdoor activities are booming. The popularity of camping reflects a long-term rise in interest in outdoor sports and activities, as well as a trend toward short-haul and local travel driven by the pandemicRead more about how investors can tap into the various related market segments: Camping and Outdoor Activity – Tapping into China’s Hottest New Travel Trend
  • The COVID-19 pandemic continues to impact Chinese tourism, more so because of the country’s zero-Covid policy. New trends have emerged – which have seen a surge in domestic tourism and changing travel preferences among various demographic categories. Read more about how China’s indigenous tourism market is diversifying in our China Briefing Article: Tourism in China: 2022 Trends and Investment Opportunities
  • Yiwu City to implement temporary whole-region static management for 3 days: From 8:00 am, August 11, 2022, Yiwu, eastern China export hub and commodity center, will implement temporary static management measures for three days to curb the recent COVID-19 flare-ups.
  • Urumqi key urban areas to implement temporary static management for 5 days: From 8:00 am, August 10, 2022, Urumqi Tianshan District, Shaybak District, Shuimogou District, High-tech Zone (new urban district), Jingkai District (Toutunhe District), and Midong District will implement temporary static management measures, and the time is tentatively set for five days. During this period, people can leave Urumpi by holding a negative nucleic acid test certificate from the last 24 hours and a green Health Code.
  • Travelers stranded in Hainan will be arranged to return in batches: Starting from August 9, 2022, Hainan will arrange for stranded travelers to leave the island in an orderly manner. In cities and counties (districts) that have no positive cases, group travelers whose travel group and hotel found no positive cases in the past 7 days, or individual travelers who have not developed clinical symptoms such as fever, dry cough, loss of smell, and muscle soreness in the past 3 days  can return by showing two negative nucleic acid certificates from the last 48 hours (that is, test taken once a day).
  • In low-risk areas, group travelers whose travel group and hotel found no positive cases in the past 7 days, or individual travelers who have not developed clinical symptoms such as fever, dry cough, loss of smell, and muscle soreness -in the past 3 days – can return by showing two negative nucleic acid certificates from the recent 72 hours (that is, test taken once a day).
  • Travelers in medium-risk or high-risk areas can only return after the area becomes a low-risk area. Confirmed cases, close contacts of confirmed cases, and close contacts of close contacts cannot leave the island.
  • On a voluntary basis, priority will be given to special groups with medical needs, the elderly, children, pregnant women, and their escorts.
  • After 900 days of almost zero COVID-19 cases, Tibet is facing new clusters. As of August 9, 2022, Tibet has recorded some new cases which led the authorities to roll out mass testing. Gatherings and public activities have been suspended in the two largest cities of Lhasa and Shigatse, while the main entertainment and religious venues, including the famous Potala Palace, have also been closed down.
  • Hainan to close off more areas. China’s island province of Hainan, whose economy is highly dependent on tourism, reportedly continued to shut down more areas on August 8, 2022, as it faces its largest COVID-19 outbreak, having had considerably low infection rates since the beginning of the pandemic compared to other Chinese provinces. The island has already reported more than 1,400 locally transmitted cases this month, a steep increase compared to the mere two cases reported last year.
  • Shanghai to lift quarantine mandate for those arriving from Macao. People traveling from Macao to Shanghai will no longer be required to follow the “7+3” quarantine rule. Instead, inbound travelers from Macao will have to complete two rounds of nucleic acid tests within 3 days from their arrival, and avoid gathering in crowded public spaces within the first 7 days from their arrival. At the same time, travelers will also have to report their arrival to the respective village committee and residence unit (or to the hotel where they will reside) within the first 12 hours of their arrival.
  • Hong Kong has reduced quarantine time for foreign travelers. Hong Kong has reduced the length of hotel quarantine for foreign visitors to 3 days, followed by 4 days of “at-home medical observation.” The system went into effect on August 7, 2022. Inbound travelers will spend 3 days quarantined in a hotel. Their health code will turn yellow as they leave the hotel and will finally turn green just after the 4 days of at-home monitoring have passed. As reported by the South China Morning Post, people arriving in Hong Kong will be able to use public transportation, travel to work, and shop at markets and malls even with their yellow code as long as they consistently provide negative antigen test results from days 4 to 7 of their arrival.
  • Sanya, Hainan ramps up COVID-19 containment measures in certain districts. From 00:00 (midnight), August 4, Sanya, Hainan (except the Haitang Bay area, Yalong Bay area, and Yucai Ecological Zone) will impose a city-wide lockdown, requiring residents to stay at home and receive door-to-door services. People will be required to show a negative nucleic acid test from the previous 24 hours or a record of a test taken plus a negative test result from the previous day to enter company buildings, public spaces, and housing communities. Residents will be issued with one to two entry/exit passes per household, which they must carry to leave their housing community. They are permitted to leave to buy groceries once every two days. All non-essential workers will be required to work from home where possible. Tourists seeking to leave the city will be required to show a negative nucleic acid test from the last 48 hours and a record of a test taken in the last 24 hours. The lockdown measures were put into place after Sanya recorded a total of 72 symptomatic cases and one asymptomatic case in the period from August 1 to 12:00 (midday), August 4.
  • Minquan County, Henan issues all residents in medium and high-risk areas with yellow and red codes. On the evening of August 3, Minquan Country of Shangqiu city in Henan province issued a notice stating that the health codes of all residents in 7 high-risk areas will be turned red and 12 medium-risk areas will be turned yellow. Red and yellow health codes are assigned to people residing in high-risk areas and those identified as being close contacts of people with COVID-19, limiting their movement and entry to certain public buildings and spaces. Authorities have clarified that the yellow code only applies to the local health code, and will not affect health codes of other regions, enabling those with yellow health codes who have traveled outside of the county to still move around freely. The measures were put into place after the county recorded 38 new COVID-19 cases on August 2, 29 of which were asymptomatic, and nine were confirmed symptomatic cases.
  • China takes further steps to implement inter-regional recognition of COVID-19 tests. Several cities in China have begun to implement inter-regional recognition of COVID-19 tests within their local health codes after a government push for nationwide recognition of local COVID-19 tests. On July 30, Beijing’s local health code called the “Health Kit” (北京健康宝) was updated with an option to import nucleic acid test results from other cities and regions, while the Shanghai health code (随身吗) has enabled a “Yangtze River Delta region nucleic acid test recognition” mechanism so that user can sync test results taken in Jiangsu, Zhejiang, and Anhui provinces. On July 29, the State Council issued a notice calling for cities and provinces to implement inter-regional recognition of COVID-19 tests in order to facilitate travel while maintaining COVID-19 prevention measures. The notice stated that valid nucleic acid tests obtained through the State Council mini-program, the national government service platform, different provinces’ health codes, the websites or apps of testing centers, and paper nucleic acid test results must be recognized by all localities and that it is strictly prohibited to refuse entry to travelers on the grounds that the test cannot be obtained through the local health code or has not been taken locally.
  • Politburo indicates China will stick to “zero-COVID” policy for foreseeable future. The 25-member Politburo indicated in a monthly meeting on Thursday, July 28, that China will maintain its “zero-COVID” policy even if it means hindering the economy in the short term. According to a readout of the meeting, writing that “we must be steadfast in placing the importance on the people and life above all else, adhere to external defense against imported cases, internal defense against a rebound in cases, and adhere to the dynamic clearing strategy.” It also stated that “when an outbreak occurs, we must immediately and strictly prevent and control it” and that “we must not relax and tire of the fight”. On the economy, the Politburo appeared to de-emphasize the GDP target of “around 5.5 percent” growth, emphasizing the need to “consolidate economic recovery, focus on stabilizing employment and prices, keep the economy operating within a reasonable range, and strive to achieve the best results.” Analysts have inferred that the statements mean China will maintain the current COVID-19 measures and policies until at least the 20th National Congress this fall, and possibly into 2023.
  • September 8, 2022 – China recorded 280 new confirmed cases, of which 39 were imported (8 in Fujian, 7 in Shanghai, 6 in Beijing, 6 in Guangdong, 3 in Shandong, 3 in Yunnan, 1 in Tianjin, 1 in Inner Mongolia, 1 in Zhejiang, 1 in Chongqing, 1 in Sichuan, and 1 in Shaanxi) and 241 were domestically transmitted (69 in Sichuan, 67 in Inner Mongolia, 27 in Guangdong, 18 in Tibet, 15 in Shandong, 8 in Guangxi, 7 in Beijing, 6 in Heilongjiang, 4 in Guizhou, 4 in Yunnan, 3 in Liaoning, 3 in Shanghai, 2 in Jiangxi, 2 in Hainan, 1 in Tianjin, 1 in Zhejiang, 1 in Henan, 1 in Shaanxi, 1 in Qinghai, and 1 case in Xinjiang). No new deaths were recorded. There were 1,159 new asymptomatic infections, of which 66 were imported and 1,093 were domestically transmitted (388 in Tibet, 104 in Heilongjiang, 95 in Sichuan, 77 in Shandong, 71 in Liaoning, 64 in Guangxi, 63 in Inner Mongolia, 57 in Jiangxi, 56 in Qinghai, and 28 in Xinjiang, 16 in Guizhou, 12 in Hubei, 12 in Guangdong, 11 in Henan, 10 in Shanghai, 6 in Jilin, 5 in Gansu, 4 in Shaanxi, 3 in Beijing, 3 in Fujian, 3 in Hainan, 2 in Tianjin, 2 in Yunnan, and 1 in Jiangsu). There were 24,698 asymptomatic infections still under medical supervision, of which 689 were imported.
  • As of 15:00, September 8, 2022, China recorded 1,503 high-risk areas (2 in Beijing, 16 in Tianjin, 2 in Hebei, 42 in Inner Mongolia, 9 in Liaoning, 22 in Jilin, 257 in Heilongjiang, 6 in Shanghai, 1 in Jiangsu, 3 in Anhui, 42 in Jiangxi, 44 in Shandong, 5 in Henan, 1 in Hubei, 111 in Guangdong, 5 in Guangxi, 55 in Hainan, 251 in Sichuan, 16 in Guizhou, 374 in Tibet, 5 in Shaanxi, 84 in Qinghai, 149 in Xinjiang, and 1 in the Xinjiang Production and Construction Corps) and 1,663 medium-risk areas.
  • September 7, 2022 – China recorded 380 new confirmed cases, of which 57 were imported (19 in Guangdong, 12 in Shanghai, 7 in Fujian, 4 in Beijing, 4 in Tianjin, 4 in Sichuan, 2 in Jiangsu, 2 in Shandong, 1 in Inner Mongolia, 1 in Heilongjiang, and 1 in Hunan) and 323 were locally transmitted (85 in Sichuan, 76 in Tibet, 57 in Inner Mongolia, 42 in Guangdong, 14 in Beijing, 14 in Heilongjiang, 13 in Hainan, 12 in Shandong, 2 in Liaoning, 2 in Jiangxi, 2 in Xinjiang, 1 in Chongqing, and 1 in Guizhou. 1 case, 1 case in Shaanxi, and 1 case in Qinghai). No new deaths were recorded. There were 1,315 new asymptomatic infections, of which 68 were imported and 1,247 were locally transmitted (389 in Tibet, 179 in Heilongjiang, 106 in Qinghai, 81 in Inner Mongolia, 80 in Shandong, 77 in Liaoning, 72 in Sichuan, 68 in Guangxi, 58 in Jiangxi, 29 in Guizhou, 29 in Xinjiang, 18 in Guangdong, 14 in Henan, 12 in Shaanxi, 7 in Tianjin, 7 in Hubei, 6 in Jilin, 6 in Hainan, 6 in Gansu, 1 in Shanghai, 1 in Zhejiang, and 1 in Anhui). There were 24,868 asymptomatic infections still under medical observation, of which 705 were imported.
  • As of 15:00, September 7, 2022, China recorded 1,689 high-risk areas (9 in Beijing, 32 in Tianjin, 2 in Hebei, 43 in Inner Mongolia, 9 in Liaoning, 39 in Jilin, 247 in Heilongjiang, 4 in Shanghai, 1 in Jiangsu, 3 in Anhui, 42 in Jiangxi, 39 in Shandong, 7 in Henan, 1 in Hubei, 120 in Guangdong, 4 in Guangxi, 77 in Hainan, 276 in Sichuan, 15 in Guizhou, 431 in Tibet, 9 in Shaanxi, 133 in Qinghai, 145 in Xinjiang, and 1 in the Xinjiang Production and Construction Corps) and 1,795 medium-risk areas.
  • September 6, 2022 – China recorded 310 new confirmed cases, of which 46 were imported (16 in Guangdong, 12 in Fujian, 4 in Beijing, 3 in Shanghai, 3 in Shandong, 2 in Yunnan, 1 in Tianjin, 1 in Liaoning, 1 in Heilongjiang, 1 in Jiangsu, 1 in Sichuan, and 1 in Shaanxi) and 264 were domestically transmitted (68 in Sichuan, 52 in Tibet, 43 in Guangdong, 39 in Inner Mongolia, 30 in Hainan, 7 in Heilongjiang, 4 in Jiangxi, 4 in Xinjiang, 3 in Hebei, 3 in Jilin and 2 in Liaoning, 2 in Shandong, 2 in Shaanxi, 2 in Qinghai, 1 in Beijing, 1 in Fujian, and 1 in Guangxi). No new deaths were recorded. There were 1,300 new asymptomatic infections, of which 65 were imported and 1,235 were locally transmitted (453 in Tibet, 148 in Heilongjiang, 93 in Qinghai, 89 in Liaoning, 70 in Jiangxi, 70 in Sichuan, 69 in Inner Mongolia, 63 in Shandong, 32 in Xinjiang, 28 in Guangxi, 20 in Henan, 19 in Jilin, 17 in Guangdong, and 1 in Hubei). There were 24,593 asymptomatic infections still under medical observation, of which 733 were imported.
  • As of 15:00, September 6, 2022, China recorded 1,849 high-risk areas (7 in Beijing, 50 in Tianjin, 15 in Hebei, 26 in Inner Mongolia, 12 in Liaoning, 39 in Jilin, 248 in Heilongjiang, 3 in Shanghai, 1 in Jiangsu, 3 in Anhui, 39 in Jiangxi, 31 in Shandong, 10 in Henan, 1 in Hubei, 149 in Guangdong, 105 in Hainan, 4 in Chongqing, 312 in Sichuan, 15 in Guizhou, 493 in Tibet, 7 in Shaanxi, 133 in Qinghai, 145 in Xinjiang, and 1 in the Xinjiang Production and Construction Corps) and 1,796 medium-risk areas.
  • September 5, 2022 – China recorded 349 new confirmed cases, of which 46 were imported (20 in Guangdong, 9 in Fujian, 5 in Shanghai, 3 in Beijing, 3 in Sichuan, 2 in Jiangsu, 2 in Shaanxi, 1 in Tianjin, and 1 in Heilongjiang) and 303 were locally transmitted (105 in Sichuan, 64 in Tibet, 63 in Guangdong, 14 in Inner Mongolia, 14 in Hainan, 13 in Liaoning, 5 in Shandong, 4 in Heilongjiang, 4 in Jiangxi, 4 in Qinghai, 3 in Henan, and 3 in Tianjin). 2 cases, 2 cases in Zhejiang, 2 cases in Hunan, 2 cases in Shaanxi, 1 case in Guizhou, 1 case in Xinjiang). No new deaths were recorded. There were 1,317 new asymptomatic infections, of which 68 were imported and 1,249 were domestically transmitted (452 in Tibet, 162 in Heilongjiang, 95 in Qinghai, 93 in Liaoning, 80 in Sichuan, 72 in Jiangxi, 52 in Shandong, 29 in Xinjiang, 26 in Jilin, 26 in Guangdong, 25 in Guizhou, 24 in Henan, 18 in Hubei, 17 in Guangxi, 16 in Hainan, 13 in Hebei, 13 in Anhui, 12 in Tianjin, 12 in Gansu, 7 in Inner Mongolia, 4 in Shaanxi, and 1 in Yunnan). There were 24,250 asymptomatic infections still under medical observation, of which 759 were imported.
  • As of 16:00, September 5, 2022, China recorded 2,006 high-risk areas (7 in Beijing, 65 in Tianjin, 52 in Hebei, 11 in Liaoning, 37 in Jilin, 218 in Heilongjiang, 3 in Shanghai, 1 in Jiangsu, 39 in Jiangxi, 26 in Shandong, 17 in Henan, 1 in Hubei, 148 in Guangdong, 128 in Hainan, 4 in Chongqing, 313 in Sichuan, 12 in Guizhou, 550 in Tibet, 59 in Shaanxi, 1 in Gansu, 130 in Qinghai, 155 in Xinjiang, and 1 in the Xinjiang Construction and Production Corps) and 1,711 medium-risk areas.
  • September 4, 2022 – China recorded 384 new confirmed cases, of which 70 were imported (18 in Guangdong, 12 in Fujian, 9 in Shanghai, 6 in Beijing, 4 in Inner Mongolia, 4 in Heilongjiang, 4 in Sichuan, 4 in Shaanxi, 3 in Tianjin, 2 in Henan, 2 in Yunnan, 1 in Liaoning, and 1 in Shandong) and 314 were locally transmitted (98 in Sichuan, 79 in Guangdong, 51 in Tibet, 24 in Hainan, 11 in Liaoning, 11 in Jilin, 10 in Inner Mongolia, 8 in Qinghai, 4 in Heilongjiang, 3 in Tianjin, 3 in Guizhou, 2 in Hebei, 2 in Zhejiang, 2 in Jiangxi, 1 in Beijing, 1 in Shanghai, 1 in Shandong, 1 in Hunan, 1 in Chongqing, and 1 in Shaanxi|). No new deaths were recorded. There were 1,464 new asymptomatic infections, of which 105 were imported cases and 1,359 were locally transmitted (505 in Tibet, 131 in Qinghai, 113 in Liaoning, 93 in Heilongjiang, 88 in Sichuan, 81 in Jilin, 78 in Shandong, 55 in Jiangxi, 33 in Xinjiang, 33 in Guangdong, 21 in Hainan, 19 in Tianjin, 18 in Guangxi, 17 in Henan, 16 in Hubei, 16 in Gansu, 15 in Hebei, 12 in Guizhou, 10 in Inner Mongolia, 8 in Shaanxi, 3 in Zhejiang, 2 in Hunan, and 1 in Chongqing). There were 24,079 asymptomatic infections still under medical observation, of which 792 were imported.
  • September 3, 2022 – China recorded 502 new confirmed cases, of which 62 were imported ( 17 in Guangdong, 12 in Shanghai, 11 in Fujian, 7 in Beijing, 4 in Sichuan, 4 in Yunnan, 2 in Tianjin, 2 in Shandong, 1 in Liaoning, 1 in Jiangsu, and 1 in Henan) and 440 were locally transmitted (128 in Sichuan, 67 in Heilongjiang, 65 in Guangdong, 65 in Tibet, 40 in Hainan, 13 in Henan, 8 in Liaoning, 8 in Shandong, 8 in Shaanxi, 6 in Chongqing, 5 in Qinghai, 4 in Inner Mongolia, 4 in Zhejiang, 4 in Guizhou, 3 in Tianjin, 3 in Jilin, 2 in Hebei, 2 in Yunnan, 1 in Beijing, 1 in Shanghai, and 1 in Xinjiang). No new deaths were recorded. There were 1,486 new asymptomatic infections, of which 107 were improted and 1,379 were locally transmitted (524 in Tibet, 168 in Heilongjiang, 116 in Liaoning, 104 in Qinghai, 75 in Shandong, 74 in Sichuan, 40 in Henan, 40 in Guangdong, 35 in Xinjiang, 30 in Jilin, 29 in Hainan, 25 in Hubei, 24 in Gansu, and 23 in Jiangxi). There were 24,029 asymptomatic infections still under medical observation, of which 769 were imported.
  • September 2, 2022 – China recorded 373 new confirmed cases, of which 55 were imported (17 in Fujian, 16 in Guangdong, 9 in Sichuan, 7 in Shanghai, 2 in Heilongjiang, 1 in Beijing, 1 in Jilin, 1 in Jiangsu, and 1 in Zhejiang), and 318 were locally transmitted (128 in Sichuan, 55 in Guangdong, 46 in Tibet, 27 in Hainan, 11 in Heilongjiang, 8 in Chongqing, 8 in Shaanxi, 5 in Qinghai, 4 in Hebei, 4 in Shandong, 4 in Henan, 4 in Xinjiang, 2 in Inner Mongolia, 2 in Zhejiang, 1 in Beijing, 1 in Tianjin, 1 in Jilin, 1 in Shanghai and 1 in Yunnan). There were 1,665 new asymptomatic infections, of which 98 were imported and 1,567 were locally transmitted (575 in Tibet, 207 in Heilongjiang, 125 in Qinghai, 114 in Liaoning, 77 in Sichuan, 75 in Hainan, 53 cases in Shandong, 46 in Henan, 42 in Gansu, 41 in Guangdong, 40 in Jilin, 34 in Xinjiang, 32 in Tianjin, 32 in Hebei, 24 cases in Jiangxi, 20 in Hubei and 8 in Guangxi, 6 in Inner Mongolia, 5 in Shaanxi, 3 in Zhejiang, 3 in Guizhou, 2 in Jiangsu, 2 in Chongqing, and 1 in Yunnan). There were 24,226 asymptomatic infections still under medical observation, of which 755 were imported.
  • As of 11:00, September 2, 2022, China recorded 1,998 high-risk areas (6 in Beijing, 79 in Tianjin, 60 in Hebei, 9 in Inner Mongolia, 9 in Liaoning, 1 in Jilin, 77 in Heilongjiang, 5 in Shanghai, 3 in Jiangsu, 2 in Anhui, 29 in Jiangxi, 2 in Shandong, 50 in Henan, 1 in Hubei, 100 in Guangdong, 167 in Hainan, 14 in Chongqing, 277 in Sichuan, 690 in Tibet, 72 in Shaanxi, 26 in Gansu Province, 126 in Qinghai Province, 192 in Xinjiang Uygur Autonomous Region, and 1 in Xinjiang Production and Construction Corps) and 1,418 medium-risk areas.
  • NMPA approves a domestically made HIV drug for treating COVID-19 patients: On Monday, July 25, 2022, the National Medical Products Administration (NMPA), China’s drug regulator, gave its approval on expanding the use of a drug that had originally been approved for treating HIV-1 infections in 2021 and which can now be used to treat COVID-19 infections.  The drug, Azvudine, was produced by Zhengzhou-based Genuine Biotech. Azudine is recognized less effective but much cheaper than Paxlovid, the only other drug available in China to treat COVID-19 patients with severe symptoms. The regulatory approval process took only around two weeks. Analysts believed that the expedited process demonstrates China’s eagerness to find a way out of the COVID-19 dilemma–protecting people’s health and life while not dampening the economy too much.
  • China removed the PU letter requirement for business and visitor visas for German applicants. On Wednesday, July 27, 2022, the Chinese Embassy in Germany announced on its website (link in German) that German applicants will no longer be required to submit a PU letter, an invitation letter issued by the Chinese government, in order to apply for an M business visa or F non-commercial visit visa. The scope of business purposes for the application for an M business visa includes business and trade, education, science and technology, and sports and culture, among others, according to the notice. The move signals further easing of restrictions on foreign travel and entry into China and will facilitate travel for German businesspeople and visits by the leadership of German companies.
  • Jiangxia District of Wuhan City to implement a 3-day lockdown. Starting from 4:00 am, July 27, 2022, almost one million residents of Jiangxia District in a suburb of Wuhan have been put under a temporary lockdown for three days, after four asymptomatic COVID-19 cases were reported.
  • Outbreaks in the Beihai City of Guangxi Province eased. In a press conference held on July 27, 2022, the Beihai government announced that the epidemic prevention and control situation in Beihai City has gradually improved after a fight of more than half a month, and some counties and districts have achieved zero or almost zero community level spread. Beihai shall continue to carry out nucleic acid screening in the whole area of Haicheng District and key areas of Yinhai District.
  • Shenzhen orders big firms to implement 7-day closed-loop management: It is reported that Shenzhen has told around 100 major companies, including BYD, Foxconn, Huawei Technologies, SMIC, DJI, and ZTE, to set up a closed-loop system for a week — starting from July 24, 2022. It is the second time that major companies have been asked to minimize entry and exit in 2022: the first time was in March this year. However, what is different from the March closed-loop management is that the state of the supply chain and exports appear to be stable, at present.
  • China’s state and party leaders have all been vaccinated with domestically made COVID-19 shots. In a press conference held on July 23, 2022, the National Health Commission (NHC) disclosed this information to demonstrate that China’s COVID-19 vaccines are safe and effective. This is one of the recent efforts that China has made to ease public concerns about the safety of the domestically developed COVID-19 vaccines and encourage the elderly to get the COVID-19 vaccination and the booster. As of July 23, 2022, 89.7 percent of people have been fully vaccinated against the COVID-19 virus, among which 71.7 percent received booster shots. However, among elderly people above 80, only 61 percent have been fully vaccinated.
  • The quarantine period might be shortened to 3 days. Chinese health authorities confirmed that the government is considering whether to further reduce the quarantine period to 3 days and introduce more specific measures to optimize the country’s COVID-19 response. 
  • Beihai (Guangxi) opens two makeshift hospitals. As of 24:00 on July 19, 2022, Beihai City recorded 992 local infections, of which 223 were symptomatic cases and 769 asymptomatic ones. The first makeshift hospital began operations on July 18, 2022. A second makeshift hospital with a capacity of 626 beds was opened the following day. Other cities in Guangxi province, including Fangchenggang, Nanning, and Chongzuo, have also reported several positive cases.
  • On July 19, 2022, Anhui province recorded 83 new cases. Most cases are related to an outbreak in Huaiyuan County, in the city of Bengbu. As of noon on July 19, 2022, Huaiyuan County had carried out five consecutive rounds of nucleic acid testing. Local authorities have also corrected the “unscientific behavior” in the use of peracetic acid to spray and disinfect urban roads for the previous seven days.
  • Mass testing in Tianjin. On July 19, 2022, Tianjin conducted extensive testing around the city and discovered 14 local positive cases.
  • New rules for normalised nucleic acid testing in Shanghai. On July 19, the city reported 15 new cases. According to a statement made by Shanghai’s anti-epidemic expert team, the most recent COVID-19 infections are linked to an original transmission, which occurred at the Putuo district karaoke bar. 23,000 close contacts and 50,000 additional ones have been identified and quarantined. In an effort to stop any viral community spread, Shanghai is carrying out extensive testing in nine of the city’s districts (Huangpu, Xuhui, Changning, Jing’an, Putuo, Hongkou, Yangpu, Minhang, and Baoshan) as well as other smaller locations. Normalized nucleic acid testing centers in Shanghai will continue to provide free testing services until August 31, while citizens must take nucleic acid tests at least once a week until August 31.
  • Over the weekend, China’s COVID-19 situation has worsened with new local outbreaks spreading. With over 1,100 new cases recorded over the weekend, the outbreaks in Guangxi and in Gansu have caused infections to reach their highest number countrywide in more than seven weeks. The number of locally transmitted cases in over 20 provinces during the past week has more than doubled since June.
  • Beihai, a coastal city in the Guangxi province of southern China, has become the new COVID-19 hotspot, with over 560 cases found in the past week. With many rounds of mass testing underway, the city has shut down at least two districts, including the well-known Weizhou island, and is requesting that people there remain at home. The restrictions have left almost 2,000 tourists stuck in the resort town.
  • Given the number of cases, the city of Lanzhou, the capital of Gansu province, will further extend the lockdown for most of its districts until July 24, 2022. With a population of over 4 million, Lanzhou recorded 152 cases on Sunday, July 17, 2022.
  • Chengdu has taken additional measures, closing entertainment venues in six districts and restricting travel for six days starting on Sunday, 17 July 2022. By Monday, July 18, 2022, 19 new cases were found in the city.
  • On Sunday, July 17, 2022, Shanghai reported 17 new cases, as the city prepares to conduct a widespread testing effort over the course of three days starting on Tuesday, July 19, 2022, in nine of its 16 districts.
  • Xi’an and Wuxi, a major business center in China’s Jiangsu province, both withdrew their “seven-days of control measures”, and resumed dine-in services starting July 15, 2022.
  • Elsewhere, the lockdown in the city of Wugang, at the heart of iron and steel production in the Henan province’, was prolonged until July 18, 2022. As of that date, however, authorities have not yet stated whether the restrictions will be loosened.
  • China’s “zero-COVID“strategy is entering a new stage. China’s zero-COVID policy, also known as “dynamic clearing”, aims to keep positive cases at the community level to a minimum through measures such as local lockdowns, travel restrictions, widespread testing, and centralized quarantine of people that test positive, is gradually becoming less stringent. Key changes include shorter quarantine times, adjustments to the definition of “medium” and “high-risk” areas to enable quicker reopening and shorter lockdowns, and the implementation of “normalized” testing to enable citizens to quickly and easily get COVID-19 tests at make-shift testing stations across towns and cities. A new prevention plan released from the provincial government of Henan called the “Pandemic Prevention Plan 3.0”, is emblematic of this change. The plan makes a series of adjustments to previous policies, including shortening quarantine times for people arriving from medium and high-risk areas, shortening the quarantine period for international arrivals from 14 to seven days, and shortening the period in which a community is classified as “high-risk” to seven days since the last COVID-19 infection was discovered, rather than 14 days. The aim of this plan is to maintain COVID-19 cases as close to zero as possible while minimizing disruption to the general population and economy, while also adapting to the Omicron variant, which is more infectious but has a shorter incubation period.
  • Shanghai to carry out two rounds of testing for all residents in affected areas. From July 12 to 14, all residents living in areas that have had positive cases in Huangpu District, Xuhui District, Changning District, Jing’an District, Putuo District, Hongkou District, Yangpu District, Minhang District, Baoshan District will be required to undergo two rounds of COVID-19 testing with a minimum of 24 hours between each test. The move comes as Shanghai has recorded an uptick in cases in recent weeks, leading to localized short-term lockdowns of affected areas.
  • Lanzhou, Gansu implements one week “silent period” to curb community spread. Lanzhou, the provincial capital of Gansu in northwestern China, will suspend public entertainment and catering services for one week starting on July 11 in Chengguan, Qilihe, Xigu, and Anning districts, which have recorded new symptomatic and asymptomatic cases in the last week. Kindergarten, primary, and middle school students have been allowed to break up for the summer holiday early, while high schools will remain open under closed-loop management.
  • Beijing rolls back the COVID-19 vaccination mandate. At a press conference on July 6, 2022, Beijing released a vaccine mandate – starting from July 11, 2022, people entering entertainment and educational facilities for seniors and offline venues including training centers, libraries, museums, cinemas, art galleries, gyms, stadiums, and performance centers in Beijing, will need to show proof of vaccination, except those who are not suitable to be vaccinated. This announcement came after three highly-transmissible Omicron BA.5.2 subvariant cases had been recorded in the city on Tuesday. However, the mandate stirred up worries among residents. Amid increasing concerns, on Thursday, July 7, Beijing rolled back the mandate and promised the COVID-19 vaccination administration in China will stick to the informed, consented, and voluntary principles. People can continue to enter public venues by showing a negative nucleic acid test from the recent 72 hours, according to the report of Beijing Daily.
  • Beijing relaxed travel curbs. At the July 6 press conference held on July 6, 2022, Beijing released relaxed restrictions on domestic inbound travelers. Previously, residents from county-level localities where there have been COVID cases in the past 14 days were not allowed to enter Beijing. This threshold was reduced to 7 days. Meanwhile, there will be no longer travel restrictions on residents from other county-level localities of the prefecture-level city where COVID-19 cases have been reported in the last 7 days.
  • Xi’an, Shaanxi to implement a seven-day silent period starting from July 6, 2022. Xi’an has decided to implement a seven-day silent period, rather than a full lockdown, after the most contagious BA.5.2 Omicron subvariant caused flareups in the city. During the seven-day period, the city has shut down crowded indoor recreational venues, suspended in-person dining, let schools start summer vacation early, prohibited offline learning, and put off large gatherings and conferences.
  • Shanghai to run two rounds of mass COVID-19 testing of its residents over a three-day period. As per an announcement released on the Shanghai Government’s official Wechat account, all residents in nine districts (Huangpu, Xuhui, Changning, Jingan, Putuo, Hongkou, Yangpu, Minhang, and Baoshan) are to be tested twice from Tuesday to Thursday. Some residents in three other districts (Pudong, Jiading, and Fengxian) also need to undergo testing. The decision came after multiple COVID-19 infections found this week was linked to a karaoke lounge, which had been visited by residents living in different districts. The testing has increased concern among residents that another lockdown may be imposed.
  • Anhui province becomes a new epicenter: Over the past week, Anhui reported more than 850 cases, making it a new epicenter in China. Neighboring Jiangsu and Zhejiang provinces have also been affected by cases spilling over from Anhui. Despite the COVID flareups, local governments in these provinces are trying to maintain business and travel as usual instead of shutting down their economy. However, it remains to be seen to what extent the local governments can balance out these objectives – maintaining growth and achieving disease control.
  • Shanghai to reopen cinemas from July 8, 2022: According to a notice released by the Shanghai Film Bureau, Shanghai will reopen movie theaters starting from July 8, 2022, following a more than two-month closure since March 10, 2022 due to the city’s COVID-19 outbreak. There will be no food and drink sold or allowed in cinemas and visitors will need to provide a negative nucleic acid text from the last 72 hours and wear masks. Starting from July 1, 2022, museums and art galleries, as well as all indoor and outdoor A-level tourist attractions, have been gradually reopened across the city.
  • As of July 1, 2022, a PU Letter will no longer be required to apply for a Chinese business M-visa, as per the announcement of the Chinese Embassies in ItalyFrance, the UK, and Singapore. For more information on PU letter updates, please refer to our China Briefing Article: PU Letter Exemption for Z-Work Visa Applicants: Latest Updates
  • The Ministry of Industry and Information Technology (MIIT) announced that in order to ease traveling, cities with positive COVID-19 cases will no longer be marked with an asterisk (*) on China’s travel code (行程卡 xingcheng ka). Asterisks had been used before to prevent people from visiting areas and cities if they had recently visited or resided in a place with COVID-19 cases. Official announcements from local authorities of cities with recent major outbreaks (such as Beijing and Shanghai) are yet to be released.
  • Hong Kong might cut down hotel quarantine for inbound travellers to five days, with another two to be spent in home isolation. The news has been reported to the SCMP by Professor Lo Chung-mau, who will become the new secretary for health on July 1, 2022.
  • According to the latest version of the COVID-19 Prevention and Control Plan released by the National Health Commission, the quarantine time for inbound travelers and close contacts of confirmed has been reduced to 7+3.
  • As of 09:00, June 28, 2022, China recorded 1 high-risk area (in Beijing) and 13 medium-risk areas.
  • Shanghai allows dine-in. The Shanghai municipal government announced that effective June 29, restaurants will be allowed to accommodate dine-in customers once there have been no positive Covid-19 cases in their area within the previous week. Individual districts are responsible for assessing their risk areas and implementing openings accordingly.
  • Beijing kids are back in class. Starting from June 27, 2022, Beijing’s education commission reported the return to in-person learning for students in primary, middle, and high school.
  • Shenzhen shuts down the city district of Futian. On June 26, 2022, Shenzhen closed wholesale markets, cinemas, and gyms in the central district of Futian, nearby Hong Kong, for the following three days to prevent a wider spread of Covid-19 cases.
  • More cities cut quarantine time for international arrivals. At least eight cities in China have cut quarantine times for international arrivals from 14 to 10 or seven days, according to a report from the Global Times. The cities are Nanjing, Wuxi, Changzhou, Beijing, Wuhan, Chengdu, Xiamen, and Ningbo. Beijing cut the quarantine period from 10 days to a 7+7 model (seven days of centralized quarantine plus seven days of home quarantine) starting from May 15 on a trial basis. Nanjing in Jiangsu province has also cut the centralized quarantine time from 14 to seven days, starting two weeks ago. Meanwhile, Chengdu, Xiamen, and Ningo have shortened the centralized quarantine time from 14 to 10 days. Other ports of entry still impose a minimum of 14 days of centralized quarantine. People planning on traveling to China are still encouraged to consult with their local embassy or consulate to confirm all travel and quarantine requirements before traveling as the requirements are subject to change.
  • Zhuhai, Guangdong imposes COVID-19 quarantine requirements on travelers from Macao after positive cases were discovered. People crossing the border from Macao to the neighboring mainland city of Zhuhai in Guangdong province will now be required to present a negative nucleic acid test taken in the last 24 hours, while those traveling from Zhuhai to Macao must have a negative nucleic acid test result from the last 48 hours. Those that have entered Zhuhai from June 15 onward will also be required to undergo 7 days of home quarantine and an additional 7 days of health monitoring at home. The requirement was imposed on Sunday, June 19 onward after at least 12 positive cases were discovered in Macao. Macao has also launched city-wide testing for all residents from Sunday to Tuesday, June 21.
  • Jilin City, Jilin suspends public transport and carries out city-wide testing. The city of Jilin in Jilin province has suspended the operation of all passenger trains, tourist passenger transport, city buses, taxis, and tourist ferries from Monday, June 20 to Wednesday, June 22. Primary and middle school classes, as well as classes organized by off-campus training institutes, have also been suspended and are required to be held online. The restrictions have been imposed after the city recorded several new symptomatic and asymptomatic infections since June 15. The city has also launched testing for residents in all urban districts from Monday, June 20 to Wednesday, June 22.
  • Local governments scale back mandatory COVID-19 testing. As daily COVID-19 infections decline, COVID-19 testing requirements are less stringent in places where new cases haven’t appeared for a while. For example, some cities in Anhui province have canceled the regular mass testing requirements. And the negative nucleic acid test certificates are no longer required to access public venues in Huizhou, Guangdong province. To be noted, for cities that are still reporting new cases, residents are still required to do regular nucleic acid tests. For example, Shanghai requires residents to get tested every 72 hours to access public venues. Also, it will conduct mass testing for all residents every weekend until the end of July.
  • China resumes processing family visit visas after 2+ years of suspension. China is resuming issuing family visit visas (S2 or Q2) to foreigners, according to statements issued by the Chinese embassies in relevant countries, including Singapore, the US, South Korea, Australia, France, Germany, Hong Kong, and India, among others.
  • Beijing closes dozens of bars in Sanlitun amid the COVID outbreak: Authorities in Beijing warned that a COVID-19 surge in cases linked to a 24-hour bar known for cheap liquor and big crowds was critical and the city of 22 million is racing to contain its most serious outbreak since the pandemic began. Beijing has checked all bars, nightclubs, karaoke parlors, and internet cafes across the city, and shut down underground and unlicensed ones, the report said.
  • The State Council takes steps to correct excessive COVID-19 control measures: On June 11, 2022, the State Council named and shamed several highway checkpoints in four cities, including  Zhangjiakou in Hebei, Hefei and Anqing in Anhui, and Shangluo in Shaanxi, for unreasonable and overly restrictive COVID control and prevention measures. This is the first time that the central government has named governments. The State Council clarified that all localities should lift travel restrictions for trucks from low-risk areas and nucleic acid test results should be recognized nationwide.
  • Hubei province and some cities in Jiangsu Province cut quarantine time: According to the  WeChat mini program owned by the State Council, travelers from areas designated as medium and high risk for COVID-19 to Hubei province and some cities in Jiangsu province, including Nanjing, Xuzhou, and Changzhou, are now subject to “7 days centralized quarantine + 7 days self-isolation”. Previously, the centralized quarantine was up to 14 days.
  • Shanghai to mass test its eight districts on weekend but lockdowns were lifted right after testing. Amid the slight flare-up of the COVID-19 cases, Shanghai decided to temporarily lockdown eight of its districts, including Pudong, Huangpu, Jing’an, Xuhui, Hongkou, Baoshan, Yangpu, and Minhang districts, and conduct mass testing for the resident. However, the lockdowns were lifted as soon as the mass testing finished, which overruled the widespread rumor that Shanghai is returning to lockdown.
  • Beijing districts shut entertainment venues to contain the COVID-19 outbreak. China’s capital city of Beijing shut down entertainment venues in its Beijing Economic Development Zone from Thursday in an effort to contain a new outbreak of COVID-19. The move came after Dongcheng District and Chaoyang District also ordered entertainment venues and internet cafes to shut from Thursday.
  • Shanghai maintains high alert as more community cases are detected. Several communities in Shanghai have been put back into lockdown as more cases are discovered at the community level. “Community-level” cases are COVID-positive cases that are discovered outside of quarantine centers or locked down areas. 4 new community-level symptomatic and asymptomatic cases were reported on Tuesday, following 3 on Monday. On Tuesday, 4 housing communities in the districts of Jing’an, Baoshan, and Pudong were designated as medium-risk areas and placed under a 14-day lockdown. As of 21:00, June 8, there were 20 medium-risk areas in Shanghai. At a press briefing on Tuesday, June 7, Deputy Director of the Shanghai Municipal Health Commission Zhao Dandan stated that the new community-level cases “remind us that pandemic prevention must remain on a tight leash, and we must not become complacent” (our translation).
  • China to waive the PU letter requirement for some visa applicants. The Shanghai Foreign Affairs Office confirmed to China Briefing yesterday (June 7) that foreigners holding a valid Notification Letter of Foreigner’s Work Permit and foreign dependents with spouses that have received approval to work in China will no longer be required to obtain a PU letter to apply for a work visa. A PU letter is a government-issued invitation letter that foreigners are required to have to apply for certain types of visas, including the Z work visa. The new policy is said to be effective from June 6. However, anyone planning on traveling to China is therefore still advised to contact their local Chinese embassy or consulate for further information. See our full article on the topic here.
  • August 12, 2022 – China recorded 704 new confirmed cases, of which 56 were imported (19 in Guangdong, 8 in Shanghai, 7 in Sichuan, 6 in Fujian, 4 in Beijing, 4 in Shandong, 2 in Tianjin, 2 in Shaanxi, 1 in Liaoning, 1 in Jilin, 1 in Zhejiang, and 1 in Guangxi) and 648 were locally transmitted (595 in Hainan, 22 in Guangdong, 9 in Inner Mongolia, 7 in Tibet, 5 in Fujian, 2 in Shanghai, 1 in Henan, 1 in Chongqing, 1 in Sichuan, 1 in Guizhou, 1 in Yunnan, 1 in Shaanxi, 1 in Gansu, and 1 in Xinjiang). No new deaths were recorded. There were 1,305 new asymptomatic infections, of which 102 were imported and 1,203 were locally transmitted (614 in Hainan, 410 in Xinjiang, 60 in Zhejiang, 43 in the Corps, 20 in Tibet, 14 in Guangdong, 11 in Jiangxi, 7 in Inner Mongolia, 6 in Hubei, 5 in Shanghai, 5 in Guangxi, 4 in Hunan, 1 in Henan, 1 in Chongqing, 1 in Sichuan, and 1 in Shaanxi). There were 7,088 asymptomatic infections still under medical observation, of which 714 were imported.
  • August 11, 2022 – China recorded 700 new confirmed cases, of which 86 were imported (27 in Guangdong, 14 in Shanghai, 11 in Fujian, 7 in Beijing, 4 in Shandong, 4 in Guangxi, 4 in Yunnan, 3 in Tianjin, 3 in Inner Mongolia, 3 in Sichuan, 2 in Liaoning, 2 in Jiangxi, 1 in Zhejiang, and 1 in Shaanxi) and 614 were locally transmitted (559 in Hainan, 25 in Guangdong, 11 in Zhejiang, 4 in Inner Mongolia, 4 in Fujian, 2 in Beijing, 2 in Jiangxi, 2 in Chongqing, 2 in Tibet, 1 in Hunan, 1 in Shaanxi, and 1 in Gansu). No new deaths were recorded. There were 1,466 new asymptomatic infections, of which 87 were imported and 1379 were locally transmitted (805 in Hainan, 380 in Xinjiang, 66 in Tibet, 56 in Zhejiang, 16 in Jiangxi, 15 in Corps,  8 in Hubei, 6 in Inner Mongolia, 6 in Gansu, 5 in Guangdong, 5 in Guangxi, 5 in Sichuan, 2 in Hebei, 2 in Chongqing, 1 in Jilin, and 1 in Henan). There were 6,263 asymptomatic infections still under medical observation, of which 692 were imported.
  • August 10, 2022 – China recorded 444 new confirmed cases, of which 64 were imported (20 in Shanghai, 20 in Guangdong, 7 in Sichuan, 6 in Shandong, 4 in Beijing, 3 in Fujian, 1 in Liaoning, 1 in Henan, 1 in Chongqing, and 1 in Yunnan) and 380 were locally transmitted (285 in Hainan, 39 in Guangdong, 27 in Inner Mongolia, 10 in Tibet, 8 in Fujian, 5 in Zhejiang, 2 in Guangxi, 1 in Hubei, 1 in Chongqing, 1 in Sichuan, and 1 in Guizhou). No new deaths were recorded. There were 650 new asymptomatic infections, of which 78 were imported and 572 were locally transmitted (285 in Hainan, 122 in Xinjiang, 49 in Zhejiang, 24 in Hubei, 21 in the Corps, 18 in Tibet, 11 in Guangxi, 10 in Henan, 7 in Guangdong, 5 in Inner Mongolia, 5 in Jiangxi, 3 in Hebei, 2 in Anhui, 2 in Fujian, 2 in Hunan, 2 in Chongqing, 1 in Sichuan, 1 in Guizhou, 1 in Yunnan, and 1 in Gansu). There were 5,440 asymptomatic infections still under medical observation, of which 677 were imported.
  • August 9, 2022 – China recorded 399 new confirmed cases, of which 49 were imported (16 in Guangdong, 9 in Beijing, 8 in Fujian, 7 in Sichuan, 2 in Shanghai, 2 in Guangxi, 1 in Tianjin, 1 in Liaoning, 1 in Heilongjiang, 1 in Jiangsu, and 1 in Yunnan) and 350 were locally transmitted (300 in Hainan, 25 in Guangdong, 16 in Inner Mongolia, 2 in Jilin, 2 in Fujian, 2 cases in Chongqing, 1 in Guangxi, 1 in Sichuan, 1 in Tibet). No new deaths were recorded. There were 540 new asymptomatic infections, of which 62 were imported and 478 were locally transmitted (171 in Hainan, 146 in Xinjiang, 67 in Zhejiang, 25 in Guangxi, 21 in Tibet, 13 in Guangdong, 7 in XPCC, 5 in Henan, 4 in Hubei, 3 in Inner Mongolia, 3 in Jilin, 3 in Fujian, 2 in Chongqing, 2 in Sichuan, 2 in Gansu, 1 in Tianjin, 1 in Hebei, 1 in Anhui, 1 in Jiangxi). There were 5,122 asymptomatic infections still under medical observation, of which 654 were imported.
  • August 8, 2022 – China recorded 380 new confirmed cases, of which 56 were imported (18 in Guangdong, 9 in Fujian, 9 in Sichuan, 7 in Shanghai, 4 in Beijing, 4 in Guangxi, 2 in Jiangsu, 1 in Tianjin, 1 in Heilongjiang, and 1 in Yunnan) and 324 were locally transmitted (259 in Hainan, 37 in Guangdong, 12 in Inner Mongolia, 4 in Zhejiang, 3 in Hunan, 2 in Beijing, 2 in Hebei, 2 in Guangxi, 1 in Hubei, 1 in Chongqing, 1 in Sichuan). No new deaths were recorded. There were 560 new asymptomatic infections, of which 77 were imported and 483 were locally transmitted (245 in Hainan, 82 in Zhejiang, 69 in Xinjiang, 25 in Henan, 13 in Hebei, 11 cases in the Corps, 10 in Guangxi, 9 in Hubei, 6 in Guangdong, 3 in Shandong, 3 in Chongqing, 3 in Gansu, 2 in Inner Mongolia, and 2 in Jilin). There were 5,067 asymptomatic infections still under medical observation, of which 654 were imported.
  • As of 12:00, August 8, 2022, China recorded 467 high-risk areas and 865 medium-risk areas.
  • August 7, 2022 – China recorded 390 new confirmed cases, of which 53 were imported (19 in Guangdong, 10 in Beijing, 8 in Fujian, 4 in Shandong, 4 in Sichuan, 3 in Shanghai, 2 in Jiangsu, 1 in Heilongjiang, 1 in Zhejiang, and 1 in Chongqing) and 337 were locally transmitted (297 in Hainan, 12 in Inner Mongolia, 12 in Guangdong, 5 in Chongqing, 3 in Zhejiang, 3 in Guangxi, 1 in Beijing, 1 in Jiangsu, 1 in Henan, 1 in Hunan, and 1  in Guizhou). No new deaths were recorded. There were 640 new asymptomatic infections, of which 75 were imported and 565 were locally transmitted (258 in Guangxi, 200 in Gansu, 48 in Shandong, 11  in Shanghai, 9  in Henan, 7 in Yunnan, 7 in Jilin, 6 in Anhui, 5 in Guangdong, 5 in Sichuan, 3 in Jiangsu, 2 in Jiangxi, 2 in Hubei). There were 5,041 asymptomatic infections still under medical observation, of which 645 were imported.
  • August 6, 2022 – China recorded 361 new confirmed cases, of which 51 were imported (11 in Fujian, 11 in Guangdong, 8 in Shanghai, 6 in Yunnan, 5 in Beijing, 4 in Sichuan, 1 in Tianjin, 1 in Liaoning, 1 in Heilongjiang, 1 in Jiangsu, 1 in Shandong, 1 in Hunan) and 310 were locally transmitted (262 in Hainan, 22 in Inner Mongolia, 11 in Guangdong, 7 in Zhejiang, 4 in Guangxi, 3 in Chongqing, and 1 in Sichuan). No new deaths were recorded. There were 343 new asymptomatic infections, of which 68 were imported and 275 were domestically transmitted (95 in Zhejiang, 46 in Hainan, 42 in Xinjiang, 28 in Henan, 27 in Guanxi, 8 in Hebei, 7 in Shandong, 6 in XPCC, 4 in Inner Mongolia, 2 in Jilin, 2 in Anhui, 2 in Guangdong, 2 in Chongqing, 2 in Gansu, 1 in Tianjin, and 1 case in Guizhou). There were 5,238 asymptomatic infections still under medical observation, of which 647 were imported.
  • August 5, 2022 – China recorded 222 new confirmed cases, of which 60 were imported (18 in Fujian, 14 in Guangdong, 6 in Inner Mongolia, 5 in Shanghai, 5 in Sichuan, 4 in Shaanxi, 3 in Beijing, 2 in Shandong, 1 in Heilongjiang, 1 in Zhejiang and 1 in Yunnan) and 162 were locally transmitted (127 in Hainan, 16 in Guangxi, 12 in Zhejiang, 12 in Chongqing, in Inner Mongolia, 1 in Guangdong, 1 in Sichuan). No new deaths were recorded. There were 317 new asymptomatic infections, of which 69 were imported and 248 were domestically transmitted (54 in Zhejiang, 42 in Henan, 35 in Hainan, 34 in Guangxi, 34 in Xinjiang, 16  in Shandong, 14 in XPCC, 10 in Gansu, 9 in Chongqing, 2 in Hebei, 1 in Tianjin, 1 in Inner Mongolia, 1 in Jiangxi, 1 in Guizhou, and 1  in Ningxia). There were 5,604 asymptomatic infections still under medical observation, of which 632 were imported.
  • As of 12:00, August 5, 2022, China recorded 468 high-risk areas (2 in Beijing, 4 in Tianjin, 8 in  Inner Mongolia, 3 in Jilin, 4 in Zhejiang, 64 in Shandong Province, 29 in Henan Province, 2 in Guangdong, 207 in Guangxi, 45 in Hainan Province, 23 in Sichuan Province, 43 Gansu, 21 + 12 in Xinjiang) and 747 medium-risk areas.
  • August 4, 2022 – China recorded 111 new confirmed cases, of which 58 were imported (29 in Guangdong, 8 in Shanghai, 8 in Fujian, 3 in Heilongjiang, 2 in Inner Mongolia, 2 in Liaoning, 2 in Chongqing, 1 in Beijing, 1 in Jiangsu, 1 in Shandong, and 1 in Yunnan) and 53 were locally transmitted (24 in Hainan, 10 in Inner Mongolia, 9 in Zhejiang, 2 in Fujian, 2 in Shandong, 2 in Henan, 2 in Guangxi, 1 in Chongqing, and 1 in Sichuan). No new deaths were recorded. There were 335 new asymptomatic infections, of which 94 were imported and 241 were domestically transmitted (62 in Guangxi, 45 in Zhejiang, 41 in Henan, 25 in Xinjiang, 24 in Shandong, 18 in the Xinjiang Production and Construction Corps, 11 in Gansu, 4 in Inner Mongolia, 3 in Hainan, 2 in Jilin, 2 in Shanghai, 1 in Beijing, 1 in Hebei, 1 in Chongqing, and 1 in Yunnan). There were 5,903 asymptomatic infections still under medical observation, of which 635 were imported.
  • As of 16:00, August 4, 2022, China recorded 468 high-risk areas (2 in Beijing, 5 in Tianjin, 8 in Inner Mongolia, 3 in Jilin, 4 in Zhejiang, 64 in Shandong, 29 in Henan, 2 in Guangdong, 207 in Guangxi, 14 in Hainan, 1 in Chongqing, 23 in Sichuan, 73 in Ganus, 21 in the Xinjiang Production and Construction Corps, and 12 in Xinjiang) and 731 medium-risk areas.
  • August 3, 2022 – China recorded 101 new confirmed cases, of which 63 were imported (19 in Guangdong, 10 in Fujian, 6 in Beijing, 4 in Jilin, 4 in Heilongjiang, 4 in Yunnan, 2 in Tianjin, 1 in Liaoning, 1 in Zhejiang, 1 in Zhejiang, 1 in Shandong, and 1 in Chongqing) and 38 were domestically transmitted (12 in Hainan, 10 in Gansu, 8 in Inner Mongolia, 4 in Guangxi, 3 in Shandong, and 1 in Sichuan). No new deaths were recorded. There were 335 new asymptomatic cases, of which 84 were imported and 251 were domestically transmitted (74 in Guangxi, 56 in Henan, 37 in Gansu, 36 in Shandong, 20 in Xinjiang, 11 in the Xinjiang Production and Construction Corps, 5 in Sichuan, 4 in Zhejiang, 3 in Inner Mongolia, 1 in Hebei, 1 in Jiangxi, 1 in Guangdong, 1 in Hainan, and 1 in Yunnan). There were 6,219 asymptomatic infections still under medical observation, of which 604 were imported.
  • As of 00:00, August 4, 2022, China recorded 472 high-risk areas (1 in Beijing, 6 in Tianjin, 6 in Inner Mongolia, 2 in Jilin, 3 in Zhejiang, 80 in Shandong, 29 in Henan, 2 n Guangdong, 207 in Guangxi, 5 in Hainan, 23 in Sichuan, 87 in Gansu, 14 in the Xinjiang Construction and Production Corps, and 7 in Xinjiang), and 715 medium-risk areas.
  • August 2, 2022 – China recorded 107 new confirmed cases, of which 61 were imported (30 in Guangdong, 8 in Shanghai, 8 in Fujian, 4 in Jiangsu, 3 in Beijing, 3 in Sichuan, 3 in Yunnan, 1 in Chongqing, and 1 in Shaanxi) and 46 were locally transmitted (10 in Gansu, 9 in Guangxi, 9 in Sichuan, 7 in Inner Mongolia, 7 in Fujian, 2 in Henan, 1 in Hainan, and 1 in the Xinjiang Production and Construction Corps). No new deaths were recorded. There were 391 new asymptomatic infections, of which 64 were imported and 327 were locally transmitted (96 in Guangxi, 69 in Gansu, 67 in Henan, 47 in Shandong, 28 in Xinjiang, 8 in Inner Mongolia, 4 in Tianjin, 3 in the Xinjiang Production and Construction Corps, 2 in Jiangxi, 2 in Sichuan, and 1 in Guangdong). There were 6,572 asymptomatic infections still under medical observation, of which 587 were imported.
  • As of 19:00, August 2, 2022, China recorded 499 high-risk areas (1 in Beijing, 6 in Tianjin, 4 in Inner Mongolia, 4 in Shanghai, 1 in Anhui, 80 in Shandong,30 in Henan, 6 in Hubei, 4 in Guangdong, 207 in Guangxi, 5 in Hainan, 40 in Sichuan, 98 in Gansu, 6 in Xinjiang, and 7 in the Xinjiang Production and Construction Corps) and 658 medium-risk areas.
  • August 1, 2022 – China recorded 84 new confirmed cases, of which 51 were imported (19 in Guangdong, 6 in shanghai, 6 in Sichuan, 5 in Beijing, 5 in Fujian, 3 in Shandong, 2 in Tianjin, 2 in Heilongjiang, 1 in Shanxi, 1 in Liaoning, and 1 in Shaanxi) and 33 were locally transmitted (15 in Gansu, 9 in Guangxi, 3 in Sichuan, 2 in Shandong, 1 in Beijing, 1 in Inner Mongolia, 1 in Fujian, and 1 in Guangdong). No new deaths were reported. There were 309 new asymptomatic infections, of which 65 were imported and 244 were locally transmitted (66 in Gansu, 49 in Shandong, 43 in Henan, 9 in Xinjiang, 5 in the Xinjiang Production and Construction Corps, 4 in Sichuan, 3 in Inner Mongolia, 2 in Yunnan, 1 in Tianjin, and 1 in Guangdong). There were 6,875 asymptomatic infections still under medical observation, of which 589 were imported.
  • As of 16:00, August 1, 2022, China recorded 620 high-risk areas (1 in Beijing, 6 in Tianjin, 4 in Shanghai, 2 in Zhejiang, 2 in Anhui, 84 in Shandong, 30 in Henan, 6 in Hubei, 5 in Guangdong, 328 in Guangxi, 47 in Sichuan, 98 in Gansu, and 7 in the Xinjiang Production and Construction Corps) and 427 medium-risk areas.
  • July 31, 2022 – China recorded 116 new confirmed cases, of which 42 were imported (9 in Shanghai, 9 in Guangdong, 7 in Fujian, 6 in Sichuan, 4 in Beijing, 3 in Shaanxi, 1 in Tianjin, 1 in Liaoning, 1 in Heilongjiang, and 1 in Hunan) and 74 were locally transmitted (32 in Guangxi, 31 in Gansu, 5 in Sichuan 3 in Shanghai, 1 in Fujian, 1 in Henan, and 1 in Guangdong). No new deaths were recorded. There were 425 new asymptomatic infections, of which 65 were imported and 360 were locally transmitted (143 in Guangxi, 103 in Gansu, 53 in Shandong, 33 in Henan, 8 in the Xinjiang Production and Construction Corps, 7 in Tianjin, 5 in Sichuan, 3 in shanghai, 2 in Guangdong, 2 in Xinjiang, and 1 in Hunan). There were 7,128 asymptomatic cases still under medical observation, of which 583 were imported.
  • July 30, 2022 – China recorded 100 new confirmed cases, of which 51 were imported (13 in Fujian, 12 in Shanghai, 6 in Guangdong, 5 in Beijing, 4 in Sichuan, 4 in Shaanxi, 2 in Liaoning, 2 in Shandong, 1 in Shanxi, 1 in Hubei, and 1 in Yunnan) and 49 were locally transmitted (19 in Gansu, 15 in Guangxi, 10 in Sichuan, 2 in Shandong, 1 in Shanghai, 1 in Henan, and 1 in Guangdong). No new deaths were recorded. There were 389 new asymptomatic infections, of which 51 were imported and 338 were locally transmitted (119 in Gansu, 82 in Anhui, 52 in Guangxi, 26 in Shanghai, 24 in Henan, 12 in Guangdong, 6 in Jiangsu, 5 in Tianjin, 3 in Fujian, 2 in Shandong, and 2 in Xinjiang). There were 7,136 asymptomatic infections still under medical observation, of which 581 were imported.
  • July 29, 2022 – China recorded 109 new confirmed cases, of which 49 were imported (14 in Fujian, 11 in Guangdong, 7 in Shandong, 4 in Shanghai, 4 in Sichuan, 2 in Beijing, 2 in Henan, 2 in Shaanxi, 1 in Tianjin, 1 in Jiangsu, and 1 in Chongqing) and 60 were locally transmitted (21 in Gansu, 16 in Sichuan, 10 in Guangxi, 5 in Shandong, 4 in Henan, 3 in Guangdong, and 1 in Shanghai). No deaths were reported. There were 455 new asymptomatic infections, of which 65 were imported and 390 were locally transmitted (121 in Guangxi, 112 in Gansu, 93 in Shandong, 29 in Sichuan, 17 in Henan, 6 in Shanghai, 4 in Jiangxi, 3 in Guangdong, 2 in Tianjin, 1 in Anhui, 1 in Fujian, and 1 in Yunnan). There were 7,200 asymptomatic infections still under medical observation (of which 557 were imported).
  • As of 0:00, July 27, 2022, there were 770 high-risk, 464 medium-risk areas, and 124 low-risk areas in the country.  The rest unspecified areas are subject to normalized control and prevention management.
  • July 27, 2022 – China recorded 120 new confirmed cases, of which 41 were imported (18 in Guangdong, 10 in Fujian, 7 in Shanghai, 2 in Sichuan, 1 in Tianjin, 1 in Liaoning, 1 in Shandong, and 1 in Shaanxi) and 79 were locally transmitted (33 in Guangxi, 19 in Sichuan, 15 in Gansu, 3 in Guangdong, 3 in Chongqing, 2 in Shanghai, 2 in Jiangxi, 1 in Shandong, and 1 in Henan). No deaths were reported. There were 583 new asymptomatic infections, of which 58 were imported and 525 were locally transmitted (236 in Guangxi, 219 in Gansu, 20 in Shandong, 14 in Shanghai, 9 in Sichuan, 7 in Henan, 5 in Jiangxi, 4 in Hubei, 4 in Guangdong, 2 in Anhui, 2 in Yunnan, 1 in Tianjin, 1 in Jiangsu, and 1 in Zhejiang). There were 7,197 asymptomatic infections still under medical observation (of which 522 were imported).
  • July 26, 2022 – China recorded 148 new confirmed cases, of which 50 were imported (19 in Guangdong, 11 in Fujian, 6 in Sichuan, 3 in Zhejiang, 2 in Beijing, 2 in Shanghai, 2 in Shandong, 1 in Tianjin, 1 in Liaoning, 1 in Hubei, 1 in Chongqing, and 1 in Shaanxi) and 98 were locally transmitted (37 in Gansu, 32 in Guangxi, 16 in Sichuan, 6 in Guangdong, 4 in Shanghai, 2 in Chongqing, and 1 in Shandong). No deaths were reported. There were 828 new asymptomatic infections, of which 58 were imported and 770 were locally transmitted (370  in Guangxi, 306 in Gansu, 27 in Shandong, 17 in Guangdong, 15 in Shanghai, 14 in Sichuan, 7 in Henan, 7 in Yunnan, 2 in Tianjin, 2 in Jiangxi, 1 in Jiangsu, 1 in Zhejiang, and 1 in Chongqing). There were 6,972 asymptomatic infections still under medical observation (of which 498 were imported).
  • July 25, 2022 – China recorded 150 new confirmed cases, of which 49 were imported (19 in Guangdong, 7 in Shanghai, 6 in Fujian, 6 in Sichuan, 4 in Beijing, 2 in Tianjin, 2 in Liaoning, 1 in Jiangsu, 1 in Shandong, and 1 in Shaanxi) and 101 were locally transmitted (34 in Sichuan, 24 in Gansu, 22 in Guangxi, 11 in Guangdong, 3 in Shanghai, 2 in Anhui, 2 in Shandong, 2 in Henan, and 1 in Beijing). No deaths were reported. There were 650 new asymptomatic infections, of which 71 were imported and 579 were locally transmitted (284 in Gansu, 210 in Guangxi, 15 in Shanghai, 13 in Henan, 13 in Guangdong, 11 in Shandong, 11 in Sichuan, 9 in Yunnan, 4 in Tianjin, 3 in Anhui, 3 in Jiangxi, 1 in Jiangsu, 1 in Chongqing, and 1 in Xinjiang). There were 6,473 asymptomatic infections still under medical observation (of which 494 were imported).
  • July 22, 2022 – China recorded 175 new confirmed cases, of which 69 were imported (133 in Guangdong, 10 in Fujian, 9 in Shanghai, 8 in Sichuan, 3 in Beijing, 2 in Tianjin, 2 in Inner Mongolia, 1 in Zhejiang, and 1 in Guangxi) and 106 were locally transmitted (52 in Gansu, 21 in Guangxi, 10 in Guangdong, 8 in Anhui, 6 in Sichuan, 5 in Chongqing, 3 in Shanghai, 1 in Jiangxi). No deaths were reported. There were 836 new asymptomatic infections, of which 62 were imported and 774 were locally transmitted (517 in Gansu, 132 in Guangxi, 44 in Anhui, 20 in Henan, 20 in Shanghai, 15  in Guangdong, 13 in Sichuan, 10 in Tianjin, 4 in Jiangxi, 3 in Yunnan, 2 in Jilin, and 1 in Chongqing). There were 5,481 asymptomatic infections still under medical observation (of which 428 were imported).
  • July 21, 2022 – China recorded 200 new confirmed cases, of which 52 were imported (12 in Fujian, 11 in Guangdong, 6 in Yunnan, 5 in Inner Mongolia, 4 in Jiangxi, 4 in Sichuan, 2 in Beijing, 2 in Shanghai, 2 in Guangxi, 1 in Tianjin, 1 in Jiangsu, 1 in Shandong, 1 in Shaanxi) and 148 were locally transmitted (52 in Guangxi, 49 in Gansu, 18 in Guangdong, 16 in Sichuan, 7 in Anhui, 3 in Shanghai, 2 in Jiangxi, 1 in Inner Mongolia). No deaths were reported. There were 233 new asymptomatic infections, of which 33 were imported and 200 were locally transmitted (49 in Shandong, 48 in Anhui, 34 in Shanghai, 27 in Jiangsu, 14 in Henan, 10 in Gansu, 8 in Fujian, 5 in Guangdong, 2 in Jiangxi, 1 in Liaoning, 1 in Guangxi, 1 in Hainan). There were 5,043 asymptomatic infections still under medical observation (of which 418 were imported).
  • July 20, 2022 – China recorded 150 new confirmed cases, of which 42 were imported (17 in Guangdong, 6 in Fujian, 5 in Tianjin, 2 in Beijing, 2 in Shanghai, 2 in Jiangxi, 2 in Sichuan, 1 in Liaoning, 1 in Jiangsu, 1 in Zhejiang, and 1 in Shandong) and 108 were locally transmitted (47 in Gansu, 21 in Guangxi, 20 in Guangdong, 7 in Sichuan, 5 in Shanghai, 4 in Anhui, 3 in Jiangxi, and 1 in Beijing). No deaths were reported. There were 862 new asymptomatic infections, of which 35 were imported and 827 were locally transmitted (306 in Gansu, 256 in Guangxi, 127 in Henan, 79 in Anhui, and 79 in Tianjin). There were 4,611 asymptomatic infections still under medical observation (of which 372 were imported).
  • As of 11:00, July 20, there were 421 high-risk areas and 633 medium-risk areas in the country.
  • July 19, 2022 – China recorded 237 new confirmed cases, of which 38 were imported (19 in Guangdong, 4 in Beijing, 4 in Tianjin, 4 in Shanghai, 4 in Fujian, 4 in Yunnan, 3 in Jiangxi, 2 in Inner Mongolia, 1 in Zhejiang, 1 in Henan, and 1 in Hubei) and 199 were locally transmitted (134 in Guangxi, 1 in Gansu, 12 in Sichuan, 6 in Anhui, 5 in Guangdong, 4 in Tianjin, 4 in Shanghai, 1 in Jiangxi, and 1 in Chongqing). No deaths were reported. There were 539 new asymptomatic infections, of which 39 were imported and 500 were locally transmitted (199 in Gansu, 109 in Guangxi, 73 in Anhui, 45 in Henan, and 45 in Shanghai). There were 4,035 asymptomatic infections still under medical observation (of which 383 were imported).
  • July 18, 2022 – China recorded 167 new confirmed cases, of which 50 were imported (124 in Guangdong, 5 in Sichuan, 4 in Fujian, 3 in Inner Mongolia, 3 in Shanghai, 2 in Tianjin, 2 in Liaoning, 2 in Zhejiang, 2 in Shandong, 1 in Beijing, 1 in Hunan, and 1 in Gansu) and 117 were locally transmitted (59 in Guangxi, 28 in Gansu, and 1 in Sichuan). No deaths were reported. There were 431 new asymptomatic infections, of which 38 were imported and 206 were locally transmitted (93 in Anhui, 57 in Jiangsu, 34 in Shanghai, 4 in Fujian, 4 in Shandong, 3 in Tianjin, 3 in Guangdong, 3 in Shaanxi, 2 in Inner Mongolia, 2 in Zhejiang, and 1 in Guangxi). There were 3,336 asymptomatic infections still under medical observation (of which 372 were imported).
  • As of 11:00, July 18, there were 402 high-risk areas and 659 medium-risk areas in the country.
  • July 17, 2022 – China recorded 154 new confirmed cases, of which 48 were imported (10 in Fujian, 10 in Guangdong, 6 in Shanghai, 4 in Tianjin, 3 in Chongqing, 3 in Sichuan, 2 in Beijing, 2 in Liaoning, 2 in Jiangsu, 2 in Shandong, 2 in Yunnan, 1 in Hubei, and 1 in Hunan) and 106 were locally transmitted (53 cases in Gansu, 21 in Guangdong, 9 in Guangxi, 7 in Sichuan, 5 in Anhui, 4 in Hainan, 2 in Shanghai, 2 in Jiangxi, 1 in Heilongjiang, 1 in Zhejiang, and 1 in Guizhou). No deaths were reported. There were 537 new asymptomatic infections, of which 63 were imported and 474 were locally transmitted (235 in Guangxi, 105 in Gansu, 42 in Anhui, 29 in Henan, 29 in Shanghai, 9 in Guangdong, 7 in Jiangxi, 6 in Jilin, 5 in Jiangsu, 5 in Sichuan, 4 in Shandong, and 3 in Fujian). There were 3,673 asymptomatic infections still under medical observation (of which 400 were imported).
  • July 16, 2022 – China recorded 129 new confirmed cases, of which 54 were imported (11 in Zhejiang, 10 in Guangdong, 8 in Tianjin, 7 in Fujian, 6 in Shanghai, 3 in Inner Mongolia, 2 in Beijing, 2 in Jiangsu, 2 in Hunan, 1 in Liaoning, 1 in Hubei, 1 in Yunnan) and 75 were locally transmitted (31 in Gansu, 16 in Anhui, 15 in Guangdong, 5 in Shanghai, 5 in Hainan, 1 in Jiangsu, 1 in Henan, and 1 in Sichuan). No deaths were reported. There were 418 new asymptomatic infections, of which 43 were imported and 375 were locally transmitted (139 in Anhui, 82 in Gansu, 40 in Guangxi, 39 in Henan, 39 in Shanghai, 26 in Guangdong, 6 in Shandong, 4 in Jiangsu, 4 in Jiangxi, 3 in Jilin, 1 in Fujian, 1 in Hainan, 1 in Chongqing, and 1 in Qinghai). There were 3457 asymptomatic infections still under medical observation (of which 372 were imported).
  • July 15, 2022 – China recorded 113 new confirmed cases, of which 49 were imported (13 in Fujian, 11 in Guangdong, 5 in Shanghai, 3 in Inner Mongolia, 3 in Sichuan, 3 in Yunnan, 2 in Tianjin, 2 in Liaoning, and 2 in Shandong) and 64 were locally transmitted (30 in Gansu, 17 in Guangdong, 7 in Hainan, 6 in Shanghai, 2 in Jiangxi, 1 in Inner Mongolia, and 1 in Henan). No deaths were reported. There were 420 new asymptomatic infections, of which 52 were imported and 368 were locally transmitted (165 in Guangxi, 51 in Henan, 41 in Gansu, 39 in Shanghai, 39 in Guangdong, 13 in Jiangsu, 9 in Shandong, 7 in Jiangxi, 3 in Fujian, and 1 in Hainan). There were 3,336 asymptomatic infections still under medical observation (of which 372 were imported).
  • As of 14:00, July 15, there were 339 high-risk areas (2 in Tianjin, 11 in Inner Mongolia, 12 in Shanghai, 19 in Jiangsu, 15 in Anhui, 12 in Fujian, 9 in Jiangxi, 18 in Shandong, 13 in Henan, 81 in Guangdong, 86 in Guangxi, 11 in Hainan, 3 in Shaanxi, and 47 in Gansu) and 642 medium-risk areas.
  • July 14, 2022 – China recorded 121 new confirmed cases, of which 35 were imported (12 in Guangdong, 7 in Fujian, 6 in Shanghai, 3 in Sichuan, 2 in Chongqing, 2 in Yunnan, 1 in Tianjin, 1 in Jiangsu, and 1 in Shaanxi) and 86 were locally transmitted (36 in Gansu, 32 in Guangdong, 5 in Shanghai, 5 in Jiangxi, 3 in Hainan, 2 in Jiangsu, 1 in Inner Mongolia, 1 in Henan, and 1 in Chongqing). No new deaths were recorded. There were 245 new asymptomatic infections, of which 39 were imported and 206 were locally transmitted (64 in Gansu, 42 in Shanghai, 29 in Henan, 25 in Guangxi, 18 in Shandong, 11 in Guangdong, 8 in Jiangsu, 4 in Jiangxi, 3 in Hainan, 1 in Fujian, and 1 in Sichuan). There were 3,214 asymptomatic infections still under medical observation, of which 379 were imported.
  • As of 15:00, July 14, China recorded 264 high-risk areas (2 in Tianjin, 11 in Inner Mongolia, 14 in Shanghai, 19 in Jiangsu, 15 in Anhui, 25 in Fujian, 7 in Jiangxi, 22 in Shandong, 13 in Henan, 78 in Guangdong, 2 in Guangxi, 3 in Shaanxi, and 42 in Gansu) and 590 medium-risk areas.
  • July 13, 2022 – China recorded 98 new confirmed cases, of which  41 were imported (9 in Shanghai, 9 in Guangdong, 8 in Fujian, 3 in Hunan, 2 in Tianjin, 2 in Inner Mongolia, 2 in Yunnan, 1 in Jiangsu, 1 in Zhejiang, 1 in Shandong, 1 in Chongqing, 1 in Sichuan, and 1 in Shaanxi) and 57 were locally transmitted (16 in Guangdong, 8 in Gansu, 7 in Anhui, 5 in Shanghai, 5 in Jiangsu, 5 in Shandong, 4 in Inner Mongolia, 3 in Henan, 3 in Hainan, and 1 in Jiangxi). No new deaths were recorded. There were 240 new asymptomatic infections, of which 36 were imported and 204 were locally transmitted (61 in Gansu, 50 in Shanghai, 33 in Shandong, 22 in Henan, 14 in Jiangsu, 6 in Guangdong, 6 in Hainan, 4 in Jiangxi, 3 in Anhui, 3 in Guangxi, and 2 in Fujian). There were 3,207 asymptomatic infections still under medical observation, of which 381 were imported.
  • As of 14:00, July 13, China recorded 289 high-risk areas (3 in Beijing, 2 in Tianjin, 11 in Inner Mongolia, 15 in Shanghai, 40 in Jiangsu, 34 in Anhui, 29 in Fujian, 7 in Jiangxi, 24 in Shandong, 8 in Henan, 73 in Guangdong, 6 in Hainan, 3 in Shaanxi, and 34 in Gansu) and 563 medium-risk areas.
  • July 12, 2022 – China recorded 107 new confirmed cases, of which 38 were imported (11 in Guangdong, 8 in Shanghai, 6 in Fujian, 4 in Tianjin, 2 in Jiangxi, 2 in Yunnan, 2 in Shaanxi, 1 in Shandong, 1 in Chongqing, and 1 in Sichuan) and 69 were locally transmitted (22 in Guangdong, 9 in Henan, 9 in Hainan, 8 in Shandong, 5 in Shanghai, 5 in Jiangsu, 5 in Anhui, 2 in Inner Mongolia, 2 in Zhejiang, 1 in Sichuan, and 1 in Shaanxi). No new deaths were recorded. There were 317 new asymptomatic infections, of which 39 were imported and 278 were locally transmitted (64 in Henan, 54 in Shanghai, 54 in Shandong, 23 in Jiangsu, 20 in Guangdong, 19 in Anhui, 19 in Gansu, 11 in Fujian, 7 in Hainan, 3 in Jiangxi, 3 in Guangxi, and 1 in Shaanxi). There were 3,208 asymptomatic infections still under medical observation, of which 375 were imported.
  • As of 14:00, July 12, China recorded 306 high-risk areas (5 in Beijing, 2 in Tianjin, 11 in Inner Mongolia, 15 in Shanghai, 41 in Jiangsu, 72 in Anhui, 41 in Fujian, 7 in Jiangxi, 22 in Shandong, 8 in Henan, 51 in Guangdong, 5 in Hainan, 6 in Shaanxi, and 20 in Gansu) and 514 medium-risk areas.
  • July 11, 2022 – China recorded 94 new confirmed cases, of which 48 were imported (11 in Shanghai, 10 in Fujian, 10 in Guangdong, 7 in Sichuan, 2 in Tianjin, 2 in Inner Mongolia, 2 in Liaoning, 1 in Beijing, 1 in Zhejiang, 1 in Shandong, and 1 in Shaanxi) and 46 were locally transmitted (17 in Guangdong, 9 in Anhui, 6 in Shanghai, 4 in Jiangsu, 2 in Hainan, 2 in Gansu, 1 in Beijing, 1 in Inner Mongolia, 1 in Zhejiang, 1 in Shandong, 1 in Shaanxi, and 1 in Qinghai). No new deaths were recorded. There were 335 new asymptomatic infections, of which 29 were imported and 306 were locally transmitted (79 in Shandong, 63 in Shanghai, 57 in Jiangsu, 30 in Anhui, 25 in Gansu, 18 in Fujian, 15 in Guangdong, 12 in Henan, 3 in Guangxi, 1 in Shanxi, 1 in Jiangxi, 1 in Hainan, and 1 in Shaanxi). There were 3,094 new asymptomatic infections still under medical observation, of which 382 were imported.
  • As of 15:00, July 11, 2022, China recorded 294 high-risk areas (5 in Beijing, 9 in Tianjin, 6 in Inner Mongolia, 12 in Shanghai, 55 in Jiangsu, 77 in Anhui, 46 in Fujian, 6 in Jiangxi, 21 in Shandong, 6 in Henan, 39 in Guangdong, 1 in Hainan, 7 in Shaanxi, and 4 in Gansu) and 446 medium-risk areas.
  • July 10, 2022 – China recorded 101 new confirmed cases, of which 36 were imported (11 in Guangdong, 7 in Fujian, 4 in Shanghai, 3 in Beijing, 3 in Chongqing, 2 in Jiangxi, 1 in Tianjin, 1 in Liaoning, 1 in Anhui, 1 in Shandong, 1 in Yunnan, and 1 in Shaanxi) and 65 locally transmitted cases (17 in Guangdong, 11 in Anhui, 9 in Inner Mongolia, 9 in Shandong, 5 in Shanghai, 5 in Gansu, 3 in Jiangsu, 2 in Jiangxi, 2 in Shaanxi, 1 in Zhejiang, and 1 in Fujian). No new deaths were recorded. There were 319 new asymptomatic infections, of which 40 were imported and 279 were locally transmitted (71 in Anhui, 59 in Jiangsu, 55 in Shandong, 52 in Shanghai, 8 in Guangdong, 8 in Gansu, 7 in Fujian, 7 in Hainan, 4 in Henan, 3 in Guangxi, 2 in Zhejiang, 1 in Tianjin, 1 in Jiangxi, and 1 in Shaanxi). There were 2,876 asymptomatic infections still under medical observation (of which 390 were imported).
  • July 9, 2022 – China recorded 112 new confirmed cases, of which 45 were imported (12 in Guangdong, 8 in Shanghai, 7 in Inner Mongolia, 6 in Fujian, 3 in Tianjin, 3 in Jiangxi, 2 in Chongqing, 2 in Shaanxi, 1 in Liaoning, and 1 in Sichuan) and 67 were locally transmitted (25 in Anhui, 11 in Shanghai, 7 in Jiangsu, 6 in Guangdong, 5 in Inner Mongolia, 4 in Gansu, 3 in Beijing, 3 in Fujian, 1 in Zhejiang, 1 in Shandong, and 1 in Shaanxi). No new deaths were recorded. There were 343 new asymptomatic infections, of which 39 were imported and 304 were locally transmitted (114 in Anhui, 71 in Jiangsu, 48 in Shanghai, 45 in Shandong, 18 in Fujian, 2 in Guangdong, 2 in Shaanxi, 1 in Tianjin, 1  in Zhejiang, 1 in Guangxi, and 1 in Gansu). There were 2,666 asymptomatic infections still under medical observation, of which 379 were imported.
  • July 8, 2022 – China recorded 97 new confirmed cases, of which 50 were imported (16 in Guangdong, 14 in Fujian, 5 in Tianjin, 4 in Shanghai, 3 in Sichuan, 2 in Shandong, 1 in Shanxi, 1 in Jiangsu, 1 in Zhejiang, 1 in Hunan, 1 in Chongqing, and q in Yunnan) and 47 domestically transmitted cases (17 in Shanghai, 17 in Anhui, 4 in Inner Mongolia, 3 in Fujian, 3 in Guangdong, 2 in Jiangsu, and 1 in Shaanxi). No new deaths were recorded. There were 381 new asymptomatic infections, of which 50 were imported and 331 were locally transmitted (140 in Anhui, 67 in Jiangsu, 66 in Shandong, 28 in Shanghai, 14 in Fujian, 8 in Shaanxi, 4 in Guangdong, 2 in Guangxi, and 2 in Hainan). There were 2,403 asymptomatic infections still under medical observation, of which 385 were imported.
  • As of 8:00, July 8, 2022, China recorded 280 high-risk areas (5 in Beijing, 7 in Tianjin, 3 in Inner Mongolia, 9 in Liaoning, 7 in Shanghai, 54 in Jiangsu, 131 in Anhui, 38 in Fujian, 9 in Shandong, 6 in Guangdong, and 11 in Shaanxi) and 212 medium-risk areas.
  • July 7, 2022 – China recorded 124 new confirmed cases, of which 30 were imported (11 in Shanghai, 7 in Fujian, 5 in Guangdong, 2 in Beijing, 2 in Jiangsu, 1 in Shanxi, 1 in Heilongjiang, and 1 in Henan) and 94 domestically transmitted cases (39 in Anhui, 32 in Shanghai, 4 in Beijing, 4 in Inner Mongolia, 4 in Jiangsu, 3 in Shaanxi, 2 in Fujian, 2 in Shandong, 2 in Guangdong, 1 in Tianjin, and 1 in Shanxi). No new deaths were recorded. There were 285 new asymptomatic infections, of which 41 were imported and 244 were locally transmitted (128 in Anhui, 57 in Jiangsu, 22 in Shanghai, 17 in Fujian, 9 in Shandong, 4 in Inner Mongolia, 3 in Tianjin, 2 in Guangdong, 1 in Liaoning, and 1 in Shaanxi). There were 2,106 asymptomatic infections still under medical observation, of which 384 were imported.
  • July 6, 2022 – China recorded 141 new confirmed cases, of which 29 were imported (9 in Guangdong, 6 in Shanghai, 3 in Fujian, 2 in Beijing, 2 in Chongqing, 1 in Tianjin, 1 in Zhejiang, 1 in Shandong, 1 in Hainan, 1 in Sichuan, 1 in Yunnan, and 1 in Shaanxi) and 112 domestically transmitted cases (81 in Anhui, 9 in Shanghai, 8 in Fujian, 5 in Beijing, 4 in Jiangsu, 2 in Zhejiang, 1 in Shandong, 1 in Sichuan, and 1 in Shaanxi). No new deaths were recorded. There were 286 new asymptomatic infections, of which 45 were imported and 241 were locally transmitted (141 in Anhui, 61 in Jiangsu, 15 in Shanghai, 10 in Shaanxi, 6 in Fujian, 5 in Tianjin, 1 in Beijing, 1 in Guangdong, and 1 in Sichuan). There were 1,951 asymptomatic infections still under medical observation, of which 388 were imported.
  • July 5, 2022 – China recorded 112 new confirmed cases, of which 43 were imported (11 in Guangdong, 8 in Fujian, 4 in Tianjin, 4 in Shanghai, 3 in Jiangsu, 3 in Chongqing, 3 in Yunnan, 2 in Inner Mongolia, 1 in Beijing, 1 in Shanxi, 1 in Zhejiang, 1 in Jiangxi, and 1 in Hubei) and 69 domestically transmitted cases (52 in Anhui, 7 in Shaanxi, 3 in Beijing, 3 in Shanghai, 3 in Shandong, and 1 in Guangdong). No new deaths were recorded. There were 306 new asymptomatic infections, of which 40 were imported and 266 were locally transmitted (179 in Anhui, 66 in Jiangsu, 7 in Fujian, 5 in Shanghai, 4 in Shandong, 2 in Guangdong, 2 in Shaanxi, and 1 in Liaoning). There were 1,774 asymptomatic infections still under medical observation, of which 384 were imported.
  • July 4, 2022 – China recorded 72 new confirmed cases, of which 31 were imported (9 in Guangdong, 7 in Shanghai, 5 in Fujian, 2 in Inner Mongolia, 2 in Zhejiang, 1 in Beijing, 1 in Tianjin, 1 in Liaoning, 1 in Jiangxi, 1 in Henan, and 1 is Sichuan) and 41 domestically transmitted cases (29 in Anhui, 4 in Jiangsu, 4 in Shandong, 2 in Shanghai, 1 in Fujian, and 1 in Guangdong). No new deaths were recorded. There were 388 new asymptomatic infections, of which 49 were imported and 339 were locally transmitted (258 in Anhui, 52 in Jiangsu, 9 in Liaoning, 9 in Fujian, 4 in Shandong, 3 in Shaanxi, 2 in Zhejiang, 1 in Shanghai, and 1 in Sichuan). There were 1,552 asymptomatic infections still under medical observation, of which 398 were imported.
  • July 1, 2022 – China recorded 37 new cases, of which 25 were imported (7 in Fujian, 4 in Shanghai, 3 in Shaanxi, 2 in Tianjin, 2 in Zhejiang, 2 in Shandong, 2 in Guangdong, 2 in Sichuan and 1 in Chongqing), and 12 were locally transmitted (9 cases in Anhui, 2 cases in Shandong, 1 case in Jiangsu). There were 208 new asymptomatic cases, of which 57 were imported from abroad and 151 were locally transmitted (98 in Anhui, 25 in Jiangsu, 11 in Shandong, 7 in Liaoning, 2 in Tianjin, 2 in Zhejiang, 2 in Hubei, 2 in Guangdong, 1 in Jiangxi, and 1 in Sichuan). No new deaths were reported.
  • June 30, 2022 – China recorded 33 new symptomatic cases, of which 25 were imported (10 in Shanghai, 7 in Fujian, 2 in Beijing, 2 in Shaanxi, 1 in Anhui, 1 in Guangdong, 1 in Chongqing, and 1 in Sichuan), and 8 were locally transmitted (5 in Jiangsu, 2 in Guangdong, 1 in Beijing). There were 77 new asymptomatic cases, including 46 imported and 31 locally transmitted (13 in Anhui, 9 in Jiangsu, 7 in Liaoning, and 2 in Guangdong). No new deaths were reported.
  • June 29, 2022 – China recorded 24 new symptomatic cases, of which 21 were imported (6 in Guangdong, 4 in Fujian, 3 in Jiangxi, 3 in Chongqing, 2 in Shandong, 1 in Beijing, 1 in Shanghai, and 1 in Sichuan), and 3 were locally transmitted (2 in Jiangsu, 1 in Guangdong). There were 105 new asymptomatic cases, including 69 imported and 36 locally transmitted (15 in Anhui, 9 in Tianjin, 4 in Jiangsu, 3 in Liaoning, 1 in Guangdong, 1 in Beijing, 1 in Sichuan, and 1 in Yunnan). No new deaths were reported.
  • June 28, 2022 – China recorded 16 new symptomatic cases. Among them, there are 15 imported cases (6 in Fujian, 4 in Guangdong, 3 in Shanghai, 1 in Beijing, and 1 in Zhejiang), including 2 who were converted from asymptomatic infections to confirmed cases (1 in Zhejiang and 1 in Fujian); 1 local case (in Guangdong). There were  84 new asymptomatic cases, including 63 imported and 21 locally-transmitted ones (6 in Anhui, 4 in Tianjin, 4 in Liaoning, 4 in Guangdong, and 4 in Guangxi). No new deaths were reported.
  • June 27, 2022 – China reported 39 new symptomatic cases, of which 34 were imported (6 in Shanghai, 6 in Shaanxi, 5 in Tianjin, 4 in Fujian, 4 in Guangdong, 3 in Chongqing, 2 in Zhejiang, 1 in Jiangsu, 1 in Hubei, 1 in Sichuan and 1 in Yunnan), while 5 were locally transmitted cases (3 in Beijing and 2 in Shanghai). There were 145 new asymptomatic cases, including 72 imported cases and 73 local cases (20 cases in Shanghai, 14 cases in Jilin, 12 cases in Beijing, 12 cases in Inner Mongolia, 10 cases in Liaoning, 2 cases in Guangxi, 1 case in Fujian, 1 in Jiangxi and 1 in Sichuan). No deaths were recorded.
  • June 26, 2022 – 39 new cases were reported, 37 of which were imported (9 in Guangdong, 8 in Tianjin, 6 in Fujian, 4 in Shanghai, 4 in Yunnan, 2 in Jiangsu, 2 in Sichuan, 1 in Heilongjiang, and 1 in Gansu), and 2 were local cases (1 in Beijing and 1 in Guangdong). Among these, 146 cases were asymptomatic, a no deaths were registered.
  • June 25, 2022 – China recorded 53 new cases. Among them, 46 were imported cases (9 in Guangdong, 5 in Shanghai, 5 in Fujian, 5 in Yunnan, 5 in Shaanxi, 4 in Sichuan, 3 in Beijing, 3 in Jiangsu, 2 in Zhejiang, 2 in Jiangxi, and 1 in Tianjin, 1 in Hunan, 1 in Chongqing), including 98 asymptomatic cases (2 in Guangdong, 2 in Sichuan, 2 in Shaanxi, 1 in Zhejiang, and 1 in Hunan). 7 cases were locally transmitted (Guangdong 5 cases and 2 cases in Beijing). No new deaths were reported.
  • June 24, 2022 – China recorded 37 new symptomatic cases, of which 19 were imported (5 in Guangdong, 4 in Beijing, 3 in Shanghai, 2 in Fujian, 2 in Sichuan, 1 in Tianjin, 1 in Inner Mongolia, and 1 in Shandong) and 18 were locally transmitted (14 in Inner Mongolia, 2 in Shanghai, 1 in Beijing, and 1 in Guangdong). No new deaths were recorded. There were 106 new asymptomatic infections, of which 80 were imported and 26 were locally transmitted (8 in Jilin, 7 in Liaoning, 4 in Guangdong, 4 in Guangxi, 2 in Beijing, and 1 in Shanghai). There were 1,210 asymptomatic infections still under medical observation, of which 554 were imported.
  • June 23, 2022 – China recorded 48 new asymptomatic infections, of which 35 were imported (12 in Guangdong, 9 in Shanghai, 6 in Fujian, 4 in Chongqing, 2 in Shaanxi, 1 in Beijing, and 1 in Sichuan) and 13 were locally transmitted (9 in Shanghai, 3 in Beijing, and 1 in Inner Mongolia). No new deaths were recorded. There were 87 new asymptomatic infections, of which 69 were imported and 18 were locally transmitted (7 in Jilin, 5 in Liaoning, 3 in Guangdong, and 3 in Guangxi). There were 1,262 asymptomatic infections still under medical observation, of which 531 were locally transmitted.
  • As of 00:00, June 23, 2022, China recorded 12 high-risk areas (11 in Inner Mongolia and 1 in Beijing) and 34 medium-risk areas.
  • June 22, 2022 – China recorded 31 new confirmed cases, of which 21 were imported (7 in Guangdong, 4 in Tianjin, 4 in Fujian, 3 in Shaanxi, 1 in Beijing, 1 in Inner Mongolia, and 1 in Zhejiang) and 10 were locally transmitted (4 in Beijing, 4 in Shanghai, 1 in Inner Mongolia, and 1 in Guangdong). No new deaths were recorded. There were 95 new asymptomatic cases, of which 83 were imported and 12 were locally transmitted (4 in Liaoning, 4 in Shanghai, 2 in Beijing, and 2 in Guangxi). There were 1,370 asymptomatic cases still under medical observation, of which 539 were imported.
  • As of 21:00, June 21, 2022, China recorded 12 high-risk areas (11 in Inner Mongolia and 1 in Beijing) and 37 high-risk areas.
  • June 21, 2022 – China recorded 37 new asymptomatic infections, of which 28 were imported (9 in Shanghai, 6 in Fujian, 6 in Guangdong, 3 in Shaanxi, 2 in Zhejiang, 1 in Beijing, and 1 in Tianjin) and 9 were locally transmitted (6 in Shanghai and 3 in Beijing). No new deaths were recorded. There were 105 new asymptomatic infections, of which 80 were imported and 25 were locally transmitted (10 in Jilin, 6 in Liaoning, 3 in Shanghai, 2 in Beijing, 2 in Guangdong, and 2 in Guangxi). There were 1,449 asymptomatic infections still under medical observation, of which 532 were imported.
  • As of 00:00, June 21, 2022, China recorded 11 high-risk areas (all in Inner Mongolia) and 38 medium-risk areas.
  • June 20, 2022 – China recorded 38 new confirmed cases, of which 24 were imported (7 in Fujian, 5 in Shanghai, 3 in Tianjin, 3 in Guangdong, 3 in Shaanxi, 2 in Yunnan, and 1 in Jiangxi) and 14 were domestically transmitted (10 in Shanghai and 4 in Beijing). No new deaths were recorded. There were 71 new asymptomatic infections, of which 61 were imported and 10 were locally transmitted (3 in Shanghai, 2 in the Xinjiang Production and Construction Corps, 1 in Beijing, 1 in Jilin, and 1 in Guangxi). There were 1,483 asymptomatic infections still under medical observation, of which 531 were imported.
  • As of 19:00, June 20, 2022, China recorded 11 high-risk areas (all in Inner Mongolia) and 42 medium-risk areas.
  • June 19, 2022 – China recorded 36 new confirmed cases, of which 31 were imported (10 in Shandong, 9 in Fujian, 6 in Shanghai, 1 in Beijing, 1 in Jiangsu, 1 in Hunan, 1 in Guangdong, 1 in Yunnan, and 1 in Shaanxi) and 5 were locally transmitted ( 3 in Shanghai, 1 in Inner Mongolia, and 1 in Liaoning). No new deaths were recorded. There were 123 new asymptomatic infections, of which 101 were imported and 22 were domestically transmitted (6 in Shanghai, 4 in Inner Mongolia, 3 in Liaoning, 3 in Jilin, 2 in Guangdong, 1 in Beijing, 1 in Zhejiang, 1 in Guangxi, and 1 in the Xinjiang Production and Construction Corps). There were 1,560 asymptomatic infections still under medical observation, of which 546 were imported.
  • June 18, 2022 – China recorded 35 new confirmed cases, of which 24 were imported (6 in Guangdong, 4 in Fujian, 4 in Yunnan, 2 in Shanghai, 2 in Jiangsu, 1 in Beijing, 1 in Heilongjiang, 1 in Hubei, 1 in Hunan, 1 in Sichuan, and 1 in Shaanxi) and 11 domestically transmitted cases (5 in Inner Mongolia, 4 in Liaoning, 1 in Beijing, and 1 in Shanghai). No new deaths were recorded. There were 169 new asymptomatic infections, of which 128 were imported and 41 were domestically transmitted (16 in Inner Mongolia, 8 in Beijing, 6 in Shanghai, 4 in Jilin, 3 in Guangxi, 2 in Hebei, and 2 in Liaoning). There were 1,585 asymptomatic infections still under medical observation, of which 523 were imported
  • June 17, 2022 – China recorded 54 new confirmed cases, of which 31 were imported (10 in Fujian, 7 in Guangdong, 3 in Shanghai, 3 in Shaanxi, 2 in Beijing, 2 in Sichuan, 1 in Zhejiang, 1 in Hubei, 1 in Hunan, and 1 in Chongqing) and 23 domestically transmitted cases (11 in Beijing, 6 in Inner Mongolia, 4 in Liaoning, and 2 in Shanghai). No new deaths were recorded. There were 103 new asymptomatic infections, of which 62 were imported and 41 were locally transmitted (13 in Inner Mongolia, 11 in Beijing, 6 in Jilin, 5 in Liaoning, 2 in Shanghai, 1 in Hebei, 1 in Guangxi, 1 in Sichuan, and 1 in Yunnan). There were 1,652 asymptomatic infections still under medical observation, of which 464 were imported.
  • As of 0:00, June 17, 2022, China recorded 9 high-risk areas (all in Inner Mongolia) and 44 medium-risk areas.
  • June 16, 2022 – China recorded 64 new confirmed cases, of which 22 were imported (7 in Fujian, 6 in Guangdong, 4 in Shanghai, 2 in Zhejiang, 1 in Beijing, 1 in Chongqing, and 1 in Sichuan) and 42 domestically transmitted cases (14 in Beijing, 13 in Inner Mongolia, 9 in Shanghai, 3 in Liaoning, 2 in Hebei, and 1 in Chongqing). No new deaths were recorded. There were 111 new asymptomatic infections, of which 73 were imported and 38 were locally transmitted (21 in Inner Mongolia, 7 in Shanghai, 4 in Beijing, 3 in Liaoning, 2 in Jilin, and 1 in Guangxi). There were 1,804 asymptomatic infections still under medical observation, of which 472 were imported.
  • June 15, 2022 – China recorded 77 new confirmed cases, of which 23 were imported (5 in Shanghai, 5 in Fujian, 5 in Guangdong, 2 in Zhejiang, 2 in Sichuan, 1 in Tianjin, 1 in Jiangsu, 1 in Hunan, and 1 in Shaanxi) and 54 domestically transmitted cases (25 in Beijing, 14 in Inner Mongolia, 13 in Shanghai, and 2 in Liaoning). No new deaths were recorded. There were 158 new asymptomatic infections, of which 93 were imported and 65 were locally transmitted (38 in Beijing, 10 in Inner Mongolia, 6 in Jilin, 4 in Liaoning, 2 in Hebei, 2 in Shanghai, 1 in Zhejiang, 1 in Chongqing, and 1 in Yunnan). There were 1,980 asymptomatic infections still under medical observation, of which 467 were imported.
  • Beijing resumes indoor dining and lifts other COVID curbs. From Monday, June 6, Beijing has permitted restaurants to resume on-premises dining in all of the city’s districts except for Fengtai and parts of Changping district. Restaurants will be required to impose COVID-19 prevention measures, maintaining a reduced capacity for in-restaurant seating and keeping diners at adequate distances from one another. Moreover, the limit on the capacity for visitors to public parks was raised to 75 percent. Visitors will have to show a negative PCR test taken in the past 72 to enter public parks. On Jun 5, the education department also confirmed that primary and secondary school students will be able to return to classrooms from June 13, while kindergarten students can return from June 20.
  • Shanghai formally lifts lockdown. From June 1, residents of all districts are permitted to leave their compounds, provided they are not in a medium or high-risk area or live in a compound under closed or controlled management (housing compounds that have recorded positive cases in the past 14 and seven days respectively). Most modes of transport have also resumed operations, with public busses and subway lines resuming basic operations, and taxis and other ride-hailing services permitted to resume business. Private passenger cars are also permitted back on the roads, except in medium or high-risk areas. Businesses including shopping malls, supermarkets, convenience stores, pharmacies, and other commercial outlets have been permitted to reopen from June 1, provided they maintain capacity at no higher than 75 percent. Theaters, cultural and expo venues, gyms, and other closed venues will remain closed until further notice. People will be required to present a negative nucleic acid test from the past 72 hours before entering a public building.
  • Beijing gradually lifts COVID-19 curbs. Beijing has begun gradually lifting restrictions in certain districts. As of May 29, except for those living in compounds that are under closed or controlled management (those that have recorded positive cases in the last 14 and 7 days respectively), residents of Fangshan and Shunyi districts have been permitted to return to their place of work, whereas the districts of Chaoyang and Tongzhou have been permitted to ‘appropriately’ adjust the rate of people permitted to go to their place of work. Transport, including subways, busses, and taxis, have also been permitted to resume operations in Fangshan, Shunyi, and Chaoyang districts. Meanwhile, scenic spots, parks, and other tourist sites across the city are required to keep capacity at 50 percent, require reservations, and implement staggered entrance of visitors. In areas that have recorded no new cases outside of controlled and closed areas for 7 consecutive days, libraries, museums, theaters, art galleries, cultural centers, and sports and fitness venues (except those located in underground spaces) are also permitted to open at 50 percent capacity.
  • Shanghai sets fixed dates for reopening parts of the city in June. Students in the second and third year of high school and third year of junior high school will return to classrooms from June 6, while students in other grades will continue at-home learning. In a set of measures released on Sunday, May 29, the Shanghai government also announced that companies will no longer require approval from the government to resume operations and production from June 1 onward.  Residents of all housing compounds in the city – except for those in medium or high-risk areas or under closed or controlled management – will also be permitted to freely leave and enter their compounds from June 1, without having to provide a reason or apply for permission. As of Wednesday, May 25, 61,994 communities in Shanghai were classified as “prevention areas”, meaning that they are subject to looser restrictions and ostensibly that residents are permitted to leave their compounds, although specific rules have been left to the discretion of local community committees.
  • Tianjin locks down one entire district and orders city-wide testing. The city of Tianjin near Beijing has ordered the lockdown of all areas of the central Heping district for an initial period of three days from May 25 onward. Residents of the district have been asked not to leave their housing compounds unless necessary. All vehicles except those needed for emergency services or COVID-19 containment are not permitted to cross over to other districts. In addition, the city ordered COVID-19 testing of all residents in the city from Wednesday onward. Cases in Tianjin have been rising over the past week, reaching 18 on Wednesday, May 25, up from 17 on Tuesday.
  • Beijing extends work from home order to more districts. Work from home orders have been extended to six districts in the capital, encompassing the districts of Chaoyang, Haidian, Fengtai, Fangshan, Shunyi, and Shijingshan. The announcement came after the city found 94 new domestic cases between 15:00 on Saturday, May 21 and 15:00 on Sunday, May 22.  A total of 83 confirmed cases and 16 asymptomatic infections were recorded on Sunday, May 22, the highest tally in the current outbreak. Offices in these districts are permitted to operate at a maximum of 30 percent capacity. Outbreaks have also been found in other districts, such as Dongcheng district, which placed several communities under lockdown after cases were discovered at a local mall.
  • China may further reduce travel quarantine requirements for inbound travelers. On May 23, the South China Morning Post reported that Beijing was considering further reducing quarantine time for inbound overseas travelers, citing unnamed sources. The city would move to a 7+7 policy, where travelers are required to undergo 7 days of centralized quarantine in a hotel followed by 7 days of home quarantine. This is a reduction from the current 10-day centralized quarantine policy announced in early May, which was already a reduction from the standard 14+7 policy.  According to the unnamed sources, the policy is being considered to help alleviate staffing issues for foreign companies, and some multi-national corporations had already been informed of the change. However, this policy is as yet unconfirmed and no official announcement has been made.
  • Shanghai resumes operations of some transport links. On Sunday, May 22, Shanghai resumed operations of 4 metro lines (Line 3, 6, 10, and 16) and 273 bus routes. These transport links cover all of the city’s central districts, as well as key transport hubs, including all airports and train stations, level 3 hospitals, and central hospitals of each district. In a press briefing on May 19, it was also reported that Shanghai would begin to gradually increase the number of trains entering and leaving the city’s two railway stations while keeping the current travel requirements in place (48-hour nucleic acid test and 24-hour antigen test). Some of the outer districts, including Jinshan, Fengxian, and Chongming, have also begun gradually restoring bus routes within the districts and allowing taxis to return to the roads Shanghai to open “green channel” to facilitate import of key goods. At a routine press briefing on May 18, Deputy Director of Shanghai Customs Liu Bo said that Shanghai would open a “green channel” for the city’s key industries, including integrated circuits, biopharmaceuticals, and car manufacturing. The green channel will aim to expand facilitation measures to entire industrial and supply chains. Goods that are eligible for the green channel range from finished products to commodities and raw materials and related equipment. The facilitation measures include sped up quarantine procedures for coronavirus vaccines, medicines, and other products for fighting the pandemic and facilitated customs clearance measures for “whitelisted” companies, such as automakers Tesla and SAIC.
  • 70% of “whitelisted” companies resume operations in Shanghai. Of the 3,000 businesses added to a whitelist of companies permitted to restart operations in Shanghai, 70% have successfully reopened. Among these were the first batch of 666 companies permitted to open, of which 95% have done so. The list also includes 847 foreign-invested enterprises, of which 80 percent had resumed work. In addition to the whitelisted companies, over 4,400 of the city’s 9,000 industrial enterprises (over a certain size) have resumed operations, according to a city official’s response to a media inquiry. In districts that achieved zero-COVID at the community level earlier than the rest of the city, such as the Jinshan, Qingpu, Fengxian, and Songjiang districts, the resumption rate of industrial enterprises was higher.
  • China relaxes travel requirements for U.S. travelers. According to a notice published on the website of the Chinese Embassy in the U.S., China has loosened requirements for travel from the U.S. to China. The notice removes the requirements for passengers to undergo 7 days of COVID-19 testing, conduct self-monitoring, and take anti-body tests prior to boarding the flight. Crew members will also no longer be required to undergo additional quarantine and can travel to China as normal passengers. Passengers will still be required to take two COVID-19 tests from two different testing centers within 48 hours of boarding the flight, regardless of whether they have been inoculated and which vaccine they have been inoculated with. These requirements were first imposed in January 2022 to prevent the spread of the Omicron variant.
  • Prefecture-level city in Sichuan becomes new center of outbreak. The prefecture-level city of Guang’an in Sichuan province has received national attention after recording over 500 cases in one week, with most of the cases found in the city’s Linshui county. The city, home to 1 million residents, began three rounds of city-wide COVID-19 testing on May 16, with the third round being conducted today (May 18). All students, except those in the final year of high school, have been required to take online classes at home, in order to curb the spread of the virus.
  • Shanghai announces it has achieved zero-COVID at the community level, issues plan for reopening. At a press briefing held on Monday, May 16, Shanghai Vice Mayor Zong Ming announced that 15 of Shanghai’s 16 districts had recorded no new COVID-19 infections at the community level for two consecutive days, meaning cases were only discovered among people in centralized quarantine or living in closed areas. On Tuesday, May 17, Xinhua reported that all of the city’s 16 districts had achieved zero-COVID at the community level. The news comes as the city’s total case count (both symptomatic and asymptomatic) fell under 1,000 for the first time in over a month. At the Monday press briefing, the vice mayor also announced a three-phase plan for reopening, which aims to return to normal life and business operations by mid- to late June. The first phase will last until May 21, during which the city will continue to focus on reducing case numbers and the number of areas that are under “closed management” (areas that have discovered positive cases in the last 7 days). “Prevention” areas (areas that have recorded no new cases in the last 14 days) will also be permitted to reopen during this period while maintaining limited movement and a low level of social activity.
  • Shanghai signals it will begin gradually opening from May 20. Shanghai’s Vice Mayor Wu Qing stated in a press briefing on May 13 that the city has set a target of reaching zero COVID-19 cases at the community level by the end of the week, as reported by the media. After that, the city will begin to reopen in an “orderly” manner while maintaining limited mobility, effective control, and continuing to implement classified management. The vice mayor also stated that the current system of classification “closed”, “controlled” and “prevention” areas will be gradually be changed back to the existing low, medium-, and high-risk areas system in place in the rest of the country. Zero COVID-19 cases at the community level means that cases are only found among people in centralized quarantine or living in the “closed” areas where they are not permitted to leave their homes.
  • China’s immigration authorities says they will restrict Chinese nationals from leaving and entering the country. In an article posted on its official WeChat account, the National Immigration Administration (NIA) said that it is “necessary to implement a strict entry-exit policy”, restrict Chinese citizens from non-essential travel abroad, and implement stricter approval procedures for the issuance of passports. It also stated that it would implement stricter measures at entry and exit ports to prevent illegal border crossings in an effort to curb the spread of the virus.
  • MIIT releases more measures to support COVID-hit small businesses. On May 9, 2022, the Ministry of Industry and Information Technology (MIIT) issued 10 measures for local governments to take to support micro-, small, and medium-sized businesses and sole proprietorships that have been impacted by the COVID-19 outbreaks. The measures include special relief funds for MSMEs, subsidies for rent, utilities, insurance fees, and other cost subsidies. Large state-owned commercial banks are also encouraged to provide RMB 1.6 trillion (US$238 billion) in inclusive loans to micro-and small-sized enterprises whose operations have been impacted by the COVID-19-related restrictions. Local governments are also encouraged to help MSMEs to solve arrears issues for companies that are unable to repay debts.
  • Beijing’s Fangshan district issues work-from-home order. Beijing’s suburban Fangshan district has ordered all office workers to work from home from Friday, May 7 onwards in order to curb the spread of COVID-19. Essential workers, such as those providing basic public services and epidemic prevention workers, will still be allowed to go to work on-site. All entertainment venues and non-essential businesses, such as massage parlors, KTVs, Internet cafes, bars, coffee shops, and various cultural and entertainment, sports and fitness venues have been ordered to close temporarily. Businesses providing food and medicine are permitted to remain open, although restaurants are permitted to provide take-out and delivery services only. The order came as the district recorded a total of 20 confirmed cases on Friday, May 6. A further 24 cases were confirmed on May 7 and 16 on May 8. As of 09:00, May 9, Fangshan district recorded 6 high-risk areas and 9 medium-risk areas.
  • Beijing’s Chaoyang district issues work-from-home order. Beijing’s Chaoyang district, the most populous in the city, ordered all residents, who are able to, to work from home from Thursday, May 5 onwards. Those who must go to work on-site are urged to use their own means of travel rather than taking public transport to reduce the risk of transmission. Epidemic control and prevention measures that were implemented over the Labor Day holiday have also been temporarily extended. These include the suspension of performance venues, entertainment venues, Internet cafes, and indoor sports facilities, as well as scenic areas and public cultural venues. Parks will also continue to be required to limit capacity to 50 percent and restaurants will continue to suspend dine-in services. Public transportation in the districts of Chaoyang, Haidian, Fangshan, and Tongzhou has been adjusted and more than 60 Beijing Subway entrances and exits across 13 lines have been closed.
  • Beijing temporarily closes gyms, entertainment and live performance venues, internet cafes, and indoor sports facilities: On April 29, 2022, the Beijing Municipal Bureau of Culture and Tourism issued a notice on epidemic prevention and control in cultural and tourist sites during the 2022 May Day holiday, which required that: (1) Scenic spots, libraries, cultural centers, and other cultural and tourist sites in the city should implement “limited quantity, reservation, and peak time adjustment” requirements and make requiring reservations a standard practice. Visitors will also be required to take their temperature, scan and test their health code, and present a negative nucleic acid test certificate taken within the last 48 hours when entering a site. (2) Visitors must also check their temperature, scan and test their health code, and present a negative nucleic acid test certificate taken within the last 48 hours when checking into hotels and rural B&Bs in the city; (3) Performance venues, entertainment venues, and Internet service venues will continue to be closed throughout the city. The city will continue to suspend off-campus training activities of cultural and art training institutions and group tours.
  • Shanghai approved the second batch of companies to resume production: The Shanghai Municipal Government has approved a second batch of companies to resume production, the majority of which are semiconductor, pharmaceutical, petrochemical, mechanics, and logistics companies. The total number of companies on the list of the second batch is unclear as the resumption orders were distributed by each district. Shanghai issued the first batch of 666 companies to resume production two weeks ago. To know more about the resumption of production in Shanghai, read our latest article on China BriefingHow Shanghai Industrial Enterprises Can Navigate Lockdown and Resume Work.
  • Shanghai relaxed lockdown conditions in six districts: With daily local infections continuing to decline, Shanghai has eased restrictions in the districts of Putuo, Jinshan, Fengxian, Chongqing, Qingpu, and Songjiang, among which 5 are suburban areas and 1 is in the downtown area. These districts have “basically” achieved zero-COVID at the community level, meaning that for three consecutive days, the daily increase of COVID-19 cases accounted for less than 1/100,000 of the total population of the district. Residents in these districts can go out to buy groceries and seek medical services.
  • Beijing orders school closures. At a news conference on April 28, Beijing’s education committee announced that all primary and secondary schools, kindergartens, and secondary vocational schools are required to end classes one day early on Friday 29 ahead of the May Day national holiday, which will take place from April 30 to May 4. The education committee did specify when schools would be able to reopen after the holiday, saying only that return to school will be determined “according to the epidemic situation” and that students, teachers, and employees will be required to have a negative COVID-19 test from the last 48 hours to be allowed back. The announcement comes as Beijing recorded 47 new locally transmitted symptomatic cases and 2 asymptomatic infections on Thursday, and outbreaks had been discovered in local schools earlier in the week.
  • Beijing added 3 new high-risk areas and 5 new medium-risk areas on Wednesday, bringing the city’s total tally up to 5 and 16 respectively. 3 of the high-risk areas and 14 of the medium-risk areas are in Chaoyang district and 2 high-risk and 2 medium-risk areas are in Fangshan district. The additions come as case numbers rose slightly from the previous day, recording 48 symptomatic cases, up from 31 the previous day.
  • Shanghai to set up “normalized nucleic acid test points” around the city. Shanghai has announced that it will set up a series of COVID-19 test points around the city in order to shore up its COVID-19 prevention capabilities after the lockdown is lifted. The test points will be a combination of “fixed sampling points, convenient sampling points, and mobile testing sites” in order to lay the infrastructure for normalized and regular COVID-19 PCR testing for the city’s 25 million residents. On April 26, Shanghai’s official WeChat account released a list of the initial 534 test points that will be set up across the city’s 16 districts, including information on the opening hours and specific location of the test points. Residents will be able to look up the test points through the Suishenban app or mini-program as the locations and opening hours are adjusted based on demand.
  • Beijing begins mass testing of most of the city’s residents. Beijing will conduct three rounds of COVID-19 testing of all residents in 11 of the city’s 16 districts over the course of three days, from April 26 to 30. The areas include the most populous districts of Chaoyang, Haidian, and Fengtai. The decision comes a day after Chaoyang district imposed quasi-lockdowns in certain areas and kicked off mass testing of all of its 3.5 million residents on Monday, following the discovery of an outbreak at a local middle school. Residents in other areas have been required to work from home and refrain from leaving their homes unless necessary. On Monday, April 26, the city recorded 32 new confirmed symptomatic cases and 1 asymptomatic infection, up from 14 symptomatic cases and 5 asymptomatic infections on Sunday. The results of the three rounds of testing in the coming days will reveal whether Beijing will be required to put in place more stringent lockdown measures, or whether the current outbreak can be contained without significant disruptions to daily life.
  • June 14, 2022 – China recorded 95 new confirmed cases, of which 35 were imported (12 in Shaanxi, 8 in Guangdong, 7 in Fujian, 3 in Tianjin, 2 in Shanghai, 2 in Hunan, and 1 in Chongqing)  and 60 domestically transmitted cases (42 in Beijing, 15 in Inner Mongolia, and 3 in Shanghai). No new deaths were recorded. There were 135 new asymptomatic infections, of which 68 were imported and 67 were locally transmitted (32 in Beijing, 14 in Shanghai, 9 in Inner Mongolia, 5 in Liaoning, 3 in Yunnan, 2 in Sichuan, 1 in Jiangsu, and 1 in Zhejiang). There were 2,162 asymptomatic infections still under medical observation, of which 444 were imported.
  • June 13, 2022 – China recorded 89 new confirmed cases, of which 20 were imported (5 in Shaanxi, 3 in Zhejiang, 3 in Fujian, 3 in Guangdong, 2 in Tianjin, 2 in Shanghai, 1 in Heilongjiang, and 1 in Sichuan)  and 69 domestically transmitted cases (29 in Beijing, 27 in Inner Mongolia, 11 in Shanghai, and 2 in Chongqing). No new deaths were recorded. There were 131 new asymptomatic infections, of which 57 were imported and 74 were locally transmitted (26 in Shanghai, 22 in Beijing, 13 in Inner Mongolia,  4 in Jilin, 3 in Yunnan, 2 in Guangxi, 1 in Liaoning, 1 in Zhejiang, 1 in Chongqing, and 1 in Sichuan). There were 2,396 asymptomatic infections still under medical observation, of which 467 were imported.
  • June 10, 2022 – China recorded 45 new confirmed cases, of which 15 were imported (3 in Guangdong, 3 in Guangxi, 2 in Beijing, 2 in Shanghai, 2 in Fujian, 1 in Shanxi, 1 in Sichuan, and 1 in Shaanxi)  and 30 domestically transmitted cases (15 in Inner Mongolia, 7 in Beijing, 6 in Shanghai, and 2 in Liaoning). No new deaths were recorded. There were 106 new asymptomatic infections, of which 63 were imported and 43 were locally transmitted (20 in Inner Mongolia, 7 in Liaoning, 7 in Jilin, 5 in Shanghai, 2 in Guangxi, 1 in Beijing, and 1 in Fujian). There were 3,058 asymptomatic infections still under medical observation, of which 487 were imported.
  • June 9, 2022 – China recorded 70 new confirmed cases, of which 17 were imported (4 in Fujian, 4 in Guangdong, 3 in Yunnan, 2 in Guangxi, 1 in Beijing 1 in Heilongjiang, 1 in Chongqing, and 1 in Sichuan) and 53 domestically transmitted cases (37 in Inner Mongolia, 11 in Liaoning, 4 in Shanghai, and 1 in Beijing). No new deaths were recorded. There were 170 new asymptomatic infections, of which 59 were imported and 111 were locally transmitted (93 in Inner Mongolia, 5 in Shanghai, 3 in Liaoning, 2 in Fujian, 1 in Henan, 1 in Guangxi, and 1  in Yunnan). There were 3,505 asymptomatic infections still under medical observation, of which 460 were imported.
  • June 7, 2022 – China recorded 57 new confirmed cases, of which 18 were imported (7 in Fujian, 3 in Shanghai, 3 in Guangdong, 2 in Guangxi, 1 in Tianjin, 1 in Sichuan, and 1 in Yunnan) and 39 domestically transmitted cases (20 in Inner Mongolia, 13 in Liaoning, 3 in Shanghai, and 3 in Sichuan). No new deaths were recorded. There were 152 new asymptomatic infections, of which 67 were imported and 85 were domestically transmitted (49 in Inner Mongolia, 19 in Liaoning, 7 in Shanghai, 4 in Jilin, 2 in Beijing, 2 in Sichuan, 1 in Zhejiang, and 1 in Fujian). There were 4,637 asymptomatic infections still under medical observation, of which 516 were imported.
  • As of 17:00, June 6, 2022, China recorded 4 high-risk areas (1 in Beijing and 3 in Inner Mongolia) and 30 medium-risk areas.
  • June 6, 2022 – China recorded 31 new confirmed cases, of which 6 were imported (2 in Fujian, 1 in Tianjin, 1 in Zhejiang, 1 in Guangdong, and 1 in Guangxi) and 25 locally transmitted cases (16 in Inner Mongolia, 5 in Beijing, and 4 in Shanghai). No new deaths were recorded. There were 140 asymptomatic infections, of which 79 were imported and 61 were domestically transmitted (33 in Inner Mongolia, 13 in Liaoning, 5 in Sichuan, 4 in Shanghai, 2 in Jilin, 2 in Guangxi, 1 in Beijing, and 1 in Yunnan). There were 5,265 asymptomatic infections still under medical observation, of which 514 were domestically transmitted.
  • As of 20:00, June 5, 2022, China recorded 1 high-risk area (in Beijing) and 32 medium-risk areas.
  • June 5, 2022 – China recorded 56 new confirmed cases, of which 23 were imported (8 in Fujian, 5 in Sichuan, 4 in Guangdong, 1 in Beijing, 1 in Tianjin, 1 in Shanghai, 1 in Shandong, 1 in Guangxi, and 1 in Yunnan) and 33 locally transmitted cases (16 in Beijing, 11 in Inner Mongolia, and 6 in Shanghai). No new deaths were recorded. There were 106 new asymptomatic infections, of which 51 were imported and 55 were locally transmitted (25 in Liaoning, 16 in Shanghai, 7 in Inner Mongolia, 3 in Beijing, 2 in Shandong, 1 in Jilin, and 1 in Guangxi). There were 6,419 asymptomatic infections still under medical observation, of which 485 were imported.
  • June 4, 2022 – China recorded 46 new confirmed cases, of which 25 were imported (7 in Fujian, 4 in Beijing, 4 in Guangdong, 2 in Shanghai, 2 in Yunnan, 1 in Zhejiang, and 2 in Guangxi) and 21 locally transmitted (11 in Inner Mongolia, 5 in Beijing, and 5 in Shanghai). No new deaths were recorded. There were 125 new asymptomatic infections, of which 70 were imported and 55 were locally transmitted (26 in Liaoning, 9 in Shanghai, 5 in Inner Mongolia, 3 in Henan, 3 in Sichuan, 2 in Guangxi, 1 in Beijing, and 1 in Yunnan). There were 7,318 asymptomatic infections still under medical observation, of which 482 were imported.
  • June 3, 2022 – China recorded 37 new confirmed cases, of which 17 were imported (7 in Fujian, 4 in Guangxi, 2 in Shanghai, 2 in Guangdong, 1 in Shanxi, and 1 in Chongqing) and 20 locally transmitted cases (8 in Beijing, 8 in Shanghai, 3 in Inner Mongolia, and 1 in Sichuan). No new deaths were recorded. There were 120 new asymptomatic infections, of which 66 were imported and 54 were locally transmitted (9 in Guangxi, 8 in Shanghai, 7 in Beijing, 7 in Liaoning, 5 in Jilin, 4 in Hebei, 4 in Inner Mongolia, 3 in Tianjin, 3 in Shandong, 2 in Henan, 1 in Jiangsu, and 1 in Zhejiang). There were 8,622 asymptomatic infections still under medical observation, of which 457 were imported.
  • June 2, 2022 – China recorded 37 new confirmed cases, of which 19 were imported (9 in Fujian, 4 in Shanghai, 3 in Sichuan, 2 in Guangdong, and 1 in Yunnan) and 18 domestically transmitted cases (11 in Beijing, 5 in Shanghai, 1 in Henan, and 1 in Sichuan). No new deaths were recorded. There were 92 new asymptomatic infections of which 49 were imported and 43 were locally transmitted (9 om Guangxi, 8 in Shanghai, 5 in Tianjin, 5 in Shandong, 4 in Liaoning, 3 in Beijing, 3 in Hebei, 3 in Sichuan, 2 in Henan, and 1 in Yunnan). There were 9,635 asymptomatic infections still under medical observation (of which 449 were imported).
  • As of 14:00, June 1, 2022, China recorded 3 high-risk areas (all in Beijing) and 19 medium-risk areas.
  • June 1, 2022 – China recorded 35 new confirmed cases, of which 13 were imported (4 in Fujian, 2 in Guangdong, 2 in Guangxi, 2 in Sichuan, 1 in Shanghai, 1 in Chongqing, and 1 in Yunnan) and 22 domestically transmitted cases (14 in Beijing, 5 in Shanghai, 2 in Henan, and 1 in Hebei). No new deaths were recorded. There were 96 new asymptomatic infections, of which 50 were imported and 46 were domestically transmitted (10 in Shanghai, 8 in Hebei, 7 in Jilin, 7 in Shandong, 4 in Liaoning, 3 in Sichuan, 1 in Beijing, 1 in Anhui, 1 in Jiangxi, 1 in Henan, 1 in Guangxi, 1 in Yunnan, and 1 in Xinjiang). There were 10,638 asymptomatic infections still under medical observations, of which 450 were imported infections.
  • As of 09:00, June 1, 2022, China recorded 3 high-risk areas (all in Beijing) and 20 medium-risk areas.
  • May 31, 2022 – China recorded 50 new confirmed cases, of which 22 were imported (7 in Fujian, 5 in Guangdong, 4 in Shanghai, 3 in Guangxi, 2 in Yunnan, and 1 in Sichuan) and 28 domestically transmitted cases (16 in Beijing, 9 in Shanghai, 1 in Jilin, 1 in Sichuan, and 1 in Yunnan). No new deaths were recorded. There were 124 new asymptomatic infections, of which 55 were imported and 69 were domestically transmitted (22 in Shanghai, 15 in Hebei, 12 in Liaoning, 7 in Jilin, 5 in Tianjin, 4 in Xinjiang, 2 in Beijing, 1 in Sichuan, and 1 in Yunnan). There were 11,950 asymptomatic infections still under medical observation (of which 453 were imported).As of 17:00, May 30, 2022, China recorded 4 high-risk areas (all in Beijing) and 22 medium-risk areas.
  • May 30, 2022 – China recorded 34 new confirmed cases, of which 14 were imported (4 in Fujian, 4 in Guangdong, 2 in Guangxi, 2 in Yunnan, 1 in Zhejiang, and 1 in Sichuan) and 20 domestically transmitted cases (8 in Beijing, 6 in Tianjin, and 6 in Shanghai). No new deaths were recorded. There were 150 new asymptomatic infections, of which 48 were imported and 102 were domestically transmitted (61 in Shanghai, 19 in Hebei, 5 in Liaoning, 5 in Jilin, 5 in Xinjiang, 4 in Beijing, 2 in Henan, and 1 in Shandong). There were 13776 asymptomatic infections still under medical observation (of which 453 were domestically transmitted).
  • As of 10:00, May 30, 2022, China recorded 7 high-risk areas (all in Beijing) and 22 medium-risk areas.
  • May 29, 2022 – China recorded 82 new confirmed cases, of which 28 were imported (15 in Fujian, 6 in Sichuan, 3 in Shanghai, 1 in Heilongjiang, 1 in Jiangsu, 1 in Guangdong, and 1 in Guangxi) and 54 locally transmitted cases (29 in Shangai, 14 in Beijing, 7 in Tianjin, 2 in Henan, 1 in Hubei, and 1 in Sichuan). No new deaths were recorded. There were 211 new asymptomatic infections, of which 50 were imported and 161 were locally transmitted (93 in Shanghai, 13 in Hebei, 10 in Jilin, 8 in Liaoning, 7 in Beijing, 7 in Henan, 7 in Xinjiang, 4 in Tianjin, 4 in Sichuan, 3 in Jiangsu, 2 in Zhejiang, 2 in Shandong, and 1 in Anhui). There were 16,181 asymptomatic infections still under medical observation (of which 449 were imported).
  • May 28, 2022 – China recorded 96 new confirmed cases, of which 25 were imported (12 in Fujian, 4 in Guangxi, 2 in Beijing, 2 in Liaoning, 2 in Guangdong, 2 in Sichuan, and 1 in Jiangsu) and 71 locally transmitted cases (39 in Shanghai, 18 in Beijing, 4 in Tianjin, 3 in Jilin, and 3 in Jiangsu). No new deaths were recorded. There were 266 new asymptomatic infections, of which 73 were imported and 193 were locally transmitted (131 in Shanghai, 11 in Liaoning, 9 in Jilin, 9 in Xinjiang, 7 in Shandong, 6 in Beijing, 5 in Henan, 3 in Tianjin, 3 in Hebei, 3 in Jiangsu, 3 in Sichuan, 2 in Zhejiang, and 1 in Yunnan). There were 17552 new asymptomatic infections still under medical observation (of which 446 were locally transmitted).
  • May 27, 2022 – China recorded 102 new confirmed cases, of which 22 were imported (8 in Fujian, 4 in Jiangsu, 4 in Sichuan, 2 in Yunnan, 1 in Beijing, 1 in Shanghai, 1 in Guangdong, and 1 in Chongqing) and 80 locally transmitted cases (45 in Shanghai, 22 in Beijing, 7 in Tianjin, 2 in Jilin, 2 in Sichuan, 1 in Jiangsu, and 1 in Yunnan). 1 new death was recorded, a locally transmitted case in Shanghai. There were 342 new asymptomatic infections, of which 68 were imported and 274 were locally transmitted (219 in Shanghai, 9 in Liaoning, 8 in Henan, 8 in Sichuan, 8 in Xinjiang, 7 in Beijing, 5 in Jilin, 3 in Tianjin, 3 in Shandong, 1 in Heilongjiang, 1 in Jiangsu, 1 in Zhejiang, and 1 in Jiangxi). There were 19,295 asymptomatic infections still under medical observation, of which 435 were imported infections.
  • As of 17:00, May 26, 2022, China recorded 9 high-risk areas (all in Beijing) and 34 medium-risk areas.
  • May 26, 2022 – China recorded 130 new confirmed cases, of which 26 were imported (11 in Fujian, 4 in Guangdong, 4 in Yunnan, 2 in Sichuan, 1 in Beijing, 1 in Shanghai, 1 in Jiangsu, 1 in Guangxi, and 1 in Chongqing) and 104 locally transmitted cases (48 in Shanghai, 36 in Beijing, 11 in Tianjin, and 9 in Henan). 1 new death was recorded, a locally transmitted case in Shanghai. There were 415 new asymptomatic infections, of which 59 were imported and 356 were locally transmitted (290 in Shanghai, 12 in Henan, 12 in Sichuan, 9 in Beijing, 9 in Tianjin, 6 in Liaoning, 6 in Jilin, 4 in Jiangsu, 4 in Xinjiang, 2 in Jiangxi, 1 in Zhejiang, and 1 in Shandong). There were 22,128 asymptomatic infections still under medical observation (of which 428 were imported).
  • As of 17:00, May 25, 2022, China recorded 9 high-risk areas (all in Beijing) and 40 medium-risk areas.
  • May 25, 2022 – China recorded 117 new confirmed cases, of which 15 were imported (8 in Fujian, 3 in Sichuan, 2 in Guangdong, and 2 in Guangxi) and 102 were domestically transmitted (44 in Shanghai, 41 in Beijing, 7 in Tianjin, 5 in Sichuan, 2 in Jilin, 2 in Henan, and 1 in Jiangsu). No new deaths were recorded. There were 473 new asymptomatic infections, of which 55 were imported and 418 were domestically transmitted (343 in Shanghai, 28 in Henan, 11 in Tianjin, 11 in Liaoning, 6 in Beijing, 5 in Jilin, 5 in Zhejiang, 4 in Sichuan, 4 in Xinjiang, and 1 in Jiangxi). There were 25,948 asymptomatic infections still under medical observation (of which 435 were imported).
  • As of 10:00, May 25, 2022, China recorded 9 high-risk areas and 42 medium-risk areas.
  • May 24, 2022 – China recorded 156 new confirmed cases, of which 15 were imported (5 in Fujian, 2 in Guangdong, 2 in Guangxi, 2 in Sichuan, 1 in Jiangsu, 1 in Zhejiang, 1 in Chongqing, and 1 in Yunnan) and 141 locally transmitted cases, (58 in Shanghai, 41 in Beijing, 19 in Sichuan, 16 in Tianjin, 4 in Shaanxi, 1 in Liaoning, 1 in Jilin, and 1 in Zhejiang). 1 new death was recorded, a locally transmitted case in Shanghai. There were 532, of which 34 were imported and 498 were locally transmitted (422 in Shanghai, 24 in Sichuan, 23 in Henan, 8 in Tianjin, 7 in Beijing, 7 in Jilin, 3 in Zhejiang, 1 in Jiangsu, 1 in Fujian, 1 in Jiangxi, and 1 in Shandong). There were 30,323 new asymptomatic cases still under medical observation (of which 429 were locally transmitted).
  • As of 17:00, May 24, 2022, China recorded 10 high-risk areas (all in Beijing) and 45 high-risk areas.
  • May 23, 2022 – China recorded 187 new confirmed cases, of which 13 were imported (8 in Fujian, 3 in Sichuan, 1 in Shanghai, and 1 in Guangdong) and 174 locally transmitted cases (83 in Beijing, 55 in Shanghai, 32 in Tianjin, 2 in Sichuan, 1 in Liaoning, and 1 in Fujian). 1 new death was recorded, a locally transmitted case in Shanghai. There were 682 new asymptomatic cases, of which 54 were imported and 628 were locally transmitted (503 in Shanghai, 53 in Henan, 29 in Sichuan, 16 in Beijing, 15 in Tianjin, 5 in Jilin, 3 in Anhui, 2 in Jiangxi, 1 in Zhejiang, and 1 in Guangdong). There were 35,217 asymptomatic infections still under medical observation (of which 454 were locally transmitted).
  • As of 17:00, May 22, 2022, China recorded 11 high-risk areas (all in Beijing) and 45 medium-risk areas.
  • May 22, 2022 – China recorded 169 new confirmed cases, of which 12 were imported (7 in Fujian, 2 in Guangxi, 2 in Yunnan, and 1  in Shanghai) and 157 were locally transmitted (52 in Beijing, 52 in Shanghai, 36 in Tianjin, 12 in Sichuan, 3 in Henan, 1 in Guangdong, and 1 in Shaanxi). 3 new deaths were recorded, all locally transmitted cases in Shanghai. There were 729 new asymptomatic infections, of which 62 were imported and 667 were locally transmitted (570 in Shanghai, 35 in Sichuan, 20 in Tianjin, 15 in Henan, 10 in Jilin, 9 in Beijing, 4 in Anhui, 1 in Liaoning, 1 in Jiangsu, 1 in Zhejiang, and 1 in Fujian). There were 37,636 asymptomatic cases still under medical observation (of which 443 were imported).
  • May 21, 2022 – China recorded 201 new confirmed cases, of which 20 were imported (9 in Fujian, 4 in Guangdong, 2 in Jiangsu, 2 in Sichuan, 1 in Zhejiang,) and 181 locally transmitted cases (84 in Shanghai, 58 in Beijing, 32 in Sichuan, 6 in Tianjin, and 1 in Henan). 1 new death was recorded, a domestically transmitted case in Shanghai. There were 1,010 new asymptomatic infections, of which 59 were imported and 951 were locally transmitted (784 in Shanghai, 77 in Sichuan, 38 in Henan, 17 in Tianjin, 12 in Beijing, 7 in Jilin, 5 in Anhui, 4 in Liaoning, 2 in Zhejiang, 2 in Guangdong, 1 in Jiangsu, 1 in Shandong, and 1 in Hubei). There were 41,812 asymptomatic infections still under medical observation (of which 428 were imported).
  • May 20, 2022 – China recorded 193 new confirmed cases, of which 17 were imported (9 in Fujian, 2 in Shanghai, 2 in Jiangsu, 2 in Guangxi, 1 in Beijing, and 1 in Yunnan) and 176 domestically transmitted cases (88 in Shanghai, 50 in Beijing, 8 in Tianjin, 4 in Henan, 3 in Guangdong, 2 in Jilin, and 1 in Liaoning). No new deaths were recorded. There were 990 new asymptomatic infections, of which 51 were imported and 939 were locally transmitted (770 in Shanghai, 102 in Sichuan, 24 in Henan, 12 in Beijing, 11 in Tianjin, 9 in Jilin, 6 in Anhui, 2 in Liaoning, 1 in Zhejiang, 1 in Jiangxi, and 1 in Hubei). There were 43,766 asymptomatic cases still under medical observation (of which 419 were locally transmitted).
  • As of 17:00, May 19, 2022, China recorded 14 high-risk areas (all in Beijing) and 61 medium-risk areas.
  • May 19, 2022 – China recorded 212 new confirmed cases, of which 21 were imported (7 in Fujian, 7 in Sichuan, 2 in Guangdong, 2 in Yunnan, 1 in Tianjin, 1 in Shanghai, and 1 in Zhejiang) and 191 we domestically transmitted (82 in Shanghai, 50 in Beijing, 34 in Sichuan, 11 in Henan, 7 in Tianjin, 6 in Jilin, and 1 in Guangdong). 1 new death was recorded, a locally transmitted case in Shanghai. There were 870 new asymptomatic infections, of which 45 were imported and 825 were locally transmitted (637 in Shanghai, 115 in Sichuan, 26 in Tianjin, 15 in Jilin, 12 in Anhui, 9 in Henan, 5 in Beijing, 3 in Liaoning, 2 in Jiangsu, and 1 in Guangdong). There were 45,519 asymptomatic infections still under medical observation, of which 419 were imported.
  • As of 07:00, May 19, 2022, China recorded 15 high-risk areas (all in Beijing) and 64 medium-risk areas.
  • May 18, 2022 – China recorded 240 new confirmed cases, including 13 imported cases (9 in Fujian, 2 in Guangdong, 1 in Shanghai, and 1 in Guangxi) and 227 locally transmitted cases (96 in Shanghai, 52 in Beijing, 49 in Sichuan, 16 in Tianjin, 9 in Jilin, 3 in Henan, 1 in Jiangsu, and 1 in Qinghai). 3 new deaths were recorded, all of which were locally transmitted cases in Shanghai. There were 1,065 new asymptomatic infections, of which 65 were imported and 1,000 were locally transmitted (759 in Shanghai, 152 in Sichuan, 39 in Tianjin, 17 in Beijing, 15 in Anhui, 8 in Henan, 3 in Jilin, 3 in Jiangsu, 1 in Liaoning, 1 in Zhejiang, 1 in Hubei, and 1 in Guangdong). There were 47,718 asymptomatic infections still under medical observation (of which 441 were imported).
  • As of 19:00, May 17, 2022, China recorded 17 high-risk areas (all in Beijing) and 62 medium-risk areas.
  • May 17, 2022 – China recorded 175 new confirmed cases, including 13 imported cases (9 in Fujian, 2 in Guangdong, and 2 in Yunnan) and 162 locally transmitted cases (77 in Shanghai, 43 in Beijing, 16 in Sichuan, 11 in Henan, 7 in Tianjin, 5 in Jilin, 1 in Jiangsu, 1 in Fujian, and 1 in Shandong). 1 new death was recorded, a locally transmitted case in Shanghai. There were 925 new asymptomatic infections, of which 38 were imported and 887 were locally transmitted (746 in Shanghai, 73 in Sichuan, 23 in Tianjin, 22 in Henan, 9 in Beijing, 6 in Jilin, 3 in Qinghai, 2 in Hebei, 1 in Jiangsu, 1 in Zhejiang, and 1 in Anhui). There were 50,461 asymptomatic infections still under medical observation (of which 452 were imported).
  • As of 21:00, May 16, 2022, China recorded 19 high-risk areas (all in Beijing) and 58 medium-risk areas.
  • May 16, 2022 – China recorded 151 new confirmed cases, including 11 imported cases (7 in Fujian, 2 in Guangdong, 1 in Shanghai, and 1 in Yunnan) and 140 locally transmitted cases (69 in Shanghai, 39 in Beijing, 14 in Sichuan, 8 in Henan, 5 in Guangdong, 2 in Zhejiang, 1 in Liaoning, 1 in Jiangsu, and 1 in Guizhou). 4 new deaths were recorded, all of which were locally transmitted in Shanghai. There were 1,076 new asymptomatic infections, of which 57 were imported and 1,019 were locally transmitted (869 in Shanghai, 74 in Sichuan, 15 in Beijing, 13 in Henan, 10 in Liaoning, 8 in Anhui, 7 in Qinghai, 4 in Tianjin, 4 in Hebei, 4 in Hubei, 3 in Jilin, 2 in Heilongjiang, 2 in Guangdong, 1 in Jiangsu, 1 in Guangxi, 1 in Guizhou, and 1 in Yunnan). There were 52,798 asymptomatic infections still under medical observation (of which 478 were imported).
  • As of 08:00, May 16, 2022, China recorded 18 high-risk areas (all in Beijing) and 59 medium-risk areas.
  • May 15, 2022 – China recorded 239 new confirmed cases, of which 13 were imported (7 in Fujian, 2 in Shanghai, 2 in Yunnan, 1 in Guangdong, and 1 in Sichuan) and 226 were locally transmitted (166 in Shanghai, 33 in Beijing, 13 in Sichuan, 5 in Henan, 2 in Liaoning, 2 in Guizhou, 1 in Hebi, 1 in Jilin, 1 in Guangdong, 1 in Jiangxi, and 1 in Chongqing). 3 new deaths were recorded, all of which were locally transmitted in Shanghai. There were 1,550 new asymptomatic infections, of which 58 were imported and 1,492 were locally transmitted (1,203 in Shanghai, 196 in Sichuan, 24 in Henan, 16 in Liaoning, 9 in Jiangsu, 8 in Beijing, 8 in Hebei, 7 in Anhui, 7 in Qinghai, 3 in Zhejiang, 2 in Jiangxi, 2 in Shandong, 2 in Guangxi, 2 in Chongqing, 2 in Guizhou, and 1 in Jilin). There were 58,878 asymptomatic infections still under medical observation (of which 481 were imported).
  • May 14, 2022 – China recorded 276 new confirmed cases, of which 23 were imported (17 in Fujian, 4 in Guangdong, 1 in Shanghai, and 1 in Guangxi) and 253 locally transmitted cases (194 in Shanghai, 32 in Beijing, 7 in Henan, 4 in Guangdong, 4 in Qinghai, 3 in Sichuan, 2 in Liaoning, 2 in Chongqing, 1 in Jilin, 1 in Fujian, 1 in Shandong, 1 in Hunan, and 1 in Guangxi). 1 new death was recorded, a locally transmitted case in Shanghai. There were 1,796 new asymptomatic infections, of which 70 were imported and 1,726 were locally transmitted (1,487 in Shanghai, 90 in Sichuan, 40 in Henan, 33 in Liaoning, 24 in Beijing, 19 in Qinghai, 17 in Jiangsu, 5 in Jiangxi, 2 in Tianjin, 2 in Hebi, 2 in Zhejiang, 2 in Guangdong, 1 in Anhui, 1 in Hubei, and 1 in Guizhou). There were 61,780 asymptomatic infections still under medical observation (of which 469 were imported).
  • May 13, 2022 –  China recorded 331 new confirmed cases, of which 19 were imported (15 cases in Fujian, 2 cases in Guangxi, 1 case in Beijing, and 1 case in Guangdong) and 312 were locally transmitted (227 cases in Shanghai, 42 in Beijing, 15 in Henan, 11 in Guangdong, 8 in Qinghai, 6 in Sichuan, 2 in Chongqing, and 1 in Shaanxi). 2 new deaths were recorded, all of which were locally transmitted in Shanghai. There were 2,201 new asymptomatic infections, of which 61 were imported and 2,140 were locally transmitted (1,869 in Shanghai, 94 in Sichuan, 58 in Liaoning, 35 in Jiangsu, 29 in Henan, 22 in Qinghai, 10 in Jiangxi, 8 in Beijing, 5 in Hebei, 4 in Zhejiang, 3 in Guangdong, 1 in Tianjin, 1 in Guangxi, and 1 in Chongqing). There were 70,770 asymptomatic infections still under medical observation (of which 447 were imported).
  • As of 11:00, May 13, 2022, China recorded 17 high-risk areas (all in Beijing) and 79 medium-risk areas.
  • May 12, 2022 – China recorded 237 new confirmed cases, of which 15 were imported (5 cases in Guangxi, 4 cases in Fujian, 4 cases in Yunnan, and 2 cases in Guangdong) and 222 were domestically transmitted (144 cases in Shanghai, 35 in Beijing, 21 in Henan, 13 in Qinghai, 3 in Jilin, 3 in Guangdong, 2 in Liaoning, and 1 in Guizhou). 5 new deaths were recorded, all of which were locally transmitted in Shanghai. There were 1,680 new asymptomatic infections, of which 50 were imported and 1,630 were domestically transmitted (1,305 in Shanghai, 85 in Liaoning, 77 in Henan, 47 in Jiangsu, 25 in Sichuan, 25 in Qinghai, 20 in Zhejiang, 14 in Jiangxi, 11 in Beijing, 10 in Hebei, 4 in Guizhou, 2 in Jilin, 2 in Guangdong, 2 cases in Guangxi, and 1 in Shandong). There were 75,532 asymptomatic infections still under medical observation, of which 434 were imported.
  • As of 09:00, May 12, 2022, China recorded 20 high-risk areas (all in Beijing) and 77 medium-risk areas.
  • May 11, 2022 – China recorded 324 new confirmed cases, of which 22 were imported (11 cases in Fujian, 3 cases in Guangxi, 2 cases in Guangdong, 1 case in Beijing, 1 case in Liaoning, 1 case in Shanghai, 1 case in Jiangsu, 1 case in Sichuan, and 1 case in Yunnan) and 302 were domestically transmitted (228 cases in Shanghai, 24 in Beijing, 22 in Henan, 10 in Guangdong, 10 in Qinghai, 4 in Liaoning, 2 in Zhejiang, and 2 in Fujian). 7 new deaths were recorded, all of which were domestically transmitted in Shanghai. There were 1,603 new asymptomatic infections, of which 58 were imported and 1,545 were domestic (1,259 in Shanghai, 67 in Henan, 60 in Liaoning, 49 in Jiangsu, 44 in Jiangxi, 13 in Beijing, 10 in Guangdong, 10 in Qinghai, 9 in Sichuan, 5 in Hebei, 5 in Zhejiang, 4 in Jilin and 3 in Guangxi, 2 in Hubei, 2 in Guizhou, 1 in Shanxi, 1 in Anhui, and 1 in Chongqing). There were 79,926 asymptomatic infections still under medical observation (of which 465 were imported).
  • May 10, 2022 – China recorded 357 new symptomatic cases, of which 8 were imported (3 cases in Guangxi, 2 cases in Guangdong, 1 case in Beijing, 1 case in Fujian, and 1 case in Sichuan) and 349 were locally transmitted (234 cases in Shanghai, 61 in Beijing, 25 in Henan, 15 in Guangdong, 10 in Qinghai, 2 in Liaoning, 1 in Fujian, and 1 in Guizhou). 6 new deaths were recorded, all of which were domestically transmitted in Shanghai. There were 3,118 new asymptomatic infections, of which 41 were imported and 3,077 were domestically transmitted (2,780 in Shanghai, 98 in Henan, 55 in Jiangsu, 53 in Liaoning, 35 in Jiangxi, 17 in Qinghai, 13 in Beijing, 9 in Zhejiang, 6 in Jilin, 6 in Guangdong, 3 in Sichuan, 1 in Hebei, and 1 in Chongqing). There were 87,294 asymptomatic infections still under medical observation, of which 452 were imported.
  • As of 08:00, May 10, 2022, China recorded 21 high-risk areas (all in Beijing) and 77 medium-risk areas.
  • May 9, 2022 – China reported 415 new confirmed cases, of which 14 were imported (7 in Guangdong, 4 in Fujian, 2 in Shanghai, and 1 in Guangxi) and 401 were domestically transmitted (322 cases in Shanghai, 33 cases in Beijing, 28 cases in Guangdong, 14 cases in Henan, 2 cases in Qinghai, 1 case in Zhejiang, and 1 case in Hunan). 11 new deaths were recorded, all of which were domestically transmitted in Shanghai. There were 3,918 new asymptomatic infections, of which 59 were imported and 3,859 were domestically transmitted (3,625 cases in Shanghai, 62 in Jiangsu, 50 in Liaoning, 46 in Henan, 18 in Qinghai, 16 in Beijing, 16 in Zhejiang, 12 in Guangdong, 10 in Jiangxi, 3 in Jilin, and 1 in Hebei). There were 92,564 asymptomatic infections still under medical observation (of which 474 were imported).
  • As of 09:00, May 9, 2022, China recorded 21 high-risk areas (all in Beijing) and 77 medium-risk areas.
  • May 8, 2022 – China reported 329 new confirmed cases, including 10 imported cases (5 in Fujian, 2 in Shanghai, 1 in Shandong, 1 in Guangdong, and 1 in Guangxi) and 319 domestically transmitted cases (215 in Shanghai, 44 in Beijing, 25 in Henan, 21 in Guangdong, 4 in Qinghai, 3 in Jilin, 2 in Chongqing, 1 in Hebei, 1 in Inner Mongolia, 1 in Heilongjiang, 1 in Jiangsu, and 1 in Zhejiang). 8 new deaths were recorded, all of which were domestically transmitted in Shanghai. There were 4,133 new asymptomatic infections, of which 68 were imported and 4,065 were domestically transmitted (3,760 in Shanghai, 85 in Liaoning, 76 in Henan, 60 in Jiangsu, 27 in Zhejiang, 21 in Jilin, 18 in Beijing, 8 in Jiangxi, 3 in Guangdong, 2 in Qinghai, 1 in Hebei, 1 in Chongqing, and 1 in Sichuan). There were 97,512 asymptomatic infections still under medical observation (of which 505 were imported).
  • May 7, 2022 – China reported 351 new confirmed cases, including 6 imported cases (2 in Fujian, 2 in Guangdong, 1 in Beijing, and 1 in Sichuan) and 345 domestically transmitted cases (253 in Shanghai, 45 in Beijing, 29 in Henan, 8 in Guangdong, 3 in Jilin, 2 in Zhejiang, 2 in Hunan,1 in Liaoning, 1 in Shandong, and 1 in Chongqing). 13 new deaths were recorded, all of which were locally transmitted in Shanghai. There were 4,324 new asymptomatic infections, of which 49 were imported and 4,275 were domestically transmitted (3,961 in Shanghai, 98 in Liaoning, 70 in Jiangsu, 69 in Henan, 22 in Jilin, 18 in Zhejiang, 10 in Jiangxi, 8 in Beijing, 4 in Shandong, 3 in Hebei, 3 in Sichuan, 3 in Xinjiang, 2 in Anhui, 1 in Heilongjiang, 1 in Guangdong, 1 in Guizhou, and 1 in Qinghai). There were 103,935 asymptomatic infections still under medical observation, of which 489 were imported.
  • As of 17:00, May 6, 2022, China reported 19 high-risk areas (18 in Beijing and 1 in Heilongjiang) and 92 medium-risk areas.
  • May 6, 2022 – China reported 374 new confirmed cases, including 18 imported cases (14 in Fujian, 2 in Guangdong, 1 in Heilongjiang, and 1 in Sichuan) and 356 locally transmitted cases (245 in Shanghai, 55 in Beijing, 24 in Henan, 13 in Guangdong, 4 in Hebei, 4 in Heilongjiang, 2 in Liaoning, 2 in Jilin, 2 in Hunan, 1 in Jiangsu, 1 in Chongqing, and 1 in Guizhou). 12 new deaths were recorded, all of which were locally transmitted in Shanghai. There were 4,340 new asymptomatic cases, of which 68 were imported and 4,272 were locally transmitted (4,024 in Shanghai, 61 in Liaoning, 55 in Henan, 47 in Jiangsu, 24 in Zhejiang, 17 in Beijing, 15 in Jiangxi, 12 in Jilin, 7 in Hebei, 5 in Shandong, 2 in Yunnan, 1 in Fujian, 1 in Guangdong, and 1 in Guizhou). There were 111,906 asymptomatic infections still under medical observation (of which 505 were imported).
  • As of 06:00, April 6, 2022, China recorded 19 high-risk areas (17 in Beijing and 2 in Heilongjiang) and 95 medium-risk areas.
  • May 5, 2022 – China reported 373 new confirmed cases, including 13 imported cases (3 in Guangdong, 2 in Shanghai, 2 in Fujian, 2 in Guangxi, 1 in Beijing, 1 in Heilongjiang, 1 in Shandong, and 1 in Yunnan) and 360 locally transmitted cases (261 in Shanghai, 42 in Beijing, 14 in Henan, 13 in Guangdong, 10 in Zhejiang, 4 in Jilin, 4 in Heilongjiang, 3 in Jiangsu, 2 in Liaoning, 2 in Hunan, 1 in Shandong, and 1 in Sichuan). 13 new deaths were recorded, all of which were locally transmitted cases in Shanghai. There were 4,740 new asymptomatic infections, of which 62 were imported and 4,678 were locally transmitted (4,390 in Shanghai, 99 in Liaoning, 38 in Jiangxi, 26 in Jiangsu, 26 in Henan, 24 in Zhejiang, 20 in Jilin, 19 in Hebei, 14 in Shandong, 8 in Beijing, 6 in Guangdong, 4 in Xinjiang, 2 in Yunnan, 1 in Hubei, and 1 in Guangxi). There were 118,737 asymptomatic infections still under medical observation (of which 526 were imported infections).
  • As of 09:00, April 5, 2022, China reported 15 high-risk areas (13 in Beijing and 2 in  Heilongjiang) and 102 medium-risk areas.
  • May 4, 2022 – China reported 362 new confirmed cases, including 9 imported cases (4 in Fujian, 3 in Shanghai, 1 in Beijing, and 1 in Shandong) and 353 locally transmitted cases (260 in Shanghai, 46 in Beijing, 12 in Henan, 12 in Guangdong, 7 in Heilongjiang, 3 in Jilin, 3 in Jiangsu, 3 in Zhejiang, 3 in Shandong, 2 in Jiangxi, 1 in Sichuan, and 1 in Xinjiang). 16 new deaths were recorded, all of which were locally transmitted in Shanghai. There were 5,136 new asymptomatic infections, of which 61 were imported and 5,075 were locally transmitted (4,722 in Shanghai, 128 in Liaoning, 46 in Jiangxi, 38 in Jilin, 32 in Henan, 28 in Hebei, 22 in Jiangsu, 20 in Zhejiang, 12 in Shandong, 10 in Xinjiang, 5 in Beijing, 4 in Guangdong, 3 in Heilongjiang, 1 in Anhui, 1 in Fujian, 1 in Hubei, 1 in Guangxi, and 1 in Sichuan). There were 128,319 asymptomatic infections still under medical observation (of which 529 were imported infections).
  • As of 9:00, May 4, 2022, China recorded 14 high-risk areas (12 in Beijing and 2 in Heilongjiang) and 104 medium-risk areas (34 in Beijing, 3 in Hebei, 4 in Inner Mongolia, 8 in Liaoning, 1 in Jilin, 27 in Heilongjiang, 13 in Shanghai, 4 in Jiangsu, 4 in Shandong, 2 in Henan, 4 in Hunan).
  • May 3, 2022 – China reported 384 new confirmed cases, including 16 imported cases (6 in Fujian, 5 in Sichuan, 3 in Guangxi, and 2 in Guangdong) and 368 locally transmitted cases (274 in Shanghai, 51 in Beijing, 13 in Heilongjiang, 7 in Guangdong, 5 in Liaoning, 5 in Jiangxi, 3 in Fujian, 3 in Shandong, 2 in Shanxi, 2 in Henan, 1 in Inner Mongolia, 1 in Chongqing, and 1 in Sichuan). 20 new deaths were recorded, all of which were locally transmitted in Shanghai. There were 5,690 new asymptomatic infections, of which 43 were imported and 5,647 were locally transmitted (5,395 in Shanghai, 79 in Liaoning, 34 in Zhejiang, 29 in Jiangxi, 26 in Xinjiang, 21 in Jilin, 13 in Jiangsu, 11 in Beijing, 11 in Shandong, 10 in Heilongjiang, 5 in Hebei, 5 in Guangdong, 4 in Henan, 2 in Yunnan, 1 in Anhui, and 1 in Chongqing). There were 133,610 asymptomatic infections still under medical observation (of which 516 were imported infections).
  • China appears to roll back plans to cut quarantine time for international arrivals. On April 12, Caixin, along with other domestic media outlets, reported that China had launched a pilot program in eight cities to reduce the total quarantine time for international arrivals from 14 to 10 days (see below update). However, the Chinese versions of the articles sharing this news have since been removed. Moreover, new articles from state media reiterated China’s zero-tolerance approach to COVID-19, stating that ‘Trying to ‘live with the virus’ […] is no choice for China”. Despite the retraction, it is possible that China did indeed have plans to reduce quarantine time for international arrivals, but given the recent outbreaks across the country, and particularly in Shanghai, it seems likely that the authorities deemed it an inopportune time to begin rolling out this pilot program. Quarantine times for inbound passengers will therefore continue to be a minimum of 14 days for the foreseeable future.
  • China Has Launched Pilot Program in 8 Cities to Test Looser Quarantine Control: According to a Caixin report, China is trying out reduced quarantine times for residents in locked-down communities, overseas arrivals, and close contact of positive cases in 8 cities, including Shanghai, Guangzhou, Chengdu, Dalian, Suzhou, Ningbo, Xiamen, and Qingdao. Under the pilot program, centralized quarantine requirements for these groups will be shortened from 14 to 10 days, after which they will have to spend a week under observation at home. Meanwhile, a high frequency of nucleic acid and antigen tests will be carried out for relevant individuals over those 17 days. The pilot program was launched on April 11, 2022 in a piecemeal manner and will run for 4 weeks. It is read as an effort of China to explore the optimal isolation period for COVID-19 and a potential sign that China will ease its stringent COVID-19 control measures gradually.
  • Latest Vaccination Rates in China: In the press conference held on April 12, 2022, the National Health Commission (NHC) said that as of April 11, 2022,  a total of 3.3328 billion doses of COVID-19 vaccines had been administered nationwide, with 1.280156 million people vaccinated and 1.244923 billion people fully vaccinated, accounting for 90.8 % and 88.3% of the total population, respectively. A total of 719.324 million people received enhanced immunization, including 22.414 million who received sequential enhanced immunization. A total of 224.777 million people over the age of 60 have been vaccinated against COVID-19, with 213.293 million people receiving full vaccinations and 150.761 million people receiving enhanced immunizations.
  • U.S. Ordered Departure for U.S. Consulate General Shanghai: According to a statement released by the US Mission China on April 12, 2022, the Department of State had on the day prior ordered the departure of non-emergency U.S. government employees and their family members from the U.S. Consulate General Shanghai. The ordered departure status of U.S. Consulate General Shanghai will be reviewed in 30-day increments. The statement also mentioned that facilities at the U.S. Consulate General Shanghai will reopen to the public as soon as possible.
  • Guangzhou is not under lockdown but COVID-19 control measures have been strengthened: Guangzhou has implemented stricter COVID-19 control measures, including school suspension, since April 11, 2022, after 22 new domestically transmitted cases were reported from 0:00 to 14:00 on April 9, 2022. In addition, residents who have necessary reasons to leave Guangzhou will need to provide a negative nucleic acid test certificate from the last 48 hours.
  • COVID-19 Control Measures Disrupted Logistics and Dampened Supply Chains Disorders: According to the latest information, affected by the continuing epidemic, various parts of East China have recently upgraded prevention and control measures and announced the temporary closure of expressway exits and service areas. Statistics show that Hangzhou, Ningbo, Yiwu, Shaoxing, Wenzhou, Nanjing, Lianyungang, Suqian, Jiaxing, Huzhou, and other cities have announced the closure of some of their expressway entrances and exits. In Jiangsu and Zhejiang provinces alone, 193 expressway exits and service areas have been closed (including 55 service areas, and 138 expressway exits). Feedback from the truck trailer and freight forwarding logistics industry also shows that, in addition to the above 193 closed expressway exits and service areas, some other expressway entrances and exits that are under normal operation have also put heavy restrictions on truck drivers. A large number of drivers can not get off the highway because their transit code has an asterisk (*) (indicating that they have been in a city that has recorded COVID-19 cases in the last 14 days)  or their plates are issued by other provinces.
  • Beijing Registered 1 High-Risk Area: According to an epidemic control press conference held on April 9, 2022, an area in Beijing was classified as high risk for COVID-19. The area, Erjiefang, is located in Jiuxianqiao Street in Chaoyang district. A total of 8 domestically transmitted cases were reported in the area in the last 14 days.
  • May 2, 2022 – China reported 865 new confirmed cases, including 19 imported cases (5 in Guangdong, 3 in Jiangsu, 3 in Guangxi, 2 in Shanghai, 2 in Fujian, 2 in Sichuan, 1 in Tianjin, and 1 in Heilongjiang) and 846 locally transmitted cases (727 in Shanghai, 36 in Beijing, 31 in Jilin, 23 in Guangdong, 8 in Heilongjiang, 6 in Sichuan, 5 in Shandong, 2 in Zhejiang, 2 in Jiangxi, 2 in Xinjiang, 1 in Inner Mongolia, 1 in Liaoning, 1 in Fujian, and 1 in Henan). 32 new deaths were recorded,  all of which were locally transmitted in Shanghai. There were 6,957 new asymptomatic infections, of which 62 were imported and 6,895 were locally transmitted (6,606 in Shanghai, 95 in Liaoning, 37 in Xinjiang, 35 in Jiangxi, 34 in Shandong, 20 in Heilongjiang, 16 in Jilin, 16 in Jiangsu, 16 in Zhejiang, 5 in Beijing, 4 in Hebei, 4 in Henan, 2 in Guangdong, 2 in Guangxi, 1 in Hunan, 1 in Sichuan, and 1 in Yunnan). There were 156,131 asymptomatic infections still under medical observation (of which 542 were imported infections).
  • May 1, 2022 – China reported 920 new confirmed cases, including 4 imported cases (1 in Shanghai, 1 in Fujian, 1 in Heilongjiang, 1 in Guangxi, and 1 in Sichuan) and 916 locally transmitted cases (788 in Shanghai, 53 in Beijing, 21 in Guangdong, 16 in Jilin, 6 in Shandong, 6 in Sichuan, 5 in Heilongjiang, 5 in Jiangxi, 4 in Henan, 4 in Xinjiang, 3 in Jiangsu, 2 in Inner Mongolia, 2 in Hunan, and 1 in Chongqing). 38 new deaths were recorded,  all of which were locally transmitted in Shanghai. There were 7,409 new asymptomatic infections, of which 69 were imported and 7,340 were locally transmitted (7,084 in Shanghai, 57 in Jiangxi, 47 in Liaoning, 44 in Xinjiang, 26 in Jilin, 18 in Zhejiang, 15 in Shandong, 9 in Heilongjiang, 9 in Anhui, 7 in Guangdong, 6 in Beijing, 6 in Jiangsu, 5 in Henan, 4 in Sichuan, 1 in Tianjin, 1 in Chongqing, and 1 in Yunnan). There were 180,362 asymptomatic infections still under medical observation (of which 590 were imported infections).
  • April 30, 2022 – China reported 1,424 new confirmed cases, including 14 imported cases (4 in Fujian, 2 in Beijing, 2 in Guangxi, 2 in Yunnan, 1 in Shanghai, 1 in Shandong, 1 in Guangdong, and 1 in Sichuan) and 1,410 locally transmitted cases (1249 in Shanghai, 48 in Beijing, 28 in Guangdong, 26 in Sichuan, 20 in Jilin, 8 in Zhejiang, 8 in Shandong, 6 in Inner Mongolia, 5 in Jiangsu, 3 in Hunan, 2 in Heilongjiang, 2 in Jiangxi, 2 in Henan 2 in Xinjiang, and 1 in Liaoning). 47 new deaths were recorded,  all of which were locally transmitted in Shanghai. There were 9,369 new asymptomatic infections, of which 76 were imported and 9,293 were locally transmitted (8,932 in Shanghai, 85 in Liaoning, 68 in Jiangxi, 40 in Xinjiang, 35 in Jilin, 31 in Shandong, 22 in Zhejiang, 19 in Anhui, 16 in Guangdong, 15 in Jiangsu, 10 in Sichuan, 6 in Beijing, 4 in Yunnan, 3 in Heilongjiang, 3 in Henan, 2 in Hebei, 1 in Hubei, and 1 in Guangxi). There were 191,036 asymptomatic infections still under medical observation (of which 589 were imported infections).
  • April 29, 2022 – China reported 5,659 new confirmed cases, including 13 imported cases (3 in Guangdong, 2 in Beijing, 2 in Shanghai, 2 in Fujian, 1 in Heilongjiang, 1 in Zhejiang, 1 in Guangxi, and 1 in Sichuan) and 5,646 locally transmitted cases (5,487 in Shanghai, 47 in Beijing, 42 in Jilin, 31 in Zhejiang, 7 in Shandong, 7 in Guangdong, 4 in Heilongjiang, 4 in Jiangxi, 3 in Inner Mongolia, 3 in Jiangsu, 3 in Sichuan, 2 in Henan, 1 in Liaoning, 1 in Fujian, 1 in Hunan, 1 in Guangxi, 1 in Chongqing, and 1 in Yunnan). 52 new deaths were recorded,  all of which were locally transmitted in Shanghai. There were 10,029 new asymptomatic infections, of which 87 were imported and 9,942 were locally transmitted (9,545 in Shanghai, 91 in Liaoning, 76 in Jiangxi, 46 in Jiangsu, 45 in Jilin, 38 in Shandong, 23 in Anhui, 20 in Zhejiang, 18 in Xinjiang, 7 in Hubei, 7 in Guangdong, 6 in Heilongjiang, 5 in Henan, 4 in Hebei, 3 in Yunnan, 2 in Beijing, 2 in Sichuan, 1 in Hunan, 1 in Guangxi, 1 in Chongqing, and 1 in Ningxia). There were 197,213 asymptomatic infections still under medical observation (of which 601 were imported infections).
  • April 28, 2022 – China reported 1,503 new confirmed cases, including 9 imported cases (3 in Sichuan, 2 in Fujian, 1 in Beijing, 1 in Tianjin, 1 in Jiangxi, and 1 in Guangdong) and 1,494 locally transmitted cases (1,292 in Shanghai, 56 in Jilin, 48 in Beijing, 46 in Zhejiang, 11 in Heilongjiang, 10 in Jiangxi, 9 in Inner Mongolia, 8 in Shandong, 4 in Henan, 2 in Hebei, 2 in Jiangsu, 1 in Liaoning, 1 in Hunan, 1 in Chongqing, 1 in Sichuan, 1 in Shaanxi, and 1 in Qinghai). 47 new deaths were recorded, all of which were locally transmitted cases in Shanghai. There were 9,864 asymptomatic infections, of which 73 were imported 9,791 were locally transmitted (9,330 in Shanghai, 98 in Jilin, 84 in Shandong, 79 in Jiangxi, 72 in Jiangsu, 55 in Liaoning, 20 in Zhejiang, 15 in Anhui, 13 in Henan, 9 in Hebei, 7 in Heilongjiang, 2 in Beijing, 2 in Xinjiang, 1 in Shanxi, 1 in Fujian, 1 in Sichuan, 1 in Guizhou, and 1 in Yunnan). There were 208,195 asymptomatic infections still under medical observation (of which 582 were imported).
  • As of 08:00, April 28, 2022, China recorded 10 high-risk areas (5 in Beijing, 2 in Heilongjiang, 2 in Fujian, and 1 in Jilin) and 113 medium-risk areas.
  • April 27, 2022 – China reported 1,824 new confirmed cases, including 6 imported cases (2 in Guangxi, 2 in Sichuan, 1 in Zhejiang, and 1 in Guangdong) and 1,818 domestically transmitted cases (1,606 in Shanghai, 56 in Jiangxi, 51 in Jilin, 31 in Beijing, 25 in Heilongjiang, 16 in Zhejiang, 8 in Jiangsu, 7 in Inner Mongolia, 6 in Shandong, 3 in Henan, 2 in Hunan, 2 in Sichuan, 1 in Hebei, 1 in Shanxi, 1 in Anhui, 1 in Fujian, and 1 in Chongqing). 48 new deaths were recorded, all of which were domestically transmitted cases in Shanghai. There were 12,474 asymptomatic infections, of which 70 were imported and 12,404 were domestically transmitted (11,956 in Shanghai, 102 in Liaoning, 80 in Jilin, 76 in Jiangsu, 66 in Shandong, 41 in Jiangxi, 31 in Zhejiang, 14 in Henan, 13 in Hebei, 8 in Anhui, 7 in Heilongjiang, 3 in Beijing, 3 in Yunnan, 2 in Hubei, and 2 in Guangxi). There were 225,249 asymptomatic infections still under medical observation, of which 602 were imported cases.
  • As of 10:00, April 27, 2022, China recorded 7 high-risk areas (2 in Fujian, 2 in Heilongjiang, 2 in Beijing, and 1 in Jilin) and 107 medium-risk areas.
  • April 26, 2022 – China reported 1,923 new confirmed cases, including 15 imported cases (4 in Guangdong, 4 in Guangxi, 3 in Fujian, 2 in Jiangxi, 1 in Inner Mongolia, and 1 in Shandong) and 1,908 locally transmitted cases (1,661 in Shanghai, 91 in Jiangxi, 44 in Jilin, 32 in Beijing, 25 in Liaoning, 18 in Heilongjiang, 8 in Zhejiang, 8 in Henan, 6 in Inner Mongolia, 2 in Hebei, 2 in Shanxi, 2 in Jiangsu, 2 in Shandong, 2 in Hunan, 2 in Guangdong, 1 in Anhui, 1 in Sichuan, and 1 in Qinghai). 52 new deaths were recorded, all of which were locally transmitted cases in Shanghai. There were 15,889 new asymptomatic infections, of which 73 were imported cases and 15,816 were locally transmitted (15,319 in Shanghai, 112 in Jiangsu, 101 in Jilin, 62 in Shandong, 49 in Hebei, 46 in Jiangxi, 39 in Liaoning, 34 in Zhejiang, 18 in Heilongjiang, 10 in Anhui, 9 in Henan, 6 in Yunnan, 3 in Hubei, 2 in Tianjin, 2 in Guangxi, 2 in Sichuan, 1 in Beijing, and 1 in Qinghai). There were 246,139 asymptomatic cases still under medical observation (of which 596 were imported infections).
  • As of 09:00, April 26, 2022, China recorded 6 high-risk areas (2 in Fujian, 2 in Heilongjiang, 1 in Jilin, and 1 in Beijing) and 103 medium-risk areas.
  • April 25, 2022 – China reported 2,680 new confirmed cases, including 14 imported cases (2 in Fujian, 2 in Guangdong, 2 in Sichuan, 2 in Yunnan, 1 in Beijing, 1 in Tianjin, 1 in Inner Mongolia, 1 in Jiangsu, 1 in Zhejiang, and 1 in Guangxi) and 2,666 locally transmitted cases (2,472 in Shanghai, 79 in Jilin, 26 in Heilongjiang 14 in Beijing, 14 in Jiangxi, 13 in Zhejiang, 12 in Hunan, 9 in Inner Mongolia, 5 in Henan, 5 in Qinghai, 4 in Jiangsu, 3 in Liaoning, 3 in Guangdong, 2 in Shanxi, 2 in Shandong, 1 in Tianjin, 1 in Fujian, and 1 in Sichuan). 51 new deaths were recorded, all of which were locally transmitted in Shanghai. There were 17,581 asymptomatic infections, of which 53 were imported and 17,528 were locally transmitted (16,983 in Shanghai, 116 in Jiangxi, 107 in Jilin, 92 in Jiangsu, 74 in Hebei, 49 in Shandong, 29 in Anhui, 19 in Zhejiang, 18 in Henan, 14 in Yunnan, 12 in Heilongjiang, 5 in Beijing, 5 in Shanxi, 2 in Hubei, 2 in Qinghai, and 1 in Guangxi). There were 245,343 asymptomatic cases still under medical observation (of which 612 were imported infections).
  • As of 07:00, April 25, 2022, China recorded 6 high-risk areas (2 in Fujian, 2 in Heilongjiang,1 in Jilin, and 1 in Beijing) and 100 medium-risk areas.
  • April 24, 2022 – China reported 1,580 new confirmed cases, including 14 imported cases (5 in Guangdong, 4 in Guangxi, 1 in Inner Mongolia, 1 in Fujian, 1 in Henan, 1 in Sichuan, and 1 in Yunnan) and 1,566 locally transmitted cases (1,401 in Shanghai, 60 in Jilin, 26 in Heilongjiang, 22 in Beijing, 12 in Zhejiang, 10 in Jiangxi, 6 in Jiangsu, 6 in Henan, 5 in Inner Mongolia, 4 in Shandong, 4 in Hunan, 4 in Guangdong, 2 in Anhui, 1 in Hebei, 1 in Liaoning, 1 in Hubei, and 1 in Yunnan. 39 new deaths were recorded, all of which were locally transmitted cases in Shanghai. There were 20,285 new asymptomatic cases, of which 55 were imported and 20,230 were locally transmitted (19,657 in Shanghai, 154 in Jilin, 120 in Jiangsu, 116 in Hebei, 45 in Shandong, 31 in Zhejiang, 29 in Jiangxi, 26 in Henan, 16 in Heilongjiang, 14 in Anhui, 8 in Yunnan, 5 in Shanxi, 4 in Liaoning, 3 in Hubei, 2 in Guangxi). There were 249212 asymptomatic cases still under medical observation (of which 656 were imported infections).
  • April 23, 2022 – China reported 2,988 new confirmed cases, including 17 imported cases (6 in Inner Mongolia, 4 in Fujian, 3 in Guangdong, 2 in Beijing, 1 in Jiangxi, and 1 in Sichuan) and 2,971 locally transmitted cases (2,736 in Shanghai, 136 in Jilin, 31 in Heilongjiang, 11 in Jiangxi, 10 in Zhejiang, 9 in Hunan, 8 in Guangdong, 6 in Beijing, 6 in Jiangsu, 5 in Henan, 4 in Hebei, 3 in Qinghai, 2 in Shanxi, 1 in Anhui, 1 in Fujian, 1 in Shandong, and 1 in Hubei). 12 new deaths were recorded, all of which were locally transmitted cases in Shanghai. There were 21,423 new asymptomatic infections, of which 68 were imported and 21,355 were locally transmitted (20,634 in Shanghai, 205 in Jilin, 172 in Hebei, 125 in Jiangsu, 57 in Zhejiang, 36 in Henan, 34 in Jiangxi, 22 in Shandong, 16 in Anhui, 14 in Heilongjiang, 14 in Yunnan, 9 in Shanxi, 6 in Qinghai, 2 in Liaoning, 2 in Hubei, 2 in Guangdong, 2 in Guangxi, 2 in Gansu, and 1 in Fujian). There are currently 247,348 asymptomatic infections still under medical observation (of which 703 are imported infections).
  • As of 08:00, April 21, 2022, China recorded 7 high-risk areas (3 in Jilin, 2 in Heilongjiang, and 2 in Fujian) and 114 medium-risk areas.
  • Shanghai to implement a 6-month rent waiver for small and micro enterprises renting state-owned property. At a routine daily press conference held on April 22, the Director of the Shanghai Municipal State-owned Assets Supervision and Administration Commission (SASAC) Bai Tingwei confirmed that small and micro enterprises and registered individual businesses renting property from state-owned enterprises (SOEs) can have their rent waived for six months. Companies in Shanghai will not be required to prove that they have been impacted by the COVID-19 outbreak and just need to provide their leasing contract and other necessary materials to qualify for the waiver. Regulators will also release a set of guidelines to clarify issues such as subletting. According to Bai Tinghui, around 80,000 small and micro enterprises and individual registered businesses will be eligible for the rent waiver, with the total amount of rent waived expected to reach RMB 10 billion (US$1.5 billion) over the six-month period.
  • April 21, 2022 – China reported 2,841 new confirmed cases, including 11 imported cases (5 in Guangxi, 3 in Fujian, 1 in Shanghai, 1 in Guangdong, and 1 in Yunnan) and 2,830 locally transmitted cases (2,634 in Shanghai, 95 in Jilin, 42 in Heilongjiang, 14 in Jiangxi, 8 in Jiangsu, 8 in Guangdong, 6 in Zhejiang, 5 in Shanxi, 4 in Sichuan, 4 in Qinghai, 3 in Hunan, 1 in Beijing, 1 in Hebei, 1 in Inner Mongolia, 1 in Fujian, 1 in Shandong, 1 in Henan, and 1 in Yunnan). 8 new deaths were recorded, all of which were locally transmitted cases in Shanghai. There were 16,617 new asymptomatic infections, of which 65 were imported and 16,552 were locally transmitted (15,861 in Shanghai, 261 in Jilin, 111 in Jiangsu, 93 in Hebei, 31 in Zhejiang, 31 in Jiangxi, 30 in Anhui, 26 in Shanxi, 25 in Henan, 23 in Heilongjiang, 20 in Shandong, 9 in Qinghai, 6 in Liaoning, 6 in Guangxi, 6 in Yunnan, 4 in Guangdong, 4 in Sichuan, 3 in Hubei, 1 in Fujian, and 1 in the Xinjiang Production and Construction Corps). There are currently 261,262 asymptomatic infections still under medical observation (of which 745 are imported infections).
  • Hong Kong reopened venues including gyms, beauty parlors, theme parks, and cinemas. On Thursday, April 21, 2022, Hong Kong eased some of its toughest COVID-19 prevention and control measures, reopening venues including gyms, beauty parlors, theme parks, and cinemas for the first time in more than four months. This happened at a time when Hong Kong’s COVID-19 situation was improved and the daily COVID-19 infections were below 700 again. Bookings at these premises surge as residents eager to embrace a return to normal life. People’s Daily warns that people should remain cautious as there might be a potential rebound in cases.
  • 1,862 container ships are stuck globally with 28% stuck in Chinese ports. The number of container ships waiting outside ports due to congestion has risen sharply in recent months, with 20 percent of all container ships traded globally now stuck, according to Windward, a maritime data consultancy. That means a fifth of the world’s container ships are stuck in congested ports and, according to its data, a quarter of all vessels are stuck in Chinese ports. According to data released by Windward on April 19, the lockdown has exacerbated congestion at ports, with the number of container ships waiting outside Chinese ports 195 percent higher than in February, climbing from 260 in February to 506 in April.
  • April 20, 2022 – China reported 2,761 new confirmed cases, including 8 imported cases (3 in Sichuan, 2 in Yunnan, 1 in Shanghai, 1 in Shandong, and 1 in Guangdong) and 2,753 locally transmitted cases (2,494 in Shanghai, 133 in Jilin, 45 in Heilongjiang, 25 in Jiangxi, 14 in Guangdong, 9 in Shanxi, 8 in Jiangsu, 8 in Zhejiang, 5 in Shaanxi, 3 in Henan, 3 in Hunan, 2 in Beijing, 2 in Fujian, 1 in Hebei, and 1 in Qinghai). 7 new deaths were recorded, all of which were locally transmitted cases in Shanghai. There were 17,166 new asymptomatic infections, of which 100 were imported and 17,066 were locally transmitted (16,407 in Shanghai, 262 in Jilin, 95 in Jiangsu, 61 in Hebei, 48 in Anhui, 47 in Zhejiang, 28 in Heilongjiang, 28 in Jiangxi, 25 in Shandong, 21 in Shanxi, 13 in Henan, 9 in Liaoning, 6 in Guangdong, 6 in Guangxi, 5 in Yunnan, 4 in Hubei, and 1 in Qinghai). There are currently 266,288 asymptomatic infections still under medical observation (of which 750 are imported infections).
  • As of 07:00, April 20, 2022, China recorded 9 high-risk areas (3 in Jilin, 2 in Heilongjiang, 2 in Fujian, 1 in Liaoning, and 1 in Beijing) and 148 medium-risk areas.
  • April 19, 2022 – China reported 3,316 new confirmed cases, including 19 imported cases (5 in Guangxi, 4 in Guangdong, 4 in Sichuan, 2 in Yunnan, 1 in Beijing, 1 in Inner Mongolia, 1 in Fujian, and 1 in Henan) and 3,297 locally transmitted infections (3,084 in Shanghai, 88 in Jilin, 64 in Heilongjiang, 20 in Guangdong, 11 in Jiangsu, 9 in Jiangxi, 5 in Shanxi, 2 in Beijing, 2 in Zhejiang, 2 in Shandong, 2 in Henan, 1 in Hebei, 1 in Liaoning, 1 in Anhui, 1 in Hubei, 1 in Hunan 1 in Yunnan, 1 in Shaanxi, and 1 in Qinghai). 7 new deaths were recorded, all of which were locally transmitted cases in Shanghai. There were 18,284 new asymptomatic infections, of which 97 were imported and 18,187 were locally transmitted (17,332 in Shanghai, 384 in Jilin, 122 in Jiangsu, 60 in Anhui, 46 in Zhejiang, 42 in Jiangxi, 31 in Heilongjiang, 28 in Hebei, 28 in Shanxi, 22 in Henan,16 in Liaoning, 16 in Shandong, 15 in Guangxi, 13 in Hubei, 13 in Yunnan, 6 in Fujian, 5 in Guangdong, 4 in Shaanxi, 2 in Qinghai, 1 in Gansu, and 1 in Xinjiang). There are currently 276,499 asymptomatic infections still under medical observation (of which 754 are imported infections).
  • As of 08:00, April 19, 2022, China recorded 7 high-risk areas (3 in Jilin, 2 in Fujian, 1 in Liaoning, and 1 in Beijing) and 171 medium-risk areas.
  • New Leading Small Group for ensuring the flow of logistics convenes first meeting. On Tuesday, April 19, a new State Council Leading Small Group (LSG) created especially to tackle the current logistics crisis convened its first-ever meeting. The creation of this LSG signals that the top leadership sees solving the current issues as a top priority and that the crisis will get considerable attention in the coming weeks. The meeting reiterated the need for “rectifying the problem of excessive prevention and control” on highways, which is a major source of the obstruction. This will involve creating a ledger of non-compliant actions, such as blocking or closing expressways, toll stations, and public roads, in order to rectify them, and strengthening vehicle tracking and scheduling to prevent these problems from rebounding. The meeting also called for prohibiting the setting up of COVID-19 checkpoints on main highways and service areas and for the mutual recognition of COVID-19 tests from different regions across the country.
  • A note on “zero-COVID” in Shanghai: Beijing has doubled down on its so-called “dynamic clearing” (动态清零 dòngtài qīnglíng) policy to fight COVID-19, also known as the “zero-COVID” or “zero-tolerance” policy in foreign media, as reported (paywall) by state media in recent weeks. This means that Shanghai is unlikely to ease current lockdowns and restrictions on movement until the spread of the virus has been contained. However, it is important to understand that “dynamic clearing” does not mean reducing total case numbers to zero, but rather reducing the community-level spread of COVID-19 to zero so that all new infections and cases are found only among populations already in quarantine areas or among those who are classified as “close contacts” of confirmed cases. Although Shanghai’s daily case numbers remain stubbornly high, the majority of reported cases have been discovered among people in quarantined areas. The number of cases found at the community level has been declining steadily, reaching just 390 on April 19, down from 550 the day before. This may therefore be the number to watch in the coming weeks to get a better gauge of when Shanghai may begin easing restrictions.
  • April 18, 2022 – China reported 2,742 new confirmed cases, including 19 imported cases (5 in Sichuan, 4 in Beijing, 3 in Shanghai, 3 in Guangdong, 2 in Yunnan, 1 in Fujian, and 1 in Guangxi) and 2,723 locally transmitted cases (2,417 in Shanghai, 166 in Jilin, 34 in Zhejiang, 30 in Heilongjiang, 25 in Guangdong, 12 in Qinghai, 10 in Jiangxi, 9 in Shanxi, 7 in Jiangsu, 3 in Beijing, 3 in Shandong, 2 in Henan, 2 in Shaanxi, 1 in Inner Mongolia, 1 in Anhui, and 1 in Guizhou). 3 new deaths were recorded, all of which were locally transmitted cases in Shanghai. There were 20,718 new asymptomatic infections, of which 79 were imported and 20,639 were locally transmitted (19,831 in Shanghai, 376 in Jilin, 90 in Jiangsu, 58 in Anhui, 50 in Shanxi, 42 in Zhejiang, 34 in Jiangxi, 31 in Yunnan, 27 in Shandong, 24 in Heilongjiang, 18 in Fujian, 16 in Guangxi, 11 in Hubei, 10 in Guangdong, 9 in Liaoning, 8 in Henan, and 4 in Qinghai). There are currently 282,764 asymptomatic infections still under medical observation (772 of which are imported infections).
  • As of 08:00, April 18, 2022, China recorded 9 high-risk areas (5 in Jilin, 2 in Fujian, 1 in Liaoning, and 1 in Beijing) and 167 medium-risk areas.
  • Shanghai has issued a whitelist of 666 companies permitted to return to work. Of the companies included on the whitelist, 251 are in the auto industry, 184 are in the pharmaceutical and medical industries, 83 are in the semiconductor and integrated circuits industry, 66 are in the energy and chemicals industries, 17 are in the food and processing industries, and 9 are in the aerospace industry. This announcement comes as an auto executive warned (paywall) that the industry would come to a standstill if the current Shanghai lockdown continues into May.
  • Ministers signal financial support for the logistics industry amid disruptions due to COVID-19. On Saturday, April 16 during a speech at a Tsinghua PBCSF alumni event, as reported by Caixin (paywall), Vice Finance Minister Liao Min stated that financial management departments had introduced targeted measures and financial institutions are providing targeted assistance to help freight logistics companies and employees improve capabilities to fight the epidemic. He also stated that he expected finance companies would increase financial services for key logistics, warehousing, and e-commerce companies. Meanwhile, Xinhua (link in Chinese) reported that at a teleconference held in Beijing on Monday, April 18, Vice Premier Liu He issued “10 important initiatives” to help ensure the smooth flow of logistics and promote the stability of industrial and supply chains. In addition to reiterating the need for a “unified and standardized pass system” and mutual recognition of nucleic acid tests for logistics workers (see update below), he called for RMB 100 billion (US$15.7 billion) of reloans for the transportation and logistics industry and RMB 200 billion (US$31.4 billion) of reloans for technological innovation to help stabilize industrial and supply chains.
  • April 17, 2022 – China reported 3,529 new confirmed cases, including 25 imported cases (12 in Guangxi, 4 in Sichuan, 3 in Guangdong, 2 in Shanghai, 1 in Liaoning, 1 in Zhejiang, 1 in Fujian, and 1 in Shandong) and 3,504 locally transmitted cases (3,238 in Shanghai, 167 in Jilin, 32 in Heilongjiang, 29 in Guangdong, 10 in Zhejiang, 9 in Shanxi, 5 in Qinghai, 3 in Henan, 3 in Shaanxi, 2 in Jiangsu, 2 in Fujian, 2 in Shandong, 1 in Liaoning, and 1 in Hunan). No new deaths were recorded. There were 22,626 new asymptomatic infections, of which 114 were imported and 22,512 were locally transmitted (21,528 in Shanghai, 525 in Jilin, 85 in Jiangsu, 58 in Anhui, 51 in Yunnan, 36 in Shanxi, 28 in Heilongjiang, 21 in Fujian, 21 in Shandong, 20 in Zhejiang, 19 in Henan, 17 in Guangxi, 12 in Hubei, 11 in Guangdong, 7 in Liaoning, 7 in Qinghai, 5 in Hebei, 3 in Jiangxi, 2 in Inner Mongolia, and 2 in Shaanxi). 283,814 of the asymptomatic infections were still under medical observation (790 of which were imported).
  • As of 13:00, April 17, 2022, China recorded 11 high-risk areas (5 in Jilin, 2 in Fujian, 2 in Hebei, 1 in Liaoning, and 1 in Beijing) and 172 medium risk areas.
  • April 16, 2022 – China reported 3,896 new confirmed cases, including 29 imported cases (15 in Fujian, 4 in Shanghai, 2 in Guangdong, 2 in Guangxi, 1 in Beijing, 1 in Jiangsu, 1 in Zhejiang, 1 in Jiangxi, 1 in Sichuan, and 1 in Yunnan) and 3,867 locally transmitted cases (3,590 in Shanghai, 195 in Jilin, 25 in Heilongjiang, 24 in Guangdong, 9 in Zhejiang, 6 in Fujian, 5 in Shanxi, 4 in Jiangsu, 2 in Hainan, 2 in Qinghai, 1 in Inner Mongolia, 1 in Liaoning, 1 in Shandong, 1 in Hunan, and 1 in Shaanxi). No new deaths were recorded. There were 20,895 new asymptomatic infections, of which 82 were imported and 20,813 were locally transmitted (19,923 in Shanghai, 437 in Jilin, 64 in Fujian, 56 in Yunnan, 55 in Guangxi, 52 in Jiangsu, 44 in Anhui, 41 in Hubei, 27 in Liaoning, 24 in Henan, 19 in Shanxi, 17 in Hebei, 13 in Guangdong, 9 in Heilongjiang, 8 in Jiangxi, 6 in Zhejiang, 5 in Shandong, 3 in Qinghai, 3 in Xinjiang, 3 in Corps, 1 in Inner Mongolia, 1 in Hainan, 1 in Shaanxi, and 1 in Gansu). 274,676 of the asymptomatic infections were still under medical observation (771 of which were imported).
  • Beijing takes steps to reduce logistics disruptions on highways. The Chinese government has stepped in to prevent further supply chain disruption following the news that local governments had closed highway exits and service stations in parts of eastern China, among other measures, in an attempt to curb the spread of COVID-19 (see update below). On Thursday, April 14, the State Council issued a notice reiterating the ban on obstructing or closing highways and public roads (the State Council had already ordered this ban on Monday, April 11) and banning service stations that have been impacted by COVID-19 outbreaks from stopping services. The notice also called for the establishment of a “unified and standardized pass system” for truck drivers, to enable them to travel in and out of areas that have been affected by COVID-19 without obstruction. According to the Ministry of Transport, as of April 12, 161 toll booths had reopened since April 10, leaving only 517 toll booths closed, and 81 service stations had reopened, leaving 283 still closed.
  • April 15, 2022 – China reported 3,486 new confirmed cases, including 14 imported cases (6 in Fujian, 3 in Guangxi, 2 in Guangdong, 2 in Sichuan, and 1 in Beijing) and 3,472 locally transmitted cases (3,200 in Shanghai, 174 in Jilin, 22 in Guangdong, 17 in Zhejiang, 10 in Shanxi, 7 in Heilongjiang, 6 in Yunnan, 5 in Shandong, 5 in Qinghai, 3 in Shaanxi, 2 in Beijing, 2 in Jiangsu, 1 in Tianjin, 1 in Liaoning, 1 in Jiangxi, 1 in Henan, 1 in Hubei, 1 in Chongqing, 1 in Sichuan). No new deaths were recorded. There were 20,782 new asymptomatic infections, of which 88 were imported and 20,694 were locally transmitted (19,872 in Shanghai, 342 in Jilin, 136 in Guangxi, 49 in Jiangsu, 47 in Anhui, 43 in Shanxi, 29 in Hubei, 25 in Henan, 24 in Shandong, 23 in Hebei, 20 in Liaoning, 19 in Guangdong, 18 in Jiangxi, 16 in Yunnan, 7 in Fujian, 6 in Zhejiang, 6 in Qinghai, 4 in Shaanxi, 3 in Heilongjiang, 2 in Inner Mongolia, 1 in Tianjin, 1 in Hainan, and 1 in Guizhou). 27,6632 of the asymptomatic infections were still under medical observation (789 of which were imported).
  • April 14, 2022 – China reported 3,020 new confirmed cases, including 21 imported cases (6 in Guangxi, 5 cases in Sichuan, 4 cases in Fujian, 3 cases in Yunnan, 1 case in Beijing, 1 case in Jiangsu, and 1 case in Guangdong) and 2,999 locally transmitted cases (2,573 cases in Shanghai, 325 cases in Jilin, 47 cases in Guangdong, 9 cases in Zhejiang, 9 cases in Fujian, 7 cases in Heilongjiang, 4 cases in Shanxi, 4 cases in Henan, 3 cases in Jiangsu, 3 cases in Hainan, 3 cases in Yunnan, 2 cases in Hebei, 2 cases in Anhui, 2 cases in Shaanxi, 2 cases in Qinghai, 1 case in Beijing, 1 case in Liaoning, 1 case in Jiangxi, and 1 case in Shandong). No new deaths were recorded. There were 26,391 new asymptomatic infections, of which 73 were imported cases and 26,318 were local cases (25,146 cases in Shanghai, 674 cases in Jilin, 129 cases in Guangxi, 50 cases in Jiangsu, 48 cases in Anhui, 42 cases in Henan,  42 cases in Hubei, 32 cases in Liaoning, 30 cases in Hebei, 28 cases in Shandong, 21 cases in Guangdong, 20 cases in Jiangxi, 15 cases in Fujian, 12 cases in Qinghai, 10 cases in Zhejiang, 7 cases in Yunnan, 4 cases in Shanxi, 3 cases in Inner Mongolia, 2 cases in Heilongjiang, 2 cases in Shaanxi, and 1 case in Chongqing); 266,230 of the asymptomatic infections were still under medical observation (844 of which were imported cases).
  • As of 18:00, April 13, 2022, China recorded 16 high-risk areas (6 areas in Jilin, 3 areas in Hebei, 2 areas in Fujian, 2 areas in Heilongjiang, 2 areas in Liaoning, and 1 area in Beijing) and 221 medium-risk areas.
  • April 13, 2022 – China reported 1,513 new confirmed cases, including 13 imported cases (5 in Guangxi, 4 in Guangdong, 1 in Shanghai, 1 in Jiangsu, 1 in Fujian, and 1 in Sichuan) and 1,500 locally transmitted cases (1,189 in Shanghai, 233 in Jilin, 22 in Guangdong, 14 in Hainan, 12 in Zhejiang, 7 in Fujian, 4 in Jiangsu, 3 in Shandong, 3 in Henan, 2 in Heilongjiang, 2 in Hunan, 2 in Shaanxi, 1 in Tianjin, 1 in Hebei, 1 in Liaoning, 1 in Anhui, 1 in Jiangxi, 1 in Hubei, and 1 in Yunnan). No new deaths were recorded. There were 26,525 new asymptomatic infections, of which 105 were imported and 26,420 were local (25,141 in Shanghai, 852 in Jilin, 71 in Jiangsu, 71 in Guangxi, 60 in Anhui, 44 in Hubei, 37 in Hebei, 31 in Liaoning, 19 in Zhenjiang, 19 in Shandong, 16 in Jiangxi, 11 in Henan, 11 in Qinghai, 10 in Yunnan, 9 in Guangdong, 7 in Fujian, 4 in Shanxi, 3 in Sichuan, 2 in Heilongjiang, 1 in Tianjin, 1 in Inner Mongolia); 258,374 of the asymptomatic infections were still under medical observation (881 of which were imported cases).
  • April 12, 2022 – China reported 1,272 new confirmed cases, including 21 imported cases (5 cases in Guangxi, 5 cases in Sichuan, 4 cases in Shanghai, 4 cases in Guangdong, and 3 cases in Fujian) and 1,251 local cases (994 cases in Shanghai, 171 cases in Jilin, 21 cases in Hainan, 16 cases in Guangdong, 14 cases in Jiangsu, 11 case in Zhejiang, 4 cases in Beijing, 4 cases in Fujian, 3 cases in Shandong, 3 cases in Henan, 2 cases in Jiangxi, 2 case in Sichuan, 1 case in Shanxi, 1 case in Inner Mongolia, 1 case in Liaoning, 1 case in Heilongjiang, 1 case in Hubei, and 1 case in Yunnan). No new deaths were reported. There were 23,387 new cases of asymptomatic infection, including 92 imported cases and 23,295 local cases (22,348 cases in Shanghai, 598 cases in Jilin, 62 cases in Jangsu, 61 cases in Anhui, 44 cases in Hebei, 36 cases in Hubei, 24 cases in Liaoning, 24 cases in Fujian, 19 cases in Guangdong, 18 cases in Zhejiang, 18 cases in Jiangxi, 13 cases in Shandong, 11 cases in Henan, 6 cases in Guangxi, 4 cases in Yunnan, 3 cases in Shanxi, 3 cases in Qinghai, 1 case in Tianjin, 1 case in Heilongjiang, and 1 case in Hainan); 240,324 cases of the asymptomatic infections were still under medical observation (887 cases imported from abroad).
  • April 11, 2022 – China reported 1,184 new confirmed cases, including 20 imported cases (8 cases in Sichuan, 4 cases in Guangxi, 3 cases in Shanghai, 3 cases in Guangdong, 1 case in Beijing, and 1 case in Jiangxi) and 1,164 local cases (914 cases in Shanghai, 187 cases in Jilin, 19 cases in Guangdong, 9 cases in Zhejiang, 9 cases in Fujian, 7 cases in Jiangsu, 7 cases in Shaanxi, 2 cases in Shandong, 2 cases in Hainan, 2 cases in Sichuan, 2 cases in Yunnan, 1 case in Shanxi, 1 case in Liaoning, 1 case in Anhui, and 1 case in Jiangxi). No new deaths were reported. There were 26,411 new cases of asymptomatic infection, including 66 imported cases and 26,345 local cases (25,173 cases in Shanghai, 797 cases in Jilin, 100 cases in Hebei, 68 cases in Anhui, 46 cases in Jiangsu, 33 cases in Hubei, 28 cases in Zhejiang, 19 cases in Jiangxi, 18 cases in Guangdong, 13 cases in Shandong, 12 cases in Liaoning, 9 cases in Fujian, 8 cases in Yunnan, 5 cases in Hainan, 4 cases in Henan, 3 cases in Shanxi, 3 cases in Heilongjiang, 3 cases in Xinjiang, 2 cases in Guangxi, and 1 case in Sichuan); 219,896 cases of asymptomatic infections were still under medic observation (899 cases imported from abroad).
  • April 10, 2022 – China reported 1,351 new confirmed cases, including 33 imported cases (9 cases in Shanghai, 7 cases in Guangdong, 5 cases in Guangxi, 4 cases in Sichuan, 3 cases in Fujian, 1 case in Beijing, 1 case in Tianjin, 1 case in Liaoning, 1 case in Shandong, and 1 case in Yunnan) and 1,318 local cases (1,006 cases in Shanghai, 242 cases in Jilin, 16 cases in Zhejiang, 10 cases in Guangdong, 9 cases in Fujian, 6 cases in Hainan, 5 cases in Shanxi, 5 cases in Jiangsu, 3 cases in Beijing, 3 cases in Hebei, 3 cases in Jiangxi, 3 cases in Shandong, 2 cases in Sichuan, 2 cases in Shaanxi, 1 case in Liaoning, 1 case in Heilongjiang, and 1 case in Hubei). No new deaths were reported. There were 25,111 new cases of asymptomatic infection, including 74 imported cases and 25,037 local cases (23,937 cases in Shanghai, 755 cases in Jilin, 84 cases in Hebei, 65 cases in Jiangsu, 44 cases in Anhui, 32 cases in Zhejiang, 26 cases in Jiangxi, 18 cases in Shandong, 16 cases in Hubei, 13 cases in Guangdong, 12 cases in Liaoning, 7 cases in Guangxi, 5 cases in Henan, 5 cases in Xinjiang, 4 cases in Shanxi, 4 cases in Fujian, 3 cases in Hainan, 3 cases in Yunnan, 2 cases in Sichuan, 1 case in Tianjin, and 1 case in Heilongjiang); 195,948 cases of asymptomatic infections were still under medic observation (927 cases imported from abroad).
  • April 9, 2022 – China reported 1,350 new confirmed cases, including 16 imported cases (4 cases in Guangdong, 3 cases in Guangxi, 2 cases in Beijing, 2 cases in Shanghai, 2 cases in Zhejiang, 2 cases in Fujian, and 1 case in Sichuan) and 1,334 local cases (1,015 cases in Shanghai, 248 cases in Jilin, 13 cases in Zhejiang, 8 cases in Shaanxi, 6 cases in Beijing, 6 cases in Shanxi, 6 cases in Anhui, 5 cases in Heilongjiang, 5 cases in Jiangsu, 5 cases in Guangdong, 4 cases in Shandong, 4 cases in Hainan, 3 cases in Fujian, 2 cases in Hebei, 2 cases in Jiangxi, 1 case in Henan, and 1 case in Chongqing). No new deaths were reported. There were 23,815 new cases of asymptomatic infection, including 78 imported cases and 23,737 local cases (22,609 cases in Shanghai, 706 cases in Jilin, 107 cases in Hebei, 73 cases in Jiangsu, 65 cases in Anhui, 39 cases in Shandong, 29 cases in Jiangxi, 26 cases in Zhejiang, 25 cases in Liaoning, 17 cases in Henan, 9 cases in Fujian, 6 cases in Heilongjiang, 5 cases in Shanxi, 5 cases in Guangdong, 4 cases in Guangxi, 3 cases in Yunnan, 2 cases in Hubei, 2 cases in Sichuan, 2 cases in Xinjiang, 1 case in Tianjin, 1 case in Inner Mongolia, and 1 case in Hainan); 174,015 cases of asymptomatic infections were still under medic observation (932 cases imported from abroad).
  • At the epidemic control press conference held on April 9, 2022, Shanghai announced that it will carry out another nucleic acid test for all residents in the city and implement stepped management according to risk degree of specific areas. This is interpreted by analysts that Shanghai government is trying to outline the way out of lockdown.
  • NHC Conference: In the press conference held on April 6, 2022, the National Health Commission (NHC) said that as of April 5, a total of 1.243226 billion people were fully vaccinated, accounting for 88.18% of the total population. From March 1, 2022  to April 5, 2022 a total of 176,455 locally infected COVID-19 cases were reported nationwide, affecting 29 provinces. Guangdong, Shandong and Hebei, among the five provinces and cities hit hardest by the epidemic, are showing signs of improvement, but the outbreaks in Shanghai and Jilin are still developing. Shanghai is at the peak of the epidemic, with more than 90,000 cases reported during the period. More than 60,000 cases have been reported in Jilin Province and the epidemic in Changchun continues to progress and remains at a high level. NHC confirmed that China will continue sticking to its zero-COVID policy.
  • April 8, 2022 – China reported 1,576 new confirmed cases, including 36 imported cases (10 cases in Guangxi, 9 cases in Sichuan, 5 cases in Guangdong, 4 cases in Shanghai, 2 cases in Fujian, 2 cases in Yunan, 1 case in Tianjin, 1 case in Heilongjiang, 1 case in Jiangxi, and 1 case in Shandong) and 1,540 local cases (824 cases in Shanghai, 617 cases in Jilin, 20 cases in Fujian, 13 cases in Jiangsu, 11 cases in Shaanxi, 9 cases in Beijing, 8 cases in Zhejiang, 7 cases in Guangdong, 5 cases in Shanxi, 5 cases in Shandong, 5 cases in Sichuan, 4 cases in Jiangxi, 3 cases in Hainan, 2 cases in Inner Mongolia, 2 cases in Guangxi, 1 case in Hebei, 1 case in Liaoning, 1 case in Heilongjiang, 1 case in Hunan, and 1 case in Yunnan). No new deaths were reported. There were 22,648 new cases of asymptomatic infection, including 87 imported cases and 22,561 local cases (20,398 cases in Shanghai, 1,649 cases in Jilin, 162 cases in Hebei, 69 cases in Anhui, 65 cases in Jiangsu, 46 cases in Shandong, 36 cases in Liaoning, 36 cases in Zhejiang, 32 cases in Jiangxi, 19 cases in Henan, 11 cases in Guangxi, 8 cases in Yunnan, 5 cases in Heilongjiang, 5 cases in Fujian, 4 cases in Shanxi, 4 cases in Guangdong, 3 cases in Hubei, 3 cases in Shaanxi, 2 cases in Hainan, 2 cases in Qinghai, 1 case in Beijing and 1 case in Xinjiang); 152,693 cases of asymptomatic infections were still under medic observation (965 cases imported from abroad).
  • Jilin Province to Lift Lockdowns Gradually: According to the press conferences of the Jilin Provincial government held on April 7 and April 8, 2022, Jilin province has basically stamped out the community spread of COVID-19 in major cities including Jilin City and Yanbian Prefecture after fighting the latest of COVID-19 outbreak for over a month. That is to say, going forward, all of the new confirmed cases in these cities will be found among those who have already been put under quarantine and there will be no more community-level transmission of the virus. By far, Yanbian Prefecture has lifted all lockdown measures and started to resume production. Jilin City and Changchun City are also planning to remove lockdown measures soon. The developments in Jilin are crucial as Jilin is one of the major grain-producing areas of China and the next few weeks are China’s spring planting season. On April 1, 2022, Vice Premier Hu Chunhua convened a teleconference on corn and rice production and required officials of key provinces to ensure COVID-19 control measures don’t disrupt agricultural production. Regardless of the current circumstances, ensuring food security is of top priority in China.
  • April 7, 2022 – China reported 1,323 new confirmed cases, including 39 imported cases (15 cases in Fujian, 11 cases in Sichuan, 7 cases in Shanghai, 1 case in Beijing, 1 case in Liaoning, 1 case in Jiangxi, 1 case in Hunan, 1 case in Guangdong, and 1 case in Yunnan) and 1,284 local cases (890 cases in Jilin, 322 cases in Shanghai, 14 cases in Zhejiang, 10 cases in Sichuan, 9 cases in Heilongjiang, 7 cases in Shanxi, 7 cases in Fujian, 4 cases in Beijing, 4 cases in Shandong, 4 cases in Hainan, 3 cases in Hebei, 3 cases in Jiangsu, 2 cases in Jiangxi, 1 case in Inner Mongolia, 1 case in Liaoning, 1 case in Anhui, 1 case in Henan, and 1 case in Guizhou). No new deaths were reported. There were 21,784 new cases of asymptomatic infection, including 73 imported cases and 21,711 local cases (19,660 cases in Shanghai, 1,546 cases in Jilin, 139 cases in Hebei, 75 cases in Jiangsu, 60 cases in Anhui, 41 cases in Zhejiang, 36 cases in Henan, 32 cases in Jiangxi, 26 cases in Shandong, 21 cases in Liaoning, 16 cases in Fujian, 11 cases in Heilongjiang, 9 cases in Hainan, 8 cases in Guangxi, 6 cases in Yunnan, 4 cases in Tianjin, 4 cases in Hubei, 4 cases in Guangdong, 4 cases in Sichuan, 4 cases in Xinjiang, 2 cases in Ningxia, 1 case in Shanxi, 1 case in Inner Mongolia, and 1 case in Qinghai); 132,948 cases of asymptomatic infections were still under medic observation (993 cases imported from abroad).
  • April 6, 2022 – China reported 1,415 new confirmed cases, including 32 imported cases (14 cases in Sichuan, 5 cases in Guangdong, 4 cases in Shanghai, 4 cases in Guangxi, 1 case in Tianjin, 1 case in Fujian, 1 case in Shandong, 1 case in Chongqing, and 1 case in Yunnan) and 1,383 local cases (973 cases in Jilin, 311 cases in Shanghai, 17 cases in Zhejiang, 10 cases in Sichuan, 8 cases in Shanxi, 8 cases in Heilongjiang, 7 cases in Liaoning, 7 cases in Fujian, 7 cases in Guangdong, 6 cases in Hebei, 4 cases in Beijing, 4 cases in Shandong, 3 cases in Tianjin, 3 cases in Jiangsu, 2 cases in Jiangxi, 1 case in Hunan, 1 case in Yunnan, and 1 case in Shaanxi). No new deaths were reported. There were 19,199 new cases of asymptomatic infection, including 110 imported cases and 19,089 local cases (16,766 cases in Shanghai, 1,798 cases in Jilin, 103 cases in Hebei, 74 cases in Jiangsu, 56 cases in Anhui, 50 cases in Zhejiang, 45 cases in Shandong, 43 cases in Liaoning, 33 cases in Jiangxi, 33 cases in Henan, 22 cases in Fujian, 22 cases in Hainan, 7 cases in Xinjiang, 6 cases in Hubei, 5 cases in Tianjin, 4 cases in Sichuan, 4 cases in Yunnan, 3 cases in Heilongjiang, 3 cases in Guangdong, 2 cases in Shanxi, 2 cases in Guangxi, 2 cases in Guizhou, 2 cases in Qinghai, 1 case in Beijing, 1 case in Hunan, 1 case in Shaanxi, and 1 case in Gansu); 113,950 cases of asymptomatic infections were still under medic observation (1,013 cases imported from abroad).
  • Latest Vaccination Rates in China: In the press conference held on April 1, 2022, the National Health Commission (NHC) said that as of March 31, a total of 3.270784 billion doses of COVID-19 vaccines had been administered nationwide, with 1.277709 million people vaccinated and 1.242281 billion people fully vaccinated, accounting for 90.63% and 88.11% of the total population, respectively. A total of 694.936 million people received enhanced immunization, including 17.344 million who received sequential enhanced immunization. A total of 223.708 million people over the age of 60 have been vaccinated against COVID-19, with 212.572 million people receiving full vaccinations and 143.637 million people receiving enhanced immunizations.
  • Latest Vaccination Rates in China: In the press conference held on March 25, 2022, the National Health Commission (NHC) said that as of March 24, a total of 3.243599 billion doses of COVID-19 vaccines had been administered nationwide, with 1.275541 million people vaccinated and 1.2477 billion people fully vaccinated, accounting for 90.47% and 88.01% of the total population, respectively. A total of 671.27 million people received enhanced immunization, including 12.191 million who received sequential enhanced immunization. A total of 222.719 million people over the age of 60 have been vaccinated against COVID-19, with 212.153 million people receiving full vaccinations and 138.237 million people receiving enhanced immunizations. Up to now, more than 90 percent of people aged 60 or above have received vaccination in Jiangxi, Anhui, and Shandong provinces. More than 85 percent of people aged 60 or above have received vaccination in Chongqing, Henan, Hubei, Guizhou, Hebei, Sichuan, and Yunnan.
  • On March 29, 2022, Shanghai released Several Policy Measures of Shanghai Municipality to Fight against COVID and Boost the Growth of Enterprises, which roll out 21 measures in six aspects. These include tax and fee cuts; rent cuts for small businesses renting state-owned property; measures that specifically target restaurants, retail businesses; travel agencies, and tourist sites; the transportation sector;  companies in the exhibition industry; credit support, etc. Notably, the  Shanghai government mentioned in the Measures that it will “support imported COVID-19 vaccines and medicine”, which analysts are viewing positively as it could mean the introduction of foreign vaccines in mainland China.
  • Shanghai implements the largest scale lockdown ever: Shanghai, a city of 25 million people that serves as China’s financial center, has decided to implement a city-wide lockdown starting from 5:00 am March 28, 2022, after battling a new wave of COVID-19 outbreaks for nearly a month. In the following 9 days, Shanghai will be locked down in two stages, with the eastern side of the city under restrictions from 5:00 am March 28 to 5:00 am April 1, 2022, and the western side under restrictions from 3:00 am April 1 to 3:00 am April 5, 2022. Within the lockdown area, residents are asked to stay at home, public transport including buses, subways, and taxis will be suspended, and businesses should either be subject to closed production or work remotely. Meanwhile, people leaving Shanghai should hold a negative PCR test certificate from the last 48 hours. This is the first time Shanghai has implemented a large-scale lockdown. The staggered lockdown approach means half of the city will keep running at all times. In any case, Shanghai must remain functioning for the good of the economy, officials said. Nevertheless, Disneyland Shanghai has been closed due to the COVID surge since March 21, 2022 and the Tesla Shanghai factory decided to suspend production on Monday, March 28, 2022, both of which are located in Pudong New Area, the eastern side of the city.
  • China’s confirmed cases declining while asymptomatic cases surgingIn the last five days from March 23 to March 27, 2022, the number of confirmed COVID-19 cases reported kept declining, from 2,667 on March 23 to 1,254 on March 27. In contrast, the number of asymptomatic cases continued to increase, from 2,469 on March 23 to 4,448 on March 27. This is in line with Omicron’s highly transmissible but less virulent features, but also a result of China’s high vaccination rates, experts said.
  • Shanghai Becomes China’s COVID Epicenter and Tightens Lockdown Rules: Shanghai has surpassed other hot spot cities with COVID-19 outbreaks to become China’s latest epicenter. In the past three days from March 24-26, 2022, Shanghai reported in total of 5,088 virus infections, including those that are asymptomatic or with symptoms. Given this, Shanghai has been tightening its COVID measures: Residents of compounds under gridding PCR test management (i.e. mass PCR testing region by region) were asked to take their PCR test before 18:00, March 25, 2022, or else their health code will turn to yellow, meaning that their movement will be restricted. Moreover, though the Shanghai authority has denied a city-wide lockdown, more compounds have been subject to “2+12” or “7+7” closed management, which means that residents in such compounds will be subject to PCR testing in the first 2 or 7 days and are not allowed to leave their building/compound. If all are tested negative, they will be allowed to exit but shall monitor their own health and report to authorities in time should any COVID-19 symptoms appear. Zhang Wenhong, Shanghai’s top epidemic doctor and a trusted public figure on COVID-19 prevention measures signaled a silver lining–only 10 percent of the new virus infections are from those who haven’t been put under quarantine control. If this percentage keeps falling down, then the “inflection point” of this round of COVID-19 outbreak could be expected, though Zhang warned that restrictions aren’t likely to be eased soon.
  • Shenzhen Released Supportive Measures to Help Businesses Survive: On the afternoon of March 25, Shenzhen issued Several Measures to Further Help Market Players Survive the COVID-19 (hereinafter referred to as “Measures”). The Measures proposed targeted measures to different sectors including industrial manufacturing, catering services, retail, tourism, logistics, private kindergartens, and services. In addition to tax, fees, and rent cuts, the Measures also promised to provide subsidies and consumption coupons to businesses and individuals, among others.
  • Hong Kong to List Flight Ban for 9 Countries: On March 21, 2022, Chief Executive Carrie Lam announced that from April 1, 2022,  the HK Government will lift the flight ban on nine countries (i.e., Australia, Canada, France, India, Pakistan, the Philippines, the UK, the USA, and Nepal)  and cut the hotel quarantine period for arrivals. Read more: Hong Kong to Lift Flight Ban on 9 Countries from April 1: What Are the Details?
  • April 5, 2022 – China reported 1,235 new confirmed cases, including 62 imported cases (34 cases in Sichuan, 6 cases in Shandong, 6 cases in Guangdong, 5 cases in Guangxi, 3 cases in Shanghai, 3 cases in Henan, 2 cases in Beijing, 2 cases in Fujian, and 1 case in Tianjin) and 1,173 local cases (792 cases in Jilin, 268 cases in Shanghai, 17 cases in Heilongjiang, 17 cases in Zhejiang, 14 cases in Shandong, 12 cases in Sichuan, 8 cases in Beijing, 7 cases in Jiangsu, 7 cases in Fujian, 6 cases in Hebei, 4 cases in Shanxi, 3 cases in Liaoning, 3 cases in Guangdong, 2 cases in Tianjin, 2 cases in Jiangxi, 2 cases in Guangxi, 2 cases in Yunnan, 2 cases in Qinghai, 1 case in Inner Mongolia, 1 case in Anhui, 1 case in Hainan, 1 case in Guizhou, and 1 case in Xinjiang). No new deaths were reported. There were 15,355 new cases of asymptomatic infection, including 116 imported cases and 15,239 local cases (13,086 cases in Shanghai, 1,680 cases in Jilin, 106 cases in Hebei, 70 cases in Jiangsu, 54 cases in Liaoning, 48 cases in Anhui, 39 cases in Jiangxi, 31 cases in Henan, 25 cases in Zhejiang, 17 cases in Shandong, 16 cases in Hubei, 14 cases in Yunnan, 10 cases in Heilongjiang, 9 cases in Fujian, 9 cases in Sichuan, 8 cases in Xinjiang, 4 cases in Tianjin, 4 cases Gansu, 2 cases in Shanxi, 1 case in Beijing, 1 case in Inner Mongolia, 1 case in Hunan, 1 case in Guangdong, 1 case in Hainan, 1 case in Chongqing, and 1 case in Guizhou); 96,803 cases of asymptomatic infections were still under medic observation (1,026 cases imported from abroad).
  • Starting from April 5, 2022, “place code” and “health check all-in-one machine” (also known as “digital sentry”) will be implemented in Shanghai. Residents must scan the code upon entering public places (schools, residential compounds, government institutes, shopping malls, farmers’ markets, supermarkets, theaters, public venues, bars, parks, entertainment venues, medical institutions, training institutions, express terminal outlets, factories and enterprises, long-distance bus stations, airports, passenger terminals, etc.)
  • April 4, 2022 – China reported 1,405 new confirmed cases, including 39 imported cases (14 cases in Sichuan, 8 cases in Shanghai, 8 cases in Guangdong, 3 cases in Beijing, 3 cases in Fujian, 1 case in Shandong, 1 case in Guangxi, and 1 case in Yunnan) and 1,366 local cases (836 cases in Jilin, 425 cases in Shanghai, 16 cases in Fujian, 15 cases in Heilongjiang, 10 cases in Jiangsu, 10 cases in Sichuan, 8 cases in Zhejiang, 7 cases in Qinghai, 6 cases in Shandong, 6 cases in Hainan, 5 cases in Guangdong, 4 cases in Shanxi, 4 cases in Anhui, 4 cases in Jiangxi, 3 cases in Hebei, 2 cases in Henan, 2 cases in Guizhou, 1 case in Beijing, and 1 case in Shaanxi). No new deaths were reported. There were 11,862 new cases of asymptomatic infection, including 91 imported cases and 11,771 local cases (8,581 cases in Shanghai, 2,742 cases in Jilin, 108 cases in Hebei, 69 cases in Anhui, 49 cases in Jiangsu, 39 cases in Liaoning, 39 cases in Jiangxi, 26 cases in Fujian, 21 cases in Hainan, 20 cases in Henan, 13 cases in Shandong, 10 cases in Zhejiang, 9 cases in Heilongjiang, 9 cases in Hubei, 9 cases in Guangdong, 9 cases in Sichuan, 6 cases in Xinjiang, 3 cases in Yunnan, 3 cases in Gansu, 2 cases in Tianjin, 2 cases in Hunan, 1 case in Shanxi, and 1 case in Chongqing); 83,364 cases of asymptomatic infections were still under medic observation (1,064 cases imported from abroad).
  • April 3, 2022 – China reported 1,506 new confirmed cases, including 51 imported cases (30 cases in Sichuan, 10 cases in Guangdong, 6 cases in Shanghai, 3 cases in Fujian, and 2 cases in Guangxi) and 1,455 local cases (956 cases in Jilin, 438 cases in Shanghai, 11 cases in Zhejiang, 8 cases in Fujian, 6 cases in Shandong, 6 cases in Sichuan, 5 cases in Heilongjiang, 5 cases in Jiangsu, 3 cases in Hainan, 3 cases in Shaanxi, 2 cases in Liaoning, 2 cases in Anhui, 2 cases in Jiangxi, 2 cases in Guangdong, 1 case in Tianjin, 1 case in Hebei, 1 case in Shanxi, 1 case in Hunan, 1 case in Guangxi, and 1 case in Xinjiang). No new deaths were reported. There were 11,781 new cases of asymptomatic infection, including 90 imported cases and 11,691 local cases (7.788 cases in Shanghai, 3,499 cases in Jilin, 93 cases in Anhui, 43 cases in Liaoning, 42 cases in Jiangsu, 42 cases in Fujian, 38 cases in Jiangxi, 35 cases in Hebei, 20 cases in Henan, 18 cases in Hubei, 12 cases in Heilongjiang, 8 cases in Zhejiang, 8 cases in Shandong, 8 cases in Guangdong, 7 cases in Gansu, 6 cases in Hainan, 5 cases in Sichaun, 4 cases in Xinjiang, 3 cases in Tianjin, 3 cases in Guangxi, 1 case in Hunan, 1 case in Chongqing, and 1 case in Guizhou); 73,689 cases of asymptomatic infections were still under medic observation (1,105 cases imported from abroad).
  • April 2, 2022 – China reported 2,129 new confirmed cases, including 43 imported cases (22 cases in Sichuan, 8 cases in Beijing, 4 cases in Guangdong, 2 cases in Shanghai, 2 cases in Shandong, 2 cases in Guangxi, 1 case in Liaoning, 1 case in Zhejiang, and 1 case in Yunnan) and 2,086 local cases (1,730 cases in Jilin, 260 cases in Shanghai, 21 cases in Heilongjiang, 14 cases in Zhejiang, 13 cases in Fujian, 12 cases in Jiangsu, 8 cases in Shandong, 8 cases in Hainan, 4 cases in Liaoning, 3 cases in Jiangxi, 3 cases in Hunan, 2 cases in Hebei, 2 cases in Sichuan, 2 cases in Qinghai, 1 case in Tianjin, 1 case in Anhui, 1 case in Henan, and 1 case in Yunnan). No new deaths were reported. There were 7,869 new cases of asymptomatic infection, including 80 imported cases and 7,789 local cases (6,051 cases in Shanghai, 1,244 cases in Jilin, 68 cases in Fujian, 66 cases in Hebei, 55 cases in Anhui, 54 cases in Jiangsu, 52 cases in Liaoning, 41 cases in Jiangxi, 29 cases in Heilongjiang, 27 cases in Shandong, 22 cases in Guangdong, 17 cases in Henan, 14 cases in Zhejiang, 11 cases in Hubei, 9 cases in Gansu, 9 cases in Xinjiang, 6 cases in Guangxi, 6 cases in Hainan, 6 cases in Yunnan, and 2 cases in Chongqing); 63,886 cases of asymptomatic infections were still under medical observation (1,118 cases imported from abroad).
  • Starting from 0:00, April 2, 2022, those who want to leave Shanghai are required to provide a negative nucleic acid test certificate from the last 48 hours and proof of negative antigen test from the last 24 hours.
  • April 1, 2022 – China reported 1,827 new confirmed cases, including 40 imported cases (19 cases in Sichuan, 7 cases in Shanghai, 5 cases in Zhejiang, 2 cases in Beijing, 2 cases in Fujian, 2 cases in Guangdong, 2 cases in Guangxi, and 1 case in Yunan) and 1,787 local cases (1,363 cases in Jilin, 358 cases in Shanghai, 16 cases in Heilongjiang, 10 cases in Zhejiang, 9 cases in Jiangsu, 5 cases in Fujian, 4 cases in Shandong, 4 cases in Guangdong, 3 cases in Henan, 3 cases in Hunan, 2 cases in Hebei, 2 cases in Liaoning, 2 cases in Anhui, 2 cases in Hainan, 1 case in Tianjin, 1 case in Jiangxi, 1 case in Sichuan, and 1 case in Guizhou). No new deaths were reported. There were 5,559 new cases of asymptomatic infection, including 117 imported cases and 5,442 local cases (4,144 cases in Shanghai, 871 cases in Jilin, 73 cases in Fujian, 61 cases in Liaoning, 50 cases in Hebei, 49 cases in Anhui, 34 cases in Jiangsu, 28 cases in Shandong, 18 cases in Jiangxi, 17 cases in Heilongjiang, 17 cases in Henan, 16 cases in Guangxi, 14 cases in Guangdong, 13 cases in Xinjiang, 9 cases in Gansu, 8 cases in Zhejiang, 5 cases in Hubei, 3 cases in Tianjin, 2 cases in Inner Mongolia, 2 cases in Hunan, 2 cases in Hainan, 2 cases in Chongqing,  2 cases in Sichuan, and 2 cases in Yunnan); 59,056 cases of asymptomatic infections were still under medical observation (1,182 cases imported from abroad).
  • Starting from 3:00 am, April 1, 2022,  the western half of Shanghai has entered into lockdown.
  • March 31, 2022 – China reported 1,839 new confirmed cases, including 36 imported cases (18 cases in Sichuan, 8 cases in Guangxi, 3 cases in Shanghai, 3 cases in Guangdong, 2 cases in Beijing, and 2 cases in Zhejiang) and 1,803 local cases (1,340 cases in Jilin, 355 cases in Shanghai, 19 cases in Heilongjiang, 15 cases in Henan, 11 cases in Fujian, 11 cases in Guangdong, 10 cases in Zhejiang, 9 cases in Liaoning, 5 cases in Hebei, 5 cases in Jiangsu, 4 cases in Tianjin, 3 cases in Sichuan, 2 cases in Shanxi, 2 cases in Shandong, 2 cases in Hunan, 2 cases in Hainan, 2 cases in Chongqing, 2 cases in Yunnan, 1 case in Inner Mongolia, 1 case in Anhui, 1 case in Jiangxi, and 1 case in Xinjiang). No new deaths were reported. There were 6,720 new cases of asymptomatic infection, including 69 imported cases and 6,651 local cases (5,298 cases in Shanghai, 835 cases in Jilin, 129 cases in Fujian, 78 cases in Hebei, 66 cases in Anhui, 42 cases in Liaoning, 41 cases in Jiangsu, 25 cases in Shandong, 23 cases in Xinjiang, 21 cases in Heilongjiang, 19 cases in Henan, 17 cases in Zhejiang, 11 cases in Jiangxi, 11 cases in Guangxi, 8 cases in Guangdong, 8 cases in Gansu, 5 cases in Hubei, 5 cases in Yunnan, 3 cases in Hunan, 2 cases in Tianjin, 2 cases in Hainan, 1 case in Shanxi, and 1 case Guizhou); 54,911 cases of asymptomatic infections were still under medical observation (1,202 cases imported from abroad).
  • On Thursday night, March 31, 2022, Shanghai decided to extend the lockdown on its eastern half as COVID-19 infections keep surging. Starting from 5:00 am, April 1, 2022, residents of the eastern half of Shanghai will be subject to a 14-day lockdown, 7-day lockdown plus 7-day community health monitoring, 7-day community health monitoring, or 7-day self-health monitoring plus COVID tests, based on the COVID-19 situation of the building/compound/area they live in. Except for the last circumstance, most residents will be unable to exit their compound during the period.
  • It is reported that the operations of the Port of Shanghai have been disrupted by Shanghai’s COVID-19 lockdown measures, despite authorities’ best efforts. Shipping giant Maersk estimates trucking services into and out of Shanghai will be “severely impacted by 30%”, as anyone entering the port needs a negative nucleic acid test certificate from the last 48 hours and drivers will face lengthy quarantine when returning to their home provinces. Some shipping companies have diverted their vessels to nearby ports, such as the Port of Ningbo in Zhejiang. However, it’s not an easy switch as COVID-19 control measures have already caused rising congestion outside both ports. The global supply chain may feel the impact in the following weeks.
  • AmCham China and AmCham Shanghai conducted a mini-survey of their members on the impact of COVID-19 regulations on the American business community. According to the results, 99% of the respondents indicated that their recent business operations were affected by COVID-19 management measures; 54% of respondents had decreased 2022 revenue projections following the recent COVID-19 outbreak; 29% of respondents had delayed investments, among others.
  • March 30, 2022 – China reported 1,629 new confirmed cases, including 64 imported cases (24 cases in Sichuan, 13 cases in Guangdong, 9 cases in Guangxi, 4 cases in Yunnan, 3 cases in Heilongjiang, 3 cases in Shanghai, 3 cases in Fujian, 2 cases in Shanxi, 1 case in Beijing, 1 case in Inner Mongolia, and 1 case in Shandong) and 1,565 local cases (1,150 cases in Jilin, 326 cases in Shanghai, 26 cases in Henan, 16 cases in Heilongjiang, 8 cases in Zhejiang, 7 cases in Fujian, 6 cases in Hebei, 5 cases in Liaoning, 4 cases in Shandong, 3 cases in Anhui, 3 cases in Hunan, 2 cases in Beijing, 2 cases in Tianjin, 2 cases in Guangdong, 1 case in Jiangsu, 1 case in Jiangxi, 1 case in Hainan, 1 case in Chongqing, and 1 case in Guizhou). No new deaths were reported. There were 7,196 new cases of asymptomatic infection, including 106 imported cases and 7,090 local cases (5,656 cases in Shanghai, 1032 cases in Jilin, 85 cases in Fujian, 75 cases in Hebei, 52 cases in Liaoning, 32 cases in Jiangsu, 31 cases in Anhui, 24 cases in Heilongjiang, 23 cases in Shandong, 14 cases in Guangdong, 13 cases in Guangxi, 10 cases in Henan, 10 cases in Gansu, 9 cases in Jiangxi, 7 cases in Zhejiang, 6 cases in Tianjin, 3 cases in Yunnan, 2 cases in Xinjiang, 1 case in Shanxi, 1 case in Inner Mongolia, 1 case in Hubei, 1 case in Hunan, 1 case in Hainan, and 1 case in Chongqing); 49,421 cases of asymptomatic infections were still under medical observation (1,267 cases imported from abroad).
  • March 29, 2022 – China reported 1,293 new confirmed cases, including 65 imported cases (27 cases in Sichuan, 15 cases in Guangxi, 11 cases in Shanghai, 3 cases in Beijing, 3 cases in Fujian, 3 cases in Guangdong, 2 cases in Yunnan, and 1 case in Shandong) and 1,228 local cases (1,055 cases in Jilin, 96 cases in Shanghai, 12 cases in Shandong, 10 cases in Liaoning, 8 cases in Guangdong, 7 cases in Tianjin, 7 cases in Fujian, 6 cases in Hebei, 5 cases in Heilongjiang, 4 cases in Zhejiang, 3 cases in Shanxi, 3 cases in Jiangsu, 3 cases in Henan, 3 cases in Hunan, 3 cases in Shaanxi, 2 cases in Anhui, and 1 case in Jiangxi). No new deaths were reported. There were 5,758 new cases of asymptomatic infection, including 100 imported cases and 5,658 local cases (4,381 cases in Shanghai, 812 cases in Jilin, 124 cases in Fujian, 108 cases in Hebei, 64 cases in Liaoning, 41 cases in Shandong, 21 cases in Jiangsu, 20 cases in Heilongjiang, 16 cases in Anhui, 11 cases in Gansu, 10 cases in Tianjin, 10 cases in Guangdong, 10 cases in Guangxi, 8 cases in Zhejiang, 8 cases in Henan, 6 cases in Yunnan, 5 cases in Jiangxi, 2 cases in Hunan, and 1 case in Sichuan); 43,425 cases of asymptomatic infections were still under medical observation (1,309 cases imported from abroad).
  • March 28, 2022 – China reported 1,275 new confirmed cases, including 56 imported cases (14 cases in Guangxi, 12 cases in Sichuan, 10 cases in Shanghai, 6 cases in Guangdong, 4 cases in Jilin, 3 cases in Zhejiang, 3 cases in Fujian, 2 cases in Beijing, 1 case in Heilongjiang, and 1 case in Henan) and 1,219 local cases (1,086 cases in Jilin, 50 cases in Shanghai, 12 cases in Liaoning, 10 cases in Heilongjiang, 9 cases in Fujian, 9 cases in Henan, 8 cases in Tianjin, 8 cases in Shandong, 7 cases in Hebei, 4 cases in Guangdong, 4 cases in Shaanxi, 3 cases in Jiangsu, 3 cases in Anhui, 2 cases in Zhejiang, 1 case in Jiangxi, 1 case in Guangxi, 1 case in Yunnan, and 1 case in Gansu). No new deaths were reported. There were 5,134 new cases of asymptomatic infection, including 138 imported cases and 4,996 local cases (3,450 cases in Shanghai, 907 cases in Jilin, 179 cases in Fujian, 144 cases in Hebei, 114 cases in Liaoning, 58 cases in Shandong, 35 cases in Anhui, 18 cases in Guangdong, 16 cases in Jiangsu, 15 cases in Heilongjiang, 12 cases in Guangxi, 11 cases in Yunan, 11 cases in Gansu, 8 cases in Tianjin, 7 cases in Jiangxi, 5 cases in Henan, 3 cases in Zhejiang, 2 cases in Hubei, and 1 case in Inner Mongolia); 38,649 cases of asymptomatic infections were still under medical observation (1,358 cases imported from abroad).
  • NHC Press Conference on March 22: In the press conference held on March 19, 2022, the National Health Commission (NHC) said that from March 1 to 21, 2022, China reported more than 41,000 COVID-19 cases, affecting 28 provinces, with Jilin province reported more than 22,000 cases during this period.
  • NHC explained the Guidelines for Organization of Regional Novel Coronavirus Nucleic Acid Tests (Third Edition)which requires PCR tests to be done within the designated areas (containment area, control area, prevention area, or even the whole area of the entire administrative area) and completed within 24 hours regardless of the size of the area, among others.
  • Regarding the vaccination rates, NHC said that as of March 21, 2022, a total of 3,230.367 million doses of COVID-19 vaccine had been administered nationwide, bringing the total number of people vaccinated to 1.274734 billion. Among them, 1.24013 billion people have completed full vaccination and 659.200 million people have been administered the third-dose booster vaccine. A total of 222.302 million people over the age of 60 were vaccinated, among whom 211.966 million people have been fully vaccinated.
  • Each province to have 2-3 “fangcang shelter hospitals”: NHC said each province should 2-3 fangcang shelter hospitals ( alternate care sites or makeshift hospitals). Even if there is no construction now, provinces should come up with a construction plan to ensure that the fangcang shelter hospitals can be built and put into operation within two days when needed. By far, 33 fangcang shelter hospitals have been built or are under construction in 19  cities of 12 provinces, of which 20 have been completed and 13 are under construction, with a total of 35,000 beds. These fangcang shelter hospitals are mainly concentrated in Jilin, Shandong, Yunnan, Hebei, Fujian, Liaoning.
  • Jilin started to treat COVID patients with Paxlovid: Jilin has started treating COVID patients with Pfizer’s COVID-19 pill Paxlovid, the first time that the drug has been used in the mainland since being approved for emergency use in February.
  • China is fine-tuning its virus response strategy while “zero-COVID” is unchanged: President Xi urged officials to implement COVID-19 measures that are more precise in scope and reduce the impact of the COVID-9 response on people’s livelihoods and productions actively. Local governments have thus been striving to fine-tune their COVID-19 strategy for “maximum effect” with “minimum cost”. Dongguan and Shenzhen resumed production this week while Shanghai tried to avoid a full lockdown. The way these governments deal with the outbreaks may be of reference for other authorities. 
  • Shenyang on lockdown: Shenyang, a city of 9 million people in northeast Shenyang Province and home to factories such as of carmaker BMW, was put under lockdown as of March 22, 2022, after 67 new cases were reported on Tuesday.
  • Dongguan factories are reopening and gradually going back to normal. Read more here: Dongguan on Lockdown Amid COVID Spikes: What Do Businesses Need to Know? (Updated)
  • Shenzhen resumes normal work, production from Monday: Government offices, enterprises, and businesses in the south China tech hub of Shenzhen are set to resume normal work and production from Monday, March 21, 2022,  as the latest COVID-19 outbreak has eased. Meanwhile, non-essential indoor public venues, including massage parlors, poker rooms, and internet cafes, as well as child-care and offline education institutions, will continue to suspend operations. Such differentiated measures are implemented to ensure the safety and stability of industrial and supply chains. Foxcon, the world’s largest electronics manufacturer, was reported to basically resumed normal operations in Shenzhen after a partial lockdown in the city.
  • March 26, 2022 – China reported 1,335 new confirmed cases, including 55 imported cases (12 cases in Sichuan, 9 cases in Shanghai, 7 cases in Beijing, 7 cases in Guangdong, 7 cases in Guangxi, 6 cases in Zhejiang, 3 cases in Shanxi, 2 cases in Shandong, 1 case in Fujian, and 1 case in Hunan) and 1,280 local cases (1,122 cases in Jilin, 38 cases in Shanghai, 35 cases in Tianjin, 19 cases in Hebei, 14 cases in Liaoning, 9 cases in Heilongjiang, 7 cases in Gansu, 6 cases in Jiangsu, 6 cases in Shandong, 4 cases in Inner Mongolia, 4 cases in Fujian, 4 cases in Guangdong, 3 cases in Jiangxi, 3 cases in Henan, 1 case in Beijing, 1 case in Anhui, 1 case in Hunan, 1 case in Chongqing, 1 case in Yunnan, and 1 case in Shaanxi). No new deaths were reported. There were 4,430 new cases of asymptomatic infection, including 110 imported cases and 4,320 local cases (2231 cases in Shanghai, 1,374 cases in Jilin, 184 cases in Hebei, 157 cases in Fujian, 132 cases in Liaoning, 75 cases in Shandong, 33 cases in Gansu, 32 cases in Tianjin, 25 cases in Jiangxi, 16 cases in Anhui, 11 cases in Heilongjiang, 11 cases in Yunnan, 10 cases in Henan, 10 cases in Guangxi, 8 cases in Jiangsu, 7 cases in Guangdong, 1 case in Beijing, and 1 case in Zhejiang); 30,850 cases of asymptomatic infections were still under medical observation (1,407 cases imported from abroad).
  • March 25, 2022 – China reported 1,366 new confirmed cases, including 65 imported cases (23 cases in Guangxi, 12 cases in Shanghai, 11 cases in Guangdong, 6 cases in Sichuan, 5 cases in Beijing, 3 cases in Shanxi, 2 cases in Jilin, 1 case in Jiangsu, 1 case in Zhejiang, and 1 case in Fujian) and 1,301 local cases (1,110 cases in Jilin, 27 cases in Shanghai, 25 cases in Tianjin, 24 cases in Hebei, 23 cases in Heilongjiang, 23 cases in Jiangxi, 17 cases in Fujian, 13 cases in Shandong, 10 cases in Henan, 9 cases in Liaoning, 4 cases in Guangdong, 4 cases in Gansu, 3 cases in Zhejiang, 3 cases in Yunnan, 3 cases in Shaanxi, 1 case in Hunan, and 1 case in Guizhou). No new deaths were reported. There were 3,622 new cases of asymptomatic infection, including 133 imported cases and 3,489 local cases (1582 cases in Shanghai, 900 cases in Jilin, 288 cases in Hebei, 180 cases in Liaoning, 153 cases in Fujian, 140 cases in Shandong, 61 cases in Jiangxi, 42 cases in Tianjin, 29 cases in Gansu, 25 cases in Jiangsu, 24 cases in Anhui, 17 cases in Guangxi,  15 cases in Yunnan, 13 cases in Heilongjiang, 12 cases in Henan, 7 cases in Guangdong, and 1 case in Zhejiang); 27,046 cases of asymptomatic infections were still under medical observation (1,455 cases imported from abroad).
  • March 24, 2022 – China reported 2,054 new confirmed cases, including 44 imported cases (11 cases in Sichuan, 10 cases in Shanghai, 8 cases in Guangdong, 7 cases in Zhejiang, 5 cases in Jiangsu, and 3 cases in Fujian) and 2,010 local cases (1,810 cases in Jilin, 69 cases in Fujian, 29 cases in Tianjin, 16 cases in Shandong, 12 cases in Jiangxi, 10 cases in Heilongjiang, 10 cases in Henan, 9 cases in Liaoning, 8 cases in Hebei, 8 cases in Guangdong, 7 cases in Hunan, 4 cases in Beijing, 4 cases in Shanghai, 4 cases in Zhejiang, 4 cases in Gansu, 3 cases in Jiangsu, 1 case in Sichuan, 1 case in Yunnan, and 1 case in Shannxi). No new deaths were reported. There were 2,829 new cases of asymptomatic infection, including 107 imported cases and 2,722 local cases (979 cases in Shanghai, 791 cases in Jilin, 229 cases in Hebei, 170 cases in Shandong, 162 cases in Fujian, 134 cases in Liaoning, 87 cases in Jiangxi, 48 cases in Tianjin, 27 cases in Heilongjiang, 25 cases in Gansu, 16 cases in Jiangsu, 15 cases in Yunnan,  8 cases in Anhui, 8 cases in Guangdong, 8 cases in Guangxi,  5 cases in Henan,  4 cases in Inner Mongolia, 3 cases in Zhejiang,  2 cases in Shaanxi, and 1 case in Hubei); 24,062 cases of asymptomatic infections were still under medical observation (1,498 cases imported from abroad).
  • March 23, 2022 – China reported 2,667 new confirmed cases, including 76 imported cases (12 cases in Guangxi, 10 cases in Shanghai, 10 cases in Zhejiang, 10 cases in Hunan, 8 cases in Guangdong, 7 cases in Sichuan, 6 cases in Fujian, 6 cases in Henan, 4 cases in Tianjin, 2 cases in Shanxi, and 1 case in Beijing) and 2,591 local cases (2,320 cases in Jilin, 110 cases in Fujian, 36 cases in Liaoning, 24 cases in Tianjin, 24 cases in Shandong, 15 cases in Guangdong, 13 cases in Heilongjiang, 9 cases in Hebei, 9 cases in Jiangxi, 6 cases in Henan, 6 cases in Gansu, 4 cases in Beijing, 4 cases in Shanghai, 3 cases in Shaanxi, 2 cases in Jiangsu, 2 cases in Hunan, 2 cases in Yunnan, 1 case in Zhejiang, and 1 case in Chongqing). No new deaths were reported. There were 2,469 new cases of asymptomatic infection, including 123 imported cases and 2,346 local cases (977 cases in Shanghai, 528 cases in Jilin, 183 cases in Hebei, 160 cases in Fujian, 157 cases in Shandong, 127 cases in Liaoning, 49 cases in Jiangxi, 37 cases in Gangsu, 28 cases in Heilongjiang, 23 cases in Tianjin, 22 cases in Jiangsu, 15 cases in Yunnan, 12 cases in Guangdong, 11 cases in Anhui, 7 cases in Guangxi, 5 cases in Zhejiang, 5 cases in Henan); 22,000 cases of asymptomatic infections were still under medical observation (1,589 cases imported from abroad).
  • As of 10:00, March 23, 2022, China recorded 49 high-risk areas (11 areas in Jiangsu, 10 areas in Shandong, 9 areas in Fujian, 5 areas in Tianjin, 3 areas in Shaanxi, 3 areas in Jilin, 2 areas in Gansu, 2 areas in Guangdong, 2 areas in Heilongjiang, 1 area in Hebei, and 1 area in Liaoning) and 611 medium-risk areas.
  • March 22, 2022 – China reported 2,338 new confirmed cases, including 57 imported cases (12 cases in Guangdong, 10 cases in Zhejiang, 9 cases in Guangxi, 8 cases in Shanghai, 6 cases in Sichuan, 5 cases in Fujian, 4 cases in Beijing, 1 case in Tianjin, 1 case in Liaoning, and 1 case in Heilongjiang) and 2,281 local cases (1,902 cases in Jilin, 110 cases in Fujian, 67 cases in Liaoning, 43 cases in Heilongjiang, 31 cases in Shanghai, 25 cases in Shangdong, 25 cases in Guangdong, 14 cases in Jiangxi, 11 cases in Hebei, 8 cases in Tianjin, 8 cases in Hunan, 7 cases in Henan, 7 cases in Shaanxi, 6 cases in Beijing, 5 cases in Gansu, 3 cases in Jiangsu, 3 cases in Yunnan, 2 cases in Inner Mongolia, 2 cases in Zhejiang, 2 cases in Chongqing). No new deaths were reported. There were 2,432 new cases of asymptomatic infection, including 119 imported cases and 2,313 local cases (865 cases in Shanghai, 563 cases in Jilin, 212 cases in Hebei, 184 cases in Shandong, 183 cases in Liaoning, 110 cases in Fujian, 35 cases in Jiangxi, 30 cases in Gangsu, 29 cases in Jiangsu, 28 cases in Tianjin, 18 cases in Guangxi, 13 cases in Heilongjiang, 12 cases in Anhui, 12 cases in Yunnan, 6 cases in Zhejiang, 5 cases in Guangdong, 4 cases in Henan, 3 cases in Inner Mongolia, and 1 case in Chongqing); 20,155 cases of asymptomatic infections were still under medical observation (1,634 cases imported from abroad).
  • NHC Press Conference on March 19: In the press conference held on March 19, 2022, the National Health Commission (NHC) said that the number of newly confirmed COVID-19 cases around the world has rebounded again in the past week, with over 40% of them concentrated in China’s neighboring countries and regions. With the rapid development of the local epidemic in China, many provinces are faced with a severe and complex epidemic prevention and control situation – dominated by the Omicron virus strain in many areas at the same time. From March 1 to 18, 2022, China reported more than 29,000 COVID-19 cases, affecting 28 provinces, including one province (Jilin province) that reported more than 10,000 cases, four provinces that reported more than 1,000 cases, and 10 provinces that reported between 100 and 1,000 cases. As of 24:00, March 18, 2022, the total number of hospitalized patients reached 29,127, among which mild and asymptomatic cases accounted for more than 95% of the total, while severe and critical cases accounted for less than 0.1% of the total.
  • Regarding the two new COVID-19 deaths reported on March 19, one was of advanced age and one was above 60 years old; both of them had severe underlying diseases and one of them was not vaccinated at all. Their COVID-19 illness itself was not severe and the immediate cause of death was the underlying disease.
  • Regarding the new development of COVID-19 vaccines, NHC said that 29 vaccines have entered clinical trials in China, accounting for 19% of the global total. 16 vaccines have conducted phase III clinical trials abroad, accounting for 27% of the global total. 7 vaccines have been approved for conditional marketing or emergency use, accounting for 21% of the global total. 2 vaccines have been added to the WHO’s list of vaccines for emergency use, representing 20% of the world’s total. To be more specific, China has 6 inactivated vaccines in the clinical phase, 12 recombinant protein vaccines in the clinical phase, 5 adenovirus vector vaccines in the clinical phase, and 5 mRNA and DNA vaccines, commonly known as nucleic acid vaccines, in the clinical phase. Many of these vaccines are undergoing phase III clinical trials abroad. Of particular interest are adenovirus vector aspiration vaccines and attenuated influenza virus vector nasal spray vaccines, which are currently undergoing phase III clinical trials abroad. Moreover, rapid progress has been made in the research and development of monovalent and polyvalent vaccines against omicron variant strains. Among them, the faster ones have completed pre-clinical studies and are submitting application materials for clinical trials to the National Medical Products Administration. However, NHC has promised that it will uphold the scientific principle of safety and efficacy in the first place.
  • Why should COVID-19 cases with mild symptoms be put under centralized quarantine management? NHC said that COVID-19 cases with mild symptoms caused by the Omicron variant do not need to be hospitalized because they only have mild upper respiratory tract infection symptoms. However, considering that Omicron cases are highly transmissible, it will put the hospital system under pressure if such cases cause large-scale virus spread. So it’s necessary to put such cases under centralized quarantine management under the supervision of medical professionals. NHC believes this measure is not only conducive to the recovery of the confirmed cases but also conducive to the containment of the flare-ups.
  • Regarding the vaccination rates, NHC said that as of March 18, 2022, a total of 3,218.716 million doses of COVID-19 vaccine had been administered nationwide, bringing the total number of people vaccinated to 1.273811 billion. Among them, 1.239706 billion people have completed full vaccination and 649.156 million people have been administered the third-dose booster vaccine. A total of 221.829 million people over the age of 60 were vaccinated, among whom 211.819 million people have been fully vaccinated. In total, 80.27% of people over the age of 60 were vaccinated.
  • China Reports Two New COVID-19 Deaths in More Than One Year: On Saturday, March 19, 2022, China reported two new deaths due to COVID-19, both of which were elderly above 60 years old in northeast Jilin Province. The deaths were the first reported in mainland China since January 26, 2021, and bring the country’s total death toll in the pandemic to 4,638. China’s “zero-COVID” policy is under great pressure with the highly transmissible Omicron variant causing flare-ups in 28 provinces. However, both the government and epidemiology experts hold that China is not yet ready to “live with COVID”. As explained by Zhang Wenhong, director of the National Center for Infectious Diseases and a trusted public figure on COVID-19 prevention measures, China needs to 1) sufficient third-dose booster shots for the elderly; 2) vaccines with higher efficacy; 3) effective COVID drugs; 4) affordable and accessible home testing kits; 5) differentiated treatment and hospitalization strategy based on symptoms; and 6) improved home quarantine procedures– before China can significantly relax it COVID-19 prevention and control policies. At the same time, the government is aware of the potential disruption to its economy because of the strict COVID-19 measures. On Thursday, President Xi Jinping called for a more “targeted” approach while sticking to its “zero-COVID” strategy. Shenzhen’s lockdown measures were partially eased following President Xi’s comments. Nevertheless, before China brings to control this round of COVID-19 outbreaks, individuals and businesses may feel more pain in the following weeks.
  • Dongguan on Lockdown: The southern Chinese manufacturing hub of Dongguan has imposed strict COVID-19 lockdown measures. Many businesses have been ordered to suspend operations or operate at a reduced capacity, factories without any prevalence of COVID-19 are required to limit their production, and those who can are required to work from home. The restrictions will have a significant impact on businesses, but compliance and maintaining a positive relationship with authorities will be beneficial in the long run. We explain what the lockdown measures are and the steps businesses can take to limit their impact. Read more here: Dongguan on Lockdown Amid COVID Spikes: What Do Businesses Need to Know?
  • March 21, 2022 – China reported 2,027 new confirmed cases, including 80 imported cases (18 cases in Hunan, 17 cases in Shanghai, 15 cases in Guangxi, 7 cases in Guangdong, 6 cases in Fujian, 4 cases in Beijing, 4 cases in Tianjin, 3 cases in Heilongjiang, 3 cases in Shandong, 2 cases in Sichuan, and 1 case in Zhejiang) and 1,947 local cases (1,542 cases in Jilin, 154 cases in Fujian, 51 cases in Hebei, 38 cases in Guangdong, 35 cases in Liaoning, 27 cases in Heilongjiang, 24 cases in Shanghai, 18 cases in Tianjin, 14 cases in Shaanxi, 13 cases in Shandong, 10 cases in Hunan, 6 cases in Gansu, 4 cases in Beijing, 4 cases in Yunnan, 2 cases in Inner Mongolia, 2 cases in Zhejiang, 1 case in Jiangxi, 1 case in Henan, and 1 case in Chongqing). No new deaths were reported. There were 2,492 new cases of asymptomatic infection, including 108 imported cases and 2,384 local cases (734 cases in Shanghai, 549 cases in Jilin, 356 cases in Hebei, 286 cases in Shandong, 109 cases in Liaoning, 107 cases in Fujian, 58 cases in Jiangsu, 33 cases in Jiangxi, 27 cases in Gangsu, 25 cases in Yunnan, 21 cases in Guangxi, 16 cases in Zhejiang, 16 cases in Guangdong, 14 cases in Heilongjiang, 10 cases in Anhui, 9 cases in Henan, 7 cases in Tianjin, 5 cases in Inner Mongolia, 1 case in Hainan, and 1 case in Chongqing); 18,327 cases of asymptomatic infections were still under medical observation (1,658 cases imported from abroad).
  • March 20, 2022 – China reported 1,737 new confirmed cases, including 81 imported cases (22 cases in Guangdong, 14 cases in Beijing, 11 cases in Zhejiang, 8 cases in Guangxi, 6 cases in Shandong, 5 cases in Shanghai, 4 cases in Tianjin, 4 cases in Sichuan, 3 cases in Hubei, 2 cases in Fujian, 1 case in Heilongjiang, and 1 case in Henan) and 1,656 local cases (1,191 cases in Jilin, 158 cases in Fujian, 51 cases in Shandong, 51 cases in Guangdong, 39 cases in Liaoning, 29 cases in Gansu, 21 cases in Tianjin, 21 cases in Hebei, 19 cases in Zhejiang, 18 cases in Heilongjiang, 17 cases in Shanghai, 15 cases in Shaanxi, 6 cases in Jiangxi, 6 cases in Hunan, 4 cases in Yunnan, 3 cases in Anhui, 3 cases in Chongqing, 2 cases in Henan, 1 case in Beijing, and 1 case in Jiangsu). No new deaths were reported. There were 2,316 new cases of asymptomatic infection, including 139 imported cases and 2,177 local cases (534 cases in Hebei, 492 cases in Shanghai, 380 cases in Shandong, 303 cases in Jilin, 132 cases in Liaoning, 109 cases in Fujian, 50 cases in Jiangsu, 28 cases in Jiangxi, 27 cases in Guangdong, 24 cases in Guangxi, 19 cases in Heilongjiang, 18 cases in Zhejiang, 17 cases in Yunnan, 17 cases in Gansu, 15 cases in Anhui, 8 cases in Inner Mongolia, and 4 cases in Chongqing); 16,196 cases of asymptomatic infections were still under medical observation (1,695 cases imported from abroad).
  • March 19, 2022 – China reported 2,228 new confirmed cases, including 71 imported cases (18 cases in Guangdong, 12 cases in Shanghai, 12 cases in Zhejiang, 10 cases in Beijing, 4 cases in Liaoning, 4 cases in Sichuan, 3 cases in Fujian, 2 cases in Shandong, 2 cases in Guangxi, 1 case in Tianjin, 1 case in Heilongjiang, 1 case in Yunnan, and 1 case in Gansu) and 2,157 local cases (1,674 cases in Jilin, 199 cases in Fujian, 69 cases in Liaoning, 47 cases in Guangdong, 42 cases in Shandong, 28 cases in Tianjin, 22 cases in Gansu, 20 cases in Heilongjiang, 11 cases in Zhejiang, 11 cases in Shaanxi, 8 cases in Shanghai, 6 cases in Hunan, 5 cases in Yunnan, 4 cases in Hebei, 3 cases in Jiangsu, 3 cases in Chongqing, 2 cases in Guangxi, 1 case in Beijing, 1 case in Henan, and 1 case in Guizhou). Two new deaths were reported. There were 1,823 new cases of asymptomatic infection, including 110 imported cases and 1,713 local cases (537 cases in Jilin, 366 cases in Shanghai, 265 cases in Hebei, 161 cases in Shandong, 77 cases in Fujian, 60 cases in Liaoning, 48 cases in Guangdong, 43 cases in Heilongjiang, 36 cases in Jiangxi, 35 cases in Jiangsu, 24 cases in Yunnan, 17 cases in Guangxi, 15 cases in Anhui, 14 cases in Zhejiang, 6 cases in Inner Mongolia, 4 cases in Henan, 2 cases in Guizhou, 2 cases in Gansu, and 1 case in Hunan); 14,318 cases of asymptomatic infections were still under medical observation (1,721 cases imported from abroad).
  • Dongguan on lockdown: Dongguan, an industrial hub in the province of Guangdong, tightened its COVID-19 prevention and control measures to contain the recent flareup of Omicron cases. According to Announcements No.53 and No.54 released by the Dongguan government, all its 10 million residents have been asked to stay at home unless they have necessary reasons not to. With the exception of enterprises that provide public services to ensure the basic operation of the city, such as water, electricity, fuel oil, gas, communications, sanitation, food, oil, meat, and vegetables, as well as enterprises guaranteeing the supplies for Hong Kong, all enterprises shall suspend their production activity should there be detection of domestically transmitted COVID-19 cases in the towns or streets (industrial parks) where the business is locatedTowns and streets (or parks) without local COVID-19 cases and industrial parks with closed-loop management can maintain basic production on the premise of strictly implementing epidemic prevention measures. With the exception of supermarkets (including farmers’ markets), pharmacies, medical institutions, and catering enterprises (only providing express delivery services) that ensure the basic needs of citizens, other business places and stores will be closed. All companies in commercial buildings should ask their employees to work from home (or at most keep no more than 50 percent of the employees on-duty). All construction sites should suspend operations. All buses and subways shall be suspended. Only those who have special needs can leave Dongguan with a negative PCR test from the last 24 hours. The lockdown measures will last from March 15, 2022 to March 21, 2022, and will be adjusted according to the epidemic situation.
  • Closed-loop management of industrial enterprises in Dongguan: Industrial enterprises with closed-loop management can maintain basic production on the premise of strictly implementing epidemic prevention measures, which requires among others that: 1) In principle, workers are supposed to live in the factory or work from home if they do not live in the factory area; 2) Workers in key positions can enter the factory after getting approval from the local epidemic control department and holding a negative nucleic acid test certificate from the last 48 hours; 3) No other visitors are allowed to enter the factory; 4) Enterprise logistics vehicles are prohibited from entering in principle, and those who need to enter shall get approval from the epidemic control departments and the truck driver should hold a negative nucleic acid test certificate from the last 24 hours; 5)Those in contact with imported goods should wear gloves, masks, goggles, and ‘isolation clothing’, conduct nucleic acid tests every two days, and be subject to strict closed-loop management. The closed-loop management measures will last from 20:00, March 15, 2022, to 24:00, March 21, 2022, and will be adjusted according to the epidemic situation. Enterprises are asked to make commitments in writing to strictly follow the measures and assume legal liability should their failure of following such measures cause or worsen the spread risks of the COVID-19 virus.
  • NHC Amended COVID-19 Hospitalization Strategy: On March 14, 2022, the National Health Commission (NHC) released the Notice on the issuance of COVID-19 Diagnosis and Treatment Protocol (Trial Version 9), which amended guidelines for treating COVID-19 patients. Going forward, asymptomatic cases and confirmed cases with mild symptoms will no longer need to be hospitalized. Rather, they will be quarantined in centralized facilities. Only confirmed cases with serious symptoms will be hospitalized. The strategy of differentiated treatment and hospitalization based on symptom levels is believed to be one of the preconditions for China to shift away from its “Zero-COVID” policy.
  • Zhang Wenhong’s Six Preconditions for China to Shift Away from “Zero-COVID” policy: Zhang Wenhong, director of the National Center for Infectious Diseases and a trusted public figure on COVID-19 prevention measures, published a long social media post on March 14, 2022, that listed the reasons why China cannot shift to a policy of “living with COVID” right away. In his opinion, the preconditions for China moving from “zero-COVID” to “living with COVID” have yet to be satisfied. China lacks: 1) sufficient third-dose booster shots for the elderly; 2) vaccines with higher efficacy; 3) effective COVID drugs; 4) affordable and accessible home testing kits; 5) differentiated treatment and hospitalization strategy based on symptoms; and 6) improved home quarantine procedures.
  • NHC Press Conference on March 15:  In the press conference held on March 14, 2022, the National Health Commission (NHC) said there were over 15,000 domestically transmitted cases being reported in the past two weeks from March 1, 2022, to March 14, 2022, affecting livelihoods in 28 provinces. At present, China’s epidemic prevention and control situation is grim and complex, but it is still under control. NHC Li Jinming, deputy director of Clinical Laboratory of NHC, clarified issues regarding the application of antigen tests. There are three main groups suitable for the application of antigen detection: 1) People who go to primary medical institutions for treatment and have clinical symptoms such as fever within 5 days. 2) People under quarantine observation, including those under home quarantine observation, those who are defined as close contact or sub-close contact, and those who are confined to closed communities when epidemic outbreaks occur. 3) Residents who want to be tested themselves. Going forward, China will continue the “dynamic clearance” strategy and endeavor to reduce the frequency of flare-ups and reduce the rates of severe symptoms. China will also promote vaccination for the elderly, especially those over 80 years old.
  • Shanghai to Conduct Twice COVID-19 Tests for Residents in Key Areas: On March 16 and March 17, Shanghai shall conduct twice COVID-19 nucleic acid tests for residents in key areas within 48 hours. Personnel who have already been under COVID-19 control shall be excluded. For those who are already in closed-loop management and subject to routine screenings, they shall be managed according to the original mechanism.
  • March 18, 2022 – China reported 2,461 new confirmed cases, including 73 imported cases (19 cases in Zhejiang, 15 cases in Guangdong, 12 cases in Guangxi, 10 cases in Shanghai, 7 cases in Beijing, 3 cases in Fujian, 3 cases in Shandong, 2 cases in Tianjin, 1 case in Liaoning, and 1 case in Yunnan) and 2,388 local cases (1,834 cases in Jilin, 113 cases in Fujian, 74 cases in Guangdong, 61 cases in Tianjin, 61 cases in Shandong, 57 cases in Shanghai, 46 cases in Liaoning, 33 cases in Shaanxi, 24 cases in Hebei, 16 cases in Heilongjiang, 16 cases in Gansu, 13 cases in Zhejiang, 10 cases in Chongqing, 7 cases in Beijing, 7 cases in Inner Mongolia, 5 cases in Yunnan, 4 cases in Jiangsu, 2 cases in Jiangxi, 2 cases in Hunan, 2 cases in Guangxi, and 1 case in Henan). No new deaths were reported. There were 1,904 new cases of asymptomatic infection, including 162 imported cases and 1,742 local cases (792 cases in Jilin, 203 cases in Shanghai, 193 cases in Hebei, 162 cases in Shandong, 83 cases in Fujian, 79 cases in Liaoning, 61 cases in Guangdong, 47 cases in Jiangsu, 35 cases in Heilongjiang, 25 cases in Yunnan, 20 cases in Guangxi, 10 cases in Zhejiang, 10 cases in Gansu, 6 cases in Chongqing, 5 cases in Jiangxi, 4 cases in Anhui, 3 cases in Inner Mongolia, 2 cases in Tianjin, 1 case in Beijing, and 1 case in Sichuan); 12,786 cases of asymptomatic infections were still under medical observation (1,802 cases imported from abroad).
  • March 17, 2022 – China reported 1,317 new confirmed cases, including 91 imported cases (21 cases in Guangdong, 15 cases in Shanghai, 11 cases in Zhejiang, 10 cases in Tianjin, 8 cases in Beijing, 6 cases in Shandong, 5 cases in Jiangsu, 5 cases in Guangxi, 4 cases in Liaoning, 2 cases in Fujian, 2 cases in Sichuan, 1 case in Yunnan, and 1 case in Gansu) and 1,226 local cases (742 cases in Jilin, 99 cases in Fujian, 83 cases in Guangdong, 62 cases in Liaoning, 48 cases in Tianjin, 38 cases in Hebei, 36 cases in Shandong, 27 cases in Zhejiang, 26 cases in Shaanxi, 16 cases in Heilongjiang, 12 cases in Gansu, 8 cases in Shanghai, 7 cases in Guangxi, 5 cases in Jiangsu, 5 cases in Yunnan, 4 cases in Beijing, 4 cases in Chongqing,  1 case in Anhui, and 1 case in Jiangxi). No new deaths were reported.
  • There were 1,310 new cases of asymptomatic infection, including 104 imported cases and 1,206 local cases (415 cases in Jilin, 178 cases in Hebei, 150 cases in Shanghai, 96 cases in Shandong, 94 cases in Liaoning, 70 cases in Guangdong, 67 cases in Jiangsu, 42 cases in Fujian, 24 cases in Yunnan, 23 cases in Guangxi, 13 cases in Heilongjiang, 10 cases in Anhui, 8 cases in Gansu, 7 cases in Tianjin, 4 cases in Inner Mongolia, 4 cases in Zhejiang, and 1 case in Chongqing); 11,029 cases of asymptomatic infections were still under medical observation (1,729 cases imported from abroad).
  • March 16, 2022 – China reported 1,952 new confirmed cases, including 92 imported cases (24 cases in Guangxi, 21 cases in Guangdong, 11 cases in Shandong, 10 cases in Shanghai, 9 cases in Sichuan, 5 cases in Zhejiang, 3 cases in Beijing, 2 cases in Tianjin, 2 cases in Liaoning, 2 cases in Fujian, 2 cases in Henan, and 1 case in Yunnan) and 1,860 local cases (1,456cases in Jilin, 75 cases in Shandong, 59 cases in Guangdong, 51 cases in Tianjin, 38 cases in Hebei, 32 cases in Liaoning, 28 cases in Shaanxi, 23 cases in Zhejiang, 23 cases in Fujian, 15 cases in Heilongjiang, 13 cases in Jiangsu, 11 cases in Chongqing, 9 cases in Beijing, 6 cases in Yunnan, 5 cases in Shanghai, 5 cases in Guangxi, 5 cases in Gansu, 2 cases in Anhui, 2 cases in Guizhou, 1 case in Hubei, and 1 case in Hunan). No new deaths were reported. There were 1,338 new cases of asymptomatic infection, including 144 imported cases and 1,194 local cases (397 cases in Jilin, 239 cases in Hebei, 197 cases in Shanghai, 105 cases in Shandong, 60 cases in Jiangsu, 54 cases in Guangdong, 32 cases in Yunnan, 20 cases in Guangxi, 17 cases in Tianjin, 16 cases in Gansu, 15 cases in Fujian, 12 cases in Liaoning, 11 cases in Heilongjiang, 6 cases in Zhejiang, 5 cases in Anhui, 3 cases in Jiangxi, 3 cases in Chongqing, 1 case in Beijing, and 1 case in Inner Mongolia); 9,864 cases of asymptomatic infections were still under medical observation (1,695 cases imported from abroad).
  • March 15, 2022 – China reported 3602 new confirmed cases, including 95 imported cases (20 cases in Guangdong, 17 cases in Guangxi, 12 cases in Shanghai, 12 cases in Zhejiang, 9 cases in Beijing, 9 cases in Shandong, 6 cases in Fujian, 4 cases in Sichuan, 3 cases in Tianjin, 1 case in Liaoning, 1 case in Jilin, and 1 case in Hubei) and 3507 local cases (3076 cases in Jilin, 106 cases in Shandong, 53 cases in Shaanxi, 51 cases in Tianjin, 48 cases in Guangdong, 33 cases in Fujian, 31 cases in Zhejiang, 24 cases in Liaoning, 20 cases in Jiangsu, 13 cases in Hebei, 10 cases in Chongqing, 9 cases in Shanghai, 7 cases in Heilongjiang, 7 cases in Gansu, 6 cases in Beijing, 4 cases in Guangxi, 4 cases in Yunnan, 2 cases in Guizhou, 1 case in Anhui, 1 case in Henan, and 1 case in Hunan). No new deaths were reported. There were 1768 new cases of asymptomatic infection, including 121 imported cases and 1647 local cases (991 cases in Jilin, 185 cases in Hebei, 130 cases in Shanghai, 107 cases in Shandong, 68 cases in Guangdong, 30 cases in Fujian, 27 cases in Jiangsu, 24 cases in Yunnan, 20 cases in Gansu, 19 cases in Guangxi, 11 cases in Anhui, 9 cases in Liaoning, 8 cases in Heilongjiang, 7 cases in Zhejiang, 4 cases in Tianjin, 2 cases in Chongqing, 2 cases in Sichuan, 2 cases in Guizhou,  and 1 case in Jiangxi); 8650 cases of asymptomatic infections were still under medical observation (1610 cases imported from abroad).
  • Shanghai Anti-COVID Measures: Starting from March 12, 2022, those who do need to leave Shanghai must have a negative nucleic acid test report from the last 48 hours, and those who come to or return to Shanghai must have a negative nucleic acid test report from the last 48 hours before arrival.
  • Shenzhen on Lockdown: The southern Chinese tech hub of Shenzhen was put under a citywide lockdown on Sunday, March 13, 2022, after 66 new COVID-19 cases were reported in the city. According to the announcement released by the Shenzhen government, all of its 17 million residents have been asked to stay at home. With the exception of enterprises that provide public services to ensure the basic operation of the city, such as water, electricity, fuel oil, gas, communications, sanitation, food, oil, meat, and vegetables, as well as enterprises guaranteeing the supplies for Hong Kong, all enterprises shall suspend production and business activities and make their employees work from home. With the exception of supermarkets (including farmers’ markets), pharmacies, medical institutions, and catering enterprises (that only provide express delivery services) that ensure the basic needs of citizens, other business places and stores will be closed. All buses and subways shall be suspended. Only those who have special needs can leave Shenzhen with a negative PCR test from the last 24 hours. The lockdown and suspension of public transport will last until March 20, 2022, and will be adjusted according to the epidemic situation.
  • China Approved COVID-19 Antigen Tests for Public Use: On Friday, the State Council approved COVID-19 antigen tests for public use and released trial rules around their deployment. Antigen tests will be required for suspected cases, people under quarantine, and close contacts. The public can buy antigen testing kits from pharmacies, or online, for voluntary testing. People with positive antigen test results will be treated as infected individuals and transferred to the hospital for additional nucleic acid tests. According to analysis, in the long term, ubiquitous at-home antigen tests could provide a pathway for China to live with the virus.
  • COVID-19 Cases Surging in China: China’s COVID-19 cases hit the highest daily count since the pandemic broke out in Wuhan in 2020. On Friday, March 11, 555 new confirmed cases and 814 new asymptomatic cases were reported – growing for nine consecutive days. Among the over 40 cities with COVID infection clusters, Shanghai is getting extra attention as the financial center of the country and due to its reputation for implementing precise COVID-19 containment measures over the past two years. This time, however, the inconvenience brought by the counter-COVID measures has been felt by more people than ever. Dozens of housing and office compounds in the city where confirmed cases and their close contacts had visited have been told to undergo up to 14-day quarantines. Some districts, such as Xuhui and Jingan, have started to shut down public venues and cultural spaces, such as parks, libraries, and cinemas. Starting from March 12, 2022, nursery institutions and kindergartens will be suspended and all primary and middle schools will move their classes online. With Omicron leading to more asymptomatic cases, it is harder to stick to the existing “zero-tolerance” (or “dynamic clearance”) strategy. Though analysts expect no relaxation of China’s COVID-19 policies before the end of this year, the recent COVID-19 surge may push Beijing to reconsider/redesign its strategy, especially when economic stability becomes the top concern of the government once again.
  • March 14, 2022 – China reported 1437 new confirmed cases, including 100 imported cases (42 cases in Guangdong, 16 cases in Shanghai, 9 cases in Zhejiang, 8 cases in Guangxi, 8 cases in Sichuan, 5 cases in Tianjin, 4 cases in Shandong, 3 cases in Beijing, 1 case in Jiangsu, 1 case in Fujian, 1 case in Henan, 1 case in Yunnan, and 1 case in Gansu) and 1337 local cases (895 cases in Jilin, 92 cases in Shandong, 79 cases in Guangdong, 60 cases in Shaanxi, 51 cases in Hebei, 41 cases in Shanghai, 40 cases in Tianjin, 16 cases in Jiangsu, 12 cases in Gansu, 10 cases in Fujian, 9 cases in Liaoning, 7 cases in Heilongjiang, 6 cases in Beijing, 6 cases in Zhejiang, 6 cases in Chongqing, 4 cases in Yunnan, and 3 cases in Guangxi). No new deaths were reported. There were 906 new cases of asymptomatic infection, including 118 imported cases and 788 local cases (162 cases in Hebei, 151 cases in Guangdong, 131 cases in Jilin, 128 cases in Shanghai, 97 cases in Shandong, 35 cases in Yunnan, 23 cases in Jiangsu, 15 cases in Gansu, 14 cases in Guangxi, 12 cases in Tianjin, 10 cases in Heilongjiang, 4 cases in Jiangxi, 2 cases in Beijing, 2 cases in Zhejiang, 1 case in Anhui, and 1 case in Chongqing); 7039 cases of asymptomatic infections were still under medical observation (1549 cases imported from abroad).
  • March 13, 2022 – China reported 1938 new confirmed cases, including 131 imported cases (39 cases in Zhejiang, 34 cases in Guangdong, 13 cases in Shanghai, 12 cases in Beijing, 11 cases in Shandong, 6 cases in Tianjin, 4 cases in Liaoning, 4 cases in Guangxi, 3 cases in Sichuan, 2 cases in Jilin, 1 case in Jiangsu, 1 case in Anhui, and 1 case in Fujian) and 1807 local cases (1412 cases in Jilin, 175 cases in Shandong, 62 cases in Guangdong, 39 cases in Shaanxi, 33 cases in Hebei, 23 cases in Jiangsu, 17 cases in Tianjin, 15 cases in Zhejiang, 8 cases in Chongqing, 6 cases in Beijing, 5 cases in Gansu, 3 cases in Heilongjiang, 2 cases in Guizhou, 2 cases in Yunnan, 1 case in Inner Mongolia, 1 case in Liaoning, 1 case in Shanghai, 1 case in Henan, and 1 case in Hunan). No new deaths were reported. There were 1455 new cases of asymptomatic infection, including 140 imported cases and 1315 local cases (744 cases in Jilin, 194 cases in Guangdong, 172 cases in Shandong, 64 cases in Shanghai, 40 cases in Hebei, 36 cases in Gansu, 20 cases in Yunnan, 19 cases in Jiangsu, 9 cases in Tianjin, 9 cases in Guangxi, 4 cases in Shaanxi, 2 cases in Liaoning, 1 case in Beijing, and 1 case in Chongqing); 6287 cases of asymptomatic infections were still under medical observation (1486 cases imported from abroad).
  • March 12, 2022 – China reported 588 new confirmed cases, including 112 imported cases (30 cases in Guangdong, 22 cases in Shanghai, 12 cases in Sichuan, 10 cases in Guangxi, 7 cases in Shandong, 7 cases in Gansu, 5 cases in Beijing, 4 cases in Henan, 3 cases in Liaoning, 2 cases in Tianjin, 2 cases in Jilin, 2 cases in Hubei, 2 cases in Chongqing, 1 case in Heilongjiang, 1 case in Zhejiang, 1 case in Anhui, and 1 case in Hunan) and 476 local cases (159 cases in Shandong, 134 cases in Jilin, 35 cases in Tianjin, 33 cases in Guangdong, 30 cases in Shaanxi, 23 cases in Zhejiang, 22 cases in Hebei, 20 cases in Jiangsu, 5 cases in Shanghai, 4 cases in Yunnan, 4 cases in Gansu, 2 cases in Heilongjiang, 1 case in Beijing, 1 case in Inner Mongolia, 1 case in Fujian, 1 case in Henan, and 1 case in Qinghai). No new deaths were reported. There were 1173 new cases of asymptomatic infection, including 125 imported cases and 1048 local cases (400 cases in Shandong, 266 cases in Jilin, 191 cases in Guangdong, 78 cases in Shanghai, 40 cases in Gansu, 22 cases in Hebei, 19 cases in Yunnan, 13 cases in Jiangsu, 6 cases in Tianjin, 5 cases in Guangxi, 2 cases in Liaoning, 2 cases in Zhejiang, 2 cases in Hainan, 1 case in Heilongjiang, and 1 case Fujian); 5076 cases of asymptomatic infections were still under medical observation (1452 cases imported from abroad).
  • China Meheco Secured Partnership with Pfizer to Commercialize Paxlovid in China:  China Meheco Corp. secured a partnership with Pfizer Inc. to commercialize the American pharmaceutical giant’s new Covid-19 pill, Paxlovid, to the Chinese mainland, the state-owned drugmaker said Wednesday. A detailed agreement has been reached between the parties.
  • Hong Kong Shifts COVID-19 Strategy: Chief Executive Carrie Lam disclosed an indefinite delay for the testing plan Wednesday and said authorities will prioritize efforts to expand vaccinations for elderly people living at care facilities and increase the number of hospital beds to treat patients.
  • March 11, 2022 – China reported 555 new confirmed cases, including 158 imported cases (51 cases in Guangdong, 32 cases in Shanghai, 21 cases in Gansu, 15 cases in Beijing, 9 cases in Guangxi, 6 cases in Tianjin, 6 cases in Sichuan, 4 cases in Hubei, 3 cases in Henan, 2 cases in Heilongjiang, 2 cases in Zhejiang, 2 cases in Anhui, 2 cases in Chongqing, 1 case in Jilin, 1 case in Fujian, and 1 case in Yunnan) and 397 local cases (121 cases in Shandong, 98 cases in Jilin, 36 cases in Jiangsu, 26 cases in Gansu, 18 cases in Tianjin, 18 cases in Shaanxi, 16 cases in Hebei, 16 cases in Zhejiang, 11 cases in Shanghai, 11 cases in Guangdong, 8 cases in Heilongjiang, 5 cases in Beijing, 5 cases in Yunnan, 4 cases in Liaoning, 2 cases in Inner Mongolia, 1 case in Henan, and 1 case in Qinghai). No new deaths were reported. There were 814 new cases of asymptomatic infection, including 111 imported cases and 703 local cases (255 cases in Shandong, 167 cases in Guangdong, 148 cases in Jilin, 64 cases in Shanghai, 25 cases in Yunnan, 16 cases in Hebei, 12 cases in Jiangsu, 6 cases in Guangxi, 4 cases in Gansu, 2 cases in Beijing, 2 cases in Heilongjiang, 1 case in Henan, and 1 case in Hubei); 3972 cases of asymptomatic infections were still under medical observation (1387 cases imported from abroad).
  • China-Style Coexistence Plan with the COVID: According to top infectious disease experts, China has been assessing whether to adopt a strategy of coexistence with COVID-19 that suits its own circumstances. The Assessment cam as the “zero-tolerance” strategy has been implemented in China for more than two years. Zeng Guang, a member of the high-ranking expert group at the National Health Commission (NHC), said in an article posted on his Weibo account Monday: “In the near future, at an appropriate time, [China] will release its roadmap for a China-style coexistence plan with the virus.” Zhang Boli, also a top infectious disease expert and a member of the Chinese Academy of Engineering, said in an interview with Hong Kong-based Phoenix TV Friday that the mainland has been assessing how to prepare for the reopening of the border in “a cautious and gradual order.”
  • Beijing Tightened Travel Policy Again: As many of the cases in Beijing’s current outbreak have been imported from other provinces, Beijing has once again tightened its policy on entering and returning to the city. At Beijing’s 284th press conference on COVID-19 prevention and control held on February 23, 2022, Xu Hejian, spokesperson of the Beijing Municipal Government, said that Beijing will strictly control the entry and return of people from medium – and high-risk areas. Those who have lived in or traveled to counties or cities more than one case has been recorded or a land port of entry in the last 14 days will be strictly restricted from returning to Beijing. Remote screening should be strengthened for people from other regions. People will need to hold a negative nucleic acid test from the last 48 hours and show a green code in the “Beijing Jiankang Bao” app to return or travel to Beijing. Considering the cause of the recent clusters in Beijing, it is expected that China will strictly control “training activity gatherings” (including various large-scale conferences), and strengthen the COVID-19 prevention measures prior to such gatherings being held.
  • March 10, 2022 – China reported 528 new confirmed cases, including 126 imported cases (42 cases in Shanghai, 33 cases in Guangdong, 14 cases in Beijing, 12 cases in Guangxi, 7 cases in Henan, 4 cases in Sichuan, 4 cases in Gansu, 3 cases in Heilongjiang, 3 cases in Zhejiang, 2 cases in Yunnan,  1 case in Jiangsu, and 1 case in Fujian) and 402 local cases (165 cases in Jilin, 66 cases in Shandong, 66 cases in Gansu, 21 cases in Shaanxi, 19 cases in Tianjin, 17 cases in Guangdong, 13 cases in Jiangsu, 10 cases in Hebei, 4 cases in Beijing, 4 cases in Liaoning, 4 cases in Shanghai, 3 cases in Inner Mongolia, 3 cases in Zhejiang, 3 cases in Yunnan, 2 cases in Shanxi, and 2 cases in Henan). No new deaths were reported. There were 586 new cases of asymptomatic infection, including 151 imported cases and 435 local cases (179 cases in Jilin, 112 cases in Shandong, 76 cases in Shanghai, 22 cases in Yunnan, 11 cases in Gansu, 9 cases in Heilongjiang, 5 cases in Hebei, 5 cases in Jiangsu, 5 cases in Guangdong, 2 cases in Tianjin, 2 cases in Liaoning, 2 cases in Anhui, 2 cases in Henan, 1 case in Beijing, 1 case in Guangxi, and 1 case in Qinghai); 3238 cases of asymptomatic infections were still under medical observation (1328 cases imported from abroad).
  • March 9, 2022 – China reported 337 new confirmed cases, including 104 imported cases (39 cases in Guangdong, 26 cases in Shanghai, 13 cases in Sichuan, 7 cases in Gansu, 6 cases in Guangxi, 5 cases in Beijing, 3 cases in Jiangsu, 2 cases in Fujian, 2 cases in Shandong, and 1 case in Yunnan) and 233 local cases (94 cases in Jilin, 59 cases in Shandong, 17 cases in Shaanxi, 12 cases in Tianjin, 11 cases in Hebei, 11 cases in Jiangsu, 7 cases in Guangdong, 6 cases in Beijing, 4 cases in Yunnan, 3 cases in Shanxi, 3 cases in Inner Mongolia, 3 cases in Shanghai, 1 case in Liaoning, 1 case in Heilongjiang, and 1 case in Zhejiang). No new deaths were reported. There were 399 new cases of asymptomatic infection, including 77 imported cases and 322 local cases (106 cases in Shandong, 80 cases in Jilin, 62 cases in Shanghai, 24 cases in Yunnan, 20 cases in Guangdong, 14 cases in Heilongjiang, 4 cases in Jiangsu, 4 cases in Guangxi, 2 cases in Shanxi, 2 cases in Liaoning, 1 case in Inner Mongolia, 1 case in Anhui, 1 case in Chongqing, and 1 case in Gansu); 2749 cases of asymptomatic infections were still under medical observation (1252 cases imported from abroad).
  • March 8, 2022 – China reported 325 new confirmed cases, including 150 imported cases (47 cases in Guangdong, 36 cases in Shanghai, 21 cases in Beijing, 17 cases in Guangxi, 11 cases in Shandong, 7 cases in Gansu, 3 cases in Tianjin, 2 cases in Zhejiang, 2 cases in Sichuan, 1 case in Liaoning, 1 case in Heilongjiang, 1 case in Fujian, and 1 case in Yunnan) and 175 local cases (46 cases in Jilin, 45 cases in Guangdong, 31 cases in Shandong, 10 cases in Jiangsu, 10 cases in Gansu, 5 cases in Yunnan, 5 cases in Shaanxi, 4 cases in Hebei, 4 cases in Shanghai, 4 cases in Zhejiang, 3 cases in Tianjin, 3 cases in Liaoning, 2 cases in Inner Mongolia, 1 case in Beijing, 1 case in Shanxi, and 1 case in Guangxi). No new deaths were reported. There were 443 new cases of asymptomatic infection, including 113 imported cases and 330 local cases (144 cases in Shandong, 73 cases in Guangdong, 51 cases in Shanghai, 29 cases in Jilin, 18 cases in Yunnan, 5 cases in Liaoning, 5 cases in Jiangsu, 3 cases in Guangxi, 1 case in Shanxi, and 1 case in Gansu); 2407 cases of asymptomatic infections were still under medical observation (1215 cases imported from abroad).
  • March 7, 2022 – China reported 327 new confirmed cases, including 113 imported cases (51 cases in Guangdong, 32 cases in Shanghai, 11 cases in Sichuan, 6 cases in Beijing, 5 cases in Henan, 4 cases in Guangxi, 1 case in Tianjin, 1 case in Jilin, 1 case in Shandong, and 1 case in Chongqing) and 214 local cases (69 cases in Guangdong, 54 cases in Jilin, 46 cases in Shandong, 12 cases in Gansu, 9 cases in Hebei, 7 cases in Inner Mongolia, 5 cases in Jiangsu, 4 cases in Yunnan, 3 cases in Shanghai, 2 cases in Hubei, 1 case in Shanxi, 1 case in Zhejiang, and 1 case in Guangxi). No new deaths were reported. There were 442 new cases of asymptomatic infection, including 130 imported cases and 312 local cases (117 cases in Shandong, 104 cases in Guangdong, 45 cases in Shanghai, 18 cases in Yunnan, 12 cases in Jilin, 10 cases in Guangxi, 3 cases in Liaoning, 1 case in Hebei, 1 case in Shanxi, and 1 case in Jiangsu); 2024 cases of asymptomatic infections were still under medical observation (1148 cases imported from abroad).
  • As of 11:00, March 7, 2022, China recorded 12 high-risk areas (8 areas in Inner Mongolia, 2 areas in Shandong, 1 area in Tianjin, and 1 area in Guangdong) and 142 medium-risk areas (66 areas in Inner Mongolia, 16 areas in Heilongjiang, 11 areas in Jiangsu,10 areas in Guangdong, 8 areas in Sichuan, 8 areas in Yunnan, 5 areas in Hubei, 4 areas in Shanghai, 4 areas in Shandong, 3 areas in Jilin, 3 areas in Shaanxi, 2 areas in Guangxi, 1 area in Gansu, and 1 area in Hebei).
  • March 6, 2022 – China reported 329 new confirmed cases, including 154 imported cases (72 cases in Guangdong, 25 cases in Shanghai, 17 cases in Guangxi, 13 cases in Beijing, 10 cases in Sichuan, 6 cases in Zhejiang, 4 cases in Henan, 2 cases in Fujian, 2 cases in Shandong, 1 case in Tianjin, 1 case in Jiangsu, and 1 case in Gansu) and 175 local cases (88 cases in Shandong, 25 cases in Jilin, 20 cases in Guangdong, 14 cases in Hebei, 9 cases in Inner Mongolia, 5 cases in Guangxi, 4 cases in Jiangsu, 4 cases in Yunnan, 2 cases in Zhejiang, 2 cases in Shaanxi, 1 case in Shanxi, and 1 case in Henan). No new deaths were reported. There were 209 new cases of asymptomatic infection, including 82 imported cases and 127 local cases (36 cases in Jilin, 33 cases in Guangdong, 28 cases in Shanghai, 17 cases in Yunnan, 7 cases in Guangxi, 3 cases in Jiangsu, 1 case in Zhejiang, 1 case in Hubei, and 1 case in Hainan); 1647 cases of asymptomatic infections were still under medical observation (1077 cases imported from abroad).
  • March 5, 2022 – China reported 281 new confirmed cases, including 179 imported cases (79 cases in Guangdong, 24 cases in Shanghai, 16 cases in Fujian, 12 cases in Guangxi, 11 cases in Tianjin, 9 cases in Beijing, 9 cases in Shandong, 8 cases in Sichuan, 3 cases Henan, 2 cases in Liaoning, 2 cases in Zhejiang, 1 case in Jilin, 1 case in Jiangsu, 1 case in Chongqing, and 1 case in Gansu) and 102 local cases (46 cases in Guangdong, 19 cases in Jilin, 8 cases in Inner Mongolia, 6 cases in Hebei, 5 cases in Shandong, 3 cases in Tianjin, 3 cases in Shanghai, 3 cases in Guangxi, 2 cases in Hainan, 2 cases in Yunnan, 1 case in Shanxi, 1 case in Heilongjiang, 1 case in Hubei, 1 case in Hunan, and 1 case in Sichuan). No new deaths were reported. There were 166 new cases of asymptomatic infection, including 93 imported cases and 73 local cases (24 cases in Jilin, 18 cases in Guangdong, 16 cases in Shanghai, 8 cases in Yunnan, 4 cases in Guangxi, 1 case in Hebei, 1 case in Jiangsu, and 1 case in Hubei); 1500 cases of asymptomatic infections were still under medical observation (1049 cases imported from abroad).
  • March 4, 2022 – China reported 294 new confirmed cases, including 233 imported cases (117 cases in Guangdong, 43 cases in Shanghai, 26 cases in Guangxi, 13 cases in Sichuan, 9 cases in Beijing, 7 cases in Zhejiang, 5 cases in Henan, 3 cases in Tianjin, 3 cases in Jilin, 2 cases in Fujian, 2 cases in Shandong, 2 cases in Yunnan, and 1 case in Heilongjiang) and 61 local cases (22 cases in Guangdong, 9 cases in Inner Mongolia, 5 cases in Hebei, 5 cases in Jilin, 4 cases in Hubei, 4 cases in Yunnan, 3 cases in Heilongjiang, 3 cases in Guangxi, 2 cases in Shanghai, 2 cases in Zhejiang, 1 case in Tianjin, and 1 case in Jiangsu). No new deaths were reported. There were 150 new cases of asymptomatic infection, including 94 imported cases and 56 local cases (14 cases in Shanghai, 14 cases in Yunnan, 11 cases in Jilin, 6 cases in Guangdong, 5 cases in Heilongjiang, 5 cases in Guangxi, and 1 case in Hainan); 1387 cases of asymptomatic infections were still under medical observation (997 cases imported from abroad).
  • March 3, 2022 – China reported 214 new confirmed cases, including 160 imported cases (66 cases in Guangdong, 39 cases in Shanghai, 11 cases in Beijing, 9 cases in Jilin, 8 cases in Guangxi, 8 cases in Sichuan, 5 cases in Henan, 4 cases in Fujian, 4 cases in Shandong, 2 cases in Hubei, 1 case in Tianjin, 1 case in Zhejiang, 1 case in Anhui, and 1 case in Gansu) and 54 local cases (28 cases in Guangdong, 7 cases in Inner Mongolia, 4 cases in Hubei, 3 cases in Jilin, 3 cases in Shanghai, 2 cases in Guangxi, 1 case in Tianjin, 1 case in Hebei, 1 case in Shanxi, 1 case in Heilongjiang, 1 case in Jiangsu, 1 case in Sichuan, and 1 case in Yunnan). No new deaths were reported. There were 143 new cases of asymptomatic infection, including 106 imported cases and 37 local cases (9 cases in Yunnan, 7 cases in Jilin, 6 cases in Guangdong, 6 cases in Guangxi, 5 cases in Shanghai, 3 cases in Heilongjiang, and 1 case in Hainan); 1298 cases of asymptomatic infections were still under medical observation (951 cases imported from abroad).
  • March 2, 2022 – China reported 224 new confirmed cases, including 153 imported cases (83 cases in Guangdong, 37 cases in Shanghai, 10 cases in Hubei, 5 cases in Beijing, 3 cases in Tianjin, 3 cases in Guangxi, 3 cases in Sichuan, 2 cases in Shandong, 2 cases in Chongqing, 2 cases in Yunnan, 1 case in Fujian, 1 case in Henan, and 1 case in Hunan) and 71 local cases (32 cases in Guangdong, 16 cases in Inner Mongolia, 4 cases in Jilin, 4 cases in Heilongjiang, 4 cases in Shandong, 3 cases in Sichuan, 2 cases in Liaoning, 2 cases in Guangxi, 1 case in Tianjin, 1 case in Shanxi, 1 case in Shanghai, and 1 case in Yunnan). No new deaths were reported. There were 169 new cases of asymptomatic infection, including 121 imported cases and 48 local cases (13 cases in Guangdong, 12 cases in Heilongjiang, 9 cases in Yunnan, 8 cases in Guangxi, 4 cases in Jilin, 1 case in Shanghai, and 1 case in Sichuan); 1209 cases of asymptomatic infections were still under medical observation (896 cases imported from abroad).
  • As of 15:00, March 2, 2022, China recorded 10 high-risk areas (8 areas in Inner Mongolia, 1 area in Tianjin, and 1 area in Guangdong) and 191 medium-risk areas (101 areas in Inner Mongolia, 42 areas in Jiangsu, 14 areas in Sichuan, 13 areas in Heilongjiang, 9 areas in Guangdong, 5 areas in Hubei, 3 areas in Yunnan, 1 area in Shanghai, 1 area in Shandong, 1 area in Jilin, and 1 are in Guangxi).
  • March 1, 2022 – China reported 200 new confirmed cases, including 125 imported cases (44 cases in Guangdong, 40 cases in Shanghai, 12 cases in Beijing, 8 cases in Guangxi, 4 cases in Chongqing, 4 cases in Yunnan, 3 cases in Fujian, 3 cases in Shandong, 2 cases in Jiangsu, 2 cases in Sichuan, 1 case in Tianjin, 1 case in Anhui, and 1 case in Hubei) and 75 local cases (31 cases in Guangdong, 14 cases in Inner Mongolia, 6 cases in Tianjin, 6 cases in Guangxi, 6 cases in Yunnan, 4 cases in Heilongjiang, 3 cases in Jiangsu, 2 cases in Hubei, 1 case in Shanxi, 1 case in Hainan, and 1 case in Sichuan). No new deaths were reported. There were 144 new cases of asymptomatic infection, including 102 imported cases and 42 local cases (25 cases in Guangdong, 6 cases in Yunnan, 5 cases in Heilongjiang, 3 cases in Shanghai, 1 case in Shandong, 1 case in Hubei, and 1 case in Sichuan); 1097 cases of asymptomatic infections were still under medical observation (825 cases imported from abroad).
  • Spring Festival Travel Rush Statistic and Recent COVID-19 Clusters: In the press conference held on February 26, 2022, the National Health Commission (NHC) said that a total of 1.06 billion passenger trips were made during the 40-day Spring Festival travel rush that ended on February 25, 2022. The figure marked a 21.8 percent increase year-on-year from the 2021 level, but this only accounts for 35.6 percent of the pre-epidemic level in 2019. The NHC also mentioned that there have been many outbreaks in China recently, with wide coverage and frequent occurrence. Among them, the confirmed cases recently detected in Beijing, Tianjin, Shanxi, Shanghai, Shandong, Xiamen, and Jixi of Heilongjiang are all personnel under quarantine control or closed-loop management, and the risk of further spread of the epidemic is low. The risk of community transmission in Jiangsu is gradually decreasing. The outbreak in Liaoning is still dragging, which indicates that the local government should keep alert of the resurgence and spread of the epidemic. The cases in Heihe (Heilongjiang province) and Honghe (Yunnan province) are concentrated in the local areas, with different transmission chains. The sources of infections are still under investigation, and there are risks of further spread. Shenzhen, Guangdong province, has complex transmission chains, with a high risk of community transmission and spillover. The newly infected people in Dongguan, Guangdong province were mainly distributed in an industrial park with a high population density, which may affect the productivity of this key manufacturing city. The outbreaks in Sichuan and Guangxi also have risks of COVID-19 spillover. The cluster in Hubei has caused outbreaks in Beijing, Shandong, Hebei, and Shanghai. The outbreak in Hohhot, Inner Mongolia is still at a high transmissible stage, but the risk of community transmission and spread has decreased. China still sticks to the Zero-COVID strategy.
  • Mixing Vaccine Booster Approach Adopted in China: In a press conference held on February 19, 2022, the National Health Commission (NHC) said that China has officially approved the “sequential booster immunization strategy” to give a different kind of COVID-19 vaccine as booster shots to increase immunity. People who received the standard two doses of inactivated vaccines developed by either Sinopharm or Sinovac at least six months earlier can choose to get the vaccines developed by either CanSino Biologics (an adenovirus viral vector vaccine) or Chongqing Zhifei Biological Products (a recombinant protein vaccine) as their third-dose boosters. Despite this news, the mRNA vaccine developed by Biotech and Fosun has not been approved for domestic use in the mainland.
  • No Lockdown without the Central Government’s Approval: On February 18, 14 authorities led by the National Development and Reform Commission (NDRC) jointly released Several Policy Measures on Boosting the Recovery of Enterprises in Difficulty in the Service Sector, which rolled out 41 policy measures aimed to help ease difficulties of the enterprises. Among others, the NDRC called for avoiding “excessive prevention control” on COVID-19 by regional authorities. Without the central government’s approval, local governments are forbidden from imposing citywide or district-wide lockdowns, cutting off public transport, and arbitrarily applying additional epidemic prevention and control measures for the service industry on top of the policy requirements of the Joint Prevention and Control Mechanism of the State Council. Without epidemic investigations and clear policy rationales, local authorities are not allowed to close or extend the closure of restaurants, supermarkets, scenic spots, and cinemas.
  • COVID-19 Surge in Hong Kong: In the recent 7-day period from February 11 to 17, 2022, an average of 2,611 cases were reported in Hong Kong per day, as compared with 601.3 cases per day reported in the previous 7-day period. On February 17, 6116 cases were tested positive for COVID-19, hitting the record for another day. 10 more deaths have been reported in the past 24 hours, including a three-year-old girl who died of acute brain inflammation, the youngest COVID-19 fatality in Hong Kong so far. The surging fifth wave of COVID-19 infections in Hong Kong has stretched the city’s health care system to the limit. As of February 16, about 12,000 residents who had tested positive were still waiting to be admitted to hospitals. Under this situation, the border controls between Guangdong and Hong Kong have been tighter, for fearing illegal arrivals from Hong Kong may flood in the quarantine hotels. The first batch of mainland Chinese supplies from Guangdong province arrived in Hong Kong on February 17, to support Hong Kong’s fight against the COVID-19 flareup.
  • Emergency use of Pfizer’s COVID drug Paxlovid: On February 11, 2022, China’s pharmaceutical regulator, the National Medical Products Administration (NMPA), gave conditional approval for Pfizer’s COVID-19 drug Paxlovid to register in China, making it the first oral pill specially developed for the disease to be cleared. According to analysis, this regulatory approval in no way guarantees market share for the drug, given the limited number of China’s COVID-19 patients. But it may indicate that China is preparing for the next stage of pandemic containment.
  • February 28, 2022 – China reported 234 new confirmed cases, including 147 imported cases (53 cases in Guangdong, 45 cases in Shanghai, 20 cases in Beijing, 11 cases in Guangxi, 4 cases in Fujian, 4 cases in Shandong, 3 cases in Heilongjiang, 3 cases in Sichuan, 2 cases in Henan, 1 case in Jiangsu, and 1 case in Yunnan) and 87 local cases (40 cases in Guangdong, 11 cases in Inner Mongolia, 11 cases in Guangxi, 9 cases in Tianjin, 5 cases in Hubei, 4 cases in Shanxi, 4 cases in Heilongjiang, 2 cases in Yunnan, and 1 case in Liaoning). No new deaths were reported. There were 114 new cases of asymptomatic infection, including 61 imported cases and 53 local cases (25 cases in Guangdong, 21 cases in Yunnan, 3 cases in Heilongjiang, 1 case in Tianjin, 1 case in Shanxi, 1 case in Shanghai, and 1 case in Sichuan); 1006 cases of asymptomatic infections were still under medical observation (765 cases imported from abroad).
  • As of 0:00, February 28, 2022, China recorded 8 high-risk areas (6 areas in Inner Mongolia, 1 area in Tianjin, and 1 area in Guangdong) and 193 medium-risk areas (106 areas in Inner Mongolia, 55 areas in Jiangsu, 14 areas in Sichuan, 6 areas in Guangdong, 5 areas in Hubei, 3 areas in Yunnan, 3 areas in Heilongjiang, and 1 are in Guangxi).
  • February 27, 2022 – China reported 239 new confirmed cases, including 127 imported cases (43 cases in Shanghai, 35 cases in Guangdong, 10 cases in Guangxi, 8 cases in Beijing, 6 cases in Sichuan, 5 cases in Fujian, 4 cases in Jiangsu, 4 cases in Yunnan, 2 cases in Tianjin, 2 cases in Liaoning, 2 cases in Jilin, 2 cases in Zhejiang, 2 cases in Shandong, and 2 cases in Hubei) and 112 local cases (48 cases in Guangdong, 38 cases in Inner Mongolia, 7 cases in Guangxi, 6 cases in Liaoning, 3 cases in Tianjin, 3 cases in Sichuan, 2 cases in Beijing, 2 cases in Jiangsu, 2 cases in Yunnan, and 1 case in Shanxi). No new deaths were reported. There were 100 new cases of asymptomatic infection, including 78 imported cases and 22 local cases (9 cases in Yunnan, 5 cases in Guangdong, 3 cases in Heilongjiang, 1 case in Tianjin, and 1 case in Shanghai); 924 cases of asymptomatic infections were still under medical observation (733 cases imported from abroad).
  • February 26, 2022 – China reported 249 new confirmed cases, including 156 imported cases (59 cases in Guangdong, 55 cases in Shanghai, 7 cases in Guangxi, 6 cases in Tianjin, 6 cases in Fujian, 6 cases in Yunnan, 4 cases in Beijing, 4 cases in Zhejiang, 4 cases in Shandong, 2 cases in Jiangsu, 2 cases in Chongqing, and 1 case in Gansu) and 93 local cases (32 cases in Inner Mongolia, 30 cases in Guangdong, 10 cases in Liaoning, 9 cases in Guangxi, 4 cases in Jiangsu, 3 cases in Yunnan, 2 cases in Sichuan, 1 case in Beijing, 1 case in Heilongjiang, and 1 case in Fujian). No new deaths were reported. There were 118 new cases of asymptomatic infection, including 88 imported cases and 30 local cases (17 cases in Yunnan, 9 cases in Guangdong, 2 cases in Sichuan, 1 case in Heilongjiang, and 1 case in Shanghai); 880 cases of asymptomatic infections were still under medical observation (709 cases imported from abroad).
  • February 25, 2022 – China reported 224 new confirmed cases, including 142 imported cases (59 cases in Shanghai, 52 cases in Guangdong, 8 cases in Beijing, 7 cases in Sichuan, 4 cases in Fujian, 4 cases in Guangxi, 2 cases in Jilin, 2 cases in Jiangsu, 1 case in Heilongjiang, 1 case in Zhejiang, 1 case in Shandong, and 1 case in Hubei) and 82 local cases (30 cases in Inner Mongolia, 18 cases in Liaoning, 8  cases in Guangdong, 5 cases in Sichuan, 5 cases in Yunnan, 4 cases in Guangxi, 3 cases in Shanxi, 2 cases in Beijing, 2 cases in Jiangsu, 2 cases in Hubei, 1 case in Tianjin, 1 case in Heilongjiang, and 1 case in Shandong). No new deaths were reported. There were 109 new cases of asymptomatic infection, including 87 imported cases and 22 local cases (9 cases in Yunnan, 5 cases in Guangdong, 4 cases in Sichuan, and 1 case in Shanghai); 816 cases of asymptomatic infections were still under medical observation (668 cases imported from abroad).
  • As of 14:00, February 25, 2022, China recorded 4 high-risk areas (3 areas in Inner Mongolia, and 1 area in Liaoning) and 164 medium-risk areas (71 areas in Inner Mongolia, 56 areas in Jiangsu, 14 areas in Sichuan, 5 areas in Heilongjiang, 5 areas in Hubei, 4 areas in Guangdong, 4 areas in Guangxi, 4 areas in Yunnan, and 1 are in Liaoning).
  • Beijing Winter Olympics: On the evening of February 20, the 24th Winter Olympic Games in Beijing came to a successful conclusion. The Beijing Winter Olympics is the first global sports event to be held as scheduled since the outbreak of COVID-19, attracting nearly 3,000 athletes from 91 countries and regions. In terms of winter sports promotion, the Games boosted the participation of 300 million Chinese people in snow sports. It is predicted that the size of China’s winter sports market will reach RMB 150 billion by 2025. In terms of epidemic prevention and control, the Winter Olympics adopted strict closed-loop management measures and only 0.01 percent of participants tested positive during the full period. In terms of the environment, the hand-held torch for the Beijing Winter Olympics achieved zero carbon emissions for the Olympic Games. The Beijing Winter Olympics used 100 percent green electricity and new energy vehicles accounted for 84.9 percent of all vehicles, the highest in Winter Olympics history.
  • China has enforced new rules on import and export food safety from January 1, 2022. The measures come at a time when China’s customs agencies have already tightened scrutiny of imported food products during the COVID-19 pandemic. To know more about China’s new requirements on food import/export, read our latest article on China Briefing: Understanding China’s New Rules on Import and Export Food Safety
  • Suzhou Omicron OutbreakA new omicron outbreak is spreading in Suzhou, Jiangsu Province, an economically important city with a population of 12.75 million. On Monday, February 14, 2022, 12 new domestically transmitted cases were discovered in Suzhou, including 8 confirmed cases and 4 asymptomatic cases. Preliminary analysis shows that the virus that led to this outbreak is the Omicron mutant strain. To contain the spread, Suzhou has shut down 15 highway entrances and halted interprovincial bus lines. Suzhou has also suspended schools and part of the medical services. Online and offline pharmacies have been required to suspend the sale of four categories of epidemic-related drugs, including antipyretic, cough, antiviral, and antibacterial medicines. A number of hospitals in Suzhou have halted outpatient and emergency medical services starting from Sunday evening. Moreover, the inter-province metro between Shanghai and Suzhou’s Kunshan has also been halted since February 14, 2022.
  • Travel restrictions update: Baise, a city of 3.5 million population near the border with Vietnam in Guangxi province has been placed under lockdown since 0:00 February 7, 2022, after 97 positive cases of COVID-19 infection were discovered in the first round of mass nucleic acid testing. During the lockdown, all residents were asked not to leave their homes, except for essential occasions such as purchasing necessary consumer goods and taking nucleic acid testing. Except for supermarkets, farmers’ markets, hospitals, and pharmacies, all other businesses have been closed. Schools and training institutions have been closed and public transport has been suspended. The catering industry is encouraged to provide takeout delivery services. As Baise is one of the most important aluminum bases in China, the lockdown of Baise is expected to disrupt China’s aluminum supply chain for at least two weeks, or even longer.
  • Will China’s entry and exit policies be relaxed in 2022? On January 27, Chen Jie, spokesman for the National Immigration Administration (NIA), responded to this question at an NIA press conference. According to him, China will continue to “strictly abide by epidemic prevention regulations, and reduce non-emergency and non-essential cross-border movement of people”. As the pandemic continues overseas and new strains are spreading at an accelerating pace, China still faces a difficult situation in stopping imported cases. It is important to cherish the hard-won achievements in preventing and controlling the pandemic. On the other hand, Chen emphasized that the NIA has asked immigration authorities at all levels to analyze each issue on a case-by-case basis and avoid rigidity and simplification in policy implementation. At the same time, China will continue to provide convenience for foreigners in China in accordance with the law and take concrete actions to support global epidemic prevention and control and help restore economic production.
  • With the recent outbreak of COVID-19 throughout China, employers might be informed that their employees are required to do home quarantine and thus cannot come to work. To know how to deal with this challenge, read our latest article on China Briefing: Can Employers in China Unilaterally Request Employees to Use Paid Leaves during the Period of COVID-19 Prevention and Control?
  • Shanghai’s travel policy during the Chinese New Year period: Between January 25, 2022 and March 31, 2022, all persons arriving in or returning to Shanghai that have come from or passed through high-risk areas or areas that have been placed under lockdown will need to go through 14 days of centralized quarantine for health observation and take 4 COVID-19 nucleic acid tests (on day 1, 4, 7 and 14); all persons arriving in and returning to Shanghai that have come from or passed through medium-risk areas will be subject to 14 days of strict community health monitoring and must take 2 COVID-19 nucleic acid tests (on day 1 and 14). In addition, all those arriving in or returning to Shanghai from high or medium-risk areas in China should report to their local committee and work unit (or hotel)  within 12 hours after their arrival.
  • Beijing’s new travel policy during the Chinese New Year Period: During the period between January 22, 2022 and March 31, 2022, people traveling or returning to Beijing are required to hold negative nucleic acid test certificates from the last 48 hours and show a green code in the “Beijing Jiankang Bao” app. Moreover, people traveling or returning to Beijing (except for commuters) are required to take another nucleic acid test within 72 hours of arrival in Beijing.
  • February 24, 2022 – China reported 186 new confirmed cases, including 101 imported cases (44 cases in Guangdong, 24 cases in Shanghai, 7 cases in Beijing, 6 cases in Fujian, 5 cases in Guangxi, 4 cases in Hubei, 3 cases in Jilin, 3 cases in Sichuan, 2 cases in Yunnan, 2 cases in Gansu, and 1 case in Tianjin) and 85 local cases (40 cases in Inner Mongolia, 10 cases in Hubei, 8 cases in Liaoning, 8  cases in Guangdong, 6 cases in Sichuan, 3 cases in Jiangsu, 3 cases in Guangxi, 3 cases in Yunnan, 2 cases in Beijing, and 2 cases in Shanxi). No new deaths were reported. There were 112 new cases of asymptomatic infection, including 88 imported cases and 24 local cases (7 cases in Yunnan, 5 cases in Heilongjiang, 5 cases in Jiangsu, 4 cases in Sichuan, 1 case in Hebei, 1 case in Hubei, and 1 case in Guangdong); 774 cases of asymptomatic infections were still under medical observation (633 cases imported from abroad).
  • February 23, 2022 – China reported 205 new confirmed cases, including 115 imported cases (49 cases in Shanghai, 38 cases in Guangdong, 8 cases in Beijing, 4 cases in Sichuan, 3 cases in Tianjin, 3 cases in Yunnan, 2 cases in Fujian, 2 cases in Shandong, 2 cases in Guangxi, 2 cases in Gansu, 1 case in Jiangsu, and 1 case in Zhejiang) and 90 local cases (47 cases in Inner Mongolia, 10 cases in Beijing, 9 cases in Liaoning, 7 cases in Guangdong, 6 cases in Sichuan, 5 cases in Hubei, 2 cases in Jiangsu, 2 cases in Yunnan, 1 case in Heilongjiang, and 1 case in Qingdao). No new deaths were reported. There were 67 new cases of asymptomatic infection, including 51 imported cases and 16 local cases (5 cases in Hubei, 5 cases in Sichuan, 3 cases in Jiangsu, 2 cases in Guangdong, and 1 case in Yunnan); 703 cases of asymptomatic infections were still under medical observation (575 cases imported from abroad).
  • As of 7:00, February 23, 2022, China recorded 5 high-risk areas (3 areas in Inner Mongolia, 1 area in Liaoning, and 1 area in Guangxi) and 160 medium-risk areas (71 areas in Inner Mongolia, 56 areas in Jiangsu, 10 areas in Guangxi, 9 areas in Sichuan, 5 areas in Heilongjiang, 4 areas in Guangdong, 2 areas in Yunnan, 2 areas in Hubei, and 1 are in Liaoning).
  • February 22, 2022 – China reported 138 new confirmed cases, including 79 imported cases (32 cases in Shanghai, 22 cases in Guangdong, 10 cases in Fujian, 4 cases in Beijing, 3 cases in Sichuan, 3 cases in Gansu, 2 cases in Zhejiang, 2 cases in Anhui, and 1 case in Yunnan) and 59 local cases (20 cases in Inner Mongolia, 12 cases in Jiangsu, 6 cases in Liaoning, 5 cases in Sichuan, 5 cases in Yunnan, 4 cases in Beijing under the close-loop management in the Winter Olympics, 4 cases in Hubei, and 3 cases in Guangdong). No new deaths were reported. There were 46 new cases of asymptomatic infection, including 40 imported cases and 6 local cases (2 cases in Inner Mongolia, 2 cases in Jiangsu, and 2 cases in Sichuan); 681 cases of asymptomatic infections were still under medical observation (568 cases imported from abroad).
  • February 21, 2022 – China reported 144 new confirmed cases, including 73 imported cases (27 cases in Shanghai, 20 cases in Guangdong, 9 cases in Beijing, 5 cases in Guangxi, 5 cases in Sichuan, 3 cases in Fujian, 1 case in Tianjin, 1 case in Jiangsu, 1 case in Chongqing, and 1  case in Gansu) and 71 local cases (32 cases in Inner Mongolia, 11 cases in Jiangsu, 7 cases in Liaoning, 6 cases in Guangdong, 5 cases in Shanxi, 4 cases in Sichuan, 4 cases in Yunnan, and 2 cases in Heilongjiang). No new deaths were reported. There were 38 new cases of asymptomatic infection, including 23 imported cases and 15 local cases (6 cases in Jiangsu, 3 cases in Sichuan, 2 cases in Heilongjiang, 2 cases in Shanghai, 1 case in Guangdong, and 1 case in Yunnan); 686 cases of asymptomatic infections were still under medical observation (572 cases imported from abroad).
  • As of 8:00, February 21, 2022, China recorded 3 high-risk areas (1 area in Inner Mongolia, 1 area in Liaoning, and 1 area in Guangxi) and 101 medium-risk areas (53 areas in Jiangsu, 24 areas in Inner Mongolia, 10 areas in Guangxi, 5 areas in Sichuan, 3 areas in Heilongjiang, 3 areas in Guangdong, 2 areas in Yunnan, and 1 are in Liaoning).
  • February 20, 2022 – China reported 195 new confirmed cases, including 94 imported cases (32 cases in Guangdong, 23 cases in Shanghai, 13 cases in Jiangsu, 6 cases in Beijing, 4 cases in Fujian, 3 cases in Zhejiang, 3 cases in Shandong, 3 cases in Gansu, 2 cases in Guangxi, 2 cases in Sichuan, 1 case in Tianjin, 1 case in Liaoning, and 1 case in Hubei) and 101 local cases (65 cases in Inner Mongolia, 16 cases in Jiangsu, 9 cases in Liaoning, 8 cases in Guangdong, and 3 cases in Yunnan). No new deaths were reported. There were 39 new cases of asymptomatic infection, including 35 imported cases and 4 local cases (2 cases in Sichuan, 1 case in Inner Mongolia, and 1 case in Hainan); 687 cases of asymptomatic infections were still under medical observation (582 cases imported from abroad).
  • February 19, 2022 – China reported 137 new confirmed cases, including 57 imported cases (22 cases in Guangdong, 18 cases in Shanghai, 4 cases in Beijing, 3 cases in Tianjin, 3 cases in Liaoning, 2 cases in Guangxi, 2 cases in Sichuan, 1 case in Zhejiang, 1 case in Shandong, and 1 case in Yunnan) and 80 local cases (46 cases in Inner Mongolia, 19 cases in Jiangsu, 8 cases in Liaoning, 3 cases in Guangdong, 3 cases in Yunnan, and 1 case in Zhejiang). No new deaths were reported. There were 37 new cases of asymptomatic infection, including 22 imported cases and 15 local cases (9 cases in Jiangsu, 4 cases in Yunnan, and 2 cases in Heilongjiang); 694 cases of asymptomatic infections were still under medical observation (592 cases imported from abroad).
  • February 18, 2022 – China reported 87 new confirmed cases, including 47 imported cases (21 cases in Guangdong, 13 cases in Shanghai, 3 cases in Fujian, 3 cases in Guangxi, 2 cases in Jilin, 2 cases in Shandong, 2 cases in Yunnan, and 1 case in Sichuan) and 40 local cases (22 cases in Inner Mongolia, 9 cases in Liaoning, 4 cases in Jiangsu, 4 cases in Guangdong, and 1 case in Yunnan). No new deaths were reported. There were 45 new cases of asymptomatic infection, including 25 imported cases and 20 local cases (12 cases in Jiangsu, 7 cases in Yunnan, and 1 case in Guangdong); 706 cases of asymptomatic infections were still under medical observation (605 cases imported from abroad).
  • As of 9:00, February 18, 2022, China recorded 2 high-risk areas (1 area in Liaoning and 1 area in Guangxi) and 59 medium-risk areas (32 areas in Jiangsu, 7 areas in Inner Mongolia, 10 areas in Guangxi, 5 areas in Heilongjiang, 3 areas in Guangdong, 1 area in Yunnan, and 1 are in Liaoning).
  • February 17, 2022 – China reported 92 new confirmed cases, including 57 imported cases (22 cases in Guangdong, 9 cases in Shanghai, 9 cases in Shandong, 4 cases in Zhejiang, 4 cases in Guangxi, 3 cases in Fujian, 2 cases in Jilin, 2 cases in Sichuan, 1 case in Henan, and 1 case in Yunnan) and 35 local cases (16 cases in Jiangsu, 7 cases in Liaoning, 7 cases in Guangdong, 3 cases in Inner Mongolia, 1 case in Guangxi, and 1 case in Yunnan). No new deaths were reported. There were 32 new cases of asymptomatic infection, including 21 imported cases and 11 local cases (7 cases in Jiangsu, 2 cases in Guangdong, and 2 cases in Yunnan); 721 cases of asymptomatic infections were still under medical observation (636 cases imported from abroad).
  • As of 17:00, February 17, 2022, China recorded 2 high-risk areas (1 area in Liaoning and 1 area in Guangxi) and 55 medium-risk areas (29 areas in Jiangsu, 10 areas in Guangxi, 5 areas in Heilongjiang, 5 areas in Guangdong, 4 areas in Inner Mongolia,1 are in Liaoning, and 1 area in Yunnan).
  • February 16, 2022 – China reported 102 new confirmed cases, including 56 imported cases (24 cases in Guangdong, 13 cases in Shanghai, 6 cases in Fujian, 3 cases in Shandong, 3 cases in Yunnan, 2 cases in Hunan, 2 cases in Guangxi, 1 case in Tianjin, 1 case in Liaoning, and 1 case in Sichuan) and 46 local cases (19 cases in Jiangsu,15 cases in Liaoning, 7 cases in Inner Mongolia, 3 cases in Guangdong, and 2 cases in Guangxi). No new deaths were reported. There were 28 new cases of asymptomatic infection, including 23 imported cases and 5 local cases (3 cases in Jiangsu, 1 case in Guangdong, and 1 case in Yunnan); 751 cases of asymptomatic infections were still under medical observation (674 cases imported from abroad).
  • As of 7:00, February 16, 2022, China recorded 2 high-risk areas (1 area in Liaoning and 1 area in Guangxi) and 30 medium-risk areas (14 areas in Jiangsu, 5 areas in Heilongjiang, 5 areas in Guangdong, 3 areas in Guangxi, 1 area in Tianjin, 1 are in Liaoning, and 1 area in Inner Mongolia).
  • February 15, 2022 – China reported 80 new confirmed cases, including 40 imported cases (16 cases in Guangdong, 8 cases in Fujian, 6 cases in Shanghai, 4 cases in Guangxi, 2 cases in Shandong, 1 case in Beijing, 1 case in Heilongjiang, 1 case in Jiangsu, and 1 case in Sichuan) and 40 local cases (29 cases in Liaoning, 8 cases in Jiangsu,  2 cases in Guangdong, and 1 case in Guangxi). No new deaths were reported. There were 44 new cases of asymptomatic infection, including 37 imported cases and 7 local cases (4 cases in Jiangsu and 3 cases in Yunnan); 791 cases of asymptomatic infections were still under medical observation (714 cases imported from abroad).
  • As of 9:00, February 15, 2022, China recorded 2 high-risk areas (1 area in Liaoning and 1 area in Guangxi) and 22 medium-risk areas (6 areas in Jiangsu, 5 areas in Heilongjiang, 4 areas in Guangdong, 3 areas in Guangxi, 2 areas in Tianjin, 1 area in Beijing, 1 are in Liaoning).
  • February 14, 2022 – China reported 84 new confirmed cases, including 58 imported cases (27 cases in Guangdong, 14 cases in Shandong, 8 cases in Shanghai, 5 cases in Fujian, 2 cases in Liaoning, 1 case in Henan, and 1 case in Sichuan) and 26 local cases (18 cases in Liaoning, 6 cases in Guangxi, 1 case in Guangdong, and 1 case in Yunnan). No new deaths were reported. There were 39 new cases of asymptomatic infection, including 31 imported cases and 8 local cases (6 cases in  Yunnan, 1 case in Heilongjiang, and 1 case in Guangdong); 801 cases of asymptomatic infections were still under medical observation (727 cases imported from abroad).
  • As of 10:00, February 14, 2022, China recorded 2 high-risk areas (1 area in Liaoning and 1 area in Guangxi) and 37 medium-risk areas (24 areas in Heilongjiang, 5 areas in Guangdong, 3 areas in Beijing, 2 areas in Tianjin, 1 area in Hebei, 1 are in Liaoning, and 1 area in Guangxi).
  • February 13, 2022 – China reported 67 new confirmed cases, including 39 imported cases (19 cases in Guangdong, 9 cases in Shanghai, 5 cases in Guangxi, 2 cases in Beijing, 1 case in Zhejiang, 1 case in Fujian, 1 case in Shandong, and 1 case in Sichuan) and 28 local cases (13 cases in Guangxi, 11 cases in Liaoning, 2 cases in Yunnan, 1 case in Tianjin, and 1 case in Guangdong). No new deaths were reported. There were 34 new cases of asymptomatic infection, including 33 imported cases and 1 local case (in Yunnan); 804 cases of asymptomatic infections were still under medical observation (733 cases imported from abroad).
  • February 12, 2022 – China reported 99 new confirmed cases, including 59 imported cases (24 cases in Guangdong, 14 cases in Fujian, 7 cases in Shanghai, 5 cases in Sichuan, 3 cases in Shandong, 2 cases in Liaoning, 2 cases in Guangxi, 1 case in Tianjin, and 1 case in Heilongjiang) and 40 local cases (30 cases in Guangxi and 10 cases in Liaoning). No new deaths were reported. There were 41 new cases of asymptomatic infection, all of which were imported from abroad; 823 cases of asymptomatic infections were still under medical observation (741 cases imported from abroad).
  • February 11, 2022 – China reported 101 new confirmed cases, including 45 imported cases (15 cases in Guangdong, 12 cases in Shanghai, 10 cases in Fujian, 3 cases in Zhejiang, 2 cases in Guangxi, 1 case in Tianjin, 1 case in Shandong, and 1 case in Yunnan) and 56 local cases (33 cases in Guangxi, 22 cases in Liaoning, and 1 case in Guizhou). No new deaths were reported. There were 66 new cases of asymptomatic infection, including 61 imported cases and 5 local cases (i2 cases in  Liaoning, 2 cases in Heilongjiang, and 1 case in Jiangsu); 832 cases of asymptomatic infections were still under medical observation (746 cases imported from abroad).
  • As of 7:00, February 11, 2022, China recorded 5 high-risk areas (2 areas in Tianjin, 1 area in Beijing, 1 area in Liaoning, and 1 area in Guangxi) and 52 medium-risk areas (24 areas in Heilongjiang, 12 areas in Zhejiang, 5 areas in Tianjin, 5 areas in Guangdong, 3 areas in Beijing, 1 area in Hebei, 1 are in Liaoning, and 1 area in Guangxi).
  • February 10, 2022 – China reported 29 new confirmed cases, including 22 imported cases (9 cases in Guangdong, 8 cases in Shanghai, 2 cases in Jilin, 1 case in Zhejiang, 1 case in Fujian, and 1 case in Guangxi) and 7 local cases (all in Baise, Guangxi Province). No new deaths were reported. There were 28 new cases of asymptomatic infection, including 27 imported cases and 1 local case (in Shenyang, Liaoning Province); 824 cases of asymptomatic infections were still under medical observation (739 cases imported from abroad).
  • As of 15:00, February 10, 2022, China recorded 5 high-risk areas (2 areas in Beijing, 2 areas in Tianjin, and 1 area in Guangxi) and 53 medium-risk areas (24 areas in Heilongjiang, 13 areas in Zhejiang, 5 areas in Tianjin, 5 areas in Guangdong, 4 areas in Beijing, 1 area in Hebei, and 1 area in Guangxi).
  • February 9, 2022 – China reported 110 new confirmed cases, including 37 imported cases (18 cases in Guangdong, 9 cases in Shanghai, 5 cases in Guangxi, 2 cases in Fujian, 1 case in Beijing, 1 case in Tianjin, and 1 case in Sichuan) and 73 local cases (72 cases in Guangxi and 1 case in Liaoning). No new deaths were reported. There were 24 new cases of asymptomatic infection, including 23 imported cases and 1 local case (in Heihe City, Heilongjiang Province); 837 cases of asymptomatic infections were still under medical observation (745 cases imported from abroad).
  • As of 10:00, February 9, 2022, China recorded 5 high-risk areas (2 areas in Beijing, 2 areas in Tianjin, and 1 area in Guangxi) and 53 medium-risk areas (24 areas in Heilongjiang, 13 areas in Zhejiang, 5 areas in Tianjin, 5 areas in Guangdong, 4 areas in Beijing, 1 area in Hebei, and 1 area in Guangxi).
  • February 8, 2022 – China reported 105 new confirmed cases, including 40 imported cases (18 cases in Guangdong, 15 cases in Shanghai, 3 cases in Sichuan, 1 case in Beijing, 1 case in Tianjin, 1 case in Henan, and 1 case in Guangxi) and 65 local cases (64 cases in Guangxi and 1 case in Tianjin). No new deaths were reported. There were 46 new cases of asymptomatic infection, including 42 imported cases and 4 local cases (2 cases in Heilongjiang and 2 cases in Guangxi); 872 cases of asymptomatic infections were still under medical observation (766 cases imported from abroad).
  • February 7, 2022 – China reported 79 new confirmed cases, including 34 imported cases (21 cases in Guangdong, 8 cases in Shanghai, 1 case in Beijing, 1 case in Zhejiang, 1 case in Fujian, 1 case in Henan, and 1 case in Guangxi) and 45 local cases (37 cases in Guangxi, 4 cases in Guangdong, 3 cases in Beijing, and 1 case in Tianjin). No new deaths were reported. There were 51 new cases of asymptomatic infection, including 41 imported cases and 10 local cases (5 cases in Heilongjiang and 5 cases in Guangxi); 876 cases of asymptomatic infections were still under medical observation (764 cases imported from abroad).
  • As of 12:00, February 7, 2022, China recorded 7 high-risk areas (3 areas in Beijing, 2 areas in Tianjin, 1 area in Zhejiang, and 1 area in Guangxi) and 56 medium-risk areas (23 areas in Heilongjiang, 12 areas in Zhejiang, 5 areas in Beijing, 5 areas in Tianjin, 5 areas in Guangdong, 2 areas in Hebei, 2 areas in Xinjiang,1 area in Guangxi, and 1 area in Yunnan).
  • February 6, 2022 – China reported 43 new confirmed cases, including 30 imported cases (12 cases in Shanghai, 7 cases in Guangdong, 3 cases in Fujian, 3 cases in Sichuan, 2 cases in Zhejiang,1 case in Jiangsu,1 case in Henan, and 1 case in Guangxi) and 13 local cases (6 cases in Guangxi, 2 cases in Tianjin, 2 cases in Hebei, 1 case in Beijing, 1 case in Hunan, and 1 case in Guangdong). No new deaths were reported. There were 40 new cases of asymptomatic infection, all of which were imported; 855 cases of asymptomatic infections were still under medical observation (747 cases imported from abroad).
  • February 5, 2022 – China reported 27 new confirmed cases, including 18 imported cases (7 cases in Shanghai, 4 cases in Guangdong, 2 cases in Zhejiang, 2 cases in Henan, 2 cases in Yunnan, and 1 case in Tianjin) and 9 local cases (6 cases in Guangdong, 2 cases in Tianjin, and 1 case in Beijing). No new deaths were reported. There were 60 new cases of asymptomatic infection, all of which were imported; 887 cases of asymptomatic infections were still under medical observation (778 cases imported from abroad).
  • Spring Festival Travel Rush: During the Chinese New Year Period, about 130 million passengers make trips on public transportation, up 31.7 percent year on year. This is a nice rebound from 2021, but is still 69.2 percent lower as compared to 2019 travel numbers.
  • February 4, 2022 – China reported 29 new confirmed cases. 17 were imported cases (8 cases in Guangdong, 7 cases in Shanghai, 1 case in Beijing, 1 case in Fujian). 12 local cases were reported (5 cases in Guangdong, including 4 cases in Shenzhen and 1 case in Huizhou; 4 cases in Tianjin, all in Hebei District; 2 cases in Zhejiang, all in Hangzhou; 1 case in Beijing, in Chaoyang District). No new deaths were reported. Four new suspected cases were added, all imported from abroad (all in Shanghai). There were 52 new asymptomatic infections, including 51 imported cases and 1 local case (in Yunfu City, Guangdong); 869 cases of asymptomatic infections were still under medical observation (754 cases imported from abroad).
  • February 3, 2022 China reported 39 new confirmed cases. Among them, 18 were imported cases (9 cases in Shanghai, 4 cases in Guangdong, 2 cases in Beijing, 1 case in Tianjin, 1 case in Henan, and 1 case in Yunnan). One imported case converted from asymptomatic infection to a confirmed case (in Henan). There were 21 local cases (9 cases in Tianjin, including 3 cases in Hebei District, 2 cases in Hedong District, 2 cases in Hongqiao District, and 2 cases in Binhai New District; 9 cases in Guangdong, including 4 cases in Shenzhen, 4 cases in Yunfu, and 1 case in Huizhou; 2 cases in Beijing, including 1 case in Fengtai District and 1 case in Daxing District; and 1 case in Zhejiang, in Hangzhou City). Among local infections, 3 cases of asymptomatic infection converted to confirmed cases (all in Guangdong). There were 96 new asymptomatic infections, including 95 imported cases and 1 local case (in Shenzhen, Guangdong); 855 cases of asymptomatic infections still under medical observation (740 cases imported from abroad).
  • February 2, 2022 China reported 63 new confirmed cases. Among them, 27 were imported cases (18 cases in Shanghai, 5 cases in Guangdong, 1 case in Beijing, 1 case in Jilin, 1 case in Henan, and 1 case in Guangxi). 2 cases had converted from asymptomatic infections to confirmed cases (1 case in Beijing and 1 case in Guangdong). There were 36 local cases recorded (15 cases in Zhejiang, all in Hangzhou; 12 cases in Tianjin, including 6 cases in Hebei District, 4 cases in Binhai New Area, and 2 cases in Hedong District; 6 cases in Guangdong, including 2 cases in Shenzhen, 1 case in Huizhou, 1 case in Meizhou City, 1 case in Heyuan City, and 1 case in Yunfu City; 2 cases in Beijing, both in Fengtai District; and 1 case in Hebei, in Hengshui City). There were 28 new cases of asymptomatic infection, including 24 imported cases and 4 local cases (all in Guangdong, including 3 cases in Yunfu City and 1 case in Shenzhen); 810 cases of asymptomatic infection were still under medical observation (688 cases imported from abroad).
  • February 1, 2022 – China reported 66 new confirmed cases. Among them, 39 were imported cases (18 cases in Shanghai, 8 cases in Guangdong, 5 cases in Guangxi, 3 cases in Shandong, 2 cases in Beijing, 2 cases in Tianjin, and 1 case in Henan). 5 cases were converted from asymptomatic infections to confirmed cases (2 cases in Tianjin, 2 cases in Guangdong, and 1 case in Henan). There were 27 local cases (13 cases in Zhejiang, all in Hangzhou; 7 cases in Tianjin, including 4 cases in Hebei District, 2 cases in Hongqiao District, and 1 case in Jinnan District; 4 cases in Hebei Province, in Hengshui City; 2 cases in Beijing, including 1 case in Chaoyang District and 1 case in Fengtai District; and 1 case in Guangdong, in Shenzhen). No new deaths were reported. There were 32 new cases of asymptomatic infections, including 31 imported cases and 1 local case (in Fengtai District, Beijing); 814 cases of asymptomatic infections are still under medical observation (693 cases imported from abroad).
  • January 31, 2022 – China begins its holiday week for the 2022 Lunar New Year/ Spring Festival. From 0 to 24:00 on January 30, 2022, China reported 58 new confirmed cases. Among them, 18 were imported cases (10 cases in Shanghai, 7 cases in Guangdong, and 1 case in Fujian). There were 40 local cases (24 cases in Zhejiang – all cases in Hangzhou City; 11 cases in Tianjin, including 8 cases in Hebei District and 3 cases in Binhai New Area; 3 cases in Beijing, including 2 cases in Fengtai District and 1 case in Chaoyang District; 1 case in Heilongjiang, in Mudanjiang; and 1 case in Henan, in Ruzhou).
  • The 2022 Chinese New Year / Spring Festival is coming up. To learn how businesses in China can prepare during this period and key dates to keep track of around the Spring Festival, read our latest article on China Briefing: 2022 Chinese New Year: How Foreign Businesses Should Prepare in the COVID Context
  • January 28, 2022 – China reported 64 new confirmed cases, including 25 imported cases (7 cases in Shanghai, 7 cases in Guangdong, 5 cases in Yunnan, 2 cases in Beijing, 2 cases in Shandong, 1 case in Zhejiang, and 1 case in Guangxi) and 39 local cases (16 cases in Zhejiang, 9 cases in Heilongjiang, 8 cases in Beijing, 4 cases in Tianjin, 1 case in Guizhou, and 1 case in the Corps). There were 54 new cases of asymptomatic infection, including 42 imported cases and 12 local cases (9 cases in Heilongjiang, 1 case in Beijing, 1 case in Hubei, and 1 case in the Corps). As of 7:00, January 28, 2022, China recorded 13 high-risk areas (11 cases in Tianjin, 1 area in Henan, and 1 area in Beijing) and 39 medium-risk areas (12 areas in Tianjin, 7 areas in Beijing, 6 areas in Heilongjiang, 5 areas in Xinjiang, 5 areas in Henan, 1 area in Zhejiang, 1 area in Shanghai, 1 area in Hebei, and 1 area in Yunnan).
  • January 27, 2022 – China reported 63 new confirmed cases, including 38 imported cases (20 cases in Shanghai, 5 cases in Yunnan, 4 cases in Zhejiang, 3 cases in Guangdong, 2 cases in Henan, 1 case in Beijing, 1 case in Jilin, 1 case in Guangxi, and 1 case in Sichuan) and 25 local cases (6 cases in Zhejiang, 5 cases in Beijing, 5 cases in Heilongjiang, 4 cases in Hebei, 1 case in Tianjin, 1 case in Shanghai, 1 case in Henan, 1 case in Xinjiang, and 1 case in the Corps). There were 55 new cases of asymptomatic infection, including 38 imported cases and 17 local cases (11 cases in Heilongjiang, 3 cases in Xinjiang, 2 cases in the Corps, and 1 case in Jiangxi).
  • As of 9:00, January 27, 2022, China recorded 12 high-risk areas (10 cases in Tianjin, 1 area in Henan, and 1 area in Beijing) and 41 medium-risk areas (12 areas in Tianjin, 6 areas in Beijing, 6 areas in Heilongjiang, 5 areas in Xinjiang, 5 areas in Henan, 3 areas in Guangdong,1 area in Zhejiang, 1 area in Shanghai, 1 area in Hebei, and 1 area in Yunnan).
  • January 26, 2022 – China reported 44 new confirmed cases, including 20 imported cases (10 cases in Shanghai, 4 cases in Guangxi, 2 cases in Beijing, 2 cases in Tianjin, 1 case in Henan, and 1 case in Chongqing) and 24 local cases (14 cases in Beijing, 4 cases in Heilongjiang, 2 cases in Xinjiang, 1 case in Hebei, 1 case in Liaoning, 1 case in Henan, and 1 case in Guangdong). There were 64 new cases of asymptomatic infection, including 44 imported cases and 20 local cases (9 cases in Heilongjiang, 6 cases in Xinjiang, and 5 cases in Beijing).
  • As of 12:00, January 26, 2022, China recorded 12 high-risk areas (10 cases in Tianjin, 1 area in Henan, and 1 area in Beijing) and 44 medium-risk areas (16 areas in Tianjin, 10 areas in Henan, 4 areas in Guangdong, 6 areas in Beijing, 5 areas in Xinjiang, 2 areas in Shanghai, and 1 area in Yunnan).
  • January 25, 2022 – China reported 45 new confirmed cases, including 27 imported cases (10 cases in Shanghai, 5 cases in Guangxi, 4 cases in Yunnan, 3 cases in Beijing, 3 cases in Zhejiang, and 2 cases in Guangdong) and 18 local cases (6 cases in Xinjiang, 5 cases in Beijing, 3 cases in Henan, 2 cases in Hebei, 1 case in Tianjin, and 1 case in Shanghai). There were 43 new cases of asymptomatic infection, including 25 imported cases and 18 local cases (16 cases in Xinjiang, 1 case in Beijing, and 1 case in Liaoning).
  • As of 0:00, January 25, 2022, China recorded 15 high-risk areas (12 cases in Tianjin, 2 areas in Henan, and 1 area in Beijing) and 48 medium-risk areas (26 areas in Tianjin, 10 areas in Henan, 6 areas in Guangdong, 4 areas in Beijing, and 2 areas in Shanghai).
  • January 24, 2022 – China reported 57 new confirmed cases, including 39 imported cases (22 cases in Shanghai, 5 cases in Guangdong, 2 cases in Tianjin, 2 cases in Zhejiang, 2 cases in Fujian, 2 cases in Sichuan, 2 cases in Yunnan, 1 case in Beijing, and 1 case in Guangxi) and 18 local cases (6 cases in Beijing, 3 cases in Hebei, 3 cases in Yunnan, 2 cases in Shandong, 1 case in Tianjin, 1 case in Shanxi, 1 case in Henan, and 1 case in Guangdong). There were 27 new cases of asymptomatic infection, including 22 imported cases and 5 local cases (2 cases in Beijing, 2 cases in Xinjiang, and 1 case in Shandong).
  • As of 8:00, January 24, 2022, China recorded 18 high-risk areas (12 cases in Tianjin, 5 areas in Henan, and 1 area in Beijing) and 59 medium-risk areas (26 areas in Tianjin, 24 areas in Henan, 6 areas in Guangdong, 2 areas in Beijing, and 1 area in Shanghai).
  • January 23, 2022 – China reported 56 new confirmed cases, including 37 imported cases (13 cases in Shanghai, 6 cases in Zhejiang, 5 cases in Guangdong, 4 cases in Sichuan, 4 cases in Yunnan, 3 cases in Shandong, 1 case in Fujian, and 1 case in Guangxi) and 43 local cases (24 cases in Henan, 14 cases in Tianjin, 3 cases in Beijing, and 2 cases in Guangdong). There were 34 new cases of asymptomatic infection, including 27 imported cases and 7 local cases (4 cases in Beijing, 2 cases in Yunnan, and 1 case in Guangdong).
  • January 22, 2022 – China reported 63 new confirmed cases, including 40 imported cases (22 cases in Shanghai, 4 cases in Fujian, 4 cases in Guangdong, 3 cases in Sichuan, 2 cases in Zhejiang, 2 cases in Guangxi, 1 case in Beijing, 1 case in Shandong, and 1 case in Yunnan) and 23 local cases (10 cases in Beijing, 6 cases in Tianjin, 4 cases in Henan, and 3 cases in Guangdong). There were 43 new cases of asymptomatic infection, including 37 imported cases and 6 local cases (all in Beijing).
  • January 21, 2022 – China reported 73 new confirmed cases, including 50 imported cases (28 cases in Shanghai, 10 cases in Guangdong, 6 cases in Shandong, 2 cases in Beijing, 2 cases in Fujian, 1 case in Henan, and 1 case in Guangxi) and 23 local cases (8 cases in Tianjin, 5 cases in Beijing, 4 cases in Guangdong, 3 cases in Henan, and 3 cases in Shaanxi). There were 31 new cases of asymptomatic infection, including 29 imported cases and 2 local cases (all in Yunnan).
  • Ningbo Port update: The COVID-19 containment measures implemented in Ningbo Port were officially lifted on January 14, 2022, 14 days after the measures were first introduced on January 1, 2022. Although Ningbo Port wasn’t completely shut down this time, the COVID-19 containment measures affected productivity within the corresponding area, adding to anxiety over the global supply chain disruption. The relaxation of the lockdown measures in Ningbo Port is good news for logistics and trading companies, giving them a chance to accelerate the shipments before the Chinese New Year. However, according to analysts, whether global port congestion can be alleviated depends ultimately on the situation of European and American ports and the overall market.
  • In the press conference held on January 15, 2022, the National Health Commission (NHC) said that as of January 14, 2022, 1.220584 billion people had been fully vaccinated in China, covering 86.58 percent of the population. 1.263691 billion people have received at least one jab of the vaccine, covering 89.63 percent of the population. According to the NHC, the Omicron outbreak in Tianjin has spread to Anyang (Henan Province) and Dalian (Liaoning Province), but the risk of spillover is decreasing as the people discovered to have COVID-19 in the past three days have already gone into quarantine. The number of newly confirmed cases in Zhengzhou(Henan Province) and Xuchang (Henan Province) keeps decreasing, showing that the outbreaks in these two cities are getting better. The outbreaks in Shanghai, Zhuhai (Guangdong Province), Zhongshan (Guangdong Province), and Hangzhou (Zhejiang Province) are all at a very early stage and need to be monitored closely.
  • Shanghai reported two new domestically transmitted COVID-19 cases and three asymptomatic cases on January 13, 2021. This round of outbreaks was started by an imported asymptomatic case reported on January 11, 2021. The workplace of the individuals with the confirmed cases, which is said to be a milk tea shop, has been designated as a medium-risk area for COVID-19. This might be the smallest medium-risk area in China, indicating the precision of Shanghai’s COVID-19 containment measures. Due to the sharp increase of imported COVID-19 cases, most flights from the United States to Shanghai have been suspended.
  • January 20, 2022 – China reported 66 new confirmed cases, including 23 imported cases (14 cases in Shanghai, 3 cases in Zhejiang, 3 cases in Guangdong, 2 cases in Yunnan, and 1 case in Beijing) and 43 local cases (24 cases in Henan, 14 cases in Tianjin, 3 cases in Beijing, and 2 cases in Guangdong). There were 28 new cases of asymptomatic infection, including 26 imported cases and 2 local cases (all in Guangdong).
  • As of 11:00, January 20, 2022, China recorded 18 high-risk areas (12 cases in Tianjin, 5 areas in Henan, and 1 area in Shaanxi) and 80 medium-risk areas (38 areas in Henan, 26 areas in Tianjin, 8 areas in Guangdong, 5 areas in Shaanxi, 2 areas in Zhejiang, and 1 area in Shanghai).
  • January 19, 2022 – China reported 87 new confirmed cases, including 32 imported cases (15 cases in Shanghai, 5 cases in Beijing, 4 cases in Shandong, 2 cases in Guangdong, 2 cases in Guangxi, 2 cases in Sichuan, 1 case in Fujian, and 1 case in Yunnan) and 55 local cases (33 cases in Henan, 14 cases in Tianjin, 7 cases in Guangdong, and 1 case in Beijing). There were 37 new cases of asymptomatic infection, including 35 imported cases and 2 local cases (1 case in Beijing and 1 case in Guangdong).
  • As of 0:00, January 19, 2022, China recorded 27 high-risk areas (14 cases in Henan, 12 cases in Tianjin, and 1 area in Shaanxi) and 64 medium-risk areas (26 areas in Tianjin, 21 areas in Henan, 8 areas in Guangdong, 6 areas in Shaanxi, 2 areas in Zhejiang, and 1 area in Shanghai).
  • January 18, 2022 – China reported 171 new confirmed cases, including 44 imported cases (17 cases in Shanghai, 13 cases in Guangdong, 4 cases in Yunnan, 3 cases in Beijing, 3 cases in Sichuan, 1 case in Liaoning, 1 case in Fujian, 1 case in Hunan, and 1 case in Guangxi) and 127 local cases (102 cases in Henan, 18 cases in Tianjin, 5 cases in Guangdong, 1 case in Beijing, and 1 case in Shaanxi). There were 33 new cases of asymptomatic infection, including 32 imported cases and 1 local case (in Dalian, Liaoning Province).
  • As of 18:00, January 17, 2022, China recorded 20 high-risk areas (14 cases in Henan, 5 cases in Tianjin, and 1 area in Shaanxi) and 57 medium-risk areas (21 areas in Henan,16 areas in Tianjin, 9 areas in Shaanxi, 8 areas in Guangdong, 2 areas in Zhejiang, and 1 area in Shanghai).
  • January 17, 2022 – China reported 223 new confirmed cases, including 60 imported cases (35 cases in Shanghai, 8 cases in Guangdong, 5 cases in Sichuan, 3 cases in Guangxi, 2 cases in Zhejiang, 2 cases in Yunnan, 1 case in Beijing, 1 case in Liaoning, 1 case in Fujian, 1 case in Shandong, and 1 case in Henan) and 163 local cases (80 cases in Tianjin, 68 cases in Henan, 9 cases in Guangdong, 5 cases in Shaanxi, and 1 case in Guangxi). There were 28 new cases of asymptomatic infection, all of which were imported.
  • As of 15:00, January 16, 2022, China recorded 20 high-risk areas (14 cases in Henan, 5 cases in Tianjin, and 1 area in Shaanxi) and 67 medium-risk areas (23 areas in Henan, 17 areas in Shaanxi, 16 areas in Tianjin, 8 areas in Guangdong, 2 areas in Zhejiang, and 1 area in Shanghai).
  • January 16, 2022 – China reported 119 new confirmed cases, including 54 imported cases (24 cases in Shanghai, 14 cases in Guangdong, 6 cases in Sichuan, 3 cases in Yunnan, 2 cases in Liaoning, 2 cases in Guangxi, 1 case in Beijing, 1 case in Tianjin, and 1 case in Fujian) and 65 local cases (33 cases in Tianjin, 29 cases in Henan, 1 case in Beijing, 1 case in Guangdong, and 1 case in Shaanxi). There were 52 new cases of asymptomatic infection, including 47 imported cases and 5 local cases (3 cases in Shanghai, 1 case in Zhejiang, and 1 case in Guangdong).
  • January 15, 2022 – China reported 165 new confirmed cases, including 61 imported cases (43 cases in Shanghai, 5 cases in Guangdong, 3 cases in Fujian, 3 cases in Shandong, 2 cases in Tianjin, 2 cases in Zhejiang, 2 cases in Yunnan, and 1 case in Liaoning) and 104 local cases (52 cases in Henan, 39 cases in Tianjin, 8 cases in Guangdong, 4 cases in Shaanxi, and 1 case in Zhejiang). There were 25 new cases of asymptomatic infection, including 23 imported cases and 2 local cases (all in Guangdong).
  • January 14, 2022 – China reported 201 new confirmed cases, including 58 imported cases (30 cases in Shanghai, 9 cases in Guangdong, 4 cases in Guangxi, 3 cases in Tianjin, 3 cases in Liaoning, 3 cases in Zhejiang, 3 cases in Fujian, 2 cases in Sichuan, and 1 case in Beijing) and 143 local cases (98 cases in Henan, 34 cases in Tianjin, 8 cases in Shaanxi, 2 cases in Shanghai, and 1 case in Guangdong). There were 42 new cases of asymptomatic infection, including 38 imported cases and 4 local cases (3 cases in Shanghai and 1 case in Tianjin).
  • As of 0:00, January 14, 2022, China recorded 19 high-risk areas (14 cases in Henan, 3 areas in Shaanxi, and 2 cases in Tianjin) and 58 medium-risk areas (23 areas in Shaanxi, 21 areas in Henan, 5 areas in Tianjin, 4 areas in Zhejiang, 4 areas in Guangdong, and 1 area in Shanghai).
  • Ningbo Port update: Several COVID-19 containment measures are in place in Ningbo Port since the first confirmed COVID-19 case was recorded in Beilun District (Ningbo City) on January 1, 2022. The containment measures include closed management of the Port, restrictions on truck movement, and shutting off key traffic lines located in the closed-off area. According to official media, Beilun District has over 20,000 container trucks, but only around 7,600 of them have received the traffic pass as of January 3, 2022 – 38 percent of total trucks. Also, this special pass is only used for point-to-point linear transportation at the ports and highways of Beilun District and cannot be used for transportation business in other areas, such as picking up empty containers at container yards. Even with the pass, when the drivers of the container trucks leave Beilun, they may face the “14+7” management, which means 14 days of closed management operation plus 7 days of home health monitoring. All these will affect the logistics productivity of the Ningbo Port, which could cause or have already caused delays in shipments. As one of the world’s most important ports, any curbs at Ningbo Port may stress the global supply chain, which is still suffering from logjams caused by the pandemic. Nevertheless, analysts think it unlikely that Ningbo Port will be completely shut, as it happened in August 2021. The government is aware of the importance of Ningbo Port in the global supply chain and has gradually issued improved measures to ensure the smooth operation of the Port.
  • In the press conference held on January 8, 2022, the National Health Commission (NHC) said that as of January 7, 2022, 1.215878 billion people have been fully vaccinated in China, covering 86.25 percent of the population. 1.262264 billion people have been administered at least one jab of the vaccine, covering 89.54 percent of the population. Over 472 million doses of the COVID-19 vaccine have been administered to children aged 3-17.
  • According to the NHC, the number of cases in Xi’an City, Shaanxi Province is declining, indicating that the current COVID-19 prevention and control measures are primarily effective. As of 8:00 am, January 8, 2022, there were in total 1,992 confirmed cases reported in this round of outbreak in Xi’an, 47 of which have serious symptoms, accounting for 2.36 percent of the total cases. The outbreak in Henan Province is still developing, with 175 confirmed cases reported in the past few days. Only sporadic cases have been found in Pudong New District of Shanghai, Jinhua City of Zhejiang, and Zhoukou City of Henan, no spread has been reported. There were two new cases reported in Shenzhen, caused by a new imported source according to the sequencing results.
  • The NHC also promised that special treatments will be given to needed groups, including people who have severe diseases, pregnant, newborns, hemodialysis patients, tumor patients with radiotherapy and chemotherapy, and any others who need regular medical treatment and follow-up. This is believed to answer to the recent improper management of similar cases that happened in Xi’an.
  • January 13, 2022 – China reported 190 new confirmed cases, including 66 imported cases (31 cases in Shanghai, 17 cases in Guangdong, 6 cases in Tianjin, 5 cases in Fujian, 4 cases in Zhejiang, 2 cases in Guangxi, and 1 case in Beijing) and 124 local cases (76 cases in Henan, 41 cases in Tianjin, 6 cases in Shaanxi, and 1 case in Guangdong); 31 new cases of asymptomatic infection, including 22 imported cases and 9 local cases (5 cases in Tianjin, 2 cases in Liaoning, 1 case in Shenzhen, and 1 case in Yunnan).
  • As of 0:00, January 13, 2022, China recorded 20 high-risk areas (14 cases in Henan, 3 areas in Shaanxi, and 3 cases in Tianjin) and 66 medium-risk areas (37 areas in Shaanxi, 18 areas in Henan, 5 cases in Tianjin, 4 areas in Zhejiang, and 2 areas in Guangdong).
  • January 12, 2022 – China reported 221 new confirmed cases, including 55 imported cases (20 cases in Shanghai, 20 cases in Guangdong, 4 cases in Tianjin, 4 cases in Fujian, 2 cases in Beijing, 2 cases in Guangxi, 1 case in Jiangsu, 1 case in Zhejiang, and 1 case in Sichuan) and 166 local cases (118 cases in Henan, 33 cases in Tianjin, 8 cases in Shaanxi, and 7 cases in Guangdong); 32 new cases of asymptomatic infection, including 28 imported cases and 4 local cases (3 cases in Tianjin and 1 case in Shenzhen).
  • As of 15:00, January 12, 2022, China recorded 20 high-risk areas (14 cases in Henan, 3 areas in Shaanxi, and 3 cases in Tianjin) and 74 medium-risk areas (45 areas in Shaanxi, 18 areas in Henan, 5 areas in Tianjin, 4 areas in Zhejiang, and 2 areas in Guangdong).
  • January 11, 2022 – China reported 192 new confirmed cases, including 82 imported cases (27 cases in Shanghai, 18 cases in Guangdong, 10 cases in Fujian, 8 cases in Tianjin, 7 cases in Zhejiang, 5 cases in Guangxi, 2 cases in Sichuan, 2 cases in Yunnan, 1 case in Beijing, 1 case in Jiangsu, and 1 case in Henan) and 110 local cases (87 cases in Henan, 13 cases in Shaanxi, and 10 cases in Tianjin); 50 new cases of asymptomatic infection, including 39 imported cases and 11 local cases (all in Tianjin).
  • As of 8:00, January 11, 2022, China recorded 18 high-risk areas (14 cases in Henan, 3 areas in Shaanxi, and 1 case in Tianjin) and 85 medium-risk areas (58 areas in Shaanxi, 14 areas in Henan, 6 areas in Tianjin, 4 areas in Zhejiang, and 2 areas in Guangdong).
  • January 10, 2022 – China reported 157 new confirmed cases, including 60 imported cases (26 cases in Shanghai, 8 cases in Guangdong, 6 cases in Yunnan, 5 cases in Fujian, 4 cases in Tianjin, 3 cases in Zhejiang, 3 cases in Guangxi, 2 cases in Liaoning, 1 case in Henan, 1 case in Hunan, and 1 case in Sichuan) and 97 local cases (60 cases in Henan, 21 cases in Tianjin, 15 cases in Shaanxi, and 1 case in Guangdong); 42 new cases of asymptomatic infection, including 40 imported cases and 2 local cases (all in Tianjin).
  • As of 8:00, January 10, 2022, China recorded 18 high-risk areas (14 cases in Henan, 3 areas in Shaanxi, and 1 case in Tianjin) and 84 medium-risk areas (56 areas in Shaanxi, 17 areas in Henan, 6 areas in Tianjin, 4 areas in Zhejiang, and 2 areas in Guangdong).
  • January 9, 2022 – China reported 165 new confirmed cases, including 73 imported cases (30 cases in Shanghai, 9 cases in Fujian, 8 cases in Guangdong, 8 cases in Sichuan, 7 cases in Zhejiang, 3 cases in Henan, 3 cases in Guangxi, 1 case in Beijing, 1 case in Tianjin, 1 case in Liaoning, 1 case in Shandong, and 1 case in Yunnan) and 92 local cases (56 cases in Henan,30 cases in Shaanxi, 3 cases in Tianjin, 2 cases in Zhejiang, and 1 case in Guangdong); 46 new cases of asymptomatic infection, all of which were imported.
  • January 8, 2022 – China reported 159 new confirmed cases, including 64 imported cases (32 cases in Shanghai, 7 cases in Guangdong, 6 cases in Tianjin, 6 cases in Guangxi, 4 cases in Fujian, 3 cases in Hunan, 3 cases in Yunnan, 1 case in Liaoning, 1 case in Henan, and 1 case in Sichuan) and 95 local cases (46 cases in Shaanxi, 43 cases in Henan, 4 cases in Zhejiang, and 2 cases in Guangdong); 52 new cases of asymptomatic infection, including 46 imported cases and 6 local cases (5 cases in Shanghai and 1 case in Henan).
  • January 7, 2022 – China reported 174 new confirmed cases, including 58 imported cases (24 cases in Shanghai, 9 cases in Tianjin, 9 cases in Guangdong, 4 cases in Guangxi, 2 cases in Liaoning, 2 cases in Henan, 2 cases in Hunan, 1 case in Beijing, 1 case in Zhejiang, 1 case in Fujian, 1 case in Hubei, 1 case in Guangdong, and 1 case in Sichuan) and 116 local cases (57 cases in Shaanxi, 56 cases in Henan, and 3 cases in Zhejiang); 45 new cases of asymptomatic infection, including 42 imported cases and 3 local cases (all in Shanghai).
  • As of 10:00, January 7, 2022, China recorded 16 high-risk areas (12 cases in Henan, 3 areas in Shaanxi, and 1 case in Guangxi) and 81 medium-risk areas (68 areas in Shaanxi, 9 areas in Henan, and 4 areas in Zhejiang).
  • January 6, 2022 – China reported 189 new confirmed cases, including 57 imported cases (20 cases in Shanghai, 10 cases in Guangdong, 7 cases in Zhejiang, 6 cases in Fujian, 4 cases in Tianjin, 2 cases in Guangxi, 2 cases in Sichuan, 2 cases in Yunnan, 1 case in Jilin, 1 case in Jiangsu, 1 case in Shandong, and 1 case in Henan) and 132 local cases (64 cases in Henan, 63 cases in Shaanxi, and 5 cases in Zhejiang); 45 new cases of asymptomatic infection, including 35 imported cases and 10 local cases (9 cases in Henan and 1 case in Zhejiang).
  • As of 0:00, January 6, 2022, China recorded 6 high-risk areas (3 areas in Shaanxi, 2 cases in Henan, and 1 case in Guangxi) and 82 medium-risk areas (71 areas in Shaanxi, 10 areas in Henan, 2 areas in Zhejiang, and 1 area in Yunnan).
  • January 5, 2022 – China reported 91 new confirmed cases, including 50 imported cases (17 cases in Shanghai, 9 cases in Guangxi, 7 cases in Fujian, 7 cases in Guangdong, 5 cases in Tianjin, 2 cases in Hubei, 1 case in Beijing, 1 case in Shandong, and 1 case in Shaanxi) and 41 local cases (35 cases in Shaanxi, 4 cases in Henan, and 2 cases in Zhejiang); 71 new cases of asymptomatic infection, including 49 imported cases and 22 local cases (18 cases in Henan and 4 cases in Shanghai).
  • As of 0:00, January 5, 2022, China recorded 6 high-risk areas (3 areas in Shaanxi, 2 cases in Henan, and 1 case in Guangxi) and 82 medium-risk areas (71 areas in Shaanxi, 8 areas in Henan, 2 areas in Zhejiang, and 1 area in Yunnan).
  • January 4, 2022 – China reported 175 new confirmed cases, including 67 imported cases (29 cases in Shanghai,13 cases in Guangdong, 9 cases in Fujian, 4 cases in Guangxi, 3 cases in Sichuan, 3 cases in Yunnan, 1 case in Tianjin, 1 case in Jiangsu, 1 case in Zhejiang, 1 case in Shandong, 1 case in Henan, and 1 case in Hunan) and 108 local cases (95 cases in Shaanxi, 8 cases in Zhejiang, and 5 cases in Henan); 54 new cases of asymptomatic infection, including 33 imported cases and 21 local cases (19 cases in Henan and 2 cases in Shanghai).
  • Total vaccine dose administered: 2.855 billion (as of January 3, 2022).
  • As of 13:00, January 3, 2022, China recorded 4 high-risk areas (1 area in Guangxi and 3 areas in Shaanxi) and 82 medium-risk areas (72 areas in Shaanxi, 5 areas in Henan, 2 areas in Zhejiang, 1 area in Guangdong, 1 area in Guangxi, and 1 area in Yunnan).
  • January 3, 2022 – China reported 161 new confirmed cases, including 60 imported cases (26 cases in Shanghai, 7 cases in Guangxi, 6 cases in Guangdong, 5 cases in Inner Mongolia, 4 cases in Beijing, 2 cases in Tianjin, 2 cases in Fujian, 2 cases in Henan, 2 cases in Yunnan, 1 case in Zhejiang, 1 case in Shandong, 1 case in Sichuan, and 1 case in Shaanxi) and 101 local cases (92 cases in Shaanxi and 9 cases in Zhejiang); 35 new cases of asymptomatic infection, including 31 imported cases and 4 local cases (3 cases in Henan and 1 case in Shanghai).
  • Total vaccine dose administered: 2.848 billion (as of January 2, 2022).
  • January 2, 2022 – China reported 191 new confirmed cases, including 60 imported cases (18 cases in Shanghai, 10 cases in Guangdong, 9 cases in Fujian, 8 cases in Guangxi, 5 cases in Tianjin, 4 cases in Sichuan, 2 cases in Zhejiang, 2 cases in Shandong, 1 case in Liaoning, and 1 case in Yunnan) and 131 local cases (123 cases in Shaanxi, 7 cases in Zhejiang, and 1 case in Henan); 52 new cases of asymptomatic infection, including 48 imported cases and 4 local cases (all in Henan).
  • Total vaccine dose administered: 2.841 billion (as of January 1, 2022).
  • January 1, 2022 – China reported 231 new confirmed cases, including 29 imported cases (9 cases in Shanghai, 4 cases in Tianjin, 3 cases in Guangdong, 3 cases in Guangxi, 3 cases in Sichuan, 2 cases in Hunan, 2 cases in Yunnan, 1 case in Liaoning, 1 case in Zhejiang, and 1 case in Fujian) and 166 local cases (165 cases in Shaanxi and 1 case in Shanxi); 29 new cases of asymptomatic infection, all of which ere imported cases.
  • Total vaccine dose administered: 2.835 billion (as of December 31, 2021).
  • December 31, 2021 – China reported 195 new confirmed cases, including 56 imported cases (11 cases in Guangdong, 10 cases in Shanghai, 9 cases in Tianjin, 9 cases in Guangxi, 4 cases in Fujian, 4 cases in Hunan, 2 cases in Beijing, 2 cases in Sichuan, 2 cases in Yunnan, 1 case in Liaoning, 1 case in Shandong, and 1 case in Shaanxi) and 175 local cases (174 cases in Shaanxi and 1 case in Guizhou); 38 new cases of asymptomatic infection, including 33 imported cases and 5 local cases (4 cases in Henan and 1 case in Guangdong).
  • Total vaccine dose administered: 2.823 billion (as of December 30, 2021).
  • In the press conference held on December 29, 2021, the National Health Commission (NHC) said that as of December 29, 2021, 1.207413 billion people have been fully vaccinated in China, covering 85.64 percent of the population. 120.58 million people have received booster vaccines. Over 465 million doses of the COVID-19 vaccine have been administered to children aged 3-17.

Managing the impact on your China business

On September 23, 2020, China’s Ministry of Foreign Affair (MFA) released the Announcement on Entry by Foreign Nationals Holding Valid Chinese Residence Permits of Three Categories. From 0 a.m., September 28, 2020, foreigners with valid residence permits for work, personal matters, and reunion, have been allowed enter the country without needing to re-apply for new visas. If the above residence permits expired – after March 28, 2020 – the holders can re-apply for relevant visas by presenting the expired residence permits and relevant materials to the Chinese embassies or consulates. The re-application must be on the condition that the purpose of the holders’ visit to China is unchanged. China had suspended the entry of most foreign nationals from March 28, 2020 as a disease control strategy to contain and eliminate the spread of coronavirus (COVID-19) within its territory. While most businesses in China restarted operations in March, once the COVID spread had slowed down to manageable levels, many employers, especially small business owners, remained under big pressure to sustain operating costs and maintain cash flow due to the impact of the outbreak. At the same time, the global spread of COVID-19, including poorly contained outbreaks in several countries, has necessitated the world’s biggest ever technology experiments to establish new work arrangements as businesses seek to effectively utilize their employees, minimize physical contact, and navigate the temporary international travel bans in place. Throughout the year, businesses across the world have had to make almost real-time decisions to guarantee the very survival of their firms and operational continuity and sustainability, and have adapted to sudden changes based on limited knowledge and/or resources. The decisions, made during the initial recovery period, will now likely become permanent. They include shifts to digitize workflows and customer relationships, reduction of global business exposure and localization strategies, upgrades, upskilling, and retooling of key resources, investments in new technology and areas depending on the shifts in business strategy, and a stronger focus on staff well-being to offset the pressures of living and working amid an ongoing pandemic. Going forward, companies must keep continuous track of their business health and exposure to any new waves of the outbreak, both, in China and across the world. Firms should start planning their 2021 budgets now while keeping in mind the wait for a COVID vaccine. The pandemic has dented economic growth and greatly influenced consumption behavior and the pace of supply-demand recovery, which will affect sales forecasts. Global businesses should check on the viability of receiving shipments on time and make contingency plans if in doubt as well as monitor for market demand and industry trends. Finally, it may not all be bad news. There are always winners and losers during difficult times. Well prepared and managed businesses will survive and ultimately gain market share in the longer term. Now is the time to plan ahead and implement decisions based on the insights gained over the last several months. Strategies may need to be revisited along shorter timelines with shifting goalposts. It is, however, important to establish company bottom lines and communicate these clearly across the organization; risk mitigation strategies are also necessary for the survival and stability of operations. Companies should ensure their China operations are in compliance with local regulations and communications are aligned between HQ and local offices. Meanwhile, if your business needs advice on operational, tax, legal, HR, or technology solutions, please contact our China offices at china@dezshira.com. As companies in China continue to grapple with HR, legal, technology, operational, and tax concerns due to the unprecedented implications of the pandemic, we address how to manage these uncertainties through our rolling coverage of the latest COVID-19 developments and practical advisory on China Briefing. Some of our latest resources are mentioned below for your easy reference:


About Us China Briefing is written and produced by Dezan Shira & Associates. The practice assists foreign investors into China and has done since 1992 through offices in Beijing, Tianjin, Dalian, Qingdao, Shanghai, Hangzhou, Ningbo, Suzhou, Guangzhou, Dongguan, Zhongshan, Shenzhen, and Hong Kong. Please contact the firm for assistance in China at china@dezshira.com We also maintain offices assisting foreign investors in Vietnam, Indonesia, Singapore, The Philippines, Malaysia, and Thailand in addition to our practices in India and Russia and our trade research facilities along the Belt & Road Initiative.